activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	81210	CHEMBL675995	Inhibition of Dual specificity mitogen-activated protein kinase kinase, MEK	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCOCC5)cc4)ccc23)c(Cl)cc1Cl		CHEMBL322395	=	IC50	nM	280.0	CHEMBL3587	Homo sapiens	IC50	nM	280.0
	81210	CHEMBL675995	Inhibition of Dual specificity mitogen-activated protein kinase kinase, MEK	B	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCOCC5)cc4)ccc23)c(Cl)cc1Cl		CHEMBL322395	=	IC50	nM	280.0	CHEMBL3587	Homo sapiens	IC50	nM	280.0
	119267	CHEMBL731421	Inhibition of Mitogen activated protein kinase kinase 1 at 10 uM	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	19.0	CHEMBL3587	Homo sapiens	Inhibition	%	19.0
	133226	CHEMBL731421	Inhibition of Mitogen activated protein kinase kinase 1 at 10 uM	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	5.0	CHEMBL3587	Homo sapiens	Inhibition	%	5.0
	138051	CHEMBL731421	Inhibition of Mitogen activated protein kinase kinase 1 at 10 uM	B	O=C(Nc1n[nH]c2nc(-c3ccccc3)c(Br)cc12)C1CC1		CHEMBL259270	=	Inhibition	%	10.0	CHEMBL3587	Homo sapiens	Inhibition	%	10.0
	144069	CHEMBL731421	Inhibition of Mitogen activated protein kinase kinase 1 at 10 uM	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)ccc12)C1CC1		CHEMBL405145	=	Inhibition	%	12.0	CHEMBL3587	Homo sapiens	Inhibition	%	12.0
	177470	CHEMBL731419	Inhibition of mitogen activated protein kinase kinase 1	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ncc(C(F)(F)F)cc1Cl		CHEMBL111620	=	Activity	%	74.0	CHEMBL3587	Homo sapiens	Activity	%	74.0
	178783	CHEMBL731419	Inhibition of mitogen activated protein kinase kinase 1	B	COCCCn1cc(C2=C(c3ccccc3O)C(=O)NC2=O)c2cccnc21		CHEMBL109944	=	Activity	%	94.0	CHEMBL3587	Homo sapiens	Activity	%	94.0
	182530	CHEMBL731419	Inhibition of mitogen activated protein kinase kinase 1	B	COc1ccccc1C1=C(c2cn(CCCNC(=O)OC(C)(C)C)c3ncccc23)C(=O)NC1=O		CHEMBL109981	=	Activity	%	100.0	CHEMBL3587	Homo sapiens	Activity	%	100.0
	184064	CHEMBL711123	Non-competitive inhibition of the dual specificity kinase MEK at the concentration 10 uM	B	N#CC(=C(/N)Sc1cccc2ccccc12)/C(C#N)=C(\N)Sc1cccc2ccccc12		CHEMBL328538	=	Inhibition	%	26.0	CHEMBL3587	Homo sapiens	Inhibition	%	26.0
	184065	CHEMBL711123	Non-competitive inhibition of the dual specificity kinase MEK at the concentration 10 uM	B	N#CC(=C(/N)Sc1cccc(C(F)(F)F)c1)/C(C#N)=C(\N)Sc1cccc(C(F)(F)F)c1		CHEMBL97732	=	Inhibition	%	32.0	CHEMBL3587	Homo sapiens	Inhibition	%	32.0
	184066	CHEMBL711119	Non-competitive inhibition of the dual specificity kinase MEK	B	N#Cc1c(N)[nH]c(Sc2ccc3ccccc3c2)c1C#N		CHEMBL97724	=	IC50	nM	1400.0	CHEMBL3587	Homo sapiens	IC50	uM	1.4
	185433	CHEMBL711123	Non-competitive inhibition of the dual specificity kinase MEK at the concentration 10 uM	B	N#CC(=C(/N)Sc1ccccc1[N+](=O)[O-])/C(C#N)=C(\N)Sc1ccccc1[N+](=O)[O-]		CHEMBL97071	=	Inhibition	%	41.0	CHEMBL3587	Homo sapiens	Inhibition	%	41.0
	185434	CHEMBL711119	Non-competitive inhibition of the dual specificity kinase MEK	B	N#CC(=C(/N)Sc1ccccc1Cl)/C(C#N)=C(\N)Sc1ccccc1Cl		CHEMBL97406	=	IC50	nM	900.0	CHEMBL3587	Homo sapiens	IC50	uM	0.9
	185436	CHEMBL711123	Non-competitive inhibition of the dual specificity kinase MEK at the concentration 10 uM	B	N#CC(=C(/N)Sc1ccc2ccccc2c1)/C(C#N)=C(\N)Sc1ccc2ccccc2c1		CHEMBL330159	=	Inhibition	%	54.0	CHEMBL3587	Homo sapiens	Inhibition	%	54.0
	186847	CHEMBL711119	Non-competitive inhibition of the dual specificity kinase MEK	B	N#CC(=C(/N)Sc1ccccc1Br)/C(C#N)=C(\N)Sc1ccccc1Br		CHEMBL318939	=	IC50	nM	1100.0	CHEMBL3587	Homo sapiens	IC50	uM	1.1
	188077	CHEMBL711119	Non-competitive inhibition of the dual specificity kinase MEK	B	N#CC(=C(/N)Sc1ccccc1O)/C(C#N)=C(\N)Sc1ccccc1O		CHEMBL95069	=	IC50	nM	300.0	CHEMBL3587	Homo sapiens	IC50	uM	0.3
	188079	CHEMBL711119	Non-competitive inhibition of the dual specificity kinase MEK	B	N#Cc1c(N)[nH]c(Sc2ccccc2N)c1C#N		CHEMBL316536	=	IC50	nM	13500.0	CHEMBL3587	Homo sapiens	IC50	uM	13.5
	189316	CHEMBL711123	Non-competitive inhibition of the dual specificity kinase MEK at the concentration 10 uM	B	N#CC(=C(/N)SCCO)/C(C#N)=C(\N)SCCO		CHEMBL95533	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	Inhibition	%	0.0
	189317	CHEMBL711120	Inhibition of the dual specificity kinase MEK-1	B	N#CC(=C(\N)Sc1ccccc1N)/C(C#N)=C(/N)Sc1ccccc1N		CHEMBL95758	=	IC50	nM	2600.0	CHEMBL3587	Homo sapiens	IC50	uM	2.6
	190481	CHEMBL711121	Inhibition of the dual specificity kinase MEK-1	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	IC50	nM	70.0	CHEMBL3587	Homo sapiens	IC50	uM	0.07
	191733	CHEMBL711123	Non-competitive inhibition of the dual specificity kinase MEK at the concentration 10 uM	B	CC(=O)Nc1ccc(S/C(N)=C(C#N)/C(C#N)=C(\N)Sc2ccc(NC(C)=O)cc2)cc1		CHEMBL98178	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	Inhibition	%	0.0
	191734	CHEMBL711123	Non-competitive inhibition of the dual specificity kinase MEK at the concentration 10 uM	B	COc1ccc(S/C(N)=C(C#N)/C(C#N)=C(\N)Sc2ccc(OC)c(OC)c2)cc1OC		CHEMBL273691	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	Inhibition	%	0.0
	191735	CHEMBL711119	Non-competitive inhibition of the dual specificity kinase MEK	B	N#CC(=C1/Nc2ccccc2S1)/C(C#N)=C1\Nc2ccccc2S1		CHEMBL316510	=	IC50	nM	700.0	CHEMBL3587	Homo sapiens	IC50	uM	0.7
	194031	CHEMBL711123	Non-competitive inhibition of the dual specificity kinase MEK at the concentration 10 uM	B	CCc1ccccc1S/C(N)=C(C#N)/C(C#N)=C(\N)Sc1ccccc1CC		CHEMBL95401	=	Inhibition	%	18.0	CHEMBL3587	Homo sapiens	Inhibition	%	18.0
	194032	CHEMBL711119	Non-competitive inhibition of the dual specificity kinase MEK	B	N#CC(=C(/N)Sc1cccs1)/C(C#N)=C(\N)Sc1cccs1		CHEMBL329492	=	IC50	nM	300.0	CHEMBL3587	Homo sapiens	IC50	uM	0.3
	195157	CHEMBL711119	Non-competitive inhibition of the dual specificity kinase MEK	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C1\Nc2ccccc2S1		CHEMBL95905	=	IC50	nM	3200.0	CHEMBL3587	Homo sapiens	IC50	uM	3.2
Not Active	196315	CHEMBL711122	Inhibition of the dual specificity kinase MEK-1 (Inactive)	B	CN1/C(=C(C#N)\C(C#N)=C2\Sc3ccccc3N2C)Sc2ccccc21		CHEMBL100050		IC50	nM		CHEMBL3587	Homo sapiens	IC50	uM	
Not Active	197398	CHEMBL711122	Inhibition of the dual specificity kinase MEK-1 (Inactive)	B	N#Cc1c(C#N)c2sc3ccccc3n2c1Sc1ccccc1N		CHEMBL316660		IC50	nM		CHEMBL3587	Homo sapiens	IC50	uM	
	197417	CHEMBL711119	Non-competitive inhibition of the dual specificity kinase MEK	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(/N)Sc1ccccc1N		CHEMBL100473	=	IC50	nM	500.0	CHEMBL3587	Homo sapiens	IC50	uM	0.5
	198567	CHEMBL711119	Non-competitive inhibition of the dual specificity kinase MEK	B	N#CC(=C(/N)Sc1ccc(Cl)cc1)/C(C#N)=C(\N)Sc1ccc(Cl)cc1		CHEMBL95728	=	IC50	nM	2100.0	CHEMBL3587	Homo sapiens	IC50	uM	2.1
	198569	CHEMBL711123	Non-competitive inhibition of the dual specificity kinase MEK at the concentration 10 uM	B	N#CC(=C(/N)Sc1ccccc1-c1ccccc1)/C(C#N)=C(\N)Sc1ccccc1-c1ccccc1		CHEMBL99619	=	Inhibition	%	8.7	CHEMBL3587	Homo sapiens	Inhibition	%	8.7
	199850	CHEMBL711123	Non-competitive inhibition of the dual specificity kinase MEK at the concentration 10 uM	B	N#CC(=C(/N)Sc1cc(I)ccc1N)/C(C#N)=C(\N)Sc1cc(I)ccc1N		CHEMBL95350	=	Inhibition	%	34.8	CHEMBL3587	Homo sapiens	Inhibition	%	34.8
	201167	CHEMBL711119	Non-competitive inhibition of the dual specificity kinase MEK	B	N#CC(=C(/N)Sc1cccc(Cl)c1)/C(C#N)=C(\N)Sc1cccc(Cl)c1		CHEMBL94565	=	IC50	nM	1900.0	CHEMBL3587	Homo sapiens	IC50	uM	1.9
	201169	CHEMBL711123	Non-competitive inhibition of the dual specificity kinase MEK at the concentration 10 uM	B	N#CC(=C(/N)Sc1cccc(-c2ccccc2)c1)/C(C#N)=C(\N)Sc1cccc(-c2ccccc2)c1		CHEMBL95705	=	Inhibition	%	54.6	CHEMBL3587	Homo sapiens	Inhibition	%	54.6
	202346	CHEMBL711119	Non-competitive inhibition of the dual specificity kinase MEK	B	N#CC(=C(/N)Sc1ccc(O)cc1)/C(C#N)=C(\N)Sc1ccc(O)cc1		CHEMBL94971	=	IC50	nM	400.0	CHEMBL3587	Homo sapiens	IC50	uM	0.4
	202347	CHEMBL711119	Non-competitive inhibition of the dual specificity kinase MEK	B	Cc1ccccc1S/C(N)=C(C#N)/C(C#N)=C(\N)Sc1ccccc1C		CHEMBL95400	=	IC50	nM	2000.0	CHEMBL3587	Homo sapiens	IC50	uM	2.0
	205968	CHEMBL711119	Non-competitive inhibition of the dual specificity kinase MEK	B	N#Cc1c(Sc2ccc3ccccc3c2)[nH]c(Sc2ccc3ccccc3c2)c1C#N		CHEMBL330195	=	IC50	nM	2100.0	CHEMBL3587	Homo sapiens	IC50	uM	2.1
	209433	CHEMBL711123	Non-competitive inhibition of the dual specificity kinase MEK at the concentration 10 uM	B	N#CC(=C(/N)Sc1ccccc1CO)/C(C#N)=C(\N)Sc1ccccc1CO		CHEMBL95696	=	Inhibition	%	51.0	CHEMBL3587	Homo sapiens	Inhibition	%	51.0
	209434	CHEMBL711123	Non-competitive inhibition of the dual specificity kinase MEK at the concentration 10 uM	B	CS/C(N)=C(C#N)/C(C#N)=C(\N)SC		CHEMBL97858	=	Inhibition	%	24.0	CHEMBL3587	Homo sapiens	Inhibition	%	24.0
	210600	CHEMBL711123	Non-competitive inhibition of the dual specificity kinase MEK at the concentration 10 uM	B	CNc1ccccc1S/C(N)=C(C#N)/C(C#N)=C(\N)Sc1ccccc1NC		CHEMBL98351	=	Inhibition	%	19.1	CHEMBL3587	Homo sapiens	Inhibition	%	19.1
	211839	CHEMBL711119	Non-competitive inhibition of the dual specificity kinase MEK	B	N#CC(=C(/N)Sc1ccccc1F)/C(C#N)=C(\N)Sc1ccccc1F		CHEMBL330393	=	IC50	nM	900.0	CHEMBL3587	Homo sapiens	IC50	uM	0.9
	211841	CHEMBL711119	Non-competitive inhibition of the dual specificity kinase MEK	B	N#CC(=C(/N)Sc1c(Cl)cccc1Cl)/C(C#N)=C(\N)Sc1c(Cl)cccc1Cl		CHEMBL97067	=	IC50	nM	2800.0	CHEMBL3587	Homo sapiens	IC50	uM	2.8
	211843	CHEMBL711119	Non-competitive inhibition of the dual specificity kinase MEK	B	N#Cc1c(NS(=O)(=O)c2ccccc2)[nH]c(Sc2ccc3ccccc3c2)c1C#N		CHEMBL316635	=	IC50	nM	1900.0	CHEMBL3587	Homo sapiens	IC50	uM	1.9
	215302	CHEMBL711123	Non-competitive inhibition of the dual specificity kinase MEK at the concentration 10 uM	B	N#CC(=C(/N)Sc1ccc(-c2ccccc2)cc1)/C(C#N)=C(\N)Sc1ccc(-c2ccccc2)cc1		CHEMBL95950	=	Inhibition	%	34.0	CHEMBL3587	Homo sapiens	Inhibition	%	34.0
	215303	CHEMBL711123	Non-competitive inhibition of the dual specificity kinase MEK at the concentration 10 uM	B	N#CC(=C(/N)Sc1c(F)c(F)c(F)c(F)c1F)/C(C#N)=C(\N)Sc1c(F)c(F)c(F)c(F)c1F		CHEMBL97035	=	Inhibition	%	17.0	CHEMBL3587	Homo sapiens	Inhibition	%	17.0
	216487	CHEMBL711119	Non-competitive inhibition of the dual specificity kinase MEK	B	N#CC(=C(/N)Sc1ccc(N)cc1)/C(C#N)=C(\N)Sc1ccc(N)cc1		CHEMBL317720	=	IC50	nM	500.0	CHEMBL3587	Homo sapiens	IC50	uM	0.5
	217709	CHEMBL711119	Non-competitive inhibition of the dual specificity kinase MEK	B	N#CC(=C(/N)Sc1ccccc1)/C(C#N)=C(\N)Sc1ccccc1		CHEMBL329698	=	IC50	nM	900.0	CHEMBL3587	Homo sapiens	IC50	uM	0.9
	217711	CHEMBL711119	Non-competitive inhibition of the dual specificity kinase MEK	B	COc1ccccc1S/C(N)=C(C#N)/C(C#N)=C(\N)Sc1ccccc1OC		CHEMBL97586	=	IC50	nM	4500.0	CHEMBL3587	Homo sapiens	IC50	uM	4.5
Not Active	218919	CHEMBL711122	Inhibition of the dual specificity kinase MEK-1 (Inactive)	B	CC(=O)Nc1ccccc1Sc1c(C#N)c(C#N)c2sc3ccccc3n12		CHEMBL329951		IC50	nM		CHEMBL3587	Homo sapiens	IC50	uM	
	221352	CHEMBL711119	Non-competitive inhibition of the dual specificity kinase MEK	B	N#CC(=C(/N)Sc1cccc(N)c1)/C(C#N)=C(\N)Sc1cccc(N)c1		CHEMBL97205	=	IC50	nM	4800.0	CHEMBL3587	Homo sapiens	IC50	uM	4.8
	221354	CHEMBL711119	Non-competitive inhibition of the dual specificity kinase MEK	B	N#CC(=C(/N)Sc1ccc2ccccc2c1N)/C(C#N)=C(\N)Sc1ccc2ccccc2c1N		CHEMBL95057	=	IC50	nM	2100.0	CHEMBL3587	Homo sapiens	IC50	uM	2.1
	221355	CHEMBL711123	Non-competitive inhibition of the dual specificity kinase MEK at the concentration 10 uM	B	N#CC(=C(/N)Sc1ccc(C(F)(F)F)cc1)/C(C#N)=C(\N)Sc1ccc(C(F)(F)F)cc1		CHEMBL418962	=	Inhibition	%	33.0	CHEMBL3587	Homo sapiens	Inhibition	%	33.0
	221356	CHEMBL711123	Non-competitive inhibition of the dual specificity kinase MEK at the concentration 10 uM	B	COc1ccc(OC)c(S/C(N)=C(C#N)/C(C#N)=C(\N)Sc2cc(OC)ccc2OC)c1		CHEMBL94347	=	Inhibition	%	18.0	CHEMBL3587	Homo sapiens	Inhibition	%	18.0
Not Determined	310564	CHEMBL731426	Inhibition of MEK1 phosphorylation by activated human recombinant Raf (Not tested)	B	CSCC[C@H](NC(=O)c1ccc(NC[C@@H](N)CS)cc1-c1ccccc1)C(=O)O		CHEMBL54044		NT			CHEMBL3587	Homo sapiens	NT		
	315772	CHEMBL731425	Inhibition of MEK1 phosphorylation by activated human recombinant Raf	B	Nc1ncc(/C=C/CNC(=O)c2cc(Br)c(Br)[nH]2)[nH]1		CHEMBL397591	=	IC50	nM	2500.0	CHEMBL3587	Homo sapiens	IC50	nM	2500.0
	315777	CHEMBL731425	Inhibition of MEK1 phosphorylation by activated human recombinant Raf	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	nM	10000.0
	317027	CHEMBL731425	Inhibition of MEK1 phosphorylation by activated human recombinant Raf	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	2.5	CHEMBL3587	Homo sapiens	IC50	nM	2.5
	321904	CHEMBL731425	Inhibition of MEK1 phosphorylation by activated human recombinant Raf	B	NC(=O)c1cc(Br)c(Br)[nH]1		CHEMBL356164	=	IC50	nM	2500.0	CHEMBL3587	Homo sapiens	IC50	nM	2500.0
	324471	CHEMBL731425	Inhibition of MEK1 phosphorylation by activated human recombinant Raf	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1		CHEMBL361708	=	IC50	nM	2500.0	CHEMBL3587	Homo sapiens	IC50	nM	2500.0
	325611	CHEMBL731425	Inhibition of MEK1 phosphorylation by activated human recombinant Raf	B	NC1=N/C(=C2/CCNC(=O)c3[nH]ccc32)C(=O)N1		CHEMBL255465	=	IC50	nM	2500.0	CHEMBL3587	Homo sapiens	IC50	nM	2500.0
	326820	CHEMBL731425	Inhibition of MEK1 phosphorylation by activated human recombinant Raf	B	Nc1nc(C2CCNC(=O)c3[nH]c(Br)c(Br)c32)c[nH]1		CHEMBL151430	=	IC50	nM	2500.0	CHEMBL3587	Homo sapiens	IC50	nM	2500.0
	328412	CHEMBL731425	Inhibition of MEK1 phosphorylation by activated human recombinant Raf	B	O=C1CCNC(=O)c2[nH]ccc21		CHEMBL357047	=	IC50	nM	2500.0	CHEMBL3587	Homo sapiens	IC50	nM	2500.0
	329635	CHEMBL731425	Inhibition of MEK1 phosphorylation by activated human recombinant Raf	B	O=C1CCNC(=O)c2[nH]c(Br)cc21		CHEMBL440356	=	IC50	nM	2500.0	CHEMBL3587	Homo sapiens	IC50	nM	2500.0
	341394	CHEMBL731425	Inhibition of MEK1 phosphorylation by activated human recombinant Raf	B	NC1=N/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)C(=O)N1		CHEMBL359106	=	IC50	nM	2500.0	CHEMBL3587	Homo sapiens	IC50	nM	2500.0
	430442	CHEMBL708518	Inhibition of MAPKK	B	COc1ccc(Oc2ccnc3cc(OC)c(OC)cc23)cc1OC		CHEMBL327300	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	431882	CHEMBL710957	Inhibition of ERK-phosphorylation by MEK-ERK in direct ELISA	B	COc1ccc2c(Nc3ccc(Oc4ccccc4)cc3)c(C#N)cnc2c1		CHEMBL98131	=	IC50	nM	125.0	CHEMBL3587	Homo sapiens	IC50	nM	125.0
	435747	CHEMBL710957	Inhibition of ERK-phosphorylation by MEK-ERK in direct ELISA	B	COc1cc2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL31733	=	IC50	nM	30.0	CHEMBL3587	Homo sapiens	IC50	nM	30.0
	437008	CHEMBL710957	Inhibition of ERK-phosphorylation by MEK-ERK in direct ELISA	B	COc1cc2c(Nc3ccc(Oc4ccccc4)cc3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL414139	=	IC50	nM	7.0	CHEMBL3587	Homo sapiens	IC50	nM	7.0
	443651	CHEMBL710957	Inhibition of ERK-phosphorylation by MEK-ERK in direct ELISA	B	COc1cc2ncc(C#N)c(Nc3cccc(Oc4ccccc4)c3)c2cc1OC		CHEMBL30763	=	IC50	nM	100.0	CHEMBL3587	Homo sapiens	IC50	nM	100.0
	446449	CHEMBL710957	Inhibition of ERK-phosphorylation by MEK-ERK in direct ELISA	B	COc1cc(OC)c2c(Nc3ccc(Oc4ccccc4)cc3)c(C#N)cnc2c1		CHEMBL97463	=	IC50	nM	185.0	CHEMBL3587	Homo sapiens	IC50	nM	185.0
	449023	CHEMBL710957	Inhibition of ERK-phosphorylation by MEK-ERK in direct ELISA	B	COc1cccc2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c12		CHEMBL330388	=	IC50	nM	450.0	CHEMBL3587	Homo sapiens	IC50	nM	450.0
	451621	CHEMBL710957	Inhibition of ERK-phosphorylation by MEK-ERK in direct ELISA	B	COc1cccc2c(Nc3ccc(Oc4ccccc4)cc3)c(C#N)cnc12		CHEMBL94956	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	nM	10000.0
	451623	CHEMBL710957	Inhibition of ERK-phosphorylation by MEK-ERK in direct ELISA	B	COc1cc2c(Nc3ccc(Oc4ccccc4)cc3)c(C#N)cnc2c(OC)c1OC		CHEMBL419333	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	nM	10000.0
	452950	CHEMBL710957	Inhibition of ERK-phosphorylation by MEK-ERK in direct ELISA	B	COc1cc2ncc(C#N)c(Nc3ccccc3Oc3ccccc3)c2cc1OC		CHEMBL286244	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	nM	10000.0
	455637	CHEMBL710957	Inhibition of ERK-phosphorylation by MEK-ERK in direct ELISA	B	COc1ccc(OC)c2c(Nc3ccc(Oc4ccccc4)cc3)c(C#N)cnc12		CHEMBL94586	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	nM	10000.0
	458354	CHEMBL710957	Inhibition of ERK-phosphorylation by MEK-ERK in direct ELISA	B	COc1cc2c(Nc3ccc(Oc4ccccc4)cc3)c(C#N)cnc2cc1OCCN1CCOCC1		CHEMBL95002	=	IC50	nM	25.0	CHEMBL3587	Homo sapiens	IC50	nM	25.0
	460789	CHEMBL710957	Inhibition of ERK-phosphorylation by MEK-ERK in direct ELISA	B	N#Cc1cnc2ccccc2c1Nc1ccc(Oc2ccccc2)cc1		CHEMBL98130	=	IC50	nM	680.0	CHEMBL3587	Homo sapiens	IC50	nM	680.0
	465923	CHEMBL710957	Inhibition of ERK-phosphorylation by MEK-ERK in direct ELISA	B	N#Cc1cnc2cc(OCCCN3CCOCC3)ccc2c1Nc1ccc(Oc2ccccc2)cc1		CHEMBL94965	=	IC50	nM	68.0	CHEMBL3587	Homo sapiens	IC50	nM	68.0
	467246	CHEMBL710957	Inhibition of ERK-phosphorylation by MEK-ERK in direct ELISA	B	COc1ccc2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL97714	=	IC50	nM	35.0	CHEMBL3587	Homo sapiens	IC50	nM	35.0
	478719	CHEMBL734032	Inhibitory concentration against Mitogen activated protein kinase kinase kinase 1 was determined using Raf/MEK1 coupled assay	B	COc1cc2c(Nc3ccc(Cc4nccn4C)c(Cl)c3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL320688	=	IC50	nM	212.0	CHEMBL3587	Homo sapiens	IC50	nM	212.0
	479863	CHEMBL734032	Inhibitory concentration against Mitogen activated protein kinase kinase kinase 1 was determined using Raf/MEK1 coupled assay	B	COc1cc2c(Nc3ccc(Sc4nccn4C)c(Cl)c3)c(C#N)cnc2cc1OCCCN1CC[S+]([O-])CC1		CHEMBL105642	=	IC50	nM	2.0	CHEMBL3587	Homo sapiens	IC50	nM	2.0
	481201	CHEMBL734032	Inhibitory concentration against Mitogen activated protein kinase kinase kinase 1 was determined using Raf/MEK1 coupled assay	B	COc1cc2c(Nc3ccc(Sc4ccccn4)c(Cl)c3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL318326	=	IC50	nM	8.0	CHEMBL3587	Homo sapiens	IC50	nM	8.0
	483684	CHEMBL734032	Inhibitory concentration against Mitogen activated protein kinase kinase kinase 1 was determined using Raf/MEK1 coupled assay	B	COc1cc2c(Nc3ccc(Sc4nccn4C)c(Br)c3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL105220	=	IC50	nM	2.0	CHEMBL3587	Homo sapiens	IC50	nM	2.0
	484894	CHEMBL734032	Inhibitory concentration against Mitogen activated protein kinase kinase kinase 1 was determined using Raf/MEK1 coupled assay	B	CCN1CCN(CCCOc2cc3ncc(C#N)c(Nc4ccc(Sc5nccn5C)c(Cl)c4)c3cc2OC)CC1		CHEMBL103045	=	IC50	nM	3.0	CHEMBL3587	Homo sapiens	IC50	nM	3.0
	489445	CHEMBL734032	Inhibitory concentration against Mitogen activated protein kinase kinase kinase 1 was determined using Raf/MEK1 coupled assay	B	COc1cc2c(Nc3ccc(Sc4ncc(C)n4C)c(Cl)c3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL106489	=	IC50	nM	1.0	CHEMBL3587	Homo sapiens	IC50	nM	1.0
	491913	CHEMBL734032	Inhibitory concentration against Mitogen activated protein kinase kinase kinase 1 was determined using Raf/MEK1 coupled assay	B	COc1cc2c(Nc3ccc(Oc4ccccc4)cc3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL414139	=	IC50	nM	4.0	CHEMBL3587	Homo sapiens	IC50	nM	4.0
	491916	CHEMBL709033	Inhibition of MEK1 phosphorylation in LoVo cells	F	COc1cc2c(Nc3ccc(Oc4ccccc4)cc3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL414139	>	IC50	nM	1000.0	CHEMBL3587	Homo sapiens	IC50	nM	1000.0
	497545	CHEMBL734032	Inhibitory concentration against Mitogen activated protein kinase kinase kinase 1 was determined using Raf/MEK1 coupled assay	B	COc1cc2c(Nc3ccc(Sc4nc(C)c(C)n4C)c(Cl)c3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL102374	=	IC50	nM	2.0	CHEMBL3587	Homo sapiens	IC50	nM	2.0
	500054	CHEMBL734032	Inhibitory concentration against Mitogen activated protein kinase kinase kinase 1 was determined using Raf/MEK1 coupled assay	B	COc1cc2c(Nc3ccc(Sc4nccn4C)c(C)c3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL321078	=	IC50	nM	28.0	CHEMBL3587	Homo sapiens	IC50	nM	28.0
	504935	CHEMBL734032	Inhibitory concentration against Mitogen activated protein kinase kinase kinase 1 was determined using Raf/MEK1 coupled assay	B	COc1cc2c(Nc3ccc(Sc4nccs4)c(Cl)c3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL102786	=	IC50	nM	9.0	CHEMBL3587	Homo sapiens	IC50	nM	9.0
	507374	CHEMBL734032	Inhibitory concentration against Mitogen activated protein kinase kinase kinase 1 was determined using Raf/MEK1 coupled assay	B	COc1cc2c(Nc3ccc(Sc4nccn4C)c(Cl)c3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL318804	=	IC50	nM	2.0	CHEMBL3587	Homo sapiens	IC50	nM	2.0
	507377	CHEMBL709033	Inhibition of MEK1 phosphorylation in LoVo cells	F	COc1cc2c(Nc3ccc(Sc4nccn4C)c(Cl)c3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL318804	=	IC50	nM	8.0	CHEMBL3587	Homo sapiens	IC50	nM	8.0
	507383	CHEMBL734032	Inhibitory concentration against Mitogen activated protein kinase kinase kinase 1 was determined using Raf/MEK1 coupled assay	B	COc1cc2c(Nc3ccc(Sc4nccn4C)c(Cl)c3)c(C#N)cnc2cc1OCCCN1CCCC1		CHEMBL323515	=	IC50	nM	4.0	CHEMBL3587	Homo sapiens	IC50	nM	4.0
	509916	CHEMBL734032	Inhibitory concentration against Mitogen activated protein kinase kinase kinase 1 was determined using Raf/MEK1 coupled assay	B	CCOc1cc2ncc(C#N)c(Nc3ccc(Sc4nccn4C)c(Cl)c3)c2cc1OCC		CHEMBL321045	=	IC50	nM	10.0	CHEMBL3587	Homo sapiens	IC50	nM	10.0
	511003	CHEMBL734032	Inhibitory concentration against Mitogen activated protein kinase kinase kinase 1 was determined using Raf/MEK1 coupled assay	B	COc1cc2c(Nc3ccc(Sc4nccn4C)cc3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL322857	=	IC50	nM	5.0	CHEMBL3587	Homo sapiens	IC50	nM	5.0
	511006	CHEMBL734032	Inhibitory concentration against Mitogen activated protein kinase kinase kinase 1 was determined using Raf/MEK1 coupled assay	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	=	IC50	nM	2.0	CHEMBL3587	Homo sapiens	IC50	nM	2.0
	554896	CHEMBL734033	Inhibition of MEK1 in presence of 10 uM ATP	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Inhibition	%	9.0	CHEMBL3587	Homo sapiens	Inhibition	%	9.0
	559740	CHEMBL734034	Inhibition of MEK1 in presence of 10 uM ATP	B	CCCC(=O)Nc1n[nH]c2nnc(-c3ccccc3)cc12		CHEMBL288143	=	Inhibition	%	5.0	CHEMBL3587	Homo sapiens	Inhibition	%	5.0
	572983	CHEMBL734034	Inhibition of MEK1 in presence of 10 uM ATP	B	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3ccccc3)cc12		CHEMBL259744	=	Inhibition	%	9.0	CHEMBL3587	Homo sapiens	Inhibition	%	9.0
	586374	CHEMBL734033	Inhibition of MEK1 in presence of 10 uM ATP	B	CCCC(=O)Nc1n[nH]c2ncc(-c3ccccc3)cc12		CHEMBL258701	=	Inhibition	%	10.0	CHEMBL3587	Homo sapiens	Inhibition	%	10.0
	590212	CHEMBL734035	Inhibition of MEK1 in presence of 10 uM ATP	B	CCCC(=O)Nc1n[nH]c2ncc(-c3ccccc3F)cc12		CHEMBL407373	=	Inhibition	%	7.0	CHEMBL3587	Homo sapiens	Inhibition	%	7.0
	616523	CHEMBL734037	Inhibition of Mitogen activated protein kinase kinase kinase 1 at 100 nM	B	Cn1ccc2ccc3c4[nH]c5c(CCCN[C@H]6CC[C@H](O)CC6)cccc5c4c4c(c3c21)C(=O)NC4=O		CHEMBL307152	=	Control	%	95.0	CHEMBL3587	Homo sapiens	Control	%	95.0
	616562	CHEMBL729498	Inhibition of Mitogen activated protein kinase kinase kinase 1 at 500 nM	B	Cn1ccc2ccc3c4[nH]c5c(CCCN[C@H]6CC[C@H](O)CC6)cccc5c4c4c(c3c21)C(=O)NC4=O		CHEMBL307152	=	Control	%	87.0	CHEMBL3587	Homo sapiens	Control	%	87.0
	897807	CHEMBL731428	Inhibition of Mitogen activated protein kinase kinase 1	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	IC50	nM	1000.0	CHEMBL3587	Homo sapiens	IC50	uM	1.0
	989305	CHEMBL731427	Inhibition of Mitogen activated protein kinase kinase 1 (MKK1)	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	IC50	nM	13000.0	CHEMBL3587	Homo sapiens	IC50	uM	13.0
	1006300	CHEMBL734031	Inhibition of mitogen activated protein kinase kinase 1	B	O=C(Nc1ccccn1)Nc1cccc2c1[C@H]1CCCN1C2=O		CHEMBL141247	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	1021689	CHEMBL731427	Inhibition of Mitogen activated protein kinase kinase 1 (MKK1)	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	IC50	nM	2000.0	CHEMBL3587	Homo sapiens	IC50	uM	2.0
	1034882	CHEMBL731424	Inhibition of Mitogen activated protein kinase kinase 1 at 10 uM	B	COc1ccc(C2=C(Nc3cccc(Cl)c3)C(=O)NC2=O)cc1		CHEMBL158208	=	Inhibition	%	5.0	CHEMBL3587	Homo sapiens	Inhibition	%	5.0
	1036277	CHEMBL731424	Inhibition of Mitogen activated protein kinase kinase 1 at 10 uM	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Inhibition	%	12.0	CHEMBL3587	Homo sapiens	Inhibition	%	12.0
	1048343	CHEMBL731424	Inhibition of Mitogen activated protein kinase kinase 1 at 10 uM	B	COc1ccccc1C1=C(N2CCc3ccccc32)C(=O)NC1=O		CHEMBL160585	=	Inhibition	%	6.0	CHEMBL3587	Homo sapiens	Inhibition	%	6.0
	1055589	CHEMBL731424	Inhibition of Mitogen activated protein kinase kinase 1 at 10 uM	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160586	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	Inhibition	%	0.0
	1058275	CHEMBL731424	Inhibition of Mitogen activated protein kinase kinase 1 at 10 uM	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156379	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	Inhibition	%	0.0
	1066389	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccccc1N)c1ccc(C(=O)c2ccccc2)cc1		CHEMBL37548	=	IC50	nM	540.0	CHEMBL3587	Homo sapiens	IC50	uM	0.54
	1066856	CHEMBL672143	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using coupled MEK assay (which uses activated Raf to activate an inactivate GST-MEK)	B	COc1cc2ncc(C#N)c(Nc3ccc(Cc4ccccc4)cc3)c2cc1OC		CHEMBL31806	=	IC50	nM	3.6	CHEMBL3587	Homo sapiens	IC50	uM	0.0036
	1066857	CHEMBL675993	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using direct MEK assay (which by-passes the need for activated Raf by using an activated GST-MEK)	B	COc1cc2ncc(C#N)c(Nc3ccc(Cc4ccccc4)cc3)c2cc1OC		CHEMBL31806	=	IC50	nM	36.0	CHEMBL3587	Homo sapiens	IC50	uM	0.036
	1067538	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccccc1N)c1cccc(C(O)c2ccc(C(F)(F)F)cc2)c1		CHEMBL38184	=	IC50	nM	57.0	CHEMBL3587	Homo sapiens	IC50	uM	0.057
	1068068	CHEMBL672143	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using coupled MEK assay (which uses activated Raf to activate an inactivate GST-MEK)	B	COc1cc2c(Nc3ccc(Cc4ccccc4)cc3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL30728	=	IC50	nM	2.7	CHEMBL3587	Homo sapiens	IC50	uM	0.0027
	1068069	CHEMBL675993	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using direct MEK assay (which by-passes the need for activated Raf by using an activated GST-MEK)	B	COc1cc2c(Nc3ccc(Cc4ccccc4)cc3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL30728	=	IC50	nM	14.0	CHEMBL3587	Homo sapiens	IC50	uM	0.014
	1068837	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccccc1N)c1cccc(C(O)c2cccc(C(F)(F)F)c2)c1		CHEMBL38260	=	IC50	nM	53.0	CHEMBL3587	Homo sapiens	IC50	uM	0.053
	1070156	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccccc1N)c1cccc(C(O)Cc2ccccc2)c1		CHEMBL34436	=	IC50	nM	170.0	CHEMBL3587	Homo sapiens	IC50	uM	0.17
	1070158	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccccc1N)c1cccc(C(O)c2cccc([N+](=O)[O-])c2)c1		CHEMBL417687	=	IC50	nM	17.0	CHEMBL3587	Homo sapiens	IC50	uM	0.017
	1070160	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccccc1N)c1cccc(C(O)c2ccc([N+](=O)[O-])cc2[N+](=O)[O-])c1		CHEMBL34184	=	IC50	nM	8.0	CHEMBL3587	Homo sapiens	IC50	uM	0.008
	1070565	CHEMBL672143	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using coupled MEK assay (which uses activated Raf to activate an inactivate GST-MEK)	B	COc1cc2c(Nc3ccc(Oc4ccncc4)cc3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL31497	=	IC50	nM	26.0	CHEMBL3587	Homo sapiens	IC50	uM	0.026
	1070566	CHEMBL675993	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using direct MEK assay (which by-passes the need for activated Raf by using an activated GST-MEK)	B	COc1cc2c(Nc3ccc(Oc4ccncc4)cc3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL31497	=	IC50	nM	81.0	CHEMBL3587	Homo sapiens	IC50	uM	0.081
	1071222	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccccc1N)c1cccc(C(O)(c2ccccc2)c2ccccc2)c1		CHEMBL35019	=	IC50	nM	2220.0	CHEMBL3587	Homo sapiens	IC50	uM	2.22
	1071584	CHEMBL672143	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using coupled MEK assay (which uses activated Raf to activate an inactivate GST-MEK)	B	COc1cc2c(Nc3ccc(Oc4ccccc4)cc3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL414139	=	IC50	nM	2.4	CHEMBL3587	Homo sapiens	IC50	uM	0.0024
	1071585	CHEMBL675993	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using direct MEK assay (which by-passes the need for activated Raf by using an activated GST-MEK)	B	COc1cc2c(Nc3ccc(Oc4ccccc4)cc3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL414139	=	IC50	nM	7.0	CHEMBL3587	Homo sapiens	IC50	uM	0.007
	1072676	CHEMBL672143	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using coupled MEK assay (which uses activated Raf to activate an inactivate GST-MEK)	B	COc1cc2c(Nc3ccc(Cc4ccsc4)cc3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL30359	=	IC50	nM	4.2	CHEMBL3587	Homo sapiens	IC50	uM	0.0042
	1072677	CHEMBL675993	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using direct MEK assay (which by-passes the need for activated Raf by using an activated GST-MEK)	B	COc1cc2c(Nc3ccc(Cc4ccsc4)cc3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL30359	=	IC50	nM	23.0	CHEMBL3587	Homo sapiens	IC50	uM	0.023
	1073435	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccccc1N)c1ccc(Oc2ccccc2)cc1		CHEMBL37646	=	IC50	nM	930.0	CHEMBL3587	Homo sapiens	IC50	uM	0.93
	1073436	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccccc1N)c1cccc(C(O)c2ccc(-c3nnn(C(c4ccccc4)(c4ccccc4)c4ccccc4)n3)cc2)c1		CHEMBL430731	=	IC50	nM	255.0	CHEMBL3587	Homo sapiens	IC50	uM	0.255
	1075932	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	CC(O)c1cccc(/C(C#N)=C(\N)Sc2ccccc2N)c1		CHEMBL35988	=	IC50	nM	183.0	CHEMBL3587	Homo sapiens	IC50	uM	0.183
	1075934	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccccc1N)c1cccc(C(O)c2ccc(C#N)cc2)c1		CHEMBL288349	=	IC50	nM	7.0	CHEMBL3587	Homo sapiens	IC50	uM	0.007
	1076333	CHEMBL672143	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using coupled MEK assay (which uses activated Raf to activate an inactivate GST-MEK)	B	COc1cc2c(Nc3ccc(OC4CCCCC4)cc3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL31149	=	IC50	nM	110.0	CHEMBL3587	Homo sapiens	IC50	uM	0.11
	1076334	CHEMBL675993	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using direct MEK assay (which by-passes the need for activated Raf by using an activated GST-MEK)	B	COc1cc2c(Nc3ccc(OC4CCCCC4)cc3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL31149	=	IC50	nM	320.0	CHEMBL3587	Homo sapiens	IC50	uM	0.32
	1077022	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccccc1N)c1cccc(C(O)c2cccs2)c1		CHEMBL284708	=	IC50	nM	17.0	CHEMBL3587	Homo sapiens	IC50	uM	0.017
	1077590	CHEMBL672143	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using coupled MEK assay (which uses activated Raf to activate an inactivate GST-MEK)	B	COc1cc2ncc(C#N)c(Nc3ccc(-c4ccccc4)cc3)c2cc1OC		CHEMBL285956	=	IC50	nM	1100.0	CHEMBL3587	Homo sapiens	IC50	uM	1.1
	1077591	CHEMBL675993	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using direct MEK assay (which by-passes the need for activated Raf by using an activated GST-MEK)	B	COc1cc2ncc(C#N)c(Nc3ccc(-c4ccccc4)cc3)c2cc1OC		CHEMBL285956	=	IC50	nM	9500.0	CHEMBL3587	Homo sapiens	IC50	uM	9.5
	1078265	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccccc1N)c1cccc(C(O)C2CCCCC2)c1		CHEMBL34601	=	IC50	nM	56.0	CHEMBL3587	Homo sapiens	IC50	uM	0.056
	1078267	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	COc1ccccc1S/C(N)=C(\C#N)c1cccc(C(O)c2ccc(C#N)cc2)c1		CHEMBL265999	=	IC50	nM	2081.0	CHEMBL3587	Homo sapiens	IC50	uM	2.081
	1078269	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	C[n+]1ccc(C(O)c2cccc(/C(C#N)=C(\N)Sc3ccccc3N)c2)cc1.[I-]		CHEMBL286239	=	IC50	nM	330.0	CHEMBL3587	Homo sapiens	IC50	uM	0.33
	1078749	CHEMBL672143	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using coupled MEK assay (which uses activated Raf to activate an inactivate GST-MEK)	B	COc1cc2ncc(C#N)c(Nc3ccc(O)cc3)c2cc1OC		CHEMBL30268	=	IC50	nM	550.0	CHEMBL3587	Homo sapiens	IC50	uM	0.55
	1078750	CHEMBL675993	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using direct MEK assay (which by-passes the need for activated Raf by using an activated GST-MEK)	B	COc1cc2ncc(C#N)c(Nc3ccc(O)cc3)c2cc1OC		CHEMBL30268	=	IC50	nM	2200.0	CHEMBL3587	Homo sapiens	IC50	uM	2.2
	1078751	CHEMBL672143	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using coupled MEK assay (which uses activated Raf to activate an inactivate GST-MEK)	B	COc1cc2ncc(C#N)c(Nc3ccc(SC)cc3)c2cc1OC		CHEMBL30597	=	IC50	nM	280.0	CHEMBL3587	Homo sapiens	IC50	uM	0.28
	1078752	CHEMBL675993	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using direct MEK assay (which by-passes the need for activated Raf by using an activated GST-MEK)	B	COc1cc2ncc(C#N)c(Nc3ccc(SC)cc3)c2cc1OC		CHEMBL30597	=	IC50	nM	1300.0	CHEMBL3587	Homo sapiens	IC50	uM	1.3
	1079479	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccccc1N)c1cccc(C(O)c2ccccc2)c1		CHEMBL37487	=	IC50	nM	30.0	CHEMBL3587	Homo sapiens	IC50	uM	0.03
	1079481	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccccc1N)c1cccc(C(O)c2cccc3ccccc23)c1		CHEMBL33906	=	IC50	nM	47.0	CHEMBL3587	Homo sapiens	IC50	uM	0.047
	1079483	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccccc1N)c1cccc(C(O)c2ccco2)c1		CHEMBL38216	=	IC50	nM	323.0	CHEMBL3587	Homo sapiens	IC50	uM	0.323
	1080596	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	IC50	nM	70.0	CHEMBL3587	Homo sapiens	IC50	uM	0.07
	1081753	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccccc1N)c1cccc(Cc2ccccc2)c1		CHEMBL37871	=	IC50	nM	40.0	CHEMBL3587	Homo sapiens	IC50	uM	0.04
	1081755	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	Cc1ccccc1C(O)c1cccc(/C(C#N)=C(\N)Sc2ccccc2N)c1		CHEMBL290017	=	IC50	nM	24.0	CHEMBL3587	Homo sapiens	IC50	uM	0.024
	1082978	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	Cc1ccccc1C(O)c1cccc(/C(C#N)=C(\N)Sc2ccc(N)cc2)c1		CHEMBL286371	=	IC50	nM	659.0	CHEMBL3587	Homo sapiens	IC50	uM	0.659
	1083308	CHEMBL672143	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using coupled MEK assay (which uses activated Raf to activate an inactivate GST-MEK)	B	COc1cc2c(Nc3ccc(Sc4ccccc4)cc3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL29714	=	IC50	nM	1.1	CHEMBL3587	Homo sapiens	IC50	uM	0.0011
	1083309	CHEMBL675993	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using direct MEK assay (which by-passes the need for activated Raf by using an activated GST-MEK)	B	COc1cc2c(Nc3ccc(Sc4ccccc4)cc3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL29714	=	IC50	nM	5.7	CHEMBL3587	Homo sapiens	IC50	uM	0.0057
	1083311	CHEMBL672143	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using coupled MEK assay (which uses activated Raf to activate an inactivate GST-MEK)	B	COc1cc2c(Nc3ccc(CC4CCCCC4)cc3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL282976	=	IC50	nM	200.0	CHEMBL3587	Homo sapiens	IC50	uM	0.2
	1083312	CHEMBL675993	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using direct MEK assay (which by-passes the need for activated Raf by using an activated GST-MEK)	B	COc1cc2c(Nc3ccc(CC4CCCCC4)cc3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL282976	=	IC50	nM	3300.0	CHEMBL3587	Homo sapiens	IC50	uM	3.3
	1084031	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccccc1N)c1cccc(C(O)c2cccc(F)c2)c1		CHEMBL35379	=	IC50	nM	44.0	CHEMBL3587	Homo sapiens	IC50	uM	0.044
	1084405	CHEMBL672143	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using coupled MEK assay (which uses activated Raf to activate an inactivate GST-MEK)	B	COc1cc2ncc(C#N)c(Nc3ccc(Oc4ccc(Cl)cc4)cc3)c2cc1OC		CHEMBL31384	=	IC50	nM	43.0	CHEMBL3587	Homo sapiens	IC50	uM	0.043
	1084406	CHEMBL675993	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using direct MEK assay (which by-passes the need for activated Raf by using an activated GST-MEK)	B	COc1cc2ncc(C#N)c(Nc3ccc(Oc4ccc(Cl)cc4)cc3)c2cc1OC		CHEMBL31384	=	IC50	nM	210.0	CHEMBL3587	Homo sapiens	IC50	uM	0.21
	1085073	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	Cc1cccc(C(O)c2cccc(/C(C#N)=C(\N)Sc3ccccc3N)c2)c1		CHEMBL37927	=	IC50	nM	57.0	CHEMBL3587	Homo sapiens	IC50	uM	0.057
	1085438	CHEMBL672143	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using coupled MEK assay (which uses activated Raf to activate an inactivate GST-MEK)	B	COc1ccc(Nc2c(C#N)cnc3cc(OC)c(OC)cc23)cc1		CHEMBL279758	=	IC50	nM	520.0	CHEMBL3587	Homo sapiens	IC50	uM	0.52
	1085439	CHEMBL675993	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using direct MEK assay (which by-passes the need for activated Raf by using an activated GST-MEK)	B	COc1ccc(Nc2c(C#N)cnc3cc(OC)c(OC)cc23)cc1		CHEMBL279758	=	IC50	nM	3000.0	CHEMBL3587	Homo sapiens	IC50	uM	3.0
	1086132	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccccc1N)c1ccccc1Oc1ccccc1		CHEMBL285905	=	IC50	nM	510.0	CHEMBL3587	Homo sapiens	IC50	uM	0.51
	1086133	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	CC(C)(O)c1cccc(/C(C#N)=C(\N)Sc2ccccc2N)c1		CHEMBL35579	=	IC50	nM	340.0	CHEMBL3587	Homo sapiens	IC50	uM	0.34
	1087181	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccc(N)cc1)c1cccc(C(=O)c2ccccc2)c1		CHEMBL35409	=	IC50	nM	1810.0	CHEMBL3587	Homo sapiens	IC50	uM	1.81
	1087182	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccccc1N)c1cccc(C(O)c2ccc(-c3nn[nH]n3)cc2)c1.OCCN(CCO)CCO		CHEMBL35029	=	IC50	nM	35.0	CHEMBL3587	Homo sapiens	IC50	uM	0.035
	1087570	CHEMBL672143	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using coupled MEK assay (which uses activated Raf to activate an inactivate GST-MEK)	B	COc1cc2c(Nc3ccc(SC4CCCCC4)cc3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL282361	=	IC50	nM	21.0	CHEMBL3587	Homo sapiens	IC50	uM	0.021
	1087571	CHEMBL675993	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using direct MEK assay (which by-passes the need for activated Raf by using an activated GST-MEK)	B	COc1cc2c(Nc3ccc(SC4CCCCC4)cc3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL282361	=	IC50	nM	300.0	CHEMBL3587	Homo sapiens	IC50	uM	0.3
	1087572	CHEMBL672141	Inhibition of Dual specificity mitogen-activated protein kinase kinase in coupled activated Raf/MEK assay	B	COc1cc2c(Nc3ccc(CCc4ccccc4)cc3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL30551	=	IC50	nM	33.0	CHEMBL3587	Homo sapiens	IC50	uM	0.033
	1087573	CHEMBL672142	Inhibition of Dual specificity mitogen-activated protein kinase kinase in direct activated MEK assay	B	COc1cc2c(Nc3ccc(CCc4ccccc4)cc3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL30551	=	IC50	nM	150.0	CHEMBL3587	Homo sapiens	IC50	uM	0.15
	1088393	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	CN(C(=O)c1cccc(/C(C#N)=C(\N)Sc2ccccc2N)c1)c1ccccc1		CHEMBL287754	=	IC50	nM	4010.0	CHEMBL3587	Homo sapiens	IC50	uM	4.01
	1088394	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccccc1N)c1cccc(C(O)c2ccc3ccccc3c2)c1		CHEMBL287959	=	IC50	nM	76.0	CHEMBL3587	Homo sapiens	IC50	uM	0.076
	1088396	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccccc1N)c1cccc(C(O)c2ccc([N+](=O)[O-])cc2)c1		CHEMBL36664	=	IC50	nM	8.0	CHEMBL3587	Homo sapiens	IC50	uM	0.008
	1089495	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccccc1O)c1cccc(C(O)c2ccc(C#N)cc2)c1		CHEMBL35598	=	IC50	nM	8.0	CHEMBL3587	Homo sapiens	IC50	uM	0.008
	1089497	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccccc1N)c1cccc(C(O)c2ccccn2)c1		CHEMBL418230	=	IC50	nM	99.0	CHEMBL3587	Homo sapiens	IC50	uM	0.099
	1089823	CHEMBL672143	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using coupled MEK assay (which uses activated Raf to activate an inactivate GST-MEK)	B	COc1ccc(Nc2c(C#N)cnc3cc(OCCCN4CCOCC4)c(OC)cc23)cc1		CHEMBL30516	=	IC50	nM	99.0	CHEMBL3587	Homo sapiens	IC50	uM	0.099
	1089824	CHEMBL675993	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using direct MEK assay (which by-passes the need for activated Raf by using an activated GST-MEK)	B	COc1ccc(Nc2c(C#N)cnc3cc(OCCCN4CCOCC4)c(OC)cc23)cc1		CHEMBL30516	=	IC50	nM	250.0	CHEMBL3587	Homo sapiens	IC50	uM	0.25
	1089825	CHEMBL672143	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using coupled MEK assay (which uses activated Raf to activate an inactivate GST-MEK)	B	COc1cc2c(Nc3ccc(Cc4ccncc4)cc3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL30540	=	IC50	nM	190.0	CHEMBL3587	Homo sapiens	IC50	uM	0.19
	1089826	CHEMBL675993	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using direct MEK assay (which by-passes the need for activated Raf by using an activated GST-MEK)	B	COc1cc2c(Nc3ccc(Cc4ccncc4)cc3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL30540	=	IC50	nM	650.0	CHEMBL3587	Homo sapiens	IC50	uM	0.65
	1089827	CHEMBL672143	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using coupled MEK assay (which uses activated Raf to activate an inactivate GST-MEK)	B	COc1cc2c(Nc3ccc(Cc4ccoc4)cc3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL30790	=	IC50	nM	14.0	CHEMBL3587	Homo sapiens	IC50	uM	0.014
	1089828	CHEMBL675993	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using direct MEK assay (which by-passes the need for activated Raf by using an activated GST-MEK)	B	COc1cc2c(Nc3ccc(Cc4ccoc4)cc3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL30790	=	IC50	nM	43.0	CHEMBL3587	Homo sapiens	IC50	uM	0.043
	1090522	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccccc1)c1cccc(C(O)c2ccc(C#N)cc2)c1		CHEMBL284760	=	IC50	nM	53.0	CHEMBL3587	Homo sapiens	IC50	uM	0.053
	1090946	CHEMBL672143	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using coupled MEK assay (which uses activated Raf to activate an inactivate GST-MEK)	B	COc1cc2c(Nc3ccc(Cc4ccco4)cc3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL31143	=	IC50	nM	20.0	CHEMBL3587	Homo sapiens	IC50	uM	0.02
	1090947	CHEMBL675993	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using direct MEK assay (which by-passes the need for activated Raf by using an activated GST-MEK)	B	COc1cc2c(Nc3ccc(Cc4ccco4)cc3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL31143	=	IC50	nM	66.0	CHEMBL3587	Homo sapiens	IC50	uM	0.066
	1091699	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	COC(=O)c1ccc(C(O)c2cccc(/C(C#N)=C(\N)Sc3ccccc3N)c2)cc1		CHEMBL290865	=	IC50	nM	14.0	CHEMBL3587	Homo sapiens	IC50	uM	0.014
	1091701	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccccc1N)c1cccc(C(O)c2ccoc2)c1		CHEMBL290886	=	IC50	nM	55.0	CHEMBL3587	Homo sapiens	IC50	uM	0.055
	1092790	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	CC(O)(c1ccccc1)c1cccc(/C(C#N)=C(\N)Sc2ccccc2N)c1		CHEMBL285661	=	IC50	nM	682.0	CHEMBL3587	Homo sapiens	IC50	uM	0.682
	1093153	CHEMBL672143	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using coupled MEK assay (which uses activated Raf to activate an inactivate GST-MEK)	B	COc1cc2c(Nc3ccc(Cc4ccccn4)cc3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL281662	=	IC50	nM	18.0	CHEMBL3587	Homo sapiens	IC50	uM	0.018
	1093154	CHEMBL675993	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using direct MEK assay (which by-passes the need for activated Raf by using an activated GST-MEK)	B	COc1cc2c(Nc3ccc(Cc4ccccn4)cc3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL281662	=	IC50	nM	72.0	CHEMBL3587	Homo sapiens	IC50	uM	0.072
	1093948	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccccc1O)c1cccc(C(O)c2cccc([N+](=O)[O-])c2)c1		CHEMBL36307	=	IC50	nM	25.0	CHEMBL3587	Homo sapiens	IC50	uM	0.025
	1095059	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccccc1N)c1cccc(C(O)c2cccnc2)c1		CHEMBL38321	=	IC50	nM	25.0	CHEMBL3587	Homo sapiens	IC50	uM	0.025
	1095061	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#CC(c1ccccc1)C(N)Sc1ccccc1N		CHEMBL284774	=	IC50	nM	140.0	CHEMBL3587	Homo sapiens	IC50	uM	0.14
	1095442	CHEMBL672143	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using coupled MEK assay (which uses activated Raf to activate an inactivate GST-MEK)	B	COc1cc2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL31733	=	IC50	nM	6.2	CHEMBL3587	Homo sapiens	IC50	uM	0.0062
	1095443	CHEMBL675993	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using direct MEK assay (which by-passes the need for activated Raf by using an activated GST-MEK)	B	COc1cc2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL31733	=	IC50	nM	34.0	CHEMBL3587	Homo sapiens	IC50	uM	0.034
	1096523	CHEMBL672143	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using coupled MEK assay (which uses activated Raf to activate an inactivate GST-MEK)	B	COc1cc2ncc(C#N)c(Nc3ccccc3Oc3ccccc3)c2cc1OC		CHEMBL286244	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	1096524	CHEMBL675993	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using direct MEK assay (which by-passes the need for activated Raf by using an activated GST-MEK)	B	COc1cc2ncc(C#N)c(Nc3ccccc3Oc3ccccc3)c2cc1OC		CHEMBL286244	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	1096525	CHEMBL672143	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using coupled MEK assay (which uses activated Raf to activate an inactivate GST-MEK)	B	COc1cc2c(Nc3ccc(Cc4cccnc4)cc3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL287852	=	IC50	nM	29.0	CHEMBL3587	Homo sapiens	IC50	uM	0.029
	1096526	CHEMBL675993	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using direct MEK assay (which by-passes the need for activated Raf by using an activated GST-MEK)	B	COc1cc2c(Nc3ccc(Cc4cccnc4)cc3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL287852	=	IC50	nM	100.0	CHEMBL3587	Homo sapiens	IC50	uM	0.1
	1097299	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	Cc1cccc(C(O)c2cccc(/C(C#N)=C(\N)Sc3ccc(N)cc3)c2)c1		CHEMBL289134	=	IC50	nM	503.0	CHEMBL3587	Homo sapiens	IC50	uM	0.503
	1097652	CHEMBL672143	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using coupled MEK assay (which uses activated Raf to activate an inactivate GST-MEK)	B	COc1cc2c(Nc3ccc(Cc4cccs4)cc3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL288081	=	IC50	nM	4.4	CHEMBL3587	Homo sapiens	IC50	uM	0.0044
	1097653	CHEMBL675993	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using direct MEK assay (which by-passes the need for activated Raf by using an activated GST-MEK)	B	COc1cc2c(Nc3ccc(Cc4cccs4)cc3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL288081	=	IC50	nM	20.0	CHEMBL3587	Homo sapiens	IC50	uM	0.02
	1098521	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	Cc1ccc(C(O)c2cccc(/C(C#N)=C(\N)Sc3ccccc3N)c2)cc1		CHEMBL38315	=	IC50	nM	50.0	CHEMBL3587	Homo sapiens	IC50	uM	0.05
	1098523	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccccc1N)c1cccc(C(O)c2cccc(C#N)c2)c1		CHEMBL37911	=	IC50	nM	13.0	CHEMBL3587	Homo sapiens	IC50	uM	0.013
	1098525	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccccc1N)c1cccc(C(O)c2ccncc2)c1		CHEMBL37493	=	IC50	nM	12.0	CHEMBL3587	Homo sapiens	IC50	uM	0.012
	1099547	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccc(N)cc1N)c1cccc(C(O)c2ccc(C#N)cc2)c1		CHEMBL417693	=	IC50	nM	53.0	CHEMBL3587	Homo sapiens	IC50	uM	0.053
	1100676	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccccc1N)c1cccc(Oc2ccccc2)c1		CHEMBL37504	=	IC50	nM	40.0	CHEMBL3587	Homo sapiens	IC50	uM	0.04
	1100678	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccc(N)cc1)c1cccc(C(O)c2ccccc2)c1		CHEMBL37634	=	IC50	nM	57.0	CHEMBL3587	Homo sapiens	IC50	uM	0.057
	1100680	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	Cc1ccc(C(O)c2cccc(/C(C#N)=C(\N)Sc3ccc(N)cc3)c2)cc1		CHEMBL38335	=	IC50	nM	390.0	CHEMBL3587	Homo sapiens	IC50	uM	0.39
	1101817	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccccc1N)c1cccc(C(=O)c2ccccc2)c1		CHEMBL422940	=	IC50	nM	410.0	CHEMBL3587	Homo sapiens	IC50	uM	0.41
	1101819	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccc(N)cc1)c1cccc(Cc2ccccc2)c1		CHEMBL37657	=	IC50	nM	450.0	CHEMBL3587	Homo sapiens	IC50	uM	0.45
	1101821	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccccc1N)c1cccc(C(O)c2ccc3c(c2)OCCO3)c1		CHEMBL34072	=	IC50	nM	25.0	CHEMBL3587	Homo sapiens	IC50	uM	0.025
	1101823	CHEMBL729500	Inhibitory potency against mitogen activated protein kinase kinase 1	B	N#C/C(=C(/N)Sc1ccccc1N)c1cccc(C(O)c2ccsc2)c1		CHEMBL38195	=	IC50	nM	17.0	CHEMBL3587	Homo sapiens	IC50	uM	0.017
	1102234	CHEMBL672143	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using coupled MEK assay (which uses activated Raf to activate an inactivate GST-MEK)	B	COc1cc2ncc(C#N)c(Nc3ccc(Nc4ccccc4)cc3)c2cc1OC		CHEMBL31639	=	IC50	nM	160.0	CHEMBL3587	Homo sapiens	IC50	uM	0.16
	1102235	CHEMBL675993	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using direct MEK assay (which by-passes the need for activated Raf by using an activated GST-MEK)	B	COc1cc2ncc(C#N)c(Nc3ccc(Nc4ccccc4)cc3)c2cc1OC		CHEMBL31639	=	IC50	nM	1200.0	CHEMBL3587	Homo sapiens	IC50	uM	1.2
	1102236	CHEMBL672143	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using coupled MEK assay (which uses activated Raf to activate an inactivate GST-MEK)	B	COc1cc2ncc(C#N)c(Nc3cccc(Oc4ccccc4)c3)c2cc1OC		CHEMBL30763	=	IC50	nM	60.0	CHEMBL3587	Homo sapiens	IC50	uM	0.06
	1102237	CHEMBL675993	Inhibitory activity against Dual specificity mitogen-activated protein kinase kinase using direct MEK assay (which by-passes the need for activated Raf by using an activated GST-MEK)	B	COc1cc2ncc(C#N)c(Nc3cccc(Oc4ccccc4)c3)c2cc1OC		CHEMBL30763	=	IC50	nM	160.0	CHEMBL3587	Homo sapiens	IC50	uM	0.16
	1106345	CHEMBL731429	Inhibition of MEK, Mitogen activated protein kinase kinase 1	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc([N+](=O)[O-])cc4)CC3)c2cc1OC		CHEMBL99743	>	IC50	nM	30000.0	CHEMBL3587	Homo sapiens	IC50	uM l-1	30.0
Not Determined	1108587	CHEMBL731431	Inhibition of MEK, Mitogen activated protein kinase kinase 1 (Not tested)	F	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(C(C)C)cc4)CC3)c2cc1OC		CHEMBL104067		NT			CHEMBL3587	Homo sapiens	NT		
Not Determined	1112123	CHEMBL731430	Inhibition of MEK, Mitogen activated protein kinase kinase 1 (Not tested)	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346		NT			CHEMBL3587	Homo sapiens	NT		
	1114591	CHEMBL731429	Inhibition of MEK, Mitogen activated protein kinase kinase 1	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Br)cc4)CC3)c2cc1OC		CHEMBL323336	>	IC50	nM	30000.0	CHEMBL3587	Homo sapiens	IC50	uM l-1	30.0
	1121306	CHEMBL675994	Inhibition of Dual specificity mitogen-activated protein kinase kinase (MEK-1)	B	COc1cc2cc3ncc(C#N)c(Nc4ccc(Oc5ccccc5)cc4)c3cc2cc1OC		CHEMBL337728	=	IC50	nM	10.0	CHEMBL3587	Homo sapiens	IC50	uM	0.01
	1123677	CHEMBL675994	Inhibition of Dual specificity mitogen-activated protein kinase kinase (MEK-1)	B	COc1cc2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL31733	=	IC50	nM	9.0	CHEMBL3587	Homo sapiens	IC50	uM	0.009
	1130115	CHEMBL731429	Inhibition of MEK, Mitogen activated protein kinase kinase 1	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)c2cc1OC		CHEMBL106966	>	IC50	nM	30000.0	CHEMBL3587	Homo sapiens	IC50	uM l-1	30.0
Not Determined	1235230	CHEMBL731422	Inhibition of Mitogen activated protein kinase kinase 1 (not tested)	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccsc4)CC3)c2cc1OC.Cl		CHEMBL553824		NT			CHEMBL3587	Homo sapiens	NT		
	1236592	CHEMBL731420	Inhibition of Mitogen activated protein kinase kinase 1	B	COc1cc2ncnc(N3CCN(/C(S)=N\Cc4ccc5c(c4)OCO5)CC3)c2cc1OC		CHEMBL102301	>	IC50	nM	30000.0	CHEMBL3587	Homo sapiens	IC50	uM l-1	30.0
	1245753	CHEMBL731420	Inhibition of Mitogen activated protein kinase kinase 1	B	COc1cc2ncnc(N3CCN(/C(S)=N\Cc4ccccc4)CC3)c2cc1OC		CHEMBL319894	>	IC50	nM	30000.0	CHEMBL3587	Homo sapiens	IC50	uM l-1	30.0
	1406060	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Cn1cnc2c(-c3ccc(F)cc3)ncnc21		CHEMBL539424	=	Inhibition	%	1.0	CHEMBL3587	Homo sapiens	Inhibition	%	1.0
	1406075	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Cn1c(-c2ccccc2)nc2c(-c3ccc(F)cc3)ncnc21		CHEMBL368896	=	Inhibition	%	5.0	CHEMBL3587	Homo sapiens	Inhibition	%	5.0
	1406196	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Cn1c(-c2ccccc2)nc2c(Sc3ccccc3)ncnc21		CHEMBL367389	=	Inhibition	%	4.0	CHEMBL3587	Homo sapiens	Inhibition	%	4.0
	1406211	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Cn1c(-c2ccccc2)nc2c(Sc3ccc(F)cc3)ncnc21		CHEMBL175541	=	Inhibition	%	7.0	CHEMBL3587	Homo sapiens	Inhibition	%	7.0
	1406336	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	CSc1ccc(-c2nc3c(Sc4ccccc4)ncnc3n2C)cc1		CHEMBL175868	=	Inhibition	%	4.0	CHEMBL3587	Homo sapiens	Inhibition	%	4.0
	1406351	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	CSc1ccc(-c2nc3c(Sc4ccc(F)cc4)ncnc3n2C)cc1		CHEMBL175619	=	Inhibition	%	4.0	CHEMBL3587	Homo sapiens	Inhibition	%	4.0
	1406366	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Cn1c(-c2ccc([S+](C)[O-])cc2)nc2c(Sc3ccccc3)ncnc21		CHEMBL353740	=	Inhibition	%	3.0	CHEMBL3587	Homo sapiens	Inhibition	%	3.0
	1406454	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	c1ccc(Nc2ncnc3[nH]cnc23)cc1		CHEMBL359730	=	Inhibition	%	19.0	CHEMBL3587	Homo sapiens	Inhibition	%	19.0
	1406469	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Fc1ccc(Nc2[nH]cnc3ncnc2-3)cc1		CHEMBL361227	=	Inhibition	%	34.0	CHEMBL3587	Homo sapiens	Inhibition	%	34.0
	1406484	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	c1ccc(Oc2ncnc3[nH]cnc23)cc1		CHEMBL366984	=	Inhibition	%	1.0	CHEMBL3587	Homo sapiens	Inhibition	%	1.0
	1406498	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Cn1c(-c2ccc([S+](C)[O-])cc2)nc2c(Sc3ccc(F)cc3)ncnc21		CHEMBL180373	=	Inhibition	%	1.0	CHEMBL3587	Homo sapiens	Inhibition	%	1.0
	1406513	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Cn1c(-c2ccc(S(C)(=O)=O)cc2)nc2c(Sc3ccccc3)ncnc21		CHEMBL177060	=	Inhibition	%	4.0	CHEMBL3587	Homo sapiens	Inhibition	%	4.0
	1406616	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Fc1ccc(Oc2[nH]cnc3ncnc2-3)cc1		CHEMBL367695	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	Inhibition	%	0.0
	1406631	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Cn1cnc2c(Nc3ccccc3)ncnc21		CHEMBL321749	=	Inhibition	%	4.0	CHEMBL3587	Homo sapiens	Inhibition	%	4.0
	1406645	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Cn1c(-c2ccc(S(C)(=O)=O)cc2)nc2c(Sc3ccc(F)cc3)ncnc21		CHEMBL367018	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	Inhibition	%	0.0
	1406660	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Cn1c(Br)nc2c(Sc3ccccc3)ncnc21		CHEMBL177289	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	Inhibition	%	0.0
	1406766	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Cn1cnc2c(Nc3ccc(F)cc3)ncnc21		CHEMBL362629	=	Inhibition	%	8.0	CHEMBL3587	Homo sapiens	Inhibition	%	8.0
	1406781	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	c1ccc(Sc2ncnc3[nH]cnc23)cc1		CHEMBL175600	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	Inhibition	%	0.0
	1406899	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Fc1ccc(Sc2ncnc3[nH]cnc23)cc1		CHEMBL175603	=	Inhibition	%	2.0	CHEMBL3587	Homo sapiens	Inhibition	%	2.0
	1406914	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	c1ccc(Sc2[nH]cnc3nccc2-3)cc1		CHEMBL360302	=	Inhibition	%	41.0	CHEMBL3587	Homo sapiens	Inhibition	%	41.0
	1406929	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Fc1ccc(Sc2[nH]cnc3nccc2-3)cc1		CHEMBL367533	=	Inhibition	%	36.0	CHEMBL3587	Homo sapiens	Inhibition	%	36.0
	1407040	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Cn1cnc2c(Sc3ccccc3)ncnc21		CHEMBL179751	=	Inhibition	%	3.0	CHEMBL3587	Homo sapiens	Inhibition	%	3.0
	1407055	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Cn1cnc2c(Sc3ccc(F)cc3)ncnc21		CHEMBL175622	=	Inhibition	%	6.0	CHEMBL3587	Homo sapiens	Inhibition	%	6.0
	1407160	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	c1ccc(CSc2ncnc3[nH]cnc23)cc1		CHEMBL397434	=	Inhibition	%	7.0	CHEMBL3587	Homo sapiens	Inhibition	%	7.0
	1407175	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Fc1ccc(CSc2[nH]cnc3ncnc2-3)cc1		CHEMBL175451	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	Inhibition	%	0.0
	1407286	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Cn1cnc2c(SCc3ccccc3)ncnc21		CHEMBL176384	=	Inhibition	%	6.0	CHEMBL3587	Homo sapiens	Inhibition	%	6.0
	1407301	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Cn1cnc2c(SCc3ccc(F)cc3)ncnc21		CHEMBL175730	=	Inhibition	%	7.0	CHEMBL3587	Homo sapiens	Inhibition	%	7.0
	1407316	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	c1ccc(-[n+]2c[nH]c3ncncc32)cc1		CHEMBL175816	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	Inhibition	%	0.0
	1407432	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Fc1ccc(-[n+]2c[nH]c3ncncc32)cc1		CHEMBL175817	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	Inhibition	%	0.0
	1407448	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	c1ccc(C[n+]2c[nH]c3ncncc32)cc1		CHEMBL369622	=	Inhibition	%	4.0	CHEMBL3587	Homo sapiens	Inhibition	%	4.0
	1407563	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Fc1ccc(C[n+]2c[nH]c3ncncc32)cc1		CHEMBL179515	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	Inhibition	%	0.0
	1407578	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Clc1ncnc2c1ncn2Cc1ccccc1		CHEMBL7944	=	Inhibition	%	3.0	CHEMBL3587	Homo sapiens	Inhibition	%	3.0
	1407689	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Clc1ncnc2ncn(Cc3ccccc3)c12		CHEMBL368715	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	Inhibition	%	0.0
	1407704	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Fc1ccc(Cn2cnc3c(Cl)ncnc32)cc1		CHEMBL369181	=	Inhibition	%	1.0	CHEMBL3587	Homo sapiens	Inhibition	%	1.0
	1407719	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Fc1ccc(Cn2cnc3ncnc(Cl)c32)cc1		CHEMBL175528	=	Inhibition	%	4.0	CHEMBL3587	Homo sapiens	Inhibition	%	4.0
	1407827	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Nc1ncnc2c1ncn2Cc1ccccc1		CHEMBL266094	=	Inhibition	%	7.0	CHEMBL3587	Homo sapiens	Inhibition	%	7.0
	1407842	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Nc1ncnc2c1ncn2Cc1ccc(F)cc1		CHEMBL426037	=	Inhibition	%	7.0	CHEMBL3587	Homo sapiens	Inhibition	%	7.0
	1407955	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Nc1ncnc2ncn(Cc3ccc(F)cc3)c12		CHEMBL180422	=	Inhibition	%	8.0	CHEMBL3587	Homo sapiens	Inhibition	%	8.0
	1407970	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	COc1ncnc2ncn(Cc3ccc(F)cc3)c12		CHEMBL368714	=	Inhibition	%	3.0	CHEMBL3587	Homo sapiens	Inhibition	%	3.0
	1408085	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	c1ccc(Cc2[nH]cnc3ncnc2-3)cc1		CHEMBL367930	=	Inhibition	%	3.0	CHEMBL3587	Homo sapiens	Inhibition	%	3.0
	1408100	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Fc1ccc(Cc2[nH]cnc3ncnc2-3)cc1		CHEMBL179158	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	Inhibition	%	0.0
	1408214	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Fc1ccc(/C=C/c2[nH]cnc3ncnc2-3)cc1		CHEMBL367470	=	Inhibition	%	7.0	CHEMBL3587	Homo sapiens	Inhibition	%	7.0
	1408229	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Cn1cnc2c(/C=C/c3ccccc3)ncnc21		CHEMBL176186	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	Inhibition	%	0.0
	1408244	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Cn1cnc2c(-c3ccccc3)ncnc21		CHEMBL179217	=	Inhibition	%	9.0	CHEMBL3587	Homo sapiens	Inhibition	%	9.0
	1408880	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Cn1c(C#CCCO)nc2c(Sc3ccccc3)ncnc21		CHEMBL177784	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	Inhibition	%	0.0
	1408895	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	c1ccc(Cn2cnc3c(Sc4ccccc4)ncnc32)cc1		CHEMBL180020	=	Inhibition	%	6.0	CHEMBL3587	Homo sapiens	Inhibition	%	6.0
	1408910	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Fc1ccc(Sc2ncnc3c2ncn3Cc2ccccc2)cc1		CHEMBL179768	=	Inhibition	%	4.0	CHEMBL3587	Homo sapiens	Inhibition	%	4.0
	1409020	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Fc1ccc(Cn2cnc3c(Sc4ccccc4)ncnc32)cc1		CHEMBL176245	=	Inhibition	%	1.0	CHEMBL3587	Homo sapiens	Inhibition	%	1.0
	1409035	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Fc1ccc(Cn2cnc3c(Sc4ccc(F)cc4)ncnc32)cc1		CHEMBL175665	=	Inhibition	%	3.0	CHEMBL3587	Homo sapiens	Inhibition	%	3.0
	1409146	CHEMBL830657	Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM	B	Nc1ncnc2[nH]cnc12		CHEMBL226345	=	Inhibition	%	9.0	CHEMBL3587	Homo sapiens	Inhibition	%	9.0
	1441463	CHEMBL832049	Inhibition of Mitogen activated protein kinase kinase 1 at 10 uM with 100 uM ATP	B	O=C(Nc1ncnc2oc(-c3cccnc3)cc12)C1CCCC1		CHEMBL182419	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	Inhibition	%	0.0
	1475818	CHEMBL830597	Percent inhibition against MKK1 at 10 uM using 100 uM ATP	B	CCn1c(-c2nonc2N)nc2cnccc21		CHEMBL189657	=	Inhibition	%	17.0	CHEMBL3587	Homo sapiens	Inhibition	%	17.0
	1489877	CHEMBL828560	Inhibition of mitogen activated protein kinase kinase 1 (MEK1)	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F		CHEMBL1788116	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	1605368	CHEMBL881952	In vitro inhibitory concentration against MEK with ATP concentration at 1/2Km	B	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NC[C@@H](O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL401930	=	IC50	nM	182.0	CHEMBL3587	Homo sapiens	IC50	nM	182.0
	1606835	CHEMBL872210	Inhibitory concentration against MEK	B	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc(NC2CCCC2)c1C#N		CHEMBL383172	>	IC50	nM	25000.0	CHEMBL3587	Homo sapiens	IC50	uM	25.0
Not Active	1658699	CHEMBL860390	Inhibitory activity against MEK1 at 10 uM	B	O=c1cc(N2CCOCC2)oc2c(-c3cccc4c3sc3ccccc34)cccc12		CHEMBL188678		Activity			CHEMBL3587	Homo sapiens	Activity		
	1658894	CHEMBL860398	Inhibitory activity against MEK	B	N#Cc1cnc2cnc(NCCN3CCOCC3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL197538	=	IC50	nM	15000.0	CHEMBL3587	Homo sapiens	IC50	uM	15.0
	1658895	CHEMBL860398	Inhibitory activity against MEK	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	>	IC50	nM	40000.0	CHEMBL3587	Homo sapiens	IC50	uM	40.0
	1658896	CHEMBL860398	Inhibitory activity against MEK	B	N#Cc1cnc2cnc(NCCN3CCOCC3)cc2c1Nc1ccc(Oc2ccccc2)cc1		CHEMBL371095	=	IC50	nM	800.0	CHEMBL3587	Homo sapiens	IC50	uM	0.8
	1658897	CHEMBL860398	Inhibitory activity against MEK	B	N#Cc1cnc2cnc(NCCN3CCOCC3)cc2c1Nc1ccc(Sc2ccccc2)cc1		CHEMBL199210	=	IC50	nM	960.0	CHEMBL3587	Homo sapiens	IC50	uM	0.96
	1658898	CHEMBL860398	Inhibitory activity against MEK	B	N#Cc1cnc2cnc(NCCN3CCOCC3)cc2c1Nc1ccc(Cc2ccccc2)cc1		CHEMBL371658	=	IC50	nM	630.0	CHEMBL3587	Homo sapiens	IC50	uM	0.63
	1660448	CHEMBL853292	Inhibition of activated human MEK1 in MEK-ERK coupling assay	B	Cc1c(Cc2ccccc2)c(=O)oc2cc(OC(=O)N(C)C)c(Cl)cc12		CHEMBL80837	=	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
Active	1662011	CHEMBL868750	Inhibition of ERK phosphorylation in THP1 cells	F	Cc1c(Cc2ccc(F)cc2)c(=O)oc2cc(OC(=O)N(C)C)ccc12		CHEMBL78779		Activity			CHEMBL3587	Homo sapiens	Activity		
Active	1662012	CHEMBL868750	Inhibition of ERK phosphorylation in THP1 cells	F	Cc1c(Cc2ccccc2)c(=O)oc2cc(OC(=O)N(C)C)c(Cl)cc12		CHEMBL80837		Activity			CHEMBL3587	Homo sapiens	Activity		
	1662081	CHEMBL868754	Inhibition of human MEK1 activation by bRaf in RAF-MEK-ERK coupling assay	B	Cc1c(Cc2ccc(F)cc2)c(=O)oc2cc(OC(=O)N(C)C)ccc12		CHEMBL78779	=	IC50	nM	300.0	CHEMBL3587	Homo sapiens	IC50	uM	0.3
	1662083	CHEMBL868754	Inhibition of human MEK1 activation by bRaf in RAF-MEK-ERK coupling assay	B	Cc1c(Cc2ccccc2)c(=O)oc2cc(OC(=O)C3CC3)ccc12		CHEMBL199006	=	IC50	nM	200.0	CHEMBL3587	Homo sapiens	IC50	uM	0.2
Not Active	1662085	CHEMBL868758	Inhibition of activated human MEK1 in MEK-ERK coupling assay at 10 uM	B	Cc1c(Cc2ccc(F)cc2)c(=O)oc2cc(OC(=O)N(C)C)ccc12		CHEMBL78779		Activity			CHEMBL3587	Homo sapiens	Activity		
Not Active	1662086	CHEMBL868758	Inhibition of activated human MEK1 in MEK-ERK coupling assay at 10 uM	B	Cc1c(Cc2ccccc2)c(=O)oc2cc(OC(=O)C3CC3)ccc12		CHEMBL199006		Activity			CHEMBL3587	Homo sapiens	Activity		
	1665729	CHEMBL859500	Inhibition of MKK1 at 10 uM	B	CN1C(=O)C(C(=O)Nc2nncs2)c2cc3occc3cc21		CHEMBL200906	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	Inhibition	%	0.0
	1666370	CHEMBL865765	Inhibition of MEK1 activity at 10 uM	B	Oc1cc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)ccc1Cl		CHEMBL373011	=	Inhibition	%	5.0	CHEMBL3587	Homo sapiens	Inhibition	%	5.0
	1666371	CHEMBL865765	Inhibition of MEK1 activity at 10 uM	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1		CHEMBL477989	=	Inhibition	%	14.0	CHEMBL3587	Homo sapiens	Inhibition	%	14.0
	1671370	CHEMBL859549	Inhibitory activity against MEK1	B	Cn1cc(C(=O)NOCC2CC2)c(Nc2ccc(Br)cc2F)cc1=O		CHEMBL201417	=	IC50	nM	39.0	CHEMBL3587	Homo sapiens	IC50	nM	39.0
	1671373	CHEMBL859549	Inhibitory activity against MEK1	B	CCONC(=O)c1cn(C)c(=O)c(C)c1Nc1ccc(Br)cc1F		CHEMBL203138	=	IC50	nM	82.0	CHEMBL3587	Homo sapiens	IC50	nM	82.0
	1671374	CHEMBL859549	Inhibitory activity against MEK1	B	CONC(=O)c1cn(C)c(=O)c(C)c1Nc1ccc(Br)cc1F		CHEMBL426840	=	IC50	nM	105.0	CHEMBL3587	Homo sapiens	IC50	nM	105.0
	1671375	CHEMBL859549	Inhibitory activity against MEK1	B	CCONC(=O)c1cn(C)c(=O)c(F)c1Nc1ccc(Br)cc1F		CHEMBL201426	=	IC50	nM	33.0	CHEMBL3587	Homo sapiens	IC50	nM	33.0
	1671376	CHEMBL859549	Inhibitory activity against MEK1	B	CONC(=O)c1cn(C)c(=O)c(F)c1Nc1ccc(Br)cc1F		CHEMBL201156	=	IC50	nM	43.0	CHEMBL3587	Homo sapiens	IC50	nM	43.0
	1671377	CHEMBL859549	Inhibitory activity against MEK1	B	Cn1cc(C(=O)NO)c(Nc2ccc(Br)cc2F)c(F)c1=O		CHEMBL203258	=	IC50	nM	15.0	CHEMBL3587	Homo sapiens	IC50	nM	15.0
	1671378	CHEMBL859549	Inhibitory activity against MEK1	B	Cn1cc(C(=O)NCC2CC2)c(Nc2ccc(Br)cc2F)c(F)c1=O		CHEMBL203257	=	IC50	nM	2200.0	CHEMBL3587	Homo sapiens	IC50	nM	2200.0
	1671379	CHEMBL859549	Inhibitory activity against MEK1	B	CNC(=O)c1cn(C)c(=O)c(F)c1Nc1ccc(Br)cc1F		CHEMBL201691	=	IC50	nM	118.0	CHEMBL3587	Homo sapiens	IC50	nM	118.0
	1671380	CHEMBL859549	Inhibitory activity against MEK1	B	Cn1cc(C(=O)O)c(Nc2ccc(Br)cc2F)c(F)c1=O		CHEMBL203417	=	IC50	nM	30.0	CHEMBL3587	Homo sapiens	IC50	nM	30.0
	1671381	CHEMBL859549	Inhibitory activity against MEK1	B	Cn1cc(C(N)=O)c(Nc2ccc(Br)cc2F)c(F)c1=O		CHEMBL371693	=	IC50	nM	14.0	CHEMBL3587	Homo sapiens	IC50	nM	14.0
	1671382	CHEMBL859549	Inhibitory activity against MEK1	B	O=C(NOCCO)c1cnc(Cl)c(Cl)c1Nc1ccc(Br)cc1F		CHEMBL202771	=	IC50	nM	4496.0	CHEMBL3587	Homo sapiens	IC50	nM	4496.0
	1671383	CHEMBL859549	Inhibitory activity against MEK1	B	COc1ncc(C(=O)NOCCO)c(Nc2ccc(Br)cc2F)c1Cl		CHEMBL201136	=	IC50	nM	6786.0	CHEMBL3587	Homo sapiens	IC50	nM	6786.0
	1671384	CHEMBL859549	Inhibitory activity against MEK1	B	Cc1c(Nc2ccc(Br)cc2F)c(C(=O)NOCCO)cn(C)c1=O		CHEMBL199860	=	IC50	nM	18.0	CHEMBL3587	Homo sapiens	IC50	nM	18.0
	1671385	CHEMBL859549	Inhibitory activity against MEK1	B	Cn1cc(C(=O)NOCCO)c(Nc2ccc(Br)cc2F)c(F)c1=O		CHEMBL372600	=	IC50	nM	9.3	CHEMBL3587	Homo sapiens	IC50	nM	9.3
	1671386	CHEMBL859549	Inhibitory activity against MEK1	B	Cn1cc(C(=O)NOCCO)c(Nc2ccc(Br)cc2F)c(Cl)c1=O		CHEMBL199774	=	IC50	nM	45.0	CHEMBL3587	Homo sapiens	IC50	nM	45.0
	1671387	CHEMBL859549	Inhibitory activity against MEK1	B	Cn1cc(C(=O)NOCCO)c(Nc2ccc(Br)cc2F)cc1=O		CHEMBL199749	=	IC50	nM	30.0	CHEMBL3587	Homo sapiens	IC50	nM	30.0
	1671388	CHEMBL859549	Inhibitory activity against MEK1	B	Cc1c(Nc2ccc(Br)cc2F)c(C(=O)NOCC2CC2)cn(C)c1=O		CHEMBL201630	=	IC50	nM	40.0	CHEMBL3587	Homo sapiens	IC50	nM	40.0
	1671389	CHEMBL859549	Inhibitory activity against MEK1	B	Cn1cc(C(=O)NOCC2CC2)c(Nc2ccc(Br)cc2F)c(F)c1=O		CHEMBL201629	=	IC50	nM	6.8	CHEMBL3587	Homo sapiens	IC50	nM	6.8
	1671390	CHEMBL859549	Inhibitory activity against MEK1	B	Cn1cc(C(=O)NOCC2CC2)c(Nc2ccc(Br)cc2F)c(Cl)c1=O		CHEMBL201379	=	IC50	nM	124.0	CHEMBL3587	Homo sapiens	IC50	nM	124.0
	1676348	CHEMBL861916	Inhibitory activity against MEK	B	COc1cccc(Oc2ccc(Nc3c(C#N)cnn4cc(NC(=O)OCCN5CCOCC5)c(C)c34)cc2)c1		CHEMBL202177	=	IC50	nM	76.0	CHEMBL3587	Homo sapiens	IC50	uM	0.076
	1676398	CHEMBL861916	Inhibitory activity against MEK	B	CCOC(=O)c1cn2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c2c1C		CHEMBL380765	=	IC50	nM	94.0	CHEMBL3587	Homo sapiens	IC50	uM	0.094
	1677252	CHEMBL861916	Inhibitory activity against MEK	B	COc1ccccc1Oc1ccc(Nc2c(C#N)cnn3cc(NC(=O)OCCN4CCOCC4)c(C)c23)cc1		CHEMBL265786	=	IC50	nM	48.0	CHEMBL3587	Homo sapiens	IC50	uM	0.048
	1677253	CHEMBL861916	Inhibitory activity against MEK	B	COc1cccc(Oc2ccc(Nc3c(C#N)cnn4cc(NC(=O)NCCN5CCOCC5)c(C)c34)cc2)c1		CHEMBL414856	=	IC50	nM	29.0	CHEMBL3587	Homo sapiens	IC50	uM	0.029
	1677254	CHEMBL861916	Inhibitory activity against MEK	B	Cc1c(NC(=O)NCCN2CCOCC2)cn2ncc(C#N)c(Nc3ccc(Oc4ccccc4F)cc3)c12		CHEMBL369992	=	IC50	nM	33.0	CHEMBL3587	Homo sapiens	IC50	uM	0.033
	1677255	CHEMBL861916	Inhibitory activity against MEK	B	COc1ccccc1Oc1ccc(Nc2c(C#N)cnn3cc(NC(=O)NCCN4CCOCC4)c(C)c23)cc1		CHEMBL202356	=	IC50	nM	24.0	CHEMBL3587	Homo sapiens	IC50	uM	0.024
	1677256	CHEMBL861916	Inhibitory activity against MEK	B	Cc1c(-c2nc3ccccc3[nH]2)cn2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c12		CHEMBL382616	=	IC50	nM	168.0	CHEMBL3587	Homo sapiens	IC50	uM	0.168
	1677257	CHEMBL861916	Inhibitory activity against MEK	B	Cc1c(OCCN2CCOCC2)cn2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c12		CHEMBL201716	=	IC50	nM	521.0	CHEMBL3587	Homo sapiens	IC50	uM	0.521
	1677258	CHEMBL861916	Inhibitory activity against MEK	B	Cc1c(Nc2ccccc2)cn2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c12		CHEMBL201384	=	IC50	nM	361.0	CHEMBL3587	Homo sapiens	IC50	uM	0.361
	1677259	CHEMBL861916	Inhibitory activity against MEK	B	Cc1c(NCc2ccccc2)cn2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c12		CHEMBL201200	=	IC50	nM	6130.0	CHEMBL3587	Homo sapiens	IC50	uM	6.13
	1677260	CHEMBL861916	Inhibitory activity against MEK	B	Cc1c(NS(=O)(=O)c2ccccc2)cn2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c12		CHEMBL204147	=	IC50	nM	14600.0	CHEMBL3587	Homo sapiens	IC50	uM	14.6
	1677261	CHEMBL861916	Inhibitory activity against MEK	B	CC(=O)Nc1cccc(C(=O)Nc2cn3ncc(C#N)c(Nc4ccc(Oc5ccccc5)cc4)c3c2C)c1		CHEMBL202286	=	IC50	nM	14.0	CHEMBL3587	Homo sapiens	IC50	uM	0.014
	1677262	CHEMBL861916	Inhibitory activity against MEK	B	Cc1c(NC(=O)c2ccccc2)cn2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c12		CHEMBL202063	=	IC50	nM	42.0	CHEMBL3587	Homo sapiens	IC50	uM	0.042
	1677263	CHEMBL861916	Inhibitory activity against MEK	B	CC(=O)Nc1cn2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c2c1C		CHEMBL201819	=	IC50	nM	87.0	CHEMBL3587	Homo sapiens	IC50	uM	0.087
	1677264	CHEMBL861916	Inhibitory activity against MEK	B	Cc1c(NC(=O)OCCN2CCOCC2)cn2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c12		CHEMBL204535	=	IC50	nM	58.0	CHEMBL3587	Homo sapiens	IC50	uM	0.058
	1677265	CHEMBL861916	Inhibitory activity against MEK	B	COC(=O)Nc1cn2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c2c1C		CHEMBL201389	=	IC50	nM	23.0	CHEMBL3587	Homo sapiens	IC50	uM	0.023
	1677266	CHEMBL861916	Inhibitory activity against MEK	B	Cc1c(NC(=O)NCCN2CCOCC2)cn2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c12		CHEMBL378385	=	IC50	nM	36.0	CHEMBL3587	Homo sapiens	IC50	uM	0.036
	1677267	CHEMBL861916	Inhibitory activity against MEK	B	CNC(=O)Nc1cn2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c2c1C		CHEMBL383108	=	IC50	nM	18.0	CHEMBL3587	Homo sapiens	IC50	uM	0.018
	1677268	CHEMBL861916	Inhibitory activity against MEK	B	Cc1c(C(=O)NCCN2CCOCC2)cn2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c12		CHEMBL201833	=	IC50	nM	386.0	CHEMBL3587	Homo sapiens	IC50	uM	0.386
	1677269	CHEMBL861916	Inhibitory activity against MEK	B	CNC(=O)c1cn2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c2c1C		CHEMBL202355	=	IC50	nM	397.0	CHEMBL3587	Homo sapiens	IC50	uM	0.397
	1677270	CHEMBL861916	Inhibitory activity against MEK	B	Cc1c(C(=O)O)cn2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c12		CHEMBL200969	=	IC50	nM	147.0	CHEMBL3587	Homo sapiens	IC50	uM	0.147
	1677271	CHEMBL861916	Inhibitory activity against MEK	B	Cc1c(C(C)(C)O)cn2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c12		CHEMBL371027	>	IC50	nM	25000.0	CHEMBL3587	Homo sapiens	IC50	uM	25.0
	1677272	CHEMBL861916	Inhibitory activity against MEK	B	Cc1c(N)cn2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c12		CHEMBL203096	=	IC50	nM	190.0	CHEMBL3587	Homo sapiens	IC50	uM	0.19
	1677273	CHEMBL861916	Inhibitory activity against MEK	B	COc1cn2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c2c1C		CHEMBL204094	=	IC50	nM	805.0	CHEMBL3587	Homo sapiens	IC50	uM	0.805
	1677274	CHEMBL861916	Inhibitory activity against MEK	B	Cc1c(O)cn2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c12		CHEMBL201251	=	IC50	nM	181.0	CHEMBL3587	Homo sapiens	IC50	uM	0.181
	1677275	CHEMBL861916	Inhibitory activity against MEK	B	Cc1ccn2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c12		CHEMBL201203	=	IC50	nM	241.0	CHEMBL3587	Homo sapiens	IC50	uM	0.241
	1677276	CHEMBL861916	Inhibitory activity against MEK	B	CCOC(=O)c1cn2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c2c1COCCOC		CHEMBL201302	=	IC50	nM	566.0	CHEMBL3587	Homo sapiens	IC50	uM	0.566
	1677277	CHEMBL861916	Inhibitory activity against MEK	B	CCOCc1c(C(=O)OCC)cn2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c12		CHEMBL371969	=	IC50	nM	331.0	CHEMBL3587	Homo sapiens	IC50	uM	0.331
	1677278	CHEMBL861916	Inhibitory activity against MEK	B	CCOC(=O)c1cn2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c2c1COC		CHEMBL382456	=	IC50	nM	191.0	CHEMBL3587	Homo sapiens	IC50	uM	0.191
	1677279	CHEMBL861916	Inhibitory activity against MEK	B	CCOC(=O)c1cn2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c2c1CO		CHEMBL201186	=	IC50	nM	203.0	CHEMBL3587	Homo sapiens	IC50	uM	0.203
	1677280	CHEMBL861916	Inhibitory activity against MEK	B	CCOC(=O)c1cn2ncc(C#N)c(Nc3ccc(Oc4ccc(Cl)cc4)cc3)c2c1C		CHEMBL203414	=	IC50	nM	642.0	CHEMBL3587	Homo sapiens	IC50	uM	0.642
	1677281	CHEMBL861916	Inhibitory activity against MEK	B	CCOC(=O)c1cn2ncc(C#N)c(Nc3ccc(Oc4ccccc4OC)cc3)c2c1C		CHEMBL377288	=	IC50	nM	23.0	CHEMBL3587	Homo sapiens	IC50	uM	0.023
	1677282	CHEMBL861916	Inhibitory activity against MEK	B	CCOC(=O)c1cn2ncc(C#N)c(Nc3ccc(OCc4ccccc4)cc3)c2c1C		CHEMBL202211	>	IC50	nM	25000.0	CHEMBL3587	Homo sapiens	IC50	uM	25.0
	1677283	CHEMBL861916	Inhibitory activity against MEK	B	CCOC(=O)c1cn2ncc(C#N)c(NCc3ccc(Oc4ccccc4)cc3)c2c1C		CHEMBL202142	>	IC50	nM	25000.0	CHEMBL3587	Homo sapiens	IC50	uM	25.0
	1677284	CHEMBL861916	Inhibitory activity against MEK	B	CCOC(=O)c1cn2ncc(C#N)c(Oc3ccc(Oc4ccccc4)cc3)c2c1C		CHEMBL201780	=	IC50	nM	5420.0	CHEMBL3587	Homo sapiens	IC50	uM	5.42
	1677285	CHEMBL861916	Inhibitory activity against MEK	B	CCOC(=O)c1cn2ncc(C#N)c(Nc3ccc(C(=O)c4ccccc4)cc3)c2c1C		CHEMBL202545	=	IC50	nM	1110.0	CHEMBL3587	Homo sapiens	IC50	uM	1.11
	1677286	CHEMBL861916	Inhibitory activity against MEK	B	CCOC(=O)c1cn2ncc(C#N)c(Nc3ccc(Cc4ccccc4)cc3)c2c1C		CHEMBL202385	=	IC50	nM	68.0	CHEMBL3587	Homo sapiens	IC50	uM	0.068
	1677287	CHEMBL861916	Inhibitory activity against MEK	B	CCOC(=O)c1cn2ncc(C#N)c(Nc3ccc(Nc4ccccc4)cc3)c2c1C		CHEMBL201246	=	IC50	nM	2320.0	CHEMBL3587	Homo sapiens	IC50	uM	2.32
	1677288	CHEMBL861916	Inhibitory activity against MEK	B	CCOC(=O)c1cn2ncc(C#N)c(Nc3ccc(-c4ccccc4)cc3)c2c1C		CHEMBL201768	>	IC50	nM	25000.0	CHEMBL3587	Homo sapiens	IC50	uM	25.0
	1677289	CHEMBL861916	Inhibitory activity against MEK	B	CCOC(=O)c1cn2ncc(C#N)c(Nc3cccc(Oc4ccccc4)c3)c2c1C		CHEMBL383098	=	IC50	nM	2650.0	CHEMBL3587	Homo sapiens	IC50	uM	2.65
	1677290	CHEMBL861916	Inhibitory activity against MEK	B	CCOC(=O)c1cn2ncc(C#N)c(Nc3ccccc3)c2c1C		CHEMBL377497	>	IC50	nM	25000.0	CHEMBL3587	Homo sapiens	IC50	uM	25.0
	1677291	CHEMBL861916	Inhibitory activity against MEK	B	CCOC(=O)c1cn2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2c1C		CHEMBL202128	=	IC50	nM	3470.0	CHEMBL3587	Homo sapiens	IC50	uM	3.47
	1677292	CHEMBL861916	Inhibitory activity against MEK	B	Cc1c(C(=O)O)cn2ncc(CNS(C)(=O)=O)c(Nc3ccc(Oc4ccccc4)cc3)c12		CHEMBL202228	>	IC50	nM	25000.0	CHEMBL3587	Homo sapiens	IC50	uM	25.0
	1677293	CHEMBL861916	Inhibitory activity against MEK	B	CC(=O)NCc1cnn2cc(C(=O)O)c(C)c2c1Nc1ccc(Oc2ccccc2)cc1		CHEMBL201269	>	IC50	nM	25000.0	CHEMBL3587	Homo sapiens	IC50	uM	25.0
	1677294	CHEMBL861916	Inhibitory activity against MEK	B	Cc1c(C(=O)O)cn2ncc(CN)c(Nc3ccc(Oc4ccccc4)cc3)c12		CHEMBL202143	>	IC50	nM	25000.0	CHEMBL3587	Homo sapiens	IC50	uM	25.0
	1677295	CHEMBL861916	Inhibitory activity against MEK	B	Cc1c(C(=O)O)cn2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c12		CHEMBL200969	=	IC50	nM	147.0	CHEMBL3587	Homo sapiens	IC50	uM	0.147
	1677360	CHEMBL862237	Antiproliferative activity against MEK2 cells (Rat1 cells transformed by human MEK1 cDNA)	F	CCOC(=O)c1cn2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c2c1C		CHEMBL380765	>	Activity	uM	20.0	CHEMBL3587	Homo sapiens	Activity	uM	20.0
	1677361	CHEMBL862237	Antiproliferative activity against MEK2 cells (Rat1 cells transformed by human MEK1 cDNA)	F	CNC(=O)Nc1cn2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c2c1C		CHEMBL383108	=	Activity	uM	9.78	CHEMBL3587	Homo sapiens	Activity	uM	9.78
	1677362	CHEMBL862237	Antiproliferative activity against MEK2 cells (Rat1 cells transformed by human MEK1 cDNA)	F	COc1ccccc1Oc1ccc(Nc2c(C#N)cnn3cc(NC(=O)OCCN4CCOCC4)c(C)c23)cc1		CHEMBL265786	=	Activity	uM	3.67	CHEMBL3587	Homo sapiens	Activity	uM	3.67
	1677363	CHEMBL862237	Antiproliferative activity against MEK2 cells (Rat1 cells transformed by human MEK1 cDNA)	F	CC(=O)Nc1cccc(C(=O)Nc2cn3ncc(C#N)c(Nc4ccc(Oc5ccccc5)cc4)c3c2C)c1		CHEMBL202286	=	Activity	uM	2.5	CHEMBL3587	Homo sapiens	Activity	uM	2.5
	1677364	CHEMBL862237	Antiproliferative activity against MEK2 cells (Rat1 cells transformed by human MEK1 cDNA)	F	Cc1c(NC(=O)c2ccccc2)cn2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c12		CHEMBL202063	=	Activity	uM	12.1	CHEMBL3587	Homo sapiens	Activity	uM	12.1
	1677365	CHEMBL862237	Antiproliferative activity against MEK2 cells (Rat1 cells transformed by human MEK1 cDNA)	F	Cc1c(NC(=O)OCCN2CCOCC2)cn2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c12		CHEMBL204535	=	Activity	uM	0.5	CHEMBL3587	Homo sapiens	Activity	uM	0.5
	1677366	CHEMBL862237	Antiproliferative activity against MEK2 cells (Rat1 cells transformed by human MEK1 cDNA)	F	COC(=O)Nc1cn2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c2c1C		CHEMBL201389	=	Activity	uM	7.65	CHEMBL3587	Homo sapiens	Activity	uM	7.65
	1677367	CHEMBL862237	Antiproliferative activity against MEK2 cells (Rat1 cells transformed by human MEK1 cDNA)	F	Cc1c(NC(=O)NCCN2CCOCC2)cn2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c12		CHEMBL378385	=	Activity	uM	2.45	CHEMBL3587	Homo sapiens	Activity	uM	2.45
	1699562	CHEMBL860405	Inhibition of MKK1 at 10 uM in presence of 100 uM ATP	B	O=C(NC1CCOCC1)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202887	=	Inhibition	%	-3.0	CHEMBL3587	Homo sapiens	Inhibition	%	-3.0
Not Determined	1728722	CHEMBL860390	Inhibitory activity against MEK1 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccco3)ccc12		CHEMBL196964		Activity			CHEMBL3587	Homo sapiens	Activity		
Not Determined	1728765	CHEMBL860390	Inhibitory activity against MEK1 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc(F)cc3)ccc12		CHEMBL197439		Activity			CHEMBL3587	Homo sapiens	Activity		
Not Determined	1728808	CHEMBL860390	Inhibitory activity against MEK1 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccsc3)ccc12		CHEMBL196764		Activity			CHEMBL3587	Homo sapiens	Activity		
Not Determined	1728851	CHEMBL860390	Inhibitory activity against MEK1 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4c3oc3ccccc34)ccc12		CHEMBL196759		Activity			CHEMBL3587	Homo sapiens	Activity		
Not Determined	1728894	CHEMBL860390	Inhibitory activity against MEK1 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cc4ccccc4s3)ccc12		CHEMBL381025		Activity			CHEMBL3587	Homo sapiens	Activity		
Not Determined	1728947	CHEMBL860390	Inhibitory activity against MEK1 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4c3Sc3ccccc3S4)ccc12		CHEMBL199216		Activity			CHEMBL3587	Homo sapiens	Activity		
Not Determined	1728990	CHEMBL860390	Inhibitory activity against MEK1 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)ccc12		CHEMBL436767		Activity			CHEMBL3587	Homo sapiens	Activity		
Not Determined	1729033	CHEMBL860390	Inhibitory activity against MEK1 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4ccccc34)ccc12		CHEMBL199050		Activity			CHEMBL3587	Homo sapiens	Activity		
Not Determined	1729076	CHEMBL860390	Inhibitory activity against MEK1 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(/C=C/c3ccc(Cl)cc3)ccc12		CHEMBL199051		Activity			CHEMBL3587	Homo sapiens	Activity		
Not Determined	1729119	CHEMBL860390	Inhibitory activity against MEK1 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc4[nH]ccc4c3)ccc12		CHEMBL369969		Activity			CHEMBL3587	Homo sapiens	Activity		
Not Determined	1729162	CHEMBL860390	Inhibitory activity against MEK1 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc4ncccc4c3)ccc12		CHEMBL198740		Activity			CHEMBL3587	Homo sapiens	Activity		
Not Determined	1729205	CHEMBL860390	Inhibitory activity against MEK1 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4c3Oc3ccccc3S4)ccc12		CHEMBL197239		Activity			CHEMBL3587	Homo sapiens	Activity		
Not Determined	1729248	CHEMBL860390	Inhibitory activity against MEK1 at 10 uM	B	Nc1cc(C(=O)O)cc(-c2ccc3c(=O)cc(N4CCOCC4)oc3c2)c1		CHEMBL370108		Activity			CHEMBL3587	Homo sapiens	Activity		
Not Determined	1729291	CHEMBL860390	Inhibitory activity against MEK1 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4c3sc3ccccc34)ccc12		CHEMBL198801		Activity			CHEMBL3587	Homo sapiens	Activity		
Not Determined	1729337	CHEMBL860390	Inhibitory activity against MEK1 at 10 uM	B	O=C1c2ccccc2C(=O)N1Cc1cccc(-c2ccc3c(=O)cc(N4CCOCC4)oc3c2)c1		CHEMBL197219		Activity			CHEMBL3587	Homo sapiens	Activity		
Not Determined	1729380	CHEMBL860390	Inhibitory activity against MEK1 at 10 uM	B	O=C1c2ccccc2C(=O)N1Cc1ccc(-c2ccc3c(=O)cc(N4CCOCC4)oc3c2)cc1		CHEMBL197227		Activity			CHEMBL3587	Homo sapiens	Activity		
Not Determined	1729423	CHEMBL860390	Inhibitory activity against MEK1 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccs3)ccc12		CHEMBL371968		Activity			CHEMBL3587	Homo sapiens	Activity		
Not Determined	1729466	CHEMBL860390	Inhibitory activity against MEK1 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc4ccccc4c3)ccc12		CHEMBL200299		Activity			CHEMBL3587	Homo sapiens	Activity		
Not Determined	1729509	CHEMBL860390	Inhibitory activity against MEK1 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3csc4ccccc34)ccc12		CHEMBL199416		Activity			CHEMBL3587	Homo sapiens	Activity		
Not Determined	1729552	CHEMBL860390	Inhibitory activity against MEK1 at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc(OCc4ccccc4)cc3)ccc12		CHEMBL382501		Activity			CHEMBL3587	Homo sapiens	Activity		
Not Determined	1729610	CHEMBL860390	Inhibitory activity against MEK1 at 10 uM	B	Cc1ccc(-c2ccc3c(=O)cc(N4CCOCC4)oc3c2)c2ccccc12		CHEMBL200275		Activity			CHEMBL3587	Homo sapiens	Activity		
Not Determined	1729653	CHEMBL860390	Inhibitory activity against MEK1 at 10 uM	B	COC(=O)/C=C/c1ccccc1-c1ccc2c(=O)cc(N3CCOCC3)oc2c1		CHEMBL199424		Activity			CHEMBL3587	Homo sapiens	Activity		
	1734169	CHEMBL862495	Residual activity at human MEK1 at 10 uM in presence of 10 uM ATP relative to control	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1		CHEMBL379156	=	Activity	%	96.0	CHEMBL3587	Homo sapiens	Activity	%	96.0
	1744626	CHEMBL866826	Inhibition of MEK	B	O=C(NC1CC1)c1cc(NCc2cnc(Nc3ccccn3)s2)c(F)cc1F		CHEMBL377734	>	IC50	nM	5000.0	CHEMBL3587	Homo sapiens	IC50	nM	5000.0
	1747813	CHEMBL867341	Inhibition of MEK1	B	N#Cc1c(O)nsc1N1CCCCC1		CHEMBL378493	>	IC50	nM	5000.0	CHEMBL3587	Homo sapiens	IC50	uM	5.0
	1747815	CHEMBL867341	Inhibition of MEK1	B	N#Cc1c(O)nsc1Oc1ccc(Oc2ccccc2)cc1		CHEMBL386042	>	IC50	nM	5000.0	CHEMBL3587	Homo sapiens	IC50	uM	5.0
	1747816	CHEMBL867341	Inhibition of MEK1	B	COc1nsc(Nc2ccccc2)c1C#N		CHEMBL215185	>	IC50	nM	5000.0	CHEMBL3587	Homo sapiens	IC50	uM	5.0
	1747817	CHEMBL867341	Inhibition of MEK1	B	Cn1sc(Nc2ccccc2)c(C#N)c1=O		CHEMBL386373	>	IC50	nM	5000.0	CHEMBL3587	Homo sapiens	IC50	uM	5.0
	1747818	CHEMBL867341	Inhibition of MEK1	B	CC(C)c1ccc(Sc2snc(O)c2C#N)cc1		CHEMBL385439	>	IC50	nM	5000.0	CHEMBL3587	Homo sapiens	IC50	uM	5.0
	1751621	CHEMBL867949	Inhibition of MKK1	B	CC(C)c1nnc2ccc(-c3ocnc3-c3ccc(F)cc3Cl)cn12		CHEMBL215652	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	1751622	CHEMBL867949	Inhibition of MKK1	B	CC(C)c1nnc2ccc(-c3ocnc3-c3cc(F)c(F)cc3F)cn12		CHEMBL213423	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	1751623	CHEMBL867949	Inhibition of MKK1	B	CCNc1nnc2ccc(-c3ocnc3-c3ccc(F)cc3)cn12		CHEMBL213451	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	1751624	CHEMBL867949	Inhibition of MKK1	B	CC(C)(C)c1nnc2ccc(-c3ocnc3-c3ccc(F)cc3F)cn12		CHEMBL212382	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	1751625	CHEMBL867949	Inhibition of MKK1	B	CC(C)(C)c1nnc2ccc(-c3ocnc3-c3cc(F)c(F)cc3F)cn12		CHEMBL212968	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	1751626	CHEMBL867949	Inhibition of MKK1	B	CC(C)c1nnc2ccc(-c3c[nH]nc3-c3cc(F)ccc3F)cn12		CHEMBL214198	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	1751661	CHEMBL867949	Inhibition of MKK1	B	CC(C)c1nnc2ccc(-c3ocnc3-c3ccccc3)cn12		CHEMBL379929	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	1755423	CHEMBL867341	Inhibition of MEK1	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(I)cc1		CHEMBL375410	=	IC50	nM	1440.0	CHEMBL3587	Homo sapiens	IC50	uM	1.44
	1755424	CHEMBL867341	Inhibition of MEK1	B	Cc1cc(I)ccc1Nc1snc(O)c1/C(N)=N/C(C)C		CHEMBL211359	=	IC50	nM	62.0	CHEMBL3587	Homo sapiens	IC50	uM	0.062
	1755425	CHEMBL867341	Inhibition of MEK1	B	CC(C)/N=C(\N)c1c(O)nsc1Nc1ccc(I)cc1Cl		CHEMBL213992	=	IC50	nM	42.0	CHEMBL3587	Homo sapiens	IC50	uM	0.042
	1755426	CHEMBL867341	Inhibition of MEK1	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(I)cc1Cl		CHEMBL213167	=	IC50	nM	44.0	CHEMBL3587	Homo sapiens	IC50	uM	0.044
	1755427	CHEMBL867341	Inhibition of MEK1	B	CC(C)/N=C(\N)c1c(O)nsc1Nc1ccc(C(F)(F)F)cc1Cl		CHEMBL377783	=	IC50	nM	68.0	CHEMBL3587	Homo sapiens	IC50	uM	0.068
	1755428	CHEMBL867341	Inhibition of MEK1	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(C(F)(F)F)cc1Cl		CHEMBL213168	=	IC50	nM	86.0	CHEMBL3587	Homo sapiens	IC50	uM	0.086
	1755429	CHEMBL867341	Inhibition of MEK1	B	CC(C)/N=C(\N)c1c(O)nsc1Nc1cccc(Cl)c1Cl		CHEMBL213651	=	IC50	nM	220.0	CHEMBL3587	Homo sapiens	IC50	uM	0.22
	1755430	CHEMBL867341	Inhibition of MEK1	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1cccc(Cl)c1Cl		CHEMBL375609	=	IC50	nM	38.0	CHEMBL3587	Homo sapiens	IC50	uM	0.038
	1755464	CHEMBL867341	Inhibition of MEK1	B	Cc1cc(I)ccc1Nc1snc(O)c1/C(N)=N/C(C)CO		CHEMBL211201	=	IC50	nM	73.0	CHEMBL3587	Homo sapiens	IC50	uM	0.073
	1755465	CHEMBL867341	Inhibition of MEK1	B	CC(C)/N=C(\N)c1c(O)nsc1Nc1ccc(I)cc1		CHEMBL209868	=	IC50	nM	510.0	CHEMBL3587	Homo sapiens	IC50	uM	0.51
	1759181	CHEMBL867341	Inhibition of MEK1	B	Cc1ccc(Nc2snc(O)c2C(=N)NCC2CCCCC2)cc1		CHEMBL212480	=	IC50	nM	1200.0	CHEMBL3587	Homo sapiens	IC50	uM	1.2
	1759182	CHEMBL867341	Inhibition of MEK1	B	COc1ccccc1Nc1snc(O)c1C(=N)NCC1CCCCC1		CHEMBL213562	=	IC50	nM	1440.0	CHEMBL3587	Homo sapiens	IC50	uM	1.44
	1759183	CHEMBL867341	Inhibition of MEK1	B	N/C(=N\CC1CCCCC1)c1c(O)nsc1Nc1ccc(Cl)cc1		CHEMBL213563	=	IC50	nM	420.0	CHEMBL3587	Homo sapiens	IC50	uM	0.42
	1759184	CHEMBL867341	Inhibition of MEK1	B	Cc1ccc(Nc2snc(O)c2C(=N)NCC2CCCCC2)c(C)c1		CHEMBL209502	=	IC50	nM	690.0	CHEMBL3587	Homo sapiens	IC50	uM	0.69
	1759185	CHEMBL867341	Inhibition of MEK1	B	COc1cc([N+](=O)[O-])ccc1Nc1snc(O)c1C(=N)NCC1CCCCC1		CHEMBL378688	=	IC50	nM	670.0	CHEMBL3587	Homo sapiens	IC50	uM	0.67
	1759186	CHEMBL867341	Inhibition of MEK1	B	N/C(=N\CC1CCCCC1)c1c(O)nsc1Nc1ccc(Cl)c([N+](=O)[O-])c1		CHEMBL209489	=	IC50	nM	1390.0	CHEMBL3587	Homo sapiens	IC50	uM	1.39
	1759187	CHEMBL867341	Inhibition of MEK1	B	N/C(=N\CC1CCCCC1)c1c(O)nsc1Nc1ccccc1F		CHEMBL209520	=	IC50	nM	1450.0	CHEMBL3587	Homo sapiens	IC50	uM	1.45
	1759188	CHEMBL867341	Inhibition of MEK1	B	COC(=O)c1ccc(Nc2snc(O)c2C(=N)NCC2CCCCC2)cc1		CHEMBL377592	=	IC50	nM	350.0	CHEMBL3587	Homo sapiens	IC50	uM	0.35
	1759189	CHEMBL867341	Inhibition of MEK1	B	N/C(=N\CC1CCCCC1)c1c(O)nsc1Nc1cccnc1		CHEMBL377591	=	IC50	nM	1230.0	CHEMBL3587	Homo sapiens	IC50	uM	1.23
	1759190	CHEMBL867341	Inhibition of MEK1	B	N/C(=N\CC1CCCCC1)c1c(O)nsc1Nc1cccc(Br)c1		CHEMBL378719	=	IC50	nM	500.0	CHEMBL3587	Homo sapiens	IC50	uM	0.5
	1759191	CHEMBL867341	Inhibition of MEK1	B	N/C(=N\CC1CCCCC1)c1c(O)nsc1Nc1ccc(Br)cc1		CHEMBL212110	=	IC50	nM	430.0	CHEMBL3587	Homo sapiens	IC50	uM	0.43
	1759192	CHEMBL867341	Inhibition of MEK1	B	N/C(=N\CC1CCCCC1)c1c(O)nsc1Nc1cccc(Cl)c1		CHEMBL378014	=	IC50	nM	500.0	CHEMBL3587	Homo sapiens	IC50	uM	0.5
	1759193	CHEMBL867341	Inhibition of MEK1	B	N/C(=N\CC1CCCCC1)c1c(O)nsc1Nc1cc(Cl)cc(Cl)c1		CHEMBL378833	=	IC50	nM	790.0	CHEMBL3587	Homo sapiens	IC50	uM	0.79
	1759194	CHEMBL867341	Inhibition of MEK1	B	N/C(=N\CC1CCCCC1)c1c(O)nsc1Nc1ccc(Cl)cc1Cl		CHEMBL380328	=	IC50	nM	410.0	CHEMBL3587	Homo sapiens	IC50	uM	0.41
	1759195	CHEMBL867341	Inhibition of MEK1	B	Cc1ccc(Nc2snc(O)c2C(=N)NCC2CCCCC2)cc1		CHEMBL212480	=	IC50	nM	740.0	CHEMBL3587	Homo sapiens	IC50	uM	0.74
	1759196	CHEMBL867341	Inhibition of MEK1	B	CCNC(=O)c1c(O)nsc1Nc1ccc(C)cc1		CHEMBL209428	>	IC50	nM	2000.0	CHEMBL3587	Homo sapiens	IC50	uM	2.0
	1759197	CHEMBL867341	Inhibition of MEK1	B	Cc1ccc(Nc2snc(O)c2C(=N)NO)cc1		CHEMBL378278	>	IC50	nM	2000.0	CHEMBL3587	Homo sapiens	IC50	uM	2.0
	1759198	CHEMBL867341	Inhibition of MEK1	B	Cc1ccc(Nc2snc(O)c2C(=N)NN2CCCCC2)cc1		CHEMBL213797	>	IC50	nM	2000.0	CHEMBL3587	Homo sapiens	IC50	uM	2.0
	1759199	CHEMBL867341	Inhibition of MEK1	B	COc1cc(Nc2snc(O)c2C2=NNNN2)cc(OC)c1		CHEMBL210072	>	IC50	nM	2000.0	CHEMBL3587	Homo sapiens	IC50	uM	2.0
	1759200	CHEMBL867341	Inhibition of MEK1	B	N#Cc1c(O)nsc1Nc1ccc(Cl)cc1		CHEMBL425065	=	IC50	nM	410.0	CHEMBL3587	Homo sapiens	IC50	uM	0.41
	1759201	CHEMBL867341	Inhibition of MEK1	B	N#Cc1c(O)nsc1Nc1cc(Cl)cc(Cl)c1		CHEMBL212474	=	IC50	nM	800.0	CHEMBL3587	Homo sapiens	IC50	uM	0.8
	1759202	CHEMBL867341	Inhibition of MEK1	B	N#Cc1c(O)nsc1Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL212305	=	IC50	nM	650.0	CHEMBL3587	Homo sapiens	IC50	uM	0.65
	1759203	CHEMBL867341	Inhibition of MEK1	B	N#Cc1c(O)nsc1Nc1cc(Cl)ccc1Cl		CHEMBL209845	=	IC50	nM	620.0	CHEMBL3587	Homo sapiens	IC50	uM	0.62
	1759204	CHEMBL867341	Inhibition of MEK1	B	N#Cc1c(O)nsc1Nc1ccc(Cl)cc1Cl		CHEMBL385820	=	IC50	nM	250.0	CHEMBL3587	Homo sapiens	IC50	uM	0.25
	1759205	CHEMBL867341	Inhibition of MEK1	B	N#Cc1c(O)nsc1Nc1cccc(Br)c1		CHEMBL212214	=	IC50	nM	500.0	CHEMBL3587	Homo sapiens	IC50	uM	0.5
	1759206	CHEMBL867341	Inhibition of MEK1	B	COCCCNc1snc(O)c1C#N		CHEMBL211316	>	IC50	nM	5000.0	CHEMBL3587	Homo sapiens	IC50	uM	5.0
	1759207	CHEMBL867341	Inhibition of MEK1	B	CC(C)Nc1snc(O)c1C#N		CHEMBL211796	>	IC50	nM	5000.0	CHEMBL3587	Homo sapiens	IC50	uM	5.0
	1759208	CHEMBL867341	Inhibition of MEK1	B	N#Cc1c(O)nsc1NCCCN1CCOCC1		CHEMBL378351	>	IC50	nM	5000.0	CHEMBL3587	Homo sapiens	IC50	uM	5.0
	1759209	CHEMBL867341	Inhibition of MEK1	B	N#Cc1c(O)nsc1NCC1CCCCC1		CHEMBL212061	>	IC50	nM	5000.0	CHEMBL3587	Homo sapiens	IC50	uM	5.0
	1759210	CHEMBL867341	Inhibition of MEK1	B	N#Cc1c(O)nsc1NCCc1cccs1		CHEMBL209675	>	IC50	nM	5000.0	CHEMBL3587	Homo sapiens	IC50	uM	5.0
	1759211	CHEMBL867341	Inhibition of MEK1	B	N#Cc1c(O)nsc1NCCc1ccc(O)cc1		CHEMBL214349	>	IC50	nM	5000.0	CHEMBL3587	Homo sapiens	IC50	uM	5.0
	1759212	CHEMBL867341	Inhibition of MEK1	B	CC(Nc1snc(O)c1C#N)c1ccccc1		CHEMBL208778	>	IC50	nM	5000.0	CHEMBL3587	Homo sapiens	IC50	uM	5.0
	1759213	CHEMBL867341	Inhibition of MEK1	B	N#Cc1c(O)nsc1Nc1cccnc1		CHEMBL213847	>	IC50	nM	5000.0	CHEMBL3587	Homo sapiens	IC50	uM	5.0
	1759214	CHEMBL867341	Inhibition of MEK1	B	CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1cn(C)c2ccccc12)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C		CHEMBL269552	>	IC50	nM	5000.0	CHEMBL3587	Homo sapiens	IC50	uM	5.0
	1759215	CHEMBL867341	Inhibition of MEK1	B	CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccc(F)cc12)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C		CHEMBL219860	>	IC50	nM	5000.0	CHEMBL3587	Homo sapiens	IC50	uM	5.0
	1759216	CHEMBL867341	Inhibition of MEK1	B	CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](Cc1cn(C)c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccc(F)cc12)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C		CHEMBL427239	>	IC50	nM	5000.0	CHEMBL3587	Homo sapiens	IC50	uM	5.0
	1759217	CHEMBL867341	Inhibition of MEK1	B	COc1ccccc1Nc1snc(O)c1C#N		CHEMBL378938	>	IC50	nM	5000.0	CHEMBL3587	Homo sapiens	IC50	uM	5.0
	1759218	CHEMBL867341	Inhibition of MEK1	B	COc1ccc(Nc2snc(O)c2C#N)cc1		CHEMBL380295	>	IC50	nM	5000.0	CHEMBL3587	Homo sapiens	IC50	uM	5.0
	1759219	CHEMBL867341	Inhibition of MEK1	B	COc1cccc(Nc2snc(O)c2C#N)c1		CHEMBL211488	>	IC50	nM	5000.0	CHEMBL3587	Homo sapiens	IC50	uM	5.0
	1759220	CHEMBL867341	Inhibition of MEK1	B	N#Cc1c(O)nsc1Nc1ccccc1[N+](=O)[O-]		CHEMBL378296	>	IC50	nM	5000.0	CHEMBL3587	Homo sapiens	IC50	uM	5.0
	1759221	CHEMBL867341	Inhibition of MEK1	B	N#Cc1c(O)nsc1Nc1cccc([N+](=O)[O-])c1		CHEMBL214067	>	IC50	nM	5000.0	CHEMBL3587	Homo sapiens	IC50	uM	5.0
	1759222	CHEMBL867341	Inhibition of MEK1	B	N#Cc1c(O)nsc1Nc1ccc([N+](=O)[O-])cc1		CHEMBL214348	>	IC50	nM	5000.0	CHEMBL3587	Homo sapiens	IC50	uM	5.0
	1759223	CHEMBL867341	Inhibition of MEK1	B	N#Cc1c(O)nsc1Nc1ccccc1C(F)(F)F		CHEMBL211481	>	IC50	nM	5000.0	CHEMBL3587	Homo sapiens	IC50	uM	5.0
	1759224	CHEMBL867341	Inhibition of MEK1	B	N#Cc1ccc(Nc2snc(O)c2C#N)cc1		CHEMBL211382	>	IC50	nM	5000.0	CHEMBL3587	Homo sapiens	IC50	uM	5.0
	1759225	CHEMBL867341	Inhibition of MEK1	B	COC(=O)c1cccc(Nc2snc(O)c2C#N)c1		CHEMBL210154	>	IC50	nM	5000.0	CHEMBL3587	Homo sapiens	IC50	uM	5.0
	1759226	CHEMBL867341	Inhibition of MEK1	B	CCCCNc1snc(O)c1C#N		CHEMBL377547	>	IC50	nM	5000.0	CHEMBL3587	Homo sapiens	IC50	uM	5.0
	1759227	CHEMBL867341	Inhibition of MEK1	B	N#Cc1c(O)nsc1Nc1ccccc1		CHEMBL209793	=	IC50	nM	7000.0	CHEMBL3587	Homo sapiens	IC50	uM	7.0
	1759650	CHEMBL867341	Inhibition of MEK1	B	N#Cc1c(O)nsc1NCCc1ccccc1		CHEMBL211546	>	IC50	nM	5000.0	CHEMBL3587	Homo sapiens	IC50	uM	5.0
	1769404	CHEMBL910924	Inhibition of MEK1	B	C[C@@H]1C[C@H]2CN1CCn1nc3c(cccc3c1O)-c1nc3c(cccc3nc1O)O2		CHEMBL215803	>	IC50	nM	1000.0	CHEMBL3587	Homo sapiens	IC50	uM	1.0
	1790033	CHEMBL854701	Percentage activity of human MEK1 in the presence of 10 uM of compound and 10 uM of ATP in comparison with control	B	O=C(NCc1ccc(S(=O)(=O)N2CCC(n3nnc4ccccc43)CC2)s1)c1ccc(Cl)cc1		CHEMBL383955	=	Activity	%	98.0	CHEMBL3587	Homo sapiens	Activity	%	98.0
	1790109	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1cccc(Cl)c1Cl		CHEMBL375609	=	IC50	nM	38.0	CHEMBL3587	Homo sapiens	IC50	nM	38.0
	1790110	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(CO)/N=C(\N)c1c(O)nsc1Nc1cccc(Cl)c1Cl		CHEMBL375609	=	EC50	nM	375.0	CHEMBL3587	Homo sapiens	EC50	nM	375.0
	1790112	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(CO)NC(=N)c1c(O)nsc1Nc1ccc(Nc2ccccc2)cc1		CHEMBL253116	=	IC50	nM	240.0	CHEMBL3587	Homo sapiens	IC50	nM	240.0
	1790113	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(CO)NC(=N)c1c(O)nsc1Nc1ccc(Nc2ccccc2)cc1		CHEMBL253116	=	EC50	nM	45.0	CHEMBL3587	Homo sapiens	EC50	nM	45.0
	1790114	CHEMBL873742	Inhibition of MEK-1	B	CC(CO)NC(=N)c1c(O)nsc1Nc1ccc(Nc2ccccc2)cc1		CHEMBL253116	=	IC50	nM	266.0	CHEMBL3587	Homo sapiens	IC50	nM	266.0
	1790121	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Cc2ccccc2)cc1		CHEMBL217310	=	IC50	nM	58.0	CHEMBL3587	Homo sapiens	IC50	nM	58.0
	1790122	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Cc2ccccc2)cc1		CHEMBL217310	=	EC50	nM	130.0	CHEMBL3587	Homo sapiens	EC50	nM	130.0
	1790125	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(C(=O)c2ccccc2)cc1		CHEMBL217130	=	IC50	nM	120.0	CHEMBL3587	Homo sapiens	IC50	nM	120.0
	1790126	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(C(=O)c2ccccc2)cc1		CHEMBL217130	=	EC50	nM	100.0	CHEMBL3587	Homo sapiens	EC50	nM	100.0
	1790129	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Sc2ccccc2)cc1		CHEMBL386230	=	IC50	nM	45.0	CHEMBL3587	Homo sapiens	IC50	nM	45.0
	1790130	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Sc2ccccc2)cc1		CHEMBL386230	=	EC50	nM	650.0	CHEMBL3587	Homo sapiens	EC50	nM	650.0
	1790133	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(S(=O)(=O)c2ccccc2)cc1		CHEMBL217117	=	IC50	nM	150.0	CHEMBL3587	Homo sapiens	IC50	nM	150.0
	1790134	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(S(=O)(=O)c2ccccc2)cc1		CHEMBL217117	=	EC50	nM	278.0	CHEMBL3587	Homo sapiens	EC50	nM	278.0
	1790137	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(C(C)(C)c2ccccc2)cc1		CHEMBL385703	=	IC50	nM	7900.0	CHEMBL3587	Homo sapiens	IC50	nM	7900.0
	1790138	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(C(C)(C)c2ccccc2)cc1		CHEMBL385703	=	EC50	nM	1500.0	CHEMBL3587	Homo sapiens	EC50	nM	1500.0
	1790141	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cccc(C(F)(F)F)c2)cc1		CHEMBL265478	=	IC50	nM	44.0	CHEMBL3587	Homo sapiens	IC50	nM	44.0
	1790142	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cccc(C(F)(F)F)c2)cc1		CHEMBL265478	=	EC50	nM	140.0	CHEMBL3587	Homo sapiens	EC50	nM	140.0
	1790144	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cccc(C(F)(F)F)c2F)cc1		CHEMBL217832	=	IC50	nM	58.0	CHEMBL3587	Homo sapiens	IC50	nM	58.0
	1790145	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cccc(C(F)(F)F)c2F)cc1		CHEMBL217832	=	EC50	nM	123.0	CHEMBL3587	Homo sapiens	EC50	nM	123.0
	1790147	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cccc(C(F)(F)F)c2Cl)cc1		CHEMBL217833	=	IC50	nM	120.0	CHEMBL3587	Homo sapiens	IC50	nM	120.0
	1790148	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cccc(C(F)(F)F)c2Cl)cc1		CHEMBL217833	=	EC50	nM	95.0	CHEMBL3587	Homo sapiens	EC50	nM	95.0
	1790150	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cc(C(F)(F)F)ccc2Cl)cc1		CHEMBL217355	=	IC50	nM	540.0	CHEMBL3587	Homo sapiens	IC50	nM	540.0
	1790151	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cc(C(F)(F)F)ccc2Cl)cc1		CHEMBL217355	=	EC50	nM	350.0	CHEMBL3587	Homo sapiens	EC50	nM	350.0
	1790153	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cc(F)cc(C(F)(F)F)c2)cc1		CHEMBL425980	=	IC50	nM	140.0	CHEMBL3587	Homo sapiens	IC50	nM	140.0
	1790154	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cc(F)cc(C(F)(F)F)c2)cc1		CHEMBL425980	=	EC50	nM	30.0	CHEMBL3587	Homo sapiens	EC50	nM	30.0
	1790156	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cccc(N(C)C)c2)cc1		CHEMBL413636	=	IC50	nM	160.0	CHEMBL3587	Homo sapiens	IC50	nM	160.0
	1790157	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cccc(N(C)C)c2)cc1		CHEMBL413636	=	EC50	nM	130.0	CHEMBL3587	Homo sapiens	EC50	nM	130.0
	1790159	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cccc(C(F)(F)F)c2Cl)c(Cl)c1		CHEMBL217126	=	IC50	nM	67.0	CHEMBL3587	Homo sapiens	IC50	nM	67.0
	1790160	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cccc(C(F)(F)F)c2Cl)c(Cl)c1		CHEMBL217126	=	EC50	nM	70.0	CHEMBL3587	Homo sapiens	EC50	nM	70.0
	1790162	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cccc(C(F)(F)F)c2Cl)c(F)c1		CHEMBL217414	=	IC50	nM	52.0	CHEMBL3587	Homo sapiens	IC50	nM	52.0
	1790163	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cccc(C(F)(F)F)c2Cl)c(F)c1		CHEMBL217414	=	EC50	nM	88.0	CHEMBL3587	Homo sapiens	EC50	nM	88.0
	1790165	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cc(C(F)(F)F)ccc2F)cc1		CHEMBL217415	=	IC50	nM	60.0	CHEMBL3587	Homo sapiens	IC50	nM	60.0
	1790166	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cc(C(F)(F)F)ccc2F)cc1		CHEMBL217415	=	EC50	nM	330.0	CHEMBL3587	Homo sapiens	EC50	nM	330.0
	1790168	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cc(Cl)ccc2Cl)cc1		CHEMBL215193	=	IC50	nM	30.0	CHEMBL3587	Homo sapiens	IC50	nM	30.0
	1790169	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cc(Cl)ccc2Cl)cc1		CHEMBL215193	=	EC50	nM	130.0	CHEMBL3587	Homo sapiens	EC50	nM	130.0
	1790171	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cc(F)ccc2Cl)cc1		CHEMBL214425	=	IC50	nM	80.0	CHEMBL3587	Homo sapiens	IC50	nM	80.0
	1790172	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cc(F)ccc2Cl)cc1		CHEMBL214425	=	EC50	nM	260.0	CHEMBL3587	Homo sapiens	EC50	nM	260.0
	1790174	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cc(Cl)ccc2Cl)c(F)c1		CHEMBL385446	=	IC50	nM	26.0	CHEMBL3587	Homo sapiens	IC50	nM	26.0
	1790175	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cc(Cl)ccc2Cl)c(F)c1		CHEMBL385446	=	EC50	nM	220.0	CHEMBL3587	Homo sapiens	EC50	nM	220.0
	1790177	CHEMBL873739	Inhibition of MEK-1 activity	B	Cc1cc(Nc2snc(O)c2/C(N)=N/C(C)CO)ccc1Oc1cc(F)ccc1Cl		CHEMBL217416	=	IC50	nM	280.0	CHEMBL3587	Homo sapiens	IC50	nM	280.0
	1790178	CHEMBL873740	Inhibitory activity against MEK-1	F	Cc1cc(Nc2snc(O)c2/C(N)=N/C(C)CO)ccc1Oc1cc(F)ccc1Cl		CHEMBL217416	=	EC50	nM	350.0	CHEMBL3587	Homo sapiens	EC50	nM	350.0
	1790180	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cc(F)ccc2Cl)c(Cl)c1		CHEMBL269696	=	IC50	nM	30.0	CHEMBL3587	Homo sapiens	IC50	nM	30.0
	1790181	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cc(F)ccc2Cl)c(Cl)c1		CHEMBL269696	>	EC50	nM	10.0	CHEMBL3587	Homo sapiens	EC50	nM	10.0
	1790183	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cccc(Cl)c2Cl)cc1		CHEMBL214032	=	IC50	nM	75.0	CHEMBL3587	Homo sapiens	IC50	nM	75.0
	1790184	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cccc(Cl)c2Cl)cc1		CHEMBL214032	=	EC50	nM	100.0	CHEMBL3587	Homo sapiens	EC50	nM	100.0
	1790186	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cccc(F)c2F)cc1		CHEMBL214613	=	IC50	nM	20.0	CHEMBL3587	Homo sapiens	IC50	nM	20.0
	1790187	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cccc(F)c2F)cc1		CHEMBL214613	=	EC50	nM	42.0	CHEMBL3587	Homo sapiens	EC50	nM	42.0
	1790189	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cccc(Cl)c2Cl)c(Cl)c1		CHEMBL214614	=	IC50	nM	27.0	CHEMBL3587	Homo sapiens	IC50	nM	27.0
	1790190	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cccc(Cl)c2Cl)c(Cl)c1		CHEMBL214614	>	EC50	nM	10.0	CHEMBL3587	Homo sapiens	EC50	nM	10.0
	1790192	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cccc(Cl)c2F)cc1		CHEMBL385203	=	IC50	nM	145.0	CHEMBL3587	Homo sapiens	IC50	nM	145.0
	1790193	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cccc(Cl)c2F)cc1		CHEMBL385203	=	EC50	nM	200.0	CHEMBL3587	Homo sapiens	EC50	nM	200.0
	1790195	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cc(Cl)cc(Cl)c2)cc1		CHEMBL214734	=	IC50	nM	20.0	CHEMBL3587	Homo sapiens	IC50	nM	20.0
	1790196	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cc(Cl)cc(Cl)c2)cc1		CHEMBL214734	=	EC50	nM	1450.0	CHEMBL3587	Homo sapiens	EC50	nM	1450.0
	1790198	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cc(F)cc(F)c2)cc1		CHEMBL215011	=	IC50	nM	207.0	CHEMBL3587	Homo sapiens	IC50	nM	207.0
	1790199	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cc(F)cc(F)c2)cc1		CHEMBL215011	=	EC50	nM	128.0	CHEMBL3587	Homo sapiens	EC50	nM	128.0
	1790201	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2ccc(F)cc2Cl)cc1		CHEMBL215012	=	IC50	nM	85.0	CHEMBL3587	Homo sapiens	IC50	nM	85.0
	1790202	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2ccc(F)cc2Cl)cc1		CHEMBL215012	=	EC50	nM	250.0	CHEMBL3587	Homo sapiens	EC50	nM	250.0
	1790204	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2ccc(F)cc2Cl)c(Cl)c1		CHEMBL384784	=	IC50	nM	107.0	CHEMBL3587	Homo sapiens	IC50	nM	107.0
	1790205	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2ccc(F)cc2Cl)c(Cl)c1		CHEMBL384784	=	EC50	nM	37.0	CHEMBL3587	Homo sapiens	EC50	nM	37.0
	1790207	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2ccc(Cl)cc2Cl)cc1		CHEMBL214816	=	IC50	nM	64.0	CHEMBL3587	Homo sapiens	IC50	nM	64.0
	1790208	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2ccc(Cl)cc2Cl)cc1		CHEMBL214816	=	EC50	nM	140.0	CHEMBL3587	Homo sapiens	EC50	nM	140.0
	1790210	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2ccc(F)cc2F)cc1		CHEMBL214752	=	IC50	nM	2007.0	CHEMBL3587	Homo sapiens	IC50	nM	2007.0
	1790211	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2ccc(F)cc2F)cc1		CHEMBL214752	=	EC50	nM	150.0	CHEMBL3587	Homo sapiens	EC50	nM	150.0
	1790213	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cc(F)cc(F)c2Cl)cc1		CHEMBL215038	=	IC50	nM	37.0	CHEMBL3587	Homo sapiens	IC50	nM	37.0
	1790214	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cc(F)cc(F)c2Cl)cc1		CHEMBL215038	=	EC50	nM	78.0	CHEMBL3587	Homo sapiens	EC50	nM	78.0
	1790216	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cc(F)cc(F)c2Cl)c(F)c1		CHEMBL387184	=	IC50	nM	27.0	CHEMBL3587	Homo sapiens	IC50	nM	27.0
	1790217	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cc(F)cc(F)c2Cl)c(F)c1		CHEMBL387184	=	EC50	nM	332.0	CHEMBL3587	Homo sapiens	EC50	nM	332.0
	1790219	CHEMBL873739	Inhibition of MEK-1 activity	B	Cc1cc(Oc2ccc(F)cc2Cl)ccc1Nc1snc(O)c1/C(N)=N/C(C)CO		CHEMBL424897	=	IC50	nM	57.0	CHEMBL3587	Homo sapiens	IC50	nM	57.0
	1790220	CHEMBL873740	Inhibitory activity against MEK-1	F	Cc1cc(Oc2ccc(F)cc2Cl)ccc1Nc1snc(O)c1/C(N)=N/C(C)CO		CHEMBL424897	=	EC50	nM	250.0	CHEMBL3587	Homo sapiens	EC50	nM	250.0
	1790222	CHEMBL873739	Inhibition of MEK-1 activity	B	N/C(=N\N1CCOCC1)c1c(O)nsc1Nc1ccc(Oc2cc(Cl)ccc2Cl)cc1		CHEMBL214901	=	IC50	nM	32.0	CHEMBL3587	Homo sapiens	IC50	nM	32.0
	1790223	CHEMBL873740	Inhibitory activity against MEK-1	F	N/C(=N\N1CCOCC1)c1c(O)nsc1Nc1ccc(Oc2cc(Cl)ccc2Cl)cc1		CHEMBL214901	=	EC50	nM	47.0	CHEMBL3587	Homo sapiens	EC50	nM	47.0
	1790225	CHEMBL873739	Inhibition of MEK-1 activity	B	N/C(=N\CCN1CCOCC1)c1c(O)nsc1Nc1ccc(Oc2cc(Cl)ccc2Cl)cc1		CHEMBL214587	=	IC50	nM	40.0	CHEMBL3587	Homo sapiens	IC50	nM	40.0
	1790226	CHEMBL873740	Inhibitory activity against MEK-1	F	N/C(=N\CCN1CCOCC1)c1c(O)nsc1Nc1ccc(Oc2cc(Cl)ccc2Cl)cc1		CHEMBL214587	=	EC50	nM	35.0	CHEMBL3587	Homo sapiens	EC50	nM	35.0
	1790228	CHEMBL873739	Inhibition of MEK-1 activity	B	N/C(=N\CCCN1CCOCC1)c1c(O)nsc1Nc1ccc(Oc2cc(Cl)ccc2Cl)cc1		CHEMBL214636	=	IC50	nM	147.0	CHEMBL3587	Homo sapiens	IC50	nM	147.0
	1790229	CHEMBL873740	Inhibitory activity against MEK-1	F	N/C(=N\CCCN1CCOCC1)c1c(O)nsc1Nc1ccc(Oc2cc(Cl)ccc2Cl)cc1		CHEMBL214636	=	EC50	nM	284.0	CHEMBL3587	Homo sapiens	EC50	nM	284.0
	1790231	CHEMBL873739	Inhibition of MEK-1 activity	B	CN1CCN(/N=C(\N)c2c(O)nsc2Nc2ccc(Oc3cc(Cl)ccc3Cl)cc2)CC1		CHEMBL383858	=	IC50	nM	34.0	CHEMBL3587	Homo sapiens	IC50	nM	34.0
	1790232	CHEMBL873740	Inhibitory activity against MEK-1	F	CN1CCN(/N=C(\N)c2c(O)nsc2Nc2ccc(Oc3cc(Cl)ccc3Cl)cc2)CC1		CHEMBL383858	=	EC50	nM	113.0	CHEMBL3587	Homo sapiens	EC50	nM	113.0
	1790234	CHEMBL873739	Inhibition of MEK-1 activity	B	CN1CCN(CC/N=C(\N)c2c(O)nsc2Nc2ccc(Oc3cc(Cl)ccc3Cl)cc2)CC1		CHEMBL214977	=	IC50	nM	137.0	CHEMBL3587	Homo sapiens	IC50	nM	137.0
	1790235	CHEMBL873740	Inhibitory activity against MEK-1	F	CN1CCN(CC/N=C(\N)c2c(O)nsc2Nc2ccc(Oc3cc(Cl)ccc3Cl)cc2)CC1		CHEMBL214977	=	EC50	nM	118.0	CHEMBL3587	Homo sapiens	EC50	nM	118.0
	1790237	CHEMBL873739	Inhibition of MEK-1 activity	B	CN1CCN(CCC/N=C(\N)c2c(O)nsc2Nc2ccc(Oc3cc(Cl)ccc3Cl)cc2)CC1		CHEMBL386457	=	IC50	nM	298.0	CHEMBL3587	Homo sapiens	IC50	nM	298.0
	1790238	CHEMBL873740	Inhibitory activity against MEK-1	F	CN1CCN(CCC/N=C(\N)c2c(O)nsc2Nc2ccc(Oc3cc(Cl)ccc3Cl)cc2)CC1		CHEMBL386457	=	EC50	nM	605.0	CHEMBL3587	Homo sapiens	EC50	nM	605.0
	1790240	CHEMBL873739	Inhibition of MEK-1 activity	B	N/C(=N\CCN1CCNCC1)c1c(O)nsc1Nc1ccc(Oc2cc(Cl)ccc2Cl)cc1		CHEMBL214683	=	IC50	nM	58.0	CHEMBL3587	Homo sapiens	IC50	nM	58.0
	1790241	CHEMBL873740	Inhibitory activity against MEK-1	F	N/C(=N\CCN1CCNCC1)c1c(O)nsc1Nc1ccc(Oc2cc(Cl)ccc2Cl)cc1		CHEMBL214683	=	EC50	nM	43.0	CHEMBL3587	Homo sapiens	EC50	nM	43.0
	1790243	CHEMBL873739	Inhibition of MEK-1 activity	B	N/C(=N\CCN1CCNC(=O)C1)c1c(O)nsc1Nc1ccc(Oc2cc(Cl)ccc2Cl)cc1		CHEMBL216832	=	IC50	nM	44.0	CHEMBL3587	Homo sapiens	IC50	nM	44.0
	1790244	CHEMBL873740	Inhibitory activity against MEK-1	F	N/C(=N\CCN1CCNC(=O)C1)c1c(O)nsc1Nc1ccc(Oc2cc(Cl)ccc2Cl)cc1		CHEMBL216832	=	EC50	nM	49.0	CHEMBL3587	Homo sapiens	EC50	nM	49.0
	1790246	CHEMBL873739	Inhibition of MEK-1 activity	B	N/C(=N\CCO)c1c(O)nsc1Nc1ccc(Oc2cc(Cl)ccc2Cl)cc1		CHEMBL216833	=	IC50	nM	46.0	CHEMBL3587	Homo sapiens	IC50	nM	46.0
	1790247	CHEMBL873740	Inhibitory activity against MEK-1	F	N/C(=N\CCO)c1c(O)nsc1Nc1ccc(Oc2cc(Cl)ccc2Cl)cc1		CHEMBL216833	=	EC50	nM	47.0	CHEMBL3587	Homo sapiens	EC50	nM	47.0
	1790249	CHEMBL873739	Inhibition of MEK-1 activity	B	N/C(=N\CC(O)CO)c1c(O)nsc1Nc1ccc(Oc2cc(Cl)ccc2Cl)cc1		CHEMBL384012	=	IC50	nM	46.0	CHEMBL3587	Homo sapiens	IC50	nM	46.0
	1790250	CHEMBL873740	Inhibitory activity against MEK-1	F	N/C(=N\CC(O)CO)c1c(O)nsc1Nc1ccc(Oc2cc(Cl)ccc2Cl)cc1		CHEMBL384012	=	EC50	nM	54.0	CHEMBL3587	Homo sapiens	EC50	nM	54.0
	1790252	CHEMBL873739	Inhibition of MEK-1 activity	B	N/C(=N\C(CO)CO)c1c(O)nsc1Nc1ccc(Oc2cc(Cl)ccc2Cl)cc1		CHEMBL216325	=	IC50	nM	35.0	CHEMBL3587	Homo sapiens	IC50	nM	35.0
	1790253	CHEMBL873740	Inhibitory activity against MEK-1	F	N/C(=N\C(CO)CO)c1c(O)nsc1Nc1ccc(Oc2cc(Cl)ccc2Cl)cc1		CHEMBL216325	=	EC50	nM	120.0	CHEMBL3587	Homo sapiens	EC50	nM	120.0
	1790255	CHEMBL873739	Inhibition of MEK-1 activity	B	N/C(=N\CCC(O)CO)c1c(O)nsc1Nc1ccc(Oc2cc(Cl)ccc2Cl)cc1		CHEMBL263039	=	IC50	nM	34.0	CHEMBL3587	Homo sapiens	IC50	nM	34.0
	1790256	CHEMBL873740	Inhibitory activity against MEK-1	F	N/C(=N\CCC(O)CO)c1c(O)nsc1Nc1ccc(Oc2cc(Cl)ccc2Cl)cc1		CHEMBL263039	=	EC50	nM	22.0	CHEMBL3587	Homo sapiens	EC50	nM	22.0
	1790258	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(O)C/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cc(Cl)ccc2Cl)cc1		CHEMBL385905	=	IC50	nM	28.0	CHEMBL3587	Homo sapiens	IC50	nM	28.0
	1790259	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(O)C/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cc(Cl)ccc2Cl)cc1		CHEMBL385905	=	EC50	nM	75.0	CHEMBL3587	Homo sapiens	EC50	nM	75.0
	1790261	CHEMBL873739	Inhibition of MEK-1 activity	B	N/C(=N\OCC(O)CO)c1c(O)nsc1Nc1ccc(Oc2cc(Cl)ccc2Cl)cc1		CHEMBL386469	=	IC50	nM	56.0	CHEMBL3587	Homo sapiens	IC50	nM	56.0
	1790262	CHEMBL873740	Inhibitory activity against MEK-1	F	N/C(=N\OCC(O)CO)c1c(O)nsc1Nc1ccc(Oc2cc(Cl)ccc2Cl)cc1		CHEMBL386469	=	EC50	nM	444.0	CHEMBL3587	Homo sapiens	EC50	nM	444.0
	1790264	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(C)C(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cc(Cl)ccc2Cl)cc1		CHEMBL216201	=	IC50	nM	744.0	CHEMBL3587	Homo sapiens	IC50	nM	744.0
	1790265	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(C)C(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cc(Cl)ccc2Cl)cc1		CHEMBL216201	=	EC50	nM	564.0	CHEMBL3587	Homo sapiens	EC50	nM	564.0
	1790267	CHEMBL873739	Inhibition of MEK-1 activity	B	CCC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cc(Cl)ccc2Cl)cc1		CHEMBL385059	=	IC50	nM	40.0	CHEMBL3587	Homo sapiens	IC50	nM	40.0
	1790268	CHEMBL873740	Inhibitory activity against MEK-1	F	CCC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2cc(Cl)ccc2Cl)cc1		CHEMBL385059	=	EC50	nM	694.0	CHEMBL3587	Homo sapiens	EC50	nM	694.0
	1790270	CHEMBL873739	Inhibition of MEK-1 activity	B	N/C(=N\CC1CCCO1)c1c(O)nsc1Nc1ccc(Oc2cc(Cl)ccc2Cl)cc1		CHEMBL216449	=	IC50	nM	34.0	CHEMBL3587	Homo sapiens	IC50	nM	34.0
	1790271	CHEMBL873740	Inhibitory activity against MEK-1	F	N/C(=N\CC1CCCO1)c1c(O)nsc1Nc1ccc(Oc2cc(Cl)ccc2Cl)cc1		CHEMBL216449	=	EC50	nM	65.0	CHEMBL3587	Homo sapiens	EC50	nM	65.0
	1790273	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(C)/N=C(\N)c1c(O)nsc1Nc1ccc(I)cc1		CHEMBL209868	=	IC50	nM	510.0	CHEMBL3587	Homo sapiens	IC50	nM	510.0
	1790274	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(C)/N=C(\N)c1c(O)nsc1Nc1ccc(I)cc1		CHEMBL209868	=	EC50	nM	8321.0	CHEMBL3587	Homo sapiens	EC50	nM	8321.0
	1790275	CHEMBL873739	Inhibition of MEK-1 activity	B	Cc1cc(I)ccc1Nc1snc(O)c1/C(N)=N/C(C)C		CHEMBL211359	=	IC50	nM	62.0	CHEMBL3587	Homo sapiens	IC50	nM	62.0
	1790276	CHEMBL873740	Inhibitory activity against MEK-1	F	Cc1cc(I)ccc1Nc1snc(O)c1/C(N)=N/C(C)C		CHEMBL211359	=	EC50	nM	1480.0	CHEMBL3587	Homo sapiens	EC50	nM	1480.0
	1790277	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(C)/N=C(\N)c1c(O)nsc1Nc1ccc(I)cc1Cl		CHEMBL213992	=	IC50	nM	42.0	CHEMBL3587	Homo sapiens	IC50	nM	42.0
	1790278	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(C)/N=C(\N)c1c(O)nsc1Nc1ccc(I)cc1Cl		CHEMBL213992	>	EC50	nM	10000.0	CHEMBL3587	Homo sapiens	EC50	nM	10000.0
	1790279	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(C)/N=C(\N)c1c(O)nsc1Nc1ccc(I)c(Cl)c1		CHEMBL216500	=	IC50	nM	200.0	CHEMBL3587	Homo sapiens	IC50	nM	200.0
	1790280	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(C)/N=C(\N)c1c(O)nsc1Nc1ccc(I)c(Cl)c1		CHEMBL216500	=	EC50	nM	6190.0	CHEMBL3587	Homo sapiens	EC50	nM	6190.0
	1790282	CHEMBL873739	Inhibition of MEK-1 activity	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2ccccc2)cc1		CHEMBL437331	=	IC50	nM	33.0	CHEMBL3587	Homo sapiens	IC50	nM	33.0
	1790283	CHEMBL873740	Inhibitory activity against MEK-1	F	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2ccccc2)cc1		CHEMBL437331	=	EC50	nM	42.0	CHEMBL3587	Homo sapiens	EC50	nM	42.0
	1790284	CHEMBL873742	Inhibition of MEK-1	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2ccccc2)cc1		CHEMBL437331	=	IC50	nM	26.0	CHEMBL3587	Homo sapiens	IC50	nM	26.0
	1790370	CHEMBL856396	Percent residual activity, relative to control, of MKK1 at 1 uM concentration of inhibitor in presence of 5 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)NC(=O)CCCCCNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL413460	=	Activity	%	84.0	CHEMBL3587	Homo sapiens	Activity	%	84.0
	1790424	CHEMBL856396	Percent residual activity, relative to control, of MKK1 at 1 uM concentration of inhibitor in presence of 5 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL279185	=	Activity	%	77.0	CHEMBL3587	Homo sapiens	Activity	%	77.0
	1810248	CHEMBL855707	Inhibition of MEK	B	N#Cc1cnc2ccc(NCc3c[nH]cn3)cc2c1Nc1ccc(F)c(Cl)c1	Non standard unit for type	CHEMBL220037	=	Inhibition	uM	2.4	CHEMBL3587	Homo sapiens	Inhibition	uM	2.4
	1820574	CHEMBL917090	Inhibition of MEK1	B	O=C(N[C@H](CO)c1ccc(F)c(Cl)c1)c1cc(-c2n[nH]cc2-c2cccc(Cl)c2)c[nH]1		CHEMBL387385	>	Ki	nM	4000.0	CHEMBL3587	Homo sapiens	Ki	uM	4.0
	1837900	CHEMBL920450	Inhibition of MKK1 at 10 uM relative to control	B	CN(C)c1nc2c(Br)c(Br)c(Br)c(Br)c2[nH]1		CHEMBL376505	=	Inhibition	%	53.0	CHEMBL3587	Homo sapiens	Inhibition	%	53.0
	1837934	CHEMBL920483	Inhibition of MKK1	B	CN(C)c1nc2c(Br)c(Br)c(Br)c(Br)c2[nH]1		CHEMBL376505	=	IC50	nM	10500.0	CHEMBL3587	Homo sapiens	IC50	uM	10.5
	1837939	CHEMBL920450	Inhibition of MKK1 at 10 uM relative to control	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Inhibition	%	94.0	CHEMBL3587	Homo sapiens	Inhibition	%	94.0
	1844266	CHEMBL920009	Inhibition of MEK1K at 10 uM	B	CCn1c(=O)sn(C2CCCCC2)c1=O		CHEMBL24693	<	Inhibition	%	10.0	CHEMBL3587	Homo sapiens	Inhibition	%	10.0
	1844281	CHEMBL920009	Inhibition of MEK1K at 10 uM	B	CCn1sc(=O)n(-c2ccc([N+](=O)[O-])cc2)c1=O		CHEMBL224236	<	Inhibition	%	10.0	CHEMBL3587	Homo sapiens	Inhibition	%	10.0
	1844282	CHEMBL920009	Inhibition of MEK1K at 10 uM	B	Cn1sc(=O)n(-c2ccc(C(F)(F)F)cc2)c1=O		CHEMBL417835	<	Inhibition	%	10.0	CHEMBL3587	Homo sapiens	Inhibition	%	10.0
	1844283	CHEMBL920009	Inhibition of MEK1K at 10 uM	B	O=c1sn(Cc2ccccc2)c(=O)n1Cc1ccccc1		CHEMBL284365	<	Inhibition	%	10.0	CHEMBL3587	Homo sapiens	Inhibition	%	10.0
	1844284	CHEMBL920009	Inhibition of MEK1K at 10 uM	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	<	Inhibition	%	10.0	CHEMBL3587	Homo sapiens	Inhibition	%	10.0
	1844300	CHEMBL920009	Inhibition of MEK1K at 10 uM	B	CCOC(=O)Cn1c(=O)sn(C)c1=O		CHEMBL388088	=	Inhibition	%	19.0	CHEMBL3587	Homo sapiens	Inhibition	%	19.0
	1891154	CHEMBL905894	Inhibition at MEK	B	NC(=O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL242237	=	IC50	nM	6800.0	CHEMBL3587	Homo sapiens	IC50	uM	6.8
	1917482	CHEMBL895136	Inhibition of MEK1 at 1 uM	B	O=c1ccc(=O)c2c1c1[nH]c3ccc(O)cc3c1c1c(=O)[nH]c(=O)c21		CHEMBL243931	=	Inhibition	%	98.0	CHEMBL3587	Homo sapiens	Inhibition	%	98.0
	1917503	CHEMBL895136	Inhibition of MEK1 at 1 uM	B	Cc1ccc2[nH]c3c4c(O)ccc(O)c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL244141	=	Inhibition	%	96.0	CHEMBL3587	Homo sapiens	Inhibition	%	96.0
	1968069	CHEMBL896385	Inhibition of MKK1 at 10 uM	B	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1cccs1)n2CCCN		CHEMBL233338	=	Inhibition	%	-2.0	CHEMBL3587	Homo sapiens	Inhibition	%	-2.0
	2020278	CHEMBL903378	Inhibition of MEK1 kinase	B	N#Cc1c(-c2ccccc2)cc(-c2cc(Br)ccc2O)[nH]c1=O		CHEMBL391586	>	IC50	nM	20000.0	CHEMBL3587	Homo sapiens	IC50	uM	20.0
	2037163	CHEMBL923958	Inhibition of MK1 after 30 mins by IMAP assay	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4nc(C(N)=O)cs4)cc3c21		CHEMBL397332	=	IC50	nM	750.0	CHEMBL3587	Homo sapiens	IC50	uM	0.75
	2037164	CHEMBL923958	Inhibition of MK1 after 30 mins by IMAP assay	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4nc(C(=O)NCC(N)=O)cs4)cc3c21		CHEMBL246089	=	IC50	nM	800.0	CHEMBL3587	Homo sapiens	IC50	uM	0.8
	2037165	CHEMBL923958	Inhibition of MK1 after 30 mins by IMAP assay	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4nc(C(=O)NCCN(C)C)cs4)cc3c21		CHEMBL245884	=	IC50	nM	660.0	CHEMBL3587	Homo sapiens	IC50	uM	0.66
	2037166	CHEMBL923958	Inhibition of MK1 after 30 mins by IMAP assay	B	CC1CNC(=O)c2[nH]c3ccc(C(=O)Nc4cccnc4)cc3c21		CHEMBL437943	=	IC50	nM	1200.0	CHEMBL3587	Homo sapiens	IC50	uM	1.2
	2099508	CHEMBL949052	Inhibition of MKK1 at 10 uM	B	CN(C)CCCOc1cc2c(cc1O)c1c3c(c(-c4ccccc4Cl)cc1n2C)C(=O)NC3=O		CHEMBL410261	=	Inhibition	%	14.0	CHEMBL3587	Homo sapiens	Inhibition	%	14.0
	2099536	CHEMBL949052	Inhibition of MKK1 at 10 uM	B	Cn1c2cc(C(=O)NCCN3CCCC3)c(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL272267	=	Inhibition	%	38.0	CHEMBL3587	Homo sapiens	Inhibition	%	38.0
	2099537	CHEMBL949052	Inhibition of MKK1 at 10 uM	B	Cn1c2cc(SCCCN3CCCC3)c(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL404335	=	Inhibition	%	20.0	CHEMBL3587	Homo sapiens	Inhibition	%	20.0
	2099538	CHEMBL949052	Inhibition of MKK1 at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)c(OCCCN3CCOCC3)cc2n1CCO		CHEMBL271715	=	Inhibition	%	16.0	CHEMBL3587	Homo sapiens	Inhibition	%	16.0
	2099539	CHEMBL949052	Inhibition of MKK1 at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)c(OCCCN3CCCC3)cc2n1CCO		CHEMBL270021	=	Inhibition	%	12.0	CHEMBL3587	Homo sapiens	Inhibition	%	12.0
	2099540	CHEMBL949052	Inhibition of MKK1 at 10 uM	B	Cn1c2cc(OCCCN3CCCC3)c(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL255427	=	Inhibition	%	20.0	CHEMBL3587	Homo sapiens	Inhibition	%	20.0
	2110290	CHEMBL950980	Inhibition of MEK1	B	COC[C@H]1OC(=O)/C(=C/N(C)CCCN(C)C)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](O)CC[C@@H]34)[C@]21C		CHEMBL410643	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	2110302	CHEMBL950980	Inhibition of MEK1	B	COC[C@H]1OC(=O)/C(=C/N(CCO)C(C)(C)C)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](O)CC[C@@H]34)[C@]21C		CHEMBL271190	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	2112565	CHEMBL951018	Inhibition of MEK1 at 10 uM	B	Nc1ncnc2oc(-c3cccnc3)c(-c3ccc(NS(=O)(=O)c4ccccc4)cc3)c12		CHEMBL258081	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	Inhibition	%	0.0
	2132668	CHEMBL938202	Inhibition of MEK1	B	Nc1nccn2c1c(-c1ccc3ccc(-c4ccccc4)nc3c1)nc2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL410659	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	2136757	CHEMBL939218	Inhibition of MEK1	B	O=C1C=CC(=O)c2ccccc21		CHEMBL55934	=	IC50	nM	380.0	CHEMBL3587	Homo sapiens	IC50	uM	0.38
	2136812	CHEMBL921092	Inhibition of MKK1	B	COc1cc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)ccc1O		CHEMBL435734	=	IC50	nM	1.0	CHEMBL3587	Homo sapiens	IC50	nM	1.0
	2136997	CHEMBL939218	Inhibition of MEK1	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1		CHEMBL361708	=	IC50	nM	6.0	CHEMBL3587	Homo sapiens	IC50	nM	6.0
	2137151	CHEMBL939218	Inhibition of MEK1	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	IC50	nM	380.0	CHEMBL3587	Homo sapiens	IC50	nM	380.0
	2137203	CHEMBL939218	Inhibition of MEK1	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	IC50	nM	72.0	CHEMBL3587	Homo sapiens	IC50	nM	72.0
	2147306	CHEMBL921991	Activity of human MEK1 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	110.0	CHEMBL3587	Homo sapiens	Activity	%	110.0
Not Evaluated	2149606	CHEMBL931303	Inhibition of human MAP2K1	B	NC(=O)c1c(NC(=O)C2CC2)sc2c1CCCC2		CHEMBL379367		Activity			CHEMBL3587	Homo sapiens	Activity		
	2153718	CHEMBL928285	Inhibition of Mek1 at 20 uM	B	CN(C)CCOc1ccc2c(-c3c(-c4ccccn4)nn4c3CCC4)ccnc2c1		CHEMBL409525	<	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	Inhibition	%	50.0
	2153753	CHEMBL928285	Inhibition of Mek1 at 20 uM	B	c1ccc(-c2nn3c(c2-c2ccnc4cc(OCCN5CCOCC5)ccc24)CCC3)nc1		CHEMBL260015	<	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	Inhibition	%	50.0
	2182433	CHEMBL941333	Inhibition of human MEK1 at 1 uM	B	CS(=O)(=O)c1cccc(CNc2nc(Nc3ccc4c(c3)CCC(=O)N4)ncc2C(F)(F)F)c1		CHEMBL514554	=	Inhibition	%	20.0	CHEMBL3587	Homo sapiens	INH	%	20.0
	2182819	CHEMBL941445	Inhibition of MAP2K1 at 5 uM	B	O=c1cc(N2CCOCC2)nc2c3ccccc3ccn12		CHEMBL179242	=	Inhibition	%	-8.0	CHEMBL3587	Homo sapiens	INH	%	-8.0
	2239706	CHEMBL1000372	Inhibition of MKK1 at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)ccc2n1CCCc1nnn[nH]1		CHEMBL471329	=	Inhibition	%	12.0	CHEMBL3587	Homo sapiens	INH	%	12.0
	2239734	CHEMBL1000372	Inhibition of MKK1 at 10 uM	B	CS(=O)(=O)NC(=O)CCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL460940	=	Inhibition	%	21.0	CHEMBL3587	Homo sapiens	INH	%	21.0
	2239762	CHEMBL1000372	Inhibition of MKK1 at 10 uM	B	CN(C)CCNC(=O)CCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL462011	=	Inhibition	%	60.0	CHEMBL3587	Homo sapiens	INH	%	60.0
	2239790	CHEMBL1000372	Inhibition of MKK1 at 10 uM	B	CNCCCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL508541	=	Inhibition	%	20.0	CHEMBL3587	Homo sapiens	INH	%	20.0
	2239818	CHEMBL1000372	Inhibition of MKK1 at 10 uM	B	CNCCCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4)cc21)C(=O)NC3=O		CHEMBL455192	=	Inhibition	%	9.0	CHEMBL3587	Homo sapiens	INH	%	9.0
	2239846	CHEMBL1000372	Inhibition of MKK1 at 10 uM	B	O=C1NC(=O)c2c1c(-c1c(Cl)cccc1Cl)cc1c2c2cc(O)ccc2n1CCCO		CHEMBL471163	=	Inhibition	%	72.0	CHEMBL3587	Homo sapiens	INH	%	72.0
	2239874	CHEMBL1000372	Inhibition of MKK1 at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)ccc2n1CCCO		CHEMBL411662	=	Inhibition	%	13.0	CHEMBL3587	Homo sapiens	INH	%	13.0
	2239901	CHEMBL1000372	Inhibition of MKK1 at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21		CHEMBL379975	=	Inhibition	%	49.0	CHEMBL3587	Homo sapiens	INH	%	49.0
	2258525	CHEMBL1005355	Inhibition of MEK1 by HTRF assay	B	c1ccc(-c2ccc(Oc3cncc4sc(-c5nn[nH]n5)cc34)cc2)cc1		CHEMBL496536	=	IC50	nM	9700.0	CHEMBL3587	Homo sapiens	IC50	uM	9.7
	2258526	CHEMBL1005355	Inhibition of MEK1 by HTRF assay	B	COc1ccccc1-c1ccc(Oc2cncc3sc(-c4nn[nH]n4)cc23)cc1		CHEMBL497791	=	IC50	nM	21800.0	CHEMBL3587	Homo sapiens	IC50	uM	21.8
	2258527	CHEMBL1005355	Inhibition of MEK1 by HTRF assay	B	COc1cccc(-c2ccc(Oc3cncc4sc(-c5nn[nH]n5)cc34)cc2)c1		CHEMBL496543	=	IC50	nM	23000.0	CHEMBL3587	Homo sapiens	IC50	uM	23.0
	2258528	CHEMBL1005355	Inhibition of MEK1 by HTRF assay	B	COc1ccc(-c2ccc(Oc3cncc4sc(-c5nn[nH]n5)cc34)cc2)cc1		CHEMBL496752	=	IC50	nM	49000.0	CHEMBL3587	Homo sapiens	IC50	uM	49.0
	2258529	CHEMBL1005355	Inhibition of MEK1 by HTRF assay	B	Clc1ccccc1-c1ccc(Oc2cncc3sc(-c4nn[nH]n4)cc23)cc1		CHEMBL491434	=	IC50	nM	1500.0	CHEMBL3587	Homo sapiens	IC50	uM	1.5
	2258530	CHEMBL1005355	Inhibition of MEK1 by HTRF assay	B	Clc1cccc(-c2ccc(Oc3cncc4sc(-c5nn[nH]n5)cc34)cc2)c1		CHEMBL522129	=	IC50	nM	1900.0	CHEMBL3587	Homo sapiens	IC50	uM	1.9
	2258531	CHEMBL1005355	Inhibition of MEK1 by HTRF assay	B	Clc1ccc(-c2ccc(Oc3cncc4sc(-c5nn[nH]n5)cc34)cc2)cc1		CHEMBL524274	=	IC50	nM	2400.0	CHEMBL3587	Homo sapiens	IC50	uM	2.4
	2258532	CHEMBL1005355	Inhibition of MEK1 by HTRF assay	B	N#Cc1ccc(-c2ccc(Oc3cncc4sc(-c5nn[nH]n5)cc34)cc2)cc1		CHEMBL497792	=	IC50	nM	21200.0	CHEMBL3587	Homo sapiens	IC50	uM	21.2
	2258533	CHEMBL1005355	Inhibition of MEK1 by HTRF assay	B	Fc1ccc(-c2ccc(Oc3cncc4sc(-c5nn[nH]n5)cc34)cc2)cc1		CHEMBL491435	=	IC50	nM	7600.0	CHEMBL3587	Homo sapiens	IC50	uM	7.6
	2258534	CHEMBL1005355	Inhibition of MEK1 by HTRF assay	B	Nc1ccc(-c2ccc(Oc3cncc4sc(-c5nn[nH]n5)cc34)cc2)cc1		CHEMBL491635	=	IC50	nM	1500.0	CHEMBL3587	Homo sapiens	IC50	uM	1.5
	2258535	CHEMBL1005355	Inhibition of MEK1 by HTRF assay	B	FC(F)(F)c1ccc(-c2ccc(Oc3cncc4sc(-c5nn[nH]n5)cc34)cc2)cc1		CHEMBL490423	=	IC50	nM	1800.0	CHEMBL3587	Homo sapiens	IC50	uM	1.8
	2258536	CHEMBL1005355	Inhibition of MEK1 by HTRF assay	B	CN(C)C(=O)c1ccc(-c2ccc(Oc3cncc4sc(-c5nn[nH]n5)cc34)cc2)cc1		CHEMBL489812	=	IC50	nM	48000.0	CHEMBL3587	Homo sapiens	IC50	uM	48.0
	2258537	CHEMBL1005355	Inhibition of MEK1 by HTRF assay	B	OCc1ccc(-c2ccc(Oc3cncc4sc(-c5nn[nH]n5)cc34)cc2)cc1		CHEMBL491029	=	IC50	nM	14000.0	CHEMBL3587	Homo sapiens	IC50	uM	14.0
	2258538	CHEMBL1005355	Inhibition of MEK1 by HTRF assay	B	NC(=O)c1ccc(-c2ccc(Oc3cncc4sc(-c5nn[nH]n5)cc34)cc2)cc1		CHEMBL491228	=	IC50	nM	18000.0	CHEMBL3587	Homo sapiens	IC50	uM	18.0
	2261797	CHEMBL998563	Inhibition of MEK1 by cRaf/mek/Erk cascade assay	B	Cc1ccc(C(=O)Nc2cccc(N3CCOCC3)c2)cc1-c1ccc2c(C3CCNCC3)noc2c1		CHEMBL485285	=	IC50	nM	40.0	CHEMBL3587	Homo sapiens	IC50	uM	0.04
	2261807	CHEMBL998563	Inhibition of MEK1 by cRaf/mek/Erk cascade assay	B	Cc1nnc(-c2ccc(-c3cc(C(=O)Nc4cccc(N5CCOCC5)c4)ccc3C)c(C)c2)o1		CHEMBL523559	=	IC50	nM	400.0	CHEMBL3587	Homo sapiens	IC50	uM	0.4
	2261817	CHEMBL998563	Inhibition of MEK1 by cRaf/mek/Erk cascade assay	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc2c(C3CCNCC3)noc2c1		CHEMBL485286	=	IC50	nM	30.0	CHEMBL3587	Homo sapiens	IC50	uM	0.03
	2261829	CHEMBL998563	Inhibition of MEK1 by cRaf/mek/Erk cascade assay	B	Cc1nnc(-c2ccc(-c3cc(NC(=O)c4ccnc(N5CCCC5)c4)ccc3C)c(C)c2)o1		CHEMBL495729	=	IC50	nM	200.0	CHEMBL3587	Homo sapiens	IC50	uM	0.2
	2261841	CHEMBL998563	Inhibition of MEK1 by cRaf/mek/Erk cascade assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(C3CCNCC3)noc2c1		CHEMBL497563	>	IC50	nM	50000.0	CHEMBL3587	Homo sapiens	IC50	uM	50.0
	2261853	CHEMBL998563	Inhibition of MEK1 by cRaf/mek/Erk cascade assay	B	Cc1nnc(-c2ccc(-c3cc(C(=O)NC4CC4)ccc3C)c(C)c2)o1		CHEMBL522579	=	IC50	nM	20000.0	CHEMBL3587	Homo sapiens	IC50	uM	20.0
	2261887	CHEMBL998563	Inhibition of MEK1 by cRaf/mek/Erk cascade assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649	>	IC50	nM	50000.0	CHEMBL3587	Homo sapiens	IC50	uM	50.0
	2279720	CHEMBL960134	Inhibition of MKK1 at 10 uM	B	CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1		CHEMBL493937	>	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	2356938	CHEMBL955830	Inhibition of MEK1 at 1 uM relative to control	B	Cc1ccn(-c2cccc(C(F)(F)F)c2)c(=O)c1-c1ccc2nc(N)ncc2c1		CHEMBL504805	>	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	2396077	CHEMBL1006316	Inhibition of MAP2K1 at 1 uM relative to control	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)Nc2cccc(NC(C)=O)c2)cc1	Outside typical range	CHEMBL515560	=	Inhibition	%	-14.0	CHEMBL3587	Homo sapiens	INH	%	-14.0
	2413027	CHEMBL965852	Inhibition of MEK1 by HTRF assay	B	NC(=O)c1cc2c(-c3cccc(-c4ccccc4)c3)cnc(N)c2s1		CHEMBL445178	=	IC50	nM	13000.0	CHEMBL3587	Homo sapiens	IC50	uM	13.0
	2419134	CHEMBL1019622	Inhibition of MAP2K1 at 1 uM	B	C[C@H]1O[C@@H]2CC(=O)O[C@@H]2C2=C1C(=O)c1c(ccc([C@H]3C[C@@H](N(C)C)[C@H](O)[C@@H](C)O3)c1O)C2=O		CHEMBL2216825	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	INH	%	0.0
	2451251	CHEMBL1013123	Inhibition of human MEK1 at 10 uM	B	CCC(Nc1cc(-c2[nH]c(SC)nc2-c2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL494666	=	Inhibition	%	4.0	CHEMBL3587	Homo sapiens	INH	%	4.0
	2451303	CHEMBL1013123	Inhibition of human MEK1 at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	INH	%	0.0
	2451304	CHEMBL1013123	Inhibition of human MEK1 at 10 uM	B	COCCn1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(NC2CCCCC2)c1		CHEMBL481943	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	INH	%	0.0
	2451305	CHEMBL1013123	Inhibition of human MEK1 at 10 uM	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NCC3CCCO3)c2)[nH]1		CHEMBL480952	=	Inhibition	%	20.0	CHEMBL3587	Homo sapiens	INH	%	20.0
	2451306	CHEMBL1013123	Inhibition of human MEK1 at 10 uM	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)CCCC(C)C)c2)[nH]1		CHEMBL518964	=	Inhibition	%	2.0	CHEMBL3587	Homo sapiens	INH	%	2.0
	2451307	CHEMBL1013123	Inhibition of human MEK1 at 10 uM	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NCCc3cccs3)c2)[nH]1		CHEMBL519617	=	Inhibition	%	1.0	CHEMBL3587	Homo sapiens	INH	%	1.0
	2451308	CHEMBL1013123	Inhibition of human MEK1 at 10 uM	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)CCc3ccccc3)c2)[nH]1		CHEMBL493669	=	Inhibition	%	3.0	CHEMBL3587	Homo sapiens	INH	%	3.0
	2451309	CHEMBL1013123	Inhibition of human MEK1 at 10 uM	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCc4ccccc43)c2)[nH]1		CHEMBL494871	=	Inhibition	%	1.0	CHEMBL3587	Homo sapiens	INH	%	1.0
	2467191	CHEMBL995059	Inhibition of MEK1 by raf/MEK1/MAPK coupled assay	B	CCN1CCN(CCCOc2cc3ncc(C#N)c(Nc4ccc(Sc5nccn5C)c(Cl)c4)c3cc2OC)CC1		CHEMBL103045	=	IC50	nM	3.0	CHEMBL3587	Homo sapiens	IC50	nM	3.0
	2467192	CHEMBL995059	Inhibition of MEK1 by raf/MEK1/MAPK coupled assay	B	Cn1ccnc1Sc1ccc(Nc2c(C#N)cnc3cc(/C=C/CO)ccc23)cc1Cl		CHEMBL519206	=	IC50	nM	35.0	CHEMBL3587	Homo sapiens	IC50	nM	35.0
	2467193	CHEMBL995059	Inhibition of MEK1 by raf/MEK1/MAPK coupled assay	B	Cn1ccnc1Sc1ccc(Nc2c(C#N)cnc3cc(/C=C/CCO)ccc23)cc1Cl		CHEMBL485377	=	IC50	nM	36.0	CHEMBL3587	Homo sapiens	IC50	nM	36.0
	2467194	CHEMBL995059	Inhibition of MEK1 by raf/MEK1/MAPK coupled assay	B	COc1cc2c(Nc3ccc(Sc4nccn4C)c(Cl)c3)c(C#N)cnc2cc1/C=C/CCO		CHEMBL520025	=	IC50	nM	5.0	CHEMBL3587	Homo sapiens	IC50	nM	5.0
	2467195	CHEMBL995059	Inhibition of MEK1 by raf/MEK1/MAPK coupled assay	B	Cn1ccnc1Sc1ccc(Nc2c(C#N)cnc3cc(/C=C/CN4CCCC4)ccc23)cc1Cl		CHEMBL521013	=	IC50	nM	59.0	CHEMBL3587	Homo sapiens	IC50	nM	59.0
	2467196	CHEMBL995059	Inhibition of MEK1 by raf/MEK1/MAPK coupled assay	B	CN1CCN(C/C=C/c2ccc3c(Nc4ccc(Sc5nccn5C)c(Cl)c4)c(C#N)cnc3c2)CC1		CHEMBL485211	=	IC50	nM	55.0	CHEMBL3587	Homo sapiens	IC50	nM	55.0
	2467197	CHEMBL995059	Inhibition of MEK1 by raf/MEK1/MAPK coupled assay	B	CCN1CCN(C/C=C/c2ccc3c(Nc4ccc(Sc5nccn5C)c(Cl)c4)c(C#N)cnc3c2)CC1		CHEMBL521320	=	IC50	nM	52.0	CHEMBL3587	Homo sapiens	IC50	nM	52.0
	2467198	CHEMBL995059	Inhibition of MEK1 by raf/MEK1/MAPK coupled assay	B	CCN(CC)CC/C=C/c1ccc2c(Nc3ccc(Sc4nccn4C)c(Cl)c3)c(C#N)cnc2c1		CHEMBL484368	=	IC50	nM	26.0	CHEMBL3587	Homo sapiens	IC50	nM	26.0
	2467199	CHEMBL995059	Inhibition of MEK1 by raf/MEK1/MAPK coupled assay	B	CN(C)CC/C=C/c1ccc2c(Nc3ccc(Sc4nccn4C)c(Cl)c3)c(C#N)cnc2c1		CHEMBL485574	=	IC50	nM	21.0	CHEMBL3587	Homo sapiens	IC50	nM	21.0
	2467200	CHEMBL995059	Inhibition of MEK1 by raf/MEK1/MAPK coupled assay	B	Cn1ccnc1Sc1ccc(Nc2c(C#N)cnc3cc(/C=C/CN4CCOCC4)ccc23)cc1Cl		CHEMBL485237	=	IC50	nM	11.0	CHEMBL3587	Homo sapiens	IC50	nM	11.0
	2467201	CHEMBL995059	Inhibition of MEK1 by raf/MEK1/MAPK coupled assay	B	Cn1ccnc1Sc1ccc(Nc2c(C#N)cnc3cc(/C=C/CCN4CCCC4)ccc23)cc1Cl		CHEMBL521502	=	IC50	nM	20.0	CHEMBL3587	Homo sapiens	IC50	nM	20.0
	2467202	CHEMBL995059	Inhibition of MEK1 by raf/MEK1/MAPK coupled assay	B	Cn1ccnc1Sc1ccc(Nc2c(C#N)cnc3cc(/C=C/CCN4CCCCC4)ccc23)cc1Cl		CHEMBL485238	=	IC50	nM	10.0	CHEMBL3587	Homo sapiens	IC50	nM	10.0
	2467203	CHEMBL995059	Inhibition of MEK1 by raf/MEK1/MAPK coupled assay	B	CN1CCN(CC/C=C/c2ccc3c(Nc4ccc(Sc5nccn5C)c(Cl)c4)c(C#N)cnc3c2)CC1		CHEMBL520142	=	IC50	nM	19.0	CHEMBL3587	Homo sapiens	IC50	nM	19.0
	2467204	CHEMBL995059	Inhibition of MEK1 by raf/MEK1/MAPK coupled assay	B	CCN1CCN(CC/C=C/c2ccc3c(Nc4ccc(Sc5nccn5C)c(Cl)c4)c(C#N)cnc3c2)CC1		CHEMBL489058	=	IC50	nM	12.0	CHEMBL3587	Homo sapiens	IC50	nM	12.0
	2467205	CHEMBL995059	Inhibition of MEK1 by raf/MEK1/MAPK coupled assay	B	CCN(CC)CCC/C=C/c1ccc2c(Nc3ccc(Sc4nccn4C)c(Cl)c3)c(C#N)cnc2c1		CHEMBL483398	=	IC50	nM	25.0	CHEMBL3587	Homo sapiens	IC50	nM	25.0
	2467206	CHEMBL995059	Inhibition of MEK1 by raf/MEK1/MAPK coupled assay	B	CN1CCN(CCC/C=C/c2ccc3c(Nc4ccc(Sc5nccn5C)c(Cl)c4)c(C#N)cnc3c2)CC1		CHEMBL489661	=	IC50	nM	33.0	CHEMBL3587	Homo sapiens	IC50	nM	33.0
	2467207	CHEMBL995059	Inhibition of MEK1 by raf/MEK1/MAPK coupled assay	B	CCN(CC)CC/C=C/c1cc2ncc(C#N)c(Nc3ccc(Sc4nccn4C)c(Cl)c3)c2cc1OC		CHEMBL485615	=	IC50	nM	3.0	CHEMBL3587	Homo sapiens	IC50	nM	3.0
	2467208	CHEMBL995059	Inhibition of MEK1 by raf/MEK1/MAPK coupled assay	B	COc1cc2c(Nc3ccc(Sc4nccn4C)c(Cl)c3)c(C#N)cnc2cc1/C=C/CCN1CCN(C)CC1		CHEMBL524111	=	IC50	nM	4.0	CHEMBL3587	Homo sapiens	IC50	nM	4.0
	2467209	CHEMBL995059	Inhibition of MEK1 by raf/MEK1/MAPK coupled assay	B	COc1cc2c(Nc3ccc(Sc4nccn4C)c(Cl)c3)c(C#N)cnc2cc1/C=C/CCCN1CCN(C)CC1		CHEMBL450271	=	IC50	nM	6.0	CHEMBL3587	Homo sapiens	IC50	nM	6.0
	2467264	CHEMBL991671	Inhibition of MEK1-mediated ERK phosphorylation in human WM266-4 cells after 2.5 hrs	B	CCN1CCN(CC/C=C/c2ccc3c(Nc4ccc(Sc5nccn5C)c(Cl)c4)c(C#N)cnc3c2)CC1		CHEMBL489058	=	IC50	nM	225.0	CHEMBL3587	Homo sapiens	IC50	uM	0.225
	2467265	CHEMBL991672	Inhibition of MEK1-mediated ERK phosphorylation in human WM266-4 cells at 0.03 uM after 2.5 hrs	B	CCN1CCN(CC/C=C/c2ccc3c(Nc4ccc(Sc5nccn5C)c(Cl)c4)c(C#N)cnc3c2)CC1		CHEMBL489058	=	Inhibition	%	22.0	CHEMBL3587	Homo sapiens	INH	%	22.0
	2467266	CHEMBL991673	Inhibition of MEK1-mediated ERK phosphorylation in human WM266-4 cells at 0.1 uM after 2.5 hrs	B	CCN1CCN(CC/C=C/c2ccc3c(Nc4ccc(Sc5nccn5C)c(Cl)c4)c(C#N)cnc3c2)CC1		CHEMBL489058	=	Inhibition	%	18.0	CHEMBL3587	Homo sapiens	INH	%	18.0
	2467267	CHEMBL991674	Inhibition of MEK1-mediated ERK phosphorylation in human WM266-4 cells at 0.3 uM after 2.5 hrs	B	CCN1CCN(CC/C=C/c2ccc3c(Nc4ccc(Sc5nccn5C)c(Cl)c4)c(C#N)cnc3c2)CC1		CHEMBL489058	=	Inhibition	%	69.0	CHEMBL3587	Homo sapiens	INH	%	69.0
	2467268	CHEMBL991675	Inhibition of MEK1-mediated ERK phosphorylation in human WM266-4 cells at 1 uM after 2.5 hrs	B	CCN1CCN(CC/C=C/c2ccc3c(Nc4ccc(Sc5nccn5C)c(Cl)c4)c(C#N)cnc3c2)CC1		CHEMBL489058	=	Inhibition	%	88.0	CHEMBL3587	Homo sapiens	INH	%	88.0
	2467269	CHEMBL991676	Inhibition of MEK1-mediated ERK phosphorylation in human WM266-4 cells at 3 uM after 2.5 hrs	B	CCN1CCN(CC/C=C/c2ccc3c(Nc4ccc(Sc5nccn5C)c(Cl)c4)c(C#N)cnc3c2)CC1		CHEMBL489058	=	Inhibition	%	95.0	CHEMBL3587	Homo sapiens	INH	%	95.0
Not Active	2467337	CHEMBL991677	Inhibition of EGFR phosphorylation in human WM266-4 cells up to 10 uM after 2.5 hrs	B	CCN1CCN(CC/C=C/c2ccc3c(Nc4ccc(Sc5nccn5C)c(Cl)c4)c(C#N)cnc3c2)CC1		CHEMBL489058		Activity			CHEMBL3587	Homo sapiens	Activity		
	2470264	CHEMBL987183	Inhibition of MEK1 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL3587	Homo sapiens	INH	%	10.0
	2506961	CHEMBL942620	Inhibition of MEK1 at 10 uM	B	COc1cc(O)ccc1-c1ccc2c(-c3nc4c(N5CCN(C)CC5)cccc4[nH]3)n[nH]c2c1		CHEMBL474619	<	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	2506962	CHEMBL942620	Inhibition of MEK1 at 10 uM	B	CN1CCN(c2cccc3nc(-c4n[nH]c5cc(-c6ccc(N)cc6)ccc45)[nH]c23)CC1		CHEMBL480391	<	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	2511948	CHEMBL969682	Inhibition of human MEK1 at 1 uM assessed as residual enzyme activity	B	O=C(Nc1ccccc1Cl)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL521949	=	Activity	%	103.0	CHEMBL3587	Homo sapiens	Activity	%	103.0
	2511996	CHEMBL970599	Inhibition of MEK1 at 1 uM	B	CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL508307	=	Inhibition	%	21.0	CHEMBL3587	Homo sapiens	INH	%	21.0
Not Active	2527099	CHEMBL984157	Inhibition of MKK1 at => 3 ug/mL	B	COc1c(NC(=O)Nc2ccc(-c3ccc(CN4CCOCC4)nc3)c3ccccc23)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL451523		Activity			CHEMBL3587	Homo sapiens	Activity		
	2528956	CHEMBL985891	Inhibition of MEK1	B	O[C@H]1CC[C@H](c2n[nH]cc2-c2ccnc(NC3CCCC3)n2)CC1		CHEMBL507249	>	IC50	nM	30000.0	CHEMBL3587	Homo sapiens	IC50	uM	30.0
	2562278	CHEMBL984691	Inhibition of human MEK1 at 10 uM	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1		CHEMBL477989	=	Inhibition	%	14.0	CHEMBL3587	Homo sapiens	INH	%	14.0
	2562300	CHEMBL984691	Inhibition of human MEK1 at 10 uM	B	O/N=C1\CCc2cc(-c3cc(CN4CCOCC4)oc3-c3ccncc3)ccc21		CHEMBL476732	=	Inhibition	%	12.0	CHEMBL3587	Homo sapiens	INH	%	12.0
	2568941	CHEMBL971704	Inhibition of MEK1	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	nM	10000.0
	2613485	CHEMBL1031527	Inhibition of MEK1	B	COc1ccc(-n2cnc3ccc(-c4nnc(SCc5cccc(C#N)c5)o4)cc32)cc1		CHEMBL516640	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	2635193	CHEMBL1000632	Inhibition of MKK1 at 1 uM relative to control	B	CSc1cc(Oc2ccnc3[nH]c(=O)[nH]c23)ccc1NC(=O)Nc1cccc(C(F)(F)F)c1		CHEMBL496009	=	Residual_activity	%	100.0	CHEMBL3587	Homo sapiens	Residual_activity	%	100.0
	2635936	CHEMBL1000632	Inhibition of MKK1 at 1 uM relative to control	B	O=C(Nc1cc(C(F)(F)F)ccc1F)Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)c2ccccc12		CHEMBL498112	=	Residual_activity	%	100.0	CHEMBL3587	Homo sapiens	Residual_activity	%	100.0
	2636004	CHEMBL1000632	Inhibition of MKK1 at 1 uM relative to control	B	CC(C)(C)c1cccc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ccccc23)c1		CHEMBL496073	=	Residual_activity	%	75.0	CHEMBL3587	Homo sapiens	Residual_activity	%	75.0
	2696410	CHEMBL1064038	Inhibition of recombinant MEK1 expressed in Escherichia coli	B	Cn1cc(C2=C(c3cn(CCCN4CCOCC4)c4ccccc34)C(=O)NC2=O)c2ncccc21		CHEMBL552265	>	IC50	nM	40000.0	CHEMBL3587	Homo sapiens	IC50	uM	40.0
	2696411	CHEMBL1064038	Inhibition of recombinant MEK1 expressed in Escherichia coli	B	O=C1NC(=O)C(n2ccc3ncccc32)=C1c1cn(CCCn2ccnc2)c2ccc(Br)cc12		CHEMBL561066	>	IC50	nM	40000.0	CHEMBL3587	Homo sapiens	IC50	uM	40.0
	2696412	CHEMBL1064038	Inhibition of recombinant MEK1 expressed in Escherichia coli	B	O=C1NC(=O)C(n2ccc3ncccc32)=C1c1cn(CCn2ccnc2)c2ccccc12		CHEMBL558512	>	IC50	nM	40000.0	CHEMBL3587	Homo sapiens	IC50	uM	40.0
	2696438	CHEMBL1064038	Inhibition of recombinant MEK1 expressed in Escherichia coli	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	670.0	CHEMBL3587	Homo sapiens	IC50	uM	0.67
	2704992	CHEMBL1054879	Inhibition of MEK1 at 10 uM by HotSpot assay relative to control	B	Cc1cc(O)cc(-c2nn(CC#N)cc2-c2cc(NC[C@H](C)O)nc(-c3cccnc3)n2)c1		CHEMBL560733	=	Inhibition	%	-6.97	CHEMBL3587	Homo sapiens	INH	%	-6.97
	2721648	CHEMBL1057477	Inhibition of MEK1 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	2894314	CHEMBL1061906	Binding constant for full-length MEK1	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	uM	10.0
	2894315	CHEMBL1061906	Binding constant for full-length MEK1	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	uM	10.0
	2894316	CHEMBL1061906	Binding constant for full-length MEK1	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	uM	10.0
	2894317	CHEMBL1061906	Binding constant for full-length MEK1	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	uM	10.0
	2894318	CHEMBL1061906	Binding constant for full-length MEK1	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	uM	10.0
	2894319	CHEMBL1061906	Binding constant for full-length MEK1	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	uM	10.0
	2894320	CHEMBL1061906	Binding constant for full-length MEK1	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	520.0	CHEMBL3587	Homo sapiens	Kd	nM	520.0
	2894321	CHEMBL1061906	Binding constant for full-length MEK1	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	uM	10.0
	2894322	CHEMBL1061906	Binding constant for full-length MEK1	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	1800.0	CHEMBL3587	Homo sapiens	Kd	nM	1800.0
	2894323	CHEMBL1061906	Binding constant for full-length MEK1	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	uM	10.0
	2894324	CHEMBL1061906	Binding constant for full-length MEK1	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	uM	10.0
	2894325	CHEMBL1061906	Binding constant for full-length MEK1	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	1000.0	CHEMBL3587	Homo sapiens	Kd	nM	1000.0
	2894326	CHEMBL1061906	Binding constant for full-length MEK1	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	360.0	CHEMBL3587	Homo sapiens	Kd	nM	360.0
	2894327	CHEMBL1061906	Binding constant for full-length MEK1	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	uM	10.0
	2894328	CHEMBL1061906	Binding constant for full-length MEK1	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	uM	10.0
	2894329	CHEMBL1061906	Binding constant for full-length MEK1	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	uM	10.0
	2894330	CHEMBL1061906	Binding constant for full-length MEK1	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	uM	10.0
	2894331	CHEMBL1061906	Binding constant for full-length MEK1	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	uM	10.0
	2894332	CHEMBL1061906	Binding constant for full-length MEK1	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	uM	10.0
	2894333	CHEMBL1061906	Binding constant for full-length MEK1	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	1800.0	CHEMBL3587	Homo sapiens	Kd	nM	1800.0
	2894334	CHEMBL1061906	Binding constant for full-length MEK1	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	uM	10.0
	2894335	CHEMBL1061906	Binding constant for full-length MEK1	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	uM	10.0
	2894336	CHEMBL1061906	Binding constant for full-length MEK1	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	uM	10.0
	2894337	CHEMBL1061906	Binding constant for full-length MEK1	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	uM	10.0
	2894338	CHEMBL1061906	Binding constant for full-length MEK1	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	uM	10.0
	2894339	CHEMBL1061906	Binding constant for full-length MEK1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	uM	10.0
	2894340	CHEMBL1061906	Binding constant for full-length MEK1	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	uM	10.0
	2894341	CHEMBL1061906	Binding constant for full-length MEK1	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	uM	10.0
	2894342	CHEMBL1061906	Binding constant for full-length MEK1	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	uM	10.0
	2894343	CHEMBL1061906	Binding constant for full-length MEK1	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	uM	10.0
	2894344	CHEMBL1061906	Binding constant for full-length MEK1	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	uM	10.0
	2894345	CHEMBL1061906	Binding constant for full-length MEK1	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	uM	10.0
	2894346	CHEMBL1061906	Binding constant for full-length MEK1	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	21.0	CHEMBL3587	Homo sapiens	Kd	nM	21.0
	2894347	CHEMBL1061906	Binding constant for full-length MEK1	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	77.0	CHEMBL3587	Homo sapiens	Kd	nM	77.0
	2894348	CHEMBL1061906	Binding constant for full-length MEK1	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	130.0	CHEMBL3587	Homo sapiens	Kd	nM	130.0
	2894349	CHEMBL1061906	Binding constant for full-length MEK1	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	1800.0	CHEMBL3587	Homo sapiens	Kd	nM	1800.0
	2894350	CHEMBL1061906	Binding constant for full-length MEK1	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	uM	10.0
	2894351	CHEMBL1061906	Binding constant for full-length MEK1	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	1800.0	CHEMBL3587	Homo sapiens	Kd	nM	1800.0
	2897135	CHEMBL1063679	Percent residual MKK1 activity in presence of 10uM inhibitor	B	O=C(O)Cc1c2ccccc2n2c1[nH]c(=O)c1ccccc12		CHEMBL92361	=	Activity	%	85.0	CHEMBL3587	Homo sapiens	Activity	%	85.0
	2897136	CHEMBL1063679	Percent residual MKK1 activity in presence of 10uM inhibitor	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL28	=	Activity	%	98.0	CHEMBL3587	Homo sapiens	Activity	%	98.0
	2897137	CHEMBL1063679	Percent residual MKK1 activity in presence of 10uM inhibitor	B	Cc1cc(O)c2c(c1)C(=O)c1cc(O)cc(O)c1C2=O		CHEMBL289277	=	Activity	%	111.0	CHEMBL3587	Homo sapiens	Activity	%	111.0
Antagonist	2897250	CHEMBL1051319	Concentration-dependent inhibition of ERK1, ERK2 phosphorylation in EGF-stimulated HeLa cells	F	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442		Activity			CHEMBL3587	Homo sapiens	Activity		
Antagonist	2897251	CHEMBL1051319	Concentration-dependent inhibition of ERK1, ERK2 phosphorylation in EGF-stimulated HeLa cells	F	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361		Activity			CHEMBL3587	Homo sapiens	Activity		
Antagonist	2897252	CHEMBL1051319	Concentration-dependent inhibition of ERK1, ERK2 phosphorylation in EGF-stimulated HeLa cells	F	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL573819		Activity			CHEMBL3587	Homo sapiens	Activity		
Antagonist	2897253	CHEMBL1051319	Concentration-dependent inhibition of ERK1, ERK2 phosphorylation in EGF-stimulated HeLa cells	F	O=C(NOC[C@@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL573579		Activity			CHEMBL3587	Homo sapiens	Activity		
	2906871	CHEMBL1060205	Percentage MKK1 activity remaining in the presence of 0.01uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	50.0	CHEMBL3587	Homo sapiens	Activity	%	50.0
	2906872	CHEMBL1060205	Percentage MKK1 activity remaining in the presence of 0.01uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	84.0	CHEMBL3587	Homo sapiens	Activity	%	84.0
	2906873	CHEMBL1060205	Percentage MKK1 activity remaining in the presence of 0.01uM inhibitor	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Activity	%	75.0	CHEMBL3587	Homo sapiens	Activity	%	75.0
	2906874	CHEMBL1061219	Percentage MKK1 activity remaining in the presence of 0.1uM inhibitor	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107	=	Activity	%	98.0	CHEMBL3587	Homo sapiens	Activity	%	98.0
Antagonist	2906875	CHEMBL1061219	Percentage MKK1 activity remaining in the presence of 0.1uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	33.0	CHEMBL3587	Homo sapiens	Activity	%	33.0
	2906876	CHEMBL1061219	Percentage MKK1 activity remaining in the presence of 0.1uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	67.0	CHEMBL3587	Homo sapiens	Activity	%	67.0
	2906877	CHEMBL1061219	Percentage MKK1 activity remaining in the presence of 0.1uM inhibitor	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Activity	%	104.0	CHEMBL3587	Homo sapiens	Activity	%	104.0
	2906878	CHEMBL1061219	Percentage MKK1 activity remaining in the presence of 0.1uM inhibitor	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Activity	%	87.0	CHEMBL3587	Homo sapiens	Activity	%	87.0
Antagonist	2906879	CHEMBL1061219	Percentage MKK1 activity remaining in the presence of 0.1uM inhibitor	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Activity	%	34.0	CHEMBL3587	Homo sapiens	Activity	%	34.0
Antagonist	2906880	CHEMBL1061219	Percentage MKK1 activity remaining in the presence of 0.1uM inhibitor	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Activity	%	42.0	CHEMBL3587	Homo sapiens	Activity	%	42.0
Antagonist	2906881	CHEMBL1060147	Percentage MKK1 activity remaining in the presence of 10uM inhibitor	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	=	Activity	%	12.0	CHEMBL3587	Homo sapiens	Activity	%	12.0
Antagonist	2906882	CHEMBL1060147	Percentage MKK1 activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	Activity	%	5.0	CHEMBL3587	Homo sapiens	Activity	%	5.0
	2906883	CHEMBL1060147	Percentage MKK1 activity remaining in the presence of 10uM inhibitor	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Activity	%	77.0	CHEMBL3587	Homo sapiens	Activity	%	77.0
Antagonist	2906884	CHEMBL1060147	Percentage MKK1 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	30.0	CHEMBL3587	Homo sapiens	Activity	%	30.0
	2906885	CHEMBL1060147	Percentage MKK1 activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	93.0	CHEMBL3587	Homo sapiens	Activity	%	93.0
	2906886	CHEMBL1060147	Percentage MKK1 activity remaining in the presence of 10uM inhibitor	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Activity	%	66.0	CHEMBL3587	Homo sapiens	Activity	%	66.0
	2906887	CHEMBL1060147	Percentage MKK1 activity remaining in the presence of 10uM inhibitor	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Activity	%	86.0	CHEMBL3587	Homo sapiens	Activity	%	86.0
	2906888	CHEMBL1060147	Percentage MKK1 activity remaining in the presence of 10uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	51.0	CHEMBL3587	Homo sapiens	Activity	%	51.0
	2906889	CHEMBL1060147	Percentage MKK1 activity remaining in the presence of 10uM inhibitor	B	CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c3c(c(C(=O)/C=C/c4ccccc4)c2O)OC(C)(C)C=C3)c1O		CHEMBL34241	=	Activity	%	83.0	CHEMBL3587	Homo sapiens	Activity	%	83.0
	2906890	CHEMBL1060147	Percentage MKK1 activity remaining in the presence of 10uM inhibitor	B	C[C@H]1CNCCN1S(=O)(=O)c1cccc2cnccc12		CHEMBL1233654	=	Activity	%	88.0	CHEMBL3587	Homo sapiens	Activity	%	88.0
Antagonist	2906891	CHEMBL1060147	Percentage MKK1 activity remaining in the presence of 10uM inhibitor	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Activity	%	28.0	CHEMBL3587	Homo sapiens	Activity	%	28.0
	2906892	CHEMBL1060147	Percentage MKK1 activity remaining in the presence of 10uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	66.0	CHEMBL3587	Homo sapiens	Activity	%	66.0
	2906893	CHEMBL1060147	Percentage MKK1 activity remaining in the presence of 10uM inhibitor	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Activity	%	78.0	CHEMBL3587	Homo sapiens	Activity	%	78.0
	2906894	CHEMBL1060147	Percentage MKK1 activity remaining in the presence of 10uM inhibitor	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Activity	%	96.0	CHEMBL3587	Homo sapiens	Activity	%	96.0
	2906895	CHEMBL1060147	Percentage MKK1 activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1sc(-c2ccsc2)cc1N		CHEMBL193093	=	Activity	%	83.0	CHEMBL3587	Homo sapiens	Activity	%	83.0
	2906896	CHEMBL1060147	Percentage MKK1 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	65.0	CHEMBL3587	Homo sapiens	Activity	%	65.0
	2906897	CHEMBL1060147	Percentage MKK1 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	76.0	CHEMBL3587	Homo sapiens	Activity	%	76.0
	2906898	CHEMBL1060147	Percentage MKK1 activity remaining in the presence of 10uM inhibitor	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Activity	%	106.0	CHEMBL3587	Homo sapiens	Activity	%	106.0
	2906899	CHEMBL1060147	Percentage MKK1 activity remaining in the presence of 10uM inhibitor	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Activity	%	74.0	CHEMBL3587	Homo sapiens	Activity	%	74.0
	2906900	CHEMBL1060147	Percentage MKK1 activity remaining in the presence of 10uM inhibitor	B	CC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(C)=O		CHEMBL240954	=	Activity	%	88.0	CHEMBL3587	Homo sapiens	Activity	%	88.0
	2906901	CHEMBL1060147	Percentage MKK1 activity remaining in the presence of 10uM inhibitor	B	O=C(Nc1cc(Cl)cc2c1[nH]c1cnccc12)c1cccnc1		CHEMBL79004	=	Activity	%	83.0	CHEMBL3587	Homo sapiens	Activity	%	83.0
Antagonist	2906902	CHEMBL1060147	Percentage MKK1 activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl.O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL540501	=	Activity	%	6.0	CHEMBL3587	Homo sapiens	Activity	%	6.0
Antagonist	2906903	CHEMBL1060147	Percentage MKK1 activity remaining in the presence of 10uM inhibitor	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	Activity	%	24.0	CHEMBL3587	Homo sapiens	Activity	%	24.0
	2906904	CHEMBL1060147	Percentage MKK1 activity remaining in the presence of 10uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	76.0	CHEMBL3587	Homo sapiens	Activity	%	76.0
	2906905	CHEMBL1062762	Percentage MKK1 activity remaining in the presence of 25uM inhibitor	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	86.0	CHEMBL3587	Homo sapiens	Activity	%	86.0
	2906906	CHEMBL1062762	Percentage MKK1 activity remaining in the presence of 25uM inhibitor	B	NCCNS(=O)(=O)c1ccc(Cl)c2ccncc12		CHEMBL489157	=	Activity	%	76.0	CHEMBL3587	Homo sapiens	Activity	%	76.0
	2906907	CHEMBL1062818	Percentage MKK1 activity remaining in the presence of 2uM inhibitor	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	Activity	%	71.0	CHEMBL3587	Homo sapiens	Activity	%	71.0
	2906908	CHEMBL1062819	Percentage MKK1 activity remaining in the presence of 3uM inhibitor	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL515414	=	Activity	%	80.0	CHEMBL3587	Homo sapiens	Activity	%	80.0
	2906909	CHEMBL1062820	Percentage MKK1 activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Activity	%	55.0	CHEMBL3587	Homo sapiens	Activity	%	55.0
	2906910	CHEMBL1062820	Percentage MKK1 activity remaining in the presence of 1uM inhibitor	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	Activity	%	71.0	CHEMBL3587	Homo sapiens	Activity	%	71.0
	2906911	CHEMBL1062820	Percentage MKK1 activity remaining in the presence of 1uM inhibitor	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Activity	%	68.0	CHEMBL3587	Homo sapiens	Activity	%	68.0
	2906912	CHEMBL1062820	Percentage MKK1 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	60.0	CHEMBL3587	Homo sapiens	Activity	%	60.0
Antagonist	2906913	CHEMBL1062820	Percentage MKK1 activity remaining in the presence of 1uM inhibitor	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	48.0	CHEMBL3587	Homo sapiens	Activity	%	48.0
Antagonist	2906914	CHEMBL1062820	Percentage MKK1 activity remaining in the presence of 1uM inhibitor	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Activity	%	31.0	CHEMBL3587	Homo sapiens	Activity	%	31.0
	2906915	CHEMBL1062820	Percentage MKK1 activity remaining in the presence of 1uM inhibitor	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Activity	%	56.0	CHEMBL3587	Homo sapiens	Activity	%	56.0
	2906916	CHEMBL1062820	Percentage MKK1 activity remaining in the presence of 1uM inhibitor	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Activity	%	85.0	CHEMBL3587	Homo sapiens	Activity	%	85.0
	2906917	CHEMBL1062820	Percentage MKK1 activity remaining in the presence of 1uM inhibitor	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Activity	%	70.0	CHEMBL3587	Homo sapiens	Activity	%	70.0
	2906918	CHEMBL1062820	Percentage MKK1 activity remaining in the presence of 1uM inhibitor	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	Activity	%	63.0	CHEMBL3587	Homo sapiens	Activity	%	63.0
	2906919	CHEMBL1062820	Percentage MKK1 activity remaining in the presence of 1uM inhibitor	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Activity	%	81.0	CHEMBL3587	Homo sapiens	Activity	%	81.0
	2906920	CHEMBL1062820	Percentage MKK1 activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Activity	%	86.0	CHEMBL3587	Homo sapiens	Activity	%	86.0
	2906921	CHEMBL1062820	Percentage MKK1 activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Activity	%	88.0	CHEMBL3587	Homo sapiens	Activity	%	88.0
	2906922	CHEMBL1062820	Percentage MKK1 activity remaining in the presence of 1uM inhibitor	B	CC(=O)O.O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL265470	=	Activity	%	88.0	CHEMBL3587	Homo sapiens	Activity	%	88.0
	2906923	CHEMBL1062820	Percentage MKK1 activity remaining in the presence of 1uM inhibitor	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Activity	%	58.0	CHEMBL3587	Homo sapiens	Activity	%	58.0
	2906924	CHEMBL1062820	Percentage MKK1 activity remaining in the presence of 1uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	73.0	CHEMBL3587	Homo sapiens	Activity	%	73.0
	2906925	CHEMBL1062820	Percentage MKK1 activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	73.0	CHEMBL3587	Homo sapiens	Activity	%	73.0
	2906926	CHEMBL1062820	Percentage MKK1 activity remaining in the presence of 1uM inhibitor	B	CC1=NCCc2c1[nH]c1cc(O)ccc21		CHEMBL129177	=	Activity	%	86.0	CHEMBL3587	Homo sapiens	Activity	%	86.0
	2906927	CHEMBL1062820	Percentage MKK1 activity remaining in the presence of 1uM inhibitor	B	Cc1nccc2c1[nH]c1ccccc12		CHEMBL12014	=	Activity	%	90.0	CHEMBL3587	Homo sapiens	Activity	%	90.0
	2906928	CHEMBL1062820	Percentage MKK1 activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c3c([nH]c2c1)C(C)=NCC3		CHEMBL340807	=	Activity	%	95.0	CHEMBL3587	Homo sapiens	Activity	%	95.0
	2906929	CHEMBL1062820	Percentage MKK1 activity remaining in the presence of 1uM inhibitor	B	Oc1c(Br)cc(C=C2c3cc(I)ccc3NC2O)cc1Br		CHEMBL1794051	=	Activity	%	73.0	CHEMBL3587	Homo sapiens	Activity	%	73.0
	2906930	CHEMBL1062820	Percentage MKK1 activity remaining in the presence of 1uM inhibitor	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Activity	%	74.0	CHEMBL3587	Homo sapiens	Activity	%	74.0
	2906931	CHEMBL1062820	Percentage MKK1 activity remaining in the presence of 1uM inhibitor	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Activity	%	77.0	CHEMBL3587	Homo sapiens	Activity	%	77.0
	2906932	CHEMBL1062820	Percentage MKK1 activity remaining in the presence of 1uM inhibitor	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Activity	%	97.0	CHEMBL3587	Homo sapiens	Activity	%	97.0
	2906933	CHEMBL1062820	Percentage MKK1 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	86.0	CHEMBL3587	Homo sapiens	Activity	%	86.0
	2906934	CHEMBL1062820	Percentage MKK1 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Activity	%	76.0	CHEMBL3587	Homo sapiens	Activity	%	76.0
	2906935	CHEMBL1062820	Percentage MKK1 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	113.0	CHEMBL3587	Homo sapiens	Activity	%	113.0
	2906936	CHEMBL1062820	Percentage MKK1 activity remaining in the presence of 1uM inhibitor	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Activity	%	93.0	CHEMBL3587	Homo sapiens	Activity	%	93.0
	2906937	CHEMBL1062820	Percentage MKK1 activity remaining in the presence of 1uM inhibitor	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Activity	%	78.0	CHEMBL3587	Homo sapiens	Activity	%	78.0
Antagonist	2906938	CHEMBL1062820	Percentage MKK1 activity remaining in the presence of 1uM inhibitor	B	CCCCCCOC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608532	=	Activity	%	16.0	CHEMBL3587	Homo sapiens	Activity	%	16.0
Antagonist	2906939	CHEMBL1062820	Percentage MKK1 activity remaining in the presence of 1uM inhibitor	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Activity	%	50.0	CHEMBL3587	Homo sapiens	Activity	%	50.0
	2906940	CHEMBL1062820	Percentage MKK1 activity remaining in the presence of 1uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	91.0	CHEMBL3587	Homo sapiens	Activity	%	91.0
	2906941	CHEMBL1062820	Percentage MKK1 activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Activity	%	67.0	CHEMBL3587	Homo sapiens	Activity	%	67.0
	2921273	CHEMBL1047443	Inhibition of MEK1 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL3587	Homo sapiens	Activity	%	100.0
	2924661	CHEMBL1047326	Inhibition of MKK1 assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c3cc[nH]c3ccc21		CHEMBL567173	=	Activity	%	75.0	CHEMBL3587	Homo sapiens	Activity	%	75.0
	2924662	CHEMBL1047326	Inhibition of MKK1 assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c2ccc2cc[nH]c21		CHEMBL584980	=	Activity	%	87.0	CHEMBL3587	Homo sapiens	Activity	%	87.0
	2924663	CHEMBL1047326	Inhibition of MKK1 assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2ccc3c4ccccc4[nH]c3c12		CHEMBL575754	=	Activity	%	104.0	CHEMBL3587	Homo sapiens	Activity	%	104.0
	2924664	CHEMBL1047326	Inhibition of MKK1 assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12		CHEMBL583972	=	Activity	%	50.0	CHEMBL3587	Homo sapiens	Activity	%	50.0
	2926187	CHEMBL1046780	Inhibition of MKK1 assessed as remaining enzyme activity at 3 uM relative to DMSO	B	COc1ccccc1-n1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL574236	=	Activity	%	70.0	CHEMBL3587	Homo sapiens	Activity	%	70.0
	2926281	CHEMBL1057665	Inhibition of MKK1 assessed as remaining enzyme activity at 1 uM relative to DMSO	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	70.0	CHEMBL3587	Homo sapiens	Activity	%	70.0
	2938409	CHEMBL1038682	Inhibition of MEK1	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	>	Ki	nM	4000.0	CHEMBL3587	Homo sapiens	Ki	uM	4.0
	2945996	CHEMBL1054431	Inhibition of MEK1 at 2 uM	B	c1ccc2c(c1)CC(Nc1nc(Nc3ccncc3)nc(N3CCNCC3)n1)C2		CHEMBL575741	<	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	2947563	CHEMBL1047361	Inhibition of MEK1 at 100 uM	B	COc1cc2nccc(Oc3ccc(NC(=O)N4CCN(c5ccccc5)C4=O)cc3F)c2cc1OC		CHEMBL573761	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	INH	%	0.0
	2992219	CHEMBL1044522	Inhibition of human MEK1 at 20 uM by FRET assay	B	C#Cn1c(C#CCCO)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL576620	=	Inhibition	%	10.0	CHEMBL3587	Homo sapiens	INH	%	10.0
	2998978	CHEMBL1048068	Inhibition of MKK1 assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 5 uM ATP	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL220227	=	Activity	%	76.0	CHEMBL3587	Homo sapiens	Activity	%	76.0
	2999768	CHEMBL1048068	Inhibition of MKK1 assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 5 uM ATP	B	CC(C)c1noc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL375428	=	Activity	%	88.0	CHEMBL3587	Homo sapiens	Activity	%	88.0
	2999846	CHEMBL1045500	Inhibition of MKK1 assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 5 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL569114	=	Activity	%	27.0	CHEMBL3587	Homo sapiens	Activity	%	27.0
	2999922	CHEMBL1045500	Inhibition of MKK1 assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 5 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c([S+](C)[O-])nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL572006	=	Activity	%	18.0	CHEMBL3587	Homo sapiens	Activity	%	18.0
	3000059	CHEMBL1045477	Inhibition of MKK1 at 0.1 uM by Cherenkov counting in presence of 5 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL569114	=	Inhibition	%	73.0	CHEMBL3587	Homo sapiens	INH	%	73.0
	3000063	CHEMBL1045477	Inhibition of MKK1 at 0.1 uM by Cherenkov counting in presence of 5 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c([S+](C)[O-])nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL572006	=	Inhibition	%	82.0	CHEMBL3587	Homo sapiens	INH	%	82.0
Not Active	3006231	CHEMBL1047291	Inhibition of MKK1 at 10 uM	B	CCCc1cc(N2CCC(N)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL578601		Activity			CHEMBL3587	Homo sapiens	Activity		
Not Active	3006232	CHEMBL1047291	Inhibition of MKK1 at 10 uM	B	CCCc1cc(N2CCNCC2)nc2sc(C(N)=O)c(N)c12		CHEMBL568922		Activity			CHEMBL3587	Homo sapiens	Activity		
Not Active	3006233	CHEMBL1047291	Inhibition of MKK1 at 10 uM	B	CCCc1cc(N2CCC(O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL576887		Activity			CHEMBL3587	Homo sapiens	Activity		
Not Active	3006234	CHEMBL1047291	Inhibition of MKK1 at 10 uM	B	CCCc1cc(N2CCCC(O)C2)nc2sc(C(N)=O)c(N)c12		CHEMBL576989		Activity			CHEMBL3587	Homo sapiens	Activity		
	3052656	CHEMBL1041143	Residual activity of wild type MEK1 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	52.0	CHEMBL3587	Homo sapiens	Residual activity	%	52.0
	3053965	CHEMBL1050296	Residual activity of wild type MEK1 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	3.0	CHEMBL3587	Homo sapiens	Residual activity	%	3.0
	3054217	CHEMBL1040685	Residual activity of wild type MEK1 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	87.0	CHEMBL3587	Homo sapiens	Residual activity	%	87.0
	3055504	CHEMBL1041143	Residual activity of wild type MEK1 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	53.0	CHEMBL3587	Homo sapiens	Residual activity	%	53.0
	3056809	CHEMBL1050296	Residual activity of wild type MEK1 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	26.0	CHEMBL3587	Homo sapiens	Residual activity	%	26.0
	3057061	CHEMBL1040685	Residual activity of wild type MEK1 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	101.0	CHEMBL3587	Homo sapiens	Residual activity	%	101.0
	3058381	CHEMBL1041143	Residual activity of wild type MEK1 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	59.0	CHEMBL3587	Homo sapiens	Residual activity	%	59.0
	3058633	CHEMBL1050296	Residual activity of wild type MEK1 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	15.0	CHEMBL3587	Homo sapiens	Residual activity	%	15.0
	3062484	CHEMBL1037971	Binding affinity to human MEK1 at 200 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595545	=	Activity	%	100.0	CHEMBL3587	Homo sapiens	Activity	%	100.0
	3063619	CHEMBL1074885	Binding affinity to human MEK1 at 500 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595546	=	Activity	%	100.0	CHEMBL3587	Homo sapiens	Activity	%	100.0
	3063709	CHEMBL1042471	Binding affinity to human MEK1 at 50 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CNC(=O)C[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL609010	=	Activity	%	95.0	CHEMBL3587	Homo sapiens	Activity	%	95.0
	3066864	CHEMBL1066070	Inhibition of MEK1 at 10 uM	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Inhibition	%	16.0	CHEMBL3587	Homo sapiens	INH	%	16.0
	3066954	CHEMBL1066070	Inhibition of MEK1 at 10 uM	B	O=C1Nc2ccccc2/C1=C1\C(=O)N(CCCc2ccccc2)c2ccccc21		CHEMBL607196	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	INH	%	0.0
	3072979	CHEMBL1040685	Residual activity of wild type MEK1 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	79.0	CHEMBL3587	Homo sapiens	Residual activity	%	79.0
	3088556	CHEMBL1049481	Inhibition of MEK1	B	CN(C)CCOc1ccc2c(c1)CCn1nc(-c3ccc(Oc4ccccc4)cc3)c(C(N)=O)c1N2		CHEMBL591325	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	nM	10000.0
	3088620	CHEMBL1049494	Inhibition of MEK1	B	NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)[nH]c(C(=O)c2c(F)cccc2F)c1N		CHEMBL589630	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	nM	10000.0
	3098434	CHEMBL1067031	Inhibition of human MEK1 at 0.1 uM	B	COc1ccccc1NC(=O)CC(Nc1ccc(Oc2ccnc3cc(-c4cn(C)cn4)sc23)c(F)c1)C(F)(F)F		CHEMBL591924	<	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	3130800	CHEMBL1065093	Inhibition of MKK1 at 3 to 6 uM relative to control	B	COc1ccc(C(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1OC		CHEMBL604087	>	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	3131764	CHEMBL1065768	Inhibition of MKK1 at 3 uM relative to control	B	NC(=O)c1ccc(NC(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1		CHEMBL600852	>	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	3186443	CHEMBL1113289	Inhibition of MEK1 ( at 20 uM	B	CCCC(=O)Nc1n[nH]c2cc(Cl)c(-c3ccccc3)cc12		CHEMBL1095040	=	Inhibition	%	13.0	CHEMBL3587	Homo sapiens	INH	%	13.0
	3191062	CHEMBL1101929	Inhibition of MEK1 at 10 uM	B	C[C@H](O)CNc1nccc(-n2ccnc2-c2cccc(NC(=O)c3ccc(Cl)c(C(F)(F)F)c3)c2)n1		CHEMBL1082876	<=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	INH	%	0.0
	3213944	CHEMBL1114900	Inhibition of MAP2K1 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	4.0	CHEMBL3587	Homo sapiens	INH	%	4.0
	3224861	CHEMBL1100379	Inhibition of MEK1 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	3225111	CHEMBL1100379	Inhibition of MEK1 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	3260088	CHEMBL1116001	Inhibition of MKK1 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2nccc(Nc3cccc(Br)c3)c2c1		CHEMBL1089524	=	Activity	%	45.0	CHEMBL3587	Homo sapiens	Activity	%	45.0
	3261385	CHEMBL1116001	Inhibition of MKK1 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL1088901	=	Activity	%	29.0	CHEMBL3587	Homo sapiens	Activity	%	29.0
	3294622	CHEMBL1103934	Inhibition of MEK1	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=O)c5cnn(-c6ccccc6)c5C(F)(F)F)cc4F)c3s2)c1		CHEMBL1094718	<	Inhibition	%	40.0	CHEMBL3587	Homo sapiens	INH	%	40.0
	3306919	CHEMBL1117944	Inhibition of MKK1 at 3 uM	B	O=C(Nc1cc2cc[nH]c(=O)c2cc1Cl)C(NC1CC1)c1ccccc1		CHEMBL1084106	=	Inhibition	%	70.0	CHEMBL3587	Homo sapiens	INH	%	70.0
Not Active	3308381	CHEMBL1119651	Inhibition of MEK1 at 3 uM	B	CCCCn1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL1082829		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Not Active	3308382	CHEMBL1119651	Inhibition of MEK1 at 3 uM	B	CC(C)Cn1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL1084337		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
	3316793	CHEMBL1120352	Inhibition of MEK1 at 1 uM	B	O=C(Nc1cccc(-n2ccc3c(NC(=O)c4ccccc4)nccc32)c1)c1ccc(N2CCOCC2)c(C(F)(F)F)c1		CHEMBL1084450	=	Inhibition	%	12.0	CHEMBL3587	Homo sapiens	INH	%	12.0
	3326162	CHEMBL1168765	Inhibition of MEK1 at 10 uM by HotSpot assay	B	CC(=O)Nc1cccc(-c2ccc(-c3ccnc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)n3)cn2)c1.Cl		CHEMBL1164847	<	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	3332021	CHEMBL1166071	Inhibition of MEK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	3333436	CHEMBL1166071	Inhibition of MEK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	3334841	CHEMBL1166071	Inhibition of MEK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	3336261	CHEMBL1166071	Inhibition of MEK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	3341803	CHEMBL1166071	Inhibition of MEK1 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	3343250	CHEMBL1166071	Inhibition of MEK1 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	3352104	CHEMBL1175386	Inhibition of MEK1 by cascade assay method	B	CC(=O)n1cc(Nc2ccc(I)cc2F)c(C(=O)O)c1		CHEMBL1169746	=	IC50	nM	220.0	CHEMBL3587	Homo sapiens	IC50	uM	0.22
	3352105	CHEMBL1175386	Inhibition of MEK1 by cascade assay method	B	CC(=O)n1cc(C(=O)O)c(Nc2ccc(I)cc2F)c1C		CHEMBL1170596	=	IC50	nM	72.0	CHEMBL3587	Homo sapiens	IC50	uM	0.072
	3352106	CHEMBL1175386	Inhibition of MEK1 by cascade assay method	B	CC(=O)n1cc(Nc2ccc(I)cc2F)c(C(=O)NOCCO)c1		CHEMBL1170802	=	IC50	nM	11.0	CHEMBL3587	Homo sapiens	IC50	uM	0.011
	3352107	CHEMBL1175386	Inhibition of MEK1 by cascade assay method	B	CC(=O)n1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)c1C		CHEMBL1169813	=	IC50	nM	20.0	CHEMBL3587	Homo sapiens	IC50	uM	0.02
	3352108	CHEMBL1175386	Inhibition of MEK1 by cascade assay method	B	CC(=O)c1cc(C(=O)O)c(Nc2ccc(I)cc2F)n1C		CHEMBL1171312	=	IC50	nM	42.0	CHEMBL3587	Homo sapiens	IC50	uM	0.042
	3352109	CHEMBL1175386	Inhibition of MEK1 by cascade assay method	B	CC(=O)c1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n1C		CHEMBL1169814	=	IC50	nM	18.0	CHEMBL3587	Homo sapiens	IC50	uM	0.018
	3352110	CHEMBL1175386	Inhibition of MEK1 by cascade assay method	B	CC(=O)c1cc(C(=O)NOCCCO)c(Nc2ccc(I)cc2F)n1C		CHEMBL1169996	=	IC50	nM	46.0	CHEMBL3587	Homo sapiens	IC50	uM	0.046
	3352111	CHEMBL1175386	Inhibition of MEK1 by cascade assay method	B	CC(=O)c1cc(C(=O)NOC[C@H](O)CO)c(Nc2ccc(I)cc2F)n1C		CHEMBL1170804	=	IC50	nM	20.0	CHEMBL3587	Homo sapiens	IC50	uM	0.02
	3352112	CHEMBL1175386	Inhibition of MEK1 by cascade assay method	B	CC(=O)c1cc(C(=O)NOC[C@@H](O)CO)c(Nc2ccc(I)cc2F)n1C		CHEMBL1170805	=	IC50	nM	11.0	CHEMBL3587	Homo sapiens	IC50	uM	0.011
	3352113	CHEMBL1175386	Inhibition of MEK1 by cascade assay method	B	CC(=O)c1cc(C(=O)NOC(CO)CO)c(Nc2ccc(I)cc2F)n1C		CHEMBL1171012	=	IC50	nM	19.0	CHEMBL3587	Homo sapiens	IC50	uM	0.019
	3352114	CHEMBL1175386	Inhibition of MEK1 by cascade assay method	B	CC(=O)c1cc(C(=O)NCCCO)c(Nc2ccc(I)cc2F)n1C		CHEMBL1169998	=	IC50	nM	90.0	CHEMBL3587	Homo sapiens	IC50	uM	0.09
	3352115	CHEMBL1175386	Inhibition of MEK1 by cascade assay method	B	CC(=O)c1c(Cl)c(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n1C		CHEMBL1169999	=	IC50	nM	18.0	CHEMBL3587	Homo sapiens	IC50	uM	0.018
	3352116	CHEMBL1175386	Inhibition of MEK1 by cascade assay method	B	CC(=O)c1c(Cl)c(C(=O)NOC[C@H](O)CO)c(Nc2ccc(I)cc2F)n1C		CHEMBL1171682	=	IC50	nM	32.0	CHEMBL3587	Homo sapiens	IC50	uM	0.032
	3352117	CHEMBL1175386	Inhibition of MEK1 by cascade assay method	B	CC(=O)c1c(Cl)c(C(=O)NOC[C@@H](O)CO)c(Nc2ccc(I)cc2F)n1C		CHEMBL1171013	=	IC50	nM	13.0	CHEMBL3587	Homo sapiens	IC50	uM	0.013
	3352118	CHEMBL1175386	Inhibition of MEK1 by cascade assay method	B	CC(=O)c1c(F)c(C(=O)NOC[C@H](O)CO)c(Nc2ccc(I)cc2F)n1C		CHEMBL1171014	=	IC50	nM	29.0	CHEMBL3587	Homo sapiens	IC50	uM	0.029
	3352119	CHEMBL1175386	Inhibition of MEK1 by cascade assay method	B	CC(=O)c1c(F)c(C(=O)NOC[C@@H](O)CO)c(Nc2ccc(I)cc2F)n1C		CHEMBL1171015	=	IC50	nM	19.0	CHEMBL3587	Homo sapiens	IC50	uM	0.019
	3352120	CHEMBL1175386	Inhibition of MEK1 by cascade assay method	B	CC(=O)c1cc(C(=O)N2CC(O)C2)c(Nc2ccc(I)cc2F)n1C		CHEMBL1170191	=	IC50	nM	30.0	CHEMBL3587	Homo sapiens	IC50	uM	0.03
	3352121	CHEMBL1175386	Inhibition of MEK1 by cascade assay method	B	CC(=O)c1cc(C(=O)N2CC(N)C2)c(Nc2ccc(I)cc2F)n1C		CHEMBL1172521	=	IC50	nM	7.0	CHEMBL3587	Homo sapiens	IC50	uM	0.007
	3352122	CHEMBL1175386	Inhibition of MEK1 by cascade assay method	B	CC(=O)c1cc(C(=O)N2CC[C@@H](O)C2)c(Nc2ccc(I)cc2F)n1C		CHEMBL1169631	=	IC50	nM	13.0	CHEMBL3587	Homo sapiens	IC50	uM	0.013
	3358662	CHEMBL1174904	Inhibition of MEK1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	100.0	CHEMBL3587	Homo sapiens	INH	%	100.0
	3359104	CHEMBL1174904	Inhibition of MEK1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	82.0	CHEMBL3587	Homo sapiens	INH	%	82.0
	3368321	CHEMBL1176567	Inhibition of MEK1 at 1 M	B	Cc1c[nH]c2ncnc(N3CC[C@@H](N)C3)c12		CHEMBL1173273	=	Inhibition	%	21.0	CHEMBL3587	Homo sapiens	INH	%	21.0
	3368322	CHEMBL1176567	Inhibition of MEK1 at 1 M	B	N#Cc1c[nH]c2ncnc(N3CC4(CCNCC4)c4ccccc43)c12		CHEMBL258837	=	Inhibition	%	71.0	CHEMBL3587	Homo sapiens	INH	%	71.0
	3370122	CHEMBL1176626	Inhibition of MEK1 at 10 uM	B	COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]cc(C(=O)O)c2C)cc1		CHEMBL1173411	=	Inhibition	%	0.9	CHEMBL3587	Homo sapiens	INH	%	0.9
	3389755	CHEMBL1216931	Binding affinity to MEK1 relative to U0126	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	FC		100.0	CHEMBL3587	Homo sapiens	FC		100.0
	3400027	CHEMBL1217224	Inhibition of human MEK1 at 10 uM	B	Cc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc2C)C3)cn1		CHEMBL1214141	=	Inhibition	%	58.0	CHEMBL3587	Homo sapiens	INH	%	58.0
	3419128	CHEMBL1228796	Inhibition of MEK1 at 100 uM relative to control	B	NC(=O)c1sc2c([N+](=O)[O-])cc(C(F)(F)F)cc2[n+]1[O-]		CHEMBL476124	=	Inhibition	%	96.0	CHEMBL3587	Homo sapiens	INH	%	96.0
	3434691	CHEMBL1246560	Inhibition of MEK1 at 5 uM	B	c1cc(-c2cc(C3CCNCC3)n[nH]2)ccn1		CHEMBL1241462	=	Inhibition	%	5.0	CHEMBL3587	Homo sapiens	INH	%	5.0
	3443433	CHEMBL1244199	Inhibition of MEK1 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	21.0	CHEMBL3587	Homo sapiens	INH	%	21.0
	3443650	CHEMBL1244199	Inhibition of MEK1 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	5.0	CHEMBL3587	Homo sapiens	INH	%	5.0
	3444805	CHEMBL1244199	Inhibition of MEK1 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	17.0	CHEMBL3587	Homo sapiens	INH	%	17.0
	3445193	CHEMBL1244505	Binding affinity to MEK1	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	3.5	CHEMBL3587	Homo sapiens	Kd	nM	3.5
	3445429	CHEMBL1244199	Inhibition of MEK1 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	6.0	CHEMBL3587	Homo sapiens	INH	%	6.0
	3445646	CHEMBL1244199	Inhibition of MEK1 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	21.0	CHEMBL3587	Homo sapiens	INH	%	21.0
	3445849	CHEMBL1244199	Inhibition of MEK1 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	17.0	CHEMBL3587	Homo sapiens	INH	%	17.0
	3446039	CHEMBL1244199	Inhibition of MEK1 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	8.0	CHEMBL3587	Homo sapiens	INH	%	8.0
	3446213	CHEMBL1244353	Inhibition of MAP2K1 at 10 mM	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Inhibition	%	56.0	CHEMBL3587	Homo sapiens	INH	%	56.0
	3448030	CHEMBL1249695	Inhibition of human MEK1 activity at 10 uM by radiometric assay	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Inhibition	%	9.0	CHEMBL3587	Homo sapiens	INH	%	9.0
	3448106	CHEMBL1249695	Inhibition of human MEK1 activity at 10 uM by radiometric assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	INH	%	0.0
	3448497	CHEMBL1244505	Binding affinity to MEK1	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	uM	10.0
	3448777	CHEMBL1244505	Binding affinity to MEK1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	uM	10.0
	3449268	CHEMBL1244505	Binding affinity to MEK1	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	130.0	CHEMBL3587	Homo sapiens	Kd	nM	130.0
	3449730	CHEMBL1244505	Binding affinity to MEK1	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	uM	10.0
	3450134	CHEMBL1244505	Binding affinity to MEK1	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	uM	10.0
	3451051	CHEMBL1244505	Binding affinity to MEK1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	uM	10.0
	3463267	CHEMBL1252470	Inhibition of MAP2K1 at 1 uM in presence of 100 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	42.0	CHEMBL3587	Homo sapiens	INH	%	42.0
	3463811	CHEMBL1252470	Inhibition of MAP2K1 at 1 uM in presence of 100 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	12.0	CHEMBL3587	Homo sapiens	INH	%	12.0
	3464030	CHEMBL1252470	Inhibition of MAP2K1 at 1 uM in presence of 100 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	67.0	CHEMBL3587	Homo sapiens	INH	%	67.0
	3525156	CHEMBL1274116	Inhibition of MKK1A at 1 uM	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL496862	=	Inhibition	%	47.0	CHEMBL3587	Homo sapiens	INH	%	47.0
	3525157	CHEMBL1274114	Inhibition of MKK1 at 1 uM	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL496862	=	Inhibition	%	48.0	CHEMBL3587	Homo sapiens	INH	%	48.0
	3525186	CHEMBL1274116	Inhibition of MKK1A at 1 uM	B	O=C1Nc2ccccc2/C1=C(/Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL500435	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	INH	%	0.0
	3525187	CHEMBL1274114	Inhibition of MKK1 at 1 uM	B	O=C1Nc2ccccc2/C1=C(/Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL500435	=	Inhibition	%	4.0	CHEMBL3587	Homo sapiens	INH	%	4.0
	3525216	CHEMBL1274116	Inhibition of MKK1A at 1 uM	B	CN(C)C(=O)c1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL1272078	=	Inhibition	%	4.0	CHEMBL3587	Homo sapiens	INH	%	4.0
	3525217	CHEMBL1274114	Inhibition of MKK1 at 1 uM	B	CN(C)C(=O)c1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL1272078	=	Inhibition	%	12.0	CHEMBL3587	Homo sapiens	INH	%	12.0
	3525246	CHEMBL1274116	Inhibition of MKK1A at 1 uM	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCN(C)C)S(C)(=O)=O)cc1)c1ccccc1		CHEMBL1272128	=	Inhibition	%	80.0	CHEMBL3587	Homo sapiens	INH	%	80.0
	3525247	CHEMBL1274114	Inhibition of MKK1 at 1 uM	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCN(C)C)S(C)(=O)=O)cc1)c1ccccc1		CHEMBL1272128	=	Inhibition	%	53.0	CHEMBL3587	Homo sapiens	INH	%	53.0
	3525276	CHEMBL1274116	Inhibition of MKK1A at 1 uM	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL1272289	=	Inhibition	%	93.0	CHEMBL3587	Homo sapiens	INH	%	93.0
	3525277	CHEMBL1274114	Inhibition of MKK1 at 1 uM	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL1272289	=	Inhibition	%	59.0	CHEMBL3587	Homo sapiens	INH	%	59.0
	3525306	CHEMBL1274116	Inhibition of MKK1A at 1 uM	B	CCNCc1ccc(N/C(=C2\C(=O)Nc3cc(C(=O)N(C)CC)ccc32)c2ccccc2)cc1		CHEMBL1271471	=	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	3525307	CHEMBL1274114	Inhibition of MKK1 at 1 uM	B	CCNCc1ccc(N/C(=C2\C(=O)Nc3cc(C(=O)N(C)CC)ccc32)c2ccccc2)cc1		CHEMBL1271471	=	Inhibition	%	61.0	CHEMBL3587	Homo sapiens	INH	%	61.0
	3556526	CHEMBL1285596	Inhibition of MAP2K at 1 uM	B	CN1C[C@@H]2C[C@H]1CN2c1cc(F)c(-c2ccnc3c(-c4cccc5[nH]ncc45)c(-c4ccncc4)nn23)c(F)c1		CHEMBL1276179	=	Inhibition	%	12.0	CHEMBL3587	Homo sapiens	INH	%	12.0
	3561319	CHEMBL1287075	Inhibition of human MEK1 at 10 uM	B	Cc1c2c(=O)n(-c3ccccc3Cl)[nH]c2cc(=O)n1Cc1ccccn1		CHEMBL1276946	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	INH	%	0.0
	3601435	CHEMBL1292409	Inhibition of MEK-1	B	COc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1		CHEMBL1288582	=	IC50	nM	2450.0	CHEMBL3587	Homo sapiens	IC50	uM	2.45
Inconclusive	4715503	CHEMBL1614327	PUBCHEM_BIOASSAY: Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay: MEK Inhibition. (Class of assay: confirmatory) [Related pubchem assays: 1454, 995 ]	F	O=C1c2ccc(O)c(O)c2C(=O)c2c(O)ccc(O)c21		CHEMBL29898	=	Potency	nM	3548.1	CHEMBL3587	Homo sapiens	Potency	um	3.5481
Inconclusive	4715504	CHEMBL1614327	PUBCHEM_BIOASSAY: Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay: MEK Inhibition. (Class of assay: confirmatory) [Related pubchem assays: 1454, 995 ]	F	CCN1C(=O)NC(=O)/C(=C/c2cc(C)n(-c3sc(C)c(C)c3C#N)c2C)C1=O		CHEMBL1499910	=	Potency	nM	44668.4	CHEMBL3587	Homo sapiens	Potency	um	44.6684
Inconclusive	4715505	CHEMBL1614327	PUBCHEM_BIOASSAY: Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay: MEK Inhibition. (Class of assay: confirmatory) [Related pubchem assays: 1454, 995 ]	F	Fc1ccc(Nc2ncnc3sc4c(c23)CCC4)cc1F		CHEMBL1557669	=	Potency	nM	39810.7	CHEMBL3587	Homo sapiens	Potency	um	39.8107
Inconclusive	4715506	CHEMBL1614327	PUBCHEM_BIOASSAY: Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay: MEK Inhibition. (Class of assay: confirmatory) [Related pubchem assays: 1454, 995 ]	F	O=C1c2ccccc2C(=O)c2c1cccc2N1CCCC1		CHEMBL1400950	=	Potency	nM	1000.0	CHEMBL3587	Homo sapiens	Potency	um	1.0
Active	4715507	CHEMBL1614327	PUBCHEM_BIOASSAY: Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay: MEK Inhibition. (Class of assay: confirmatory) [Related pubchem assays: 1454, 995 ]	F	CCn1nc(-c2ccccc2)nc2c(=O)n(C)c(=O)nc1-2		CHEMBL1488035	=	Potency	nM	631.0	CHEMBL3587	Homo sapiens	Potency	um	0.631
Inconclusive	4715508	CHEMBL1614327	PUBCHEM_BIOASSAY: Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay: MEK Inhibition. (Class of assay: confirmatory) [Related pubchem assays: 1454, 995 ]	F	CC1=CC(=O)c2c(O)cccc2C1=O		CHEMBL295316	=	Potency	nM	12589.3	CHEMBL3587	Homo sapiens	Potency	um	12.5893
Active	4715509	CHEMBL1614327	PUBCHEM_BIOASSAY: Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay: MEK Inhibition. (Class of assay: confirmatory) [Related pubchem assays: 1454, 995 ]	F	Cn1nc(-c2ccccc2)nc2c(=O)n(C)c(=O)nc1-2		CHEMBL1527391	=	Potency	nM	707.9	CHEMBL3587	Homo sapiens	Potency	um	0.7079
Inconclusive	4715510	CHEMBL1614327	PUBCHEM_BIOASSAY: Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay: MEK Inhibition. (Class of assay: confirmatory) [Related pubchem assays: 1454, 995 ]	F	Cc1nc2c(=O)n(C)c(=O)nc-2n(C)n1		CHEMBL601757	=	Potency	nM	1995.3	CHEMBL3587	Homo sapiens	Potency	um	1.9953
Inconclusive	4715511	CHEMBL1614327	PUBCHEM_BIOASSAY: Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay: MEK Inhibition. (Class of assay: confirmatory) [Related pubchem assays: 1454, 995 ]	F	O=C1NC(=O)C(=Cc2ccccc2Oc2ccc(F)cc2)C(=O)N1		CHEMBL1543152	=	Potency	nM	17782.8	CHEMBL3587	Homo sapiens	Potency	um	17.7828
Active	4715512	CHEMBL1614327	PUBCHEM_BIOASSAY: Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay: MEK Inhibition. (Class of assay: confirmatory) [Related pubchem assays: 1454, 995 ]	F	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Potency	nM	100.0	CHEMBL3587	Homo sapiens	Potency	um	0.1
Inconclusive	4715513	CHEMBL1614327	PUBCHEM_BIOASSAY: Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay: MEK Inhibition. (Class of assay: confirmatory) [Related pubchem assays: 1454, 995 ]	F	Cc1cc2nc3ccc(N(C)C)cc3[s+]c2cc1N.[Cl-]		CHEMBL1790006	=	Potency	nM	35481.3	CHEMBL3587	Homo sapiens	Potency	um	35.4813
Active	4715514	CHEMBL1614327	PUBCHEM_BIOASSAY: Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay: MEK Inhibition. (Class of assay: confirmatory) [Related pubchem assays: 1454, 995 ]	F	CCn1nc(-c2cccs2)nc2c(=O)n(C)c(=O)nc1-2		CHEMBL555689	=	Potency	nM	891.3	CHEMBL3587	Homo sapiens	Potency	um	0.8913
Inconclusive	4715515	CHEMBL1614327	PUBCHEM_BIOASSAY: Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay: MEK Inhibition. (Class of assay: confirmatory) [Related pubchem assays: 1454, 995 ]	F	Cn1nc(-c2ccc(Cl)cc2)nc2c(=O)n(C)c(=O)nc1-2		CHEMBL1334062	=	Potency	nM	794.3	CHEMBL3587	Homo sapiens	Potency	um	0.7943
Inconclusive	4715516	CHEMBL1614327	PUBCHEM_BIOASSAY: Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay: MEK Inhibition. (Class of assay: confirmatory) [Related pubchem assays: 1454, 995 ]	F	CN(C)c1ccc(/N=C2\C(=O)N(C)c3cccc4c(O)c5ccccc5c2c34)cc1		CHEMBL2000619	=	Potency	nM	1995.3	CHEMBL3587	Homo sapiens	Potency	um	1.9953
	5120434	CHEMBL1646191	Inhibition of human MEK1 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	110.0	CHEMBL3587	Homo sapiens	INH	%	110.0
	5132612	CHEMBL1648753	Inhibition of MKK1 assessed as residual activity at 10 uM	B	CN(C)C/C=C/C(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641990	=	Activity	%	47.0	CHEMBL3587	Homo sapiens	Activity	%	47.0
	5133755	CHEMBL1648753	Inhibition of MKK1 assessed as residual activity at 10 uM	B	CN(C)CCCC(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641989	=	Activity	%	100.0	CHEMBL3587	Homo sapiens	Activity	%	100.0
	5133916	CHEMBL1648753	Inhibition of MKK1 assessed as residual activity at 10 uM	B	CN1CCN(CCC(=O)Nc2ccc3c(C#N)cnc(Nc4cccc(Br)c4)c3c2)CC1		CHEMBL1641992	=	Activity	%	79.0	CHEMBL3587	Homo sapiens	Activity	%	79.0
	5191327	CHEMBL1663821	Inhibition of MKK1 at 1 uM	B	COc1cc2nc(-c3cc(F)ccc3O)nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC		CHEMBL1236782	=	Inhibition	%	31.0	CHEMBL3587	Homo sapiens	INH	%	31.0
	5191328	CHEMBL1663821	Inhibition of MKK1 at 1 uM	B	CC(C)(O)[C@@H]1CNC[C@H]1Nc1nc(-c2cc(-c3cc[nH]n3)ccc2O)nc2ccccc12		CHEMBL1650131	=	Inhibition	%	37.0	CHEMBL3587	Homo sapiens	INH	%	37.0
	5203080	CHEMBL1670834	Inhibition of human recombinant MEK1 expressed in insect cells after 20 mins	B	COc1cc(O)c2c(c1)/C=C/C[C@@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1668411	=	IC50	nM	2.0	CHEMBL3587	Homo sapiens	IC50	uM	0.002
	5203081	CHEMBL1670834	Inhibition of human recombinant MEK1 expressed in insect cells after 20 mins	B	COc1cc(O)c2c(c1)/C=C/CCCC(=O)/C=C/C[C@H](C)OC2=O		CHEMBL1668418	=	IC50	nM	22000.0	CHEMBL3587	Homo sapiens	IC50	uM	22.0
	5203082	CHEMBL1670834	Inhibition of human recombinant MEK1 expressed in insect cells after 20 mins	B	COc1cc(O)c2c(c1)CCCCCC(=O)/C=C/C[C@H](C)OC2=O		CHEMBL1668419	=	IC50	nM	12000.0	CHEMBL3587	Homo sapiens	IC50	uM	12.0
	5203083	CHEMBL1670834	Inhibition of human recombinant MEK1 expressed in insect cells after 20 mins	B	COc1cc(O)c2c(c1)/C=C\CCCC(=O)/C=C/C[C@H](C)OC2=O		CHEMBL1668420	>	IC50	nM	100000.0	CHEMBL3587	Homo sapiens	IC50	uM	100.0
	5203084	CHEMBL1670834	Inhibition of human recombinant MEK1 expressed in insect cells after 20 mins	B	COc1cc(O)c2c(c1)CCCCCC(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1651523	=	IC50	nM	17000.0	CHEMBL3587	Homo sapiens	IC50	uM	17.0
	5239470	CHEMBL1686836	Inhibition of MEK1 by IMAP assay	B	Cn1cnc2c(c(Nc3ccc(I)cc3F)cc(=O)n2C)c1=O		CHEMBL1684060	=	IC50	nM	26.0	CHEMBL3587	Homo sapiens	IC50	nM	26.0
	5239471	CHEMBL1686836	Inhibition of MEK1 by IMAP assay	B	Cn1c(=O)cc(Nc2ccc(I)cc2F)c2c(=O)n(CCO)cnc21		CHEMBL1684061	=	IC50	nM	9.8	CHEMBL3587	Homo sapiens	IC50	nM	9.8
	5239472	CHEMBL1686836	Inhibition of MEK1 by IMAP assay	B	Cn1c(=O)cc(Nc2ccc(I)cc2F)c2c(=O)n(CCCO)cnc21		CHEMBL1684062	=	IC50	nM	4.9	CHEMBL3587	Homo sapiens	IC50	nM	4.9
	5239473	CHEMBL1686836	Inhibition of MEK1 by IMAP assay	B	Cn1c(=O)cc(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1684063	=	IC50	nM	4.6	CHEMBL3587	Homo sapiens	IC50	nM	4.6
	5239474	CHEMBL1686836	Inhibition of MEK1 by IMAP assay	B	Cn1c(=O)cc(Nc2ccc(I)cc2F)c2c(=O)n(C[C@H](O)CO)cnc21		CHEMBL1684064	=	IC50	nM	8.3	CHEMBL3587	Homo sapiens	IC50	nM	8.3
	5239475	CHEMBL1686836	Inhibition of MEK1 by IMAP assay	B	Cn1c(=O)cc(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CCO)cnc21		CHEMBL1684065	=	IC50	nM	53.0	CHEMBL3587	Homo sapiens	IC50	nM	53.0
	5239476	CHEMBL1686836	Inhibition of MEK1 by IMAP assay	B	CN(C)CCn1cnc2c(c(Nc3ccc(I)cc3F)cc(=O)n2C)c1=O		CHEMBL1684066	=	IC50	nM	740.0	CHEMBL3587	Homo sapiens	IC50	nM	740.0
	5239477	CHEMBL1686836	Inhibition of MEK1 by IMAP assay	B	Cn1c(=O)c(Cl)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1681812	=	IC50	nM	5.9	CHEMBL3587	Homo sapiens	IC50	nM	5.9
	5239478	CHEMBL1686836	Inhibition of MEK1 by IMAP assay	B	Cc1c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc2n(C)c1=O		CHEMBL1684067	=	IC50	nM	3.8	CHEMBL3587	Homo sapiens	IC50	nM	3.8
	5239479	CHEMBL1686836	Inhibition of MEK1 by IMAP assay	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	=	IC50	nM	3.2	CHEMBL3587	Homo sapiens	IC50	nM	3.2
	5239480	CHEMBL1686836	Inhibition of MEK1 by IMAP assay	B	Cn1c(=O)c(F)c(Nc2ccc(Br)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1684068	=	IC50	nM	16.0	CHEMBL3587	Homo sapiens	IC50	nM	16.0
	5239481	CHEMBL1686836	Inhibition of MEK1 by IMAP assay	B	C#Cc1ccc(Nc2c(F)c(=O)n(C)c3ncn(C[C@@H](O)CO)c(=O)c23)c(F)c1		CHEMBL1684069	=	IC50	nM	4.8	CHEMBL3587	Homo sapiens	IC50	nM	4.8
	5239482	CHEMBL1686836	Inhibition of MEK1 by IMAP assay	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@H](O)CO)cnc21		CHEMBL1684070	=	IC50	nM	3.2	CHEMBL3587	Homo sapiens	IC50	nM	3.2
	5239483	CHEMBL1686836	Inhibition of MEK1 by IMAP assay	B	Cc1c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@H](O)CO)cnc2n(C)c1=O		CHEMBL1684071	=	IC50	nM	5.0	CHEMBL3587	Homo sapiens	IC50	nM	5.0
	5239484	CHEMBL1686836	Inhibition of MEK1 by IMAP assay	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(CCO)cnc21		CHEMBL1684072	=	IC50	nM	8.6	CHEMBL3587	Homo sapiens	IC50	nM	8.6
	5239485	CHEMBL1686836	Inhibition of MEK1 by IMAP assay	B	Cc1c(Nc2ccc(I)cc2F)c2c(=O)n(CCO)cnc2n(C)c1=O		CHEMBL1684073	=	IC50	nM	4.0	CHEMBL3587	Homo sapiens	IC50	nM	4.0
	5239486	CHEMBL1686836	Inhibition of MEK1 by IMAP assay	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C(CO)CO)cnc21		CHEMBL1684074	=	IC50	nM	3.3	CHEMBL3587	Homo sapiens	IC50	nM	3.3
	5239487	CHEMBL1686836	Inhibition of MEK1 by IMAP assay	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(OC[C@H](O)CO)cnc21		CHEMBL1684075	=	IC50	nM	3.1	CHEMBL3587	Homo sapiens	IC50	nM	3.1
	5242908	CHEMBL1685627	Binding affinity to MEK1 by surface plasmon resonance in absence of ATP	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	=	Kd	nM	8.7	CHEMBL3587	Homo sapiens	Kd	nM	8.7
	5242909	CHEMBL1685627	Binding affinity to MEK1 by surface plasmon resonance in absence of ATP	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	Kd	nM	31.0	CHEMBL3587	Homo sapiens	Kd	nM	31.0
	5242910	CHEMBL1685628	Binding affinity to MEK1 by surface plasmon resonance in presence of ATP	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	=	Kd	nM	0.24	CHEMBL3587	Homo sapiens	Kd	nM	0.24
	5242911	CHEMBL1685628	Binding affinity to MEK1 by surface plasmon resonance in presence of ATP	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	Kd	nM	0.4	CHEMBL3587	Homo sapiens	Kd	nM	0.4
	5243735	CHEMBL1685698	Inhibition of MEK1 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	96.0	CHEMBL3587	Homo sapiens	INH	%	96.0
	5243843	CHEMBL1686055	Inhibition of MEK1 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	87.0	CHEMBL3587	Homo sapiens	INH	%	87.0
	5243956	CHEMBL1685698	Inhibition of MEK1 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	51.0	CHEMBL3587	Homo sapiens	INH	%	51.0
	5244064	CHEMBL1686055	Inhibition of MEK1 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	13.0	CHEMBL3587	Homo sapiens	INH	%	13.0
	5244937	CHEMBL1685698	Inhibition of MEK1 at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	96.0	CHEMBL3587	Homo sapiens	INH	%	96.0
	5245045	CHEMBL1686055	Inhibition of MEK1 at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	91.0	CHEMBL3587	Homo sapiens	INH	%	91.0
	5245196	CHEMBL1685698	Inhibition of MEK1 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	104.0	CHEMBL3587	Homo sapiens	INH	%	104.0
	5246026	CHEMBL1686055	Inhibition of MEK1 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	111.0	CHEMBL3587	Homo sapiens	INH	%	111.0
	5249792	CHEMBL1687342	inhibition of MEK1 at 10 uM	B	COc1ccc(Cn2ncc(NC(=O)c3cc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)ccc3C)c2N)cc1		CHEMBL1684800	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	INH	%	0.0
	5249853	CHEMBL1687368	inhibition of MEK1	B	COc1ccc(Cn2ncc(NC(=O)c3cc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)ccc3C)c2N)cc1		CHEMBL1684800	=	IC50	nM	18.19	CHEMBL3587	Homo sapiens	IC50	nM	18.19
Not Active	6150864	CHEMBL1764801	Inhibition of MEK1	B	C[C@H]1C(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C(=O)N1Cc1ccnc2ccccc12		CHEMBL1738841		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
	6154904	CHEMBL1763004	Inhibition of MEK1	B	CC(=O)NC[C@H]1CC[C@H](c2nc(-c3cc4ccccc4[nH]3)c3c(N)nccn32)CC1		CHEMBL1762110	=	IC50	nM	960.0	CHEMBL3587	Homo sapiens	IC50	uM	0.96
	6154949	CHEMBL1763004	Inhibition of MEK1	B	CN(C)C(=O)N1CCC(c2nc(-c3cc4ccccc4[nH]3)c3c(N)nccn23)CC1		CHEMBL1762114	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	6167657	CHEMBL1769198	Inhibition of MEK1	B	CNc1cncc(-c2c[nH]c(=O)c(NC(=O)c3ccc(N4CCC[C@H]4CN4CCCC4)cc3)c2)n1		CHEMBL1765781	>	Ki	nM	1000.0	CHEMBL3587	Homo sapiens	Ki	uM	1.0
	6173417	CHEMBL1768225	Inhibition of MAK2K1 at 25 uM by TR-FRET assay	B	NC(=O)c1ccsc1NC(=O)Cc1csc2ccccc12		CHEMBL1767254	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	INH	%	0.0
	6175001	CHEMBL1767718	Inhibition of human recombinant MEK1 at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2[nH]nc(C(C)C)c2n1		CHEMBL1738742	=	Inhibition	%	58.0	CHEMBL3587	Homo sapiens	INH	%	58.0
	6175018	CHEMBL1767718	Inhibition of human recombinant MEK1 at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Inhibition	%	38.0	CHEMBL3587	Homo sapiens	INH	%	38.0
	6262763	CHEMBL1798986	Inhibition of MEK1	B	Cc1ccc(C(=O)NCCO)cc1-n1cnc(OCc2ccc(F)cc2F)c(Cl)c1=O		CHEMBL1738710	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	6267521	CHEMBL1799033	Inhibition of MEK1 at 10 uM	B	O=c1c(Cl)c(OCc2ccc(F)cc2F)cc(CO)n1-c1c(F)cccc1F		CHEMBL1797211	<	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	6267522	CHEMBL1799033	Inhibition of MEK1 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cccc(C(N)=O)c1		CHEMBL1797224	<	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	6274426	CHEMBL1805999	Inhibition of MKK1 assessed as residual enzyme activity at 10 uM	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833	=	Activity	%	65.0	CHEMBL3587	Homo sapiens	Activity	%	65.0
Not Active	6307627	CHEMBL1816869	Inhibition of wild type MEK1 assessed as 33Pi incorporation after 60 mins by scintillation counting	B	C=C[C@]1(C)C=C2[C@@H](O)[C@@H]3OC(=O)[C@@]4(C)CC[C@H]5C[C@]5([C@@H]34)[C@@]2(O)C(=O)C1		CHEMBL1812030		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Not Active	6307628	CHEMBL1816869	Inhibition of wild type MEK1 assessed as 33Pi incorporation after 60 mins by scintillation counting	B	C=C[C@@]1(C)C=C2C(=O)C(O)=C3[C@](C)(C(=O)O)CC[C@@H]4C[C@]34[C@]2(O)C(=O)C1		CHEMBL516554		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
	6307629	CHEMBL1816869	Inhibition of wild type MEK1 assessed as 33Pi incorporation after 60 mins by scintillation counting	B	Cc1cc(O)cc2oc3cc(O)cc(O)c3c(=O)c12		CHEMBL466154	>	IC50	nM	100000.0	CHEMBL3587	Homo sapiens	IC50	uM	100.0
	6307630	CHEMBL1816869	Inhibition of wild type MEK1 assessed as 33Pi incorporation after 60 mins by scintillation counting	B	Cc1c(O)c(O)cc2oc3cc(O)cc(O)c3c(=O)c12		CHEMBL454440	>	IC50	nM	100000.0	CHEMBL3587	Homo sapiens	IC50	uM	100.0
	6340989	CHEMBL1827575	Activity of MEK1 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	98.0	CHEMBL3587	Homo sapiens	Activity	%	98.0
	6352239	CHEMBL1825846	Inhibition of MKK1 assessed as residual activity at 10 uM by radioactivity assay in presence of 5 uM ATP	B	Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1		CHEMBL215205	=	Activity	%	60.0	CHEMBL3587	Homo sapiens	Activity	%	60.0
	6385723	CHEMBL1838174	Inhibition of human MAP2K1 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCCc2ccccc2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834114	<	Inhibition	%	35.0	CHEMBL3587	Homo sapiens	INH	%	35.0
	6385724	CHEMBL1838174	Inhibition of human MAP2K1 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CCCC1		CHEMBL1834318	<	Inhibition	%	35.0	CHEMBL3587	Homo sapiens	INH	%	35.0
	6385725	CHEMBL1838174	Inhibition of human MAP2K1 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	C[C@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834323	<	Inhibition	%	35.0	CHEMBL3587	Homo sapiens	INH	%	35.0
	6385726	CHEMBL1838174	Inhibition of human MAP2K1 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	CC(C)[C@@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834324	<	Inhibition	%	35.0	CHEMBL3587	Homo sapiens	INH	%	35.0
	6385727	CHEMBL1838174	Inhibition of human MAP2K1 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCCC1)CO2		CHEMBL1834330	<	Inhibition	%	35.0	CHEMBL3587	Homo sapiens	INH	%	35.0
	7567288	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7567747	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7568218	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7568244	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	830.0	CHEMBL3587	Homo sapiens	Kd	nM	830.0
	7568676	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	77.0	CHEMBL3587	Homo sapiens	Kd	nM	77.0
	7569261	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	=	Kd	nM	99.0	CHEMBL3587	Homo sapiens	Kd	nM	99.0
	7569721	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7570214	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	1100.0	CHEMBL3587	Homo sapiens	Kd	nM	1100.0
	7570641	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	130.0	CHEMBL3587	Homo sapiens	Kd	nM	130.0
	7571237	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7571728	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	1900.0	CHEMBL3587	Homo sapiens	Kd	nM	1900.0
	7572191	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7572607	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	550.0	CHEMBL3587	Homo sapiens	Kd	nM	550.0
	7573218	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	10.0	CHEMBL3587	Homo sapiens	Kd	nM	10.0
	7573233	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	1000.0	CHEMBL3587	Homo sapiens	Kd	nM	1000.0
	7573709	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	200.0	CHEMBL3587	Homo sapiens	Kd	nM	200.0
	7574178	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7574586	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7575215	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7575686	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	=	Kd	nM	1700.0	CHEMBL3587	Homo sapiens	Kd	nM	1700.0
	7576151	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	=	Kd	nM	550.0	CHEMBL3587	Homo sapiens	Kd	nM	550.0
	7576559	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	5100.0	CHEMBL3587	Homo sapiens	Kd	nM	5100.0
	7576728	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7577187	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	12.0	CHEMBL3587	Homo sapiens	Kd	nM	12.0
	7577665	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	530.0	CHEMBL3587	Homo sapiens	Kd	nM	530.0
	7578135	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	51.0	CHEMBL3587	Homo sapiens	Kd	nM	51.0
	7578540	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	1800.0	CHEMBL3587	Homo sapiens	Kd	nM	1800.0
	7578736	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7579110	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7579560	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7580034	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7580503	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7580906	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	1800.0	CHEMBL3587	Homo sapiens	Kd	nM	1800.0
	7581094	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7581479	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7581924	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7582395	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7583440	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7583837	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7584282	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7584773	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	320.0	CHEMBL3587	Homo sapiens	Kd	nM	320.0
	7585177	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7585770	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7586178	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7586624	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7586653	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7587107	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7587731	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	2700.0	CHEMBL3587	Homo sapiens	Kd	nM	2700.0
	7588150	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	3.5	CHEMBL3587	Homo sapiens	Kd	nM	3.5
	7588632	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7589083	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7589696	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7590145	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7590619	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7591070	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7591649	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	520.0	CHEMBL3587	Homo sapiens	Kd	nM	520.0
	7592121	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7592594	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7593047	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	19.0	CHEMBL3587	Homo sapiens	Kd	nM	19.0
	7593194	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7593629	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7594101	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7594574	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7595026	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7595162	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7595606	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	1800.0	CHEMBL3587	Homo sapiens	Kd	nM	1800.0
	7596080	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7596551	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	nM	10000.0
	7597134	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	1900.0	CHEMBL3587	Homo sapiens	Kd	nM	1900.0
	7597587	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	=	Kd	nM	120.0	CHEMBL3587	Homo sapiens	Kd	nM	120.0
	7598060	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	=	Kd	nM	14.0	CHEMBL3587	Homo sapiens	Kd	nM	14.0
	7598530	CHEMBL1908590	Binding constant for MEK1 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	21.0	CHEMBL3587	Homo sapiens	Kd	nM	21.0
	7843036	CHEMBL1913272	Inhibition of human recombinant MEK1 at 10 uM after 4 hrs by Kinase-Glo luminescent assay	B	O=C(c1c[nH]c2ccccc12)c1nccc2c1[nH]c1ccc(O)cc12		CHEMBL1910715	=	Inhibition	%	11.0	CHEMBL3587	Homo sapiens	INH	%	11.0
	7922691	CHEMBL1918455	Inhibition of human recombinant MEK1 at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	28.0	CHEMBL3587	Homo sapiens	INH	%	28.0
	7943744	CHEMBL1919764	Inhibition of MEK1	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	8.07	CHEMBL3587	Homo sapiens	IC50	nM	8.07
	7943785	CHEMBL1921553	Inhibition of MEK1 at 10 uM	B	O=C1CC(c2cccc(NC(=O)c3ccc(Cl)c(C(F)(F)F)c3)c2)=Nc2cnn(Cc3ccccc3)c2N1		CHEMBL1917776	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	INH	%	0.0
	7951374	CHEMBL1926226	Inhibition of wild type human MEK1	B	Cc1ccc(O)cc1CC[C@@H]1[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)/C=C/CC(C)C		CHEMBL1922224	>	IC50	nM	100000.0	CHEMBL3587	Homo sapiens	IC50	uM	100.0
	7951375	CHEMBL1926226	Inhibition of wild type human MEK1	B	Cc1ccc(O)cc1CC[C@@H]1C(=O)CC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)/C=C/CC(C)C		CHEMBL518060	>	IC50	nM	100000.0	CHEMBL3587	Homo sapiens	IC50	uM	100.0
	7951376	CHEMBL1926226	Inhibition of wild type human MEK1	B	C=C(CC[C@@H](C)[C@H]1CC[C@H]2[C@H](CCc3cc(O)ccc3C)C(=O)CC[C@@]21C)C(C)C		CHEMBL1922225	>	IC50	nM	100000.0	CHEMBL3587	Homo sapiens	IC50	uM	100.0
	7951377	CHEMBL1926226	Inhibition of wild type human MEK1	B	Cc1ccc(O)cc1CC[C@@H]1C(=O)CC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)C		CHEMBL456936	>	IC50	nM	100000.0	CHEMBL3587	Homo sapiens	IC50	uM	100.0
	7951378	CHEMBL1926226	Inhibition of wild type human MEK1	B	Cc1ccc(O)cc1CC[C@H]1[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC[C@H]1O		CHEMBL517956	=	IC50	nM	48900.0	CHEMBL3587	Homo sapiens	IC50	uM	48.9
	7951379	CHEMBL1926226	Inhibition of wild type human MEK1	B	Cc1ccc(O)cc1CC[C@@H]1C(=O)CC[C@@]2(C)[C@H]1C[C@H](O)[C@@H]2[C@H](C)CCCC(C)C		CHEMBL456294	>	IC50	nM	100000.0	CHEMBL3587	Homo sapiens	IC50	uM	100.0
	7951380	CHEMBL1926226	Inhibition of wild type human MEK1	B	C=C(CC[C@@H](C)[C@H]1CC[C@H]2[C@H](CCc3cc(O)ccc3C)[C@H](O)CC[C@@]21C)C(C)C		CHEMBL515982	>	IC50	nM	100000.0	CHEMBL3587	Homo sapiens	IC50	uM	100.0
	7951381	CHEMBL1926226	Inhibition of wild type human MEK1	B	Cc1ccc(O)cc1CC[C@H]1[C@@H]2C[C@H](O)[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC[C@H]1O		CHEMBL464351	>	IC50	nM	100000.0	CHEMBL3587	Homo sapiens	IC50	uM	100.0
	7956214	CHEMBL1924833	Inhibition of C-terminus flag-tagged MEK1 expressed in baculovirus infected insect cells using [gamma33P]ATP as substrate after 60 mins by scintillation counting	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	=	IC50	nM	1100.0	CHEMBL3587	Homo sapiens	IC50	nM	1100.0
	7960785	CHEMBL1932538	Inhibition of MKK1 assessed as residual activity at 1 uM	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928541	=	Activity	%	10.0	CHEMBL3587	Homo sapiens	Activity	%	10.0
	7960786	CHEMBL1932539	Inhibition of MKK1 assessed as residual activity at 10 uM	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928541	=	Activity	%	8.0	CHEMBL3587	Homo sapiens	Activity	%	8.0
	7960994	CHEMBL1932619	Inhibition of MKK1 assessed as residual activity at 1 uM	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(CCO)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928561	=	Activity	%	65.0	CHEMBL3587	Homo sapiens	Activity	%	65.0
	7960995	CHEMBL1932620	Inhibition of MKK1 assessed as residual activity at 10 uM	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(CCO)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928561	=	Activity	%	5.0	CHEMBL3587	Homo sapiens	Activity	%	5.0
	7969749	CHEMBL1931448	Inhibition of MEKK1 assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	115.0	CHEMBL3587	Homo sapiens	Activity	%	115.0
	7969752	CHEMBL1931451	Inhibition of MKK1 assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	29.0	CHEMBL3587	Homo sapiens	Activity	%	29.0
	7970439	CHEMBL1929920	Inhibition of MEK1 at 10 uM	B	NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O		CHEMBL1929247	=	Inhibition	%	69.0	CHEMBL3587	Homo sapiens	INH	%	69.0
	7989263	CHEMBL1936348	Inhibition of human MEK1 at 3 uM	B	Cn1cc(NC(=O)c2ccc3cc4n(c3c2)C(C)(C)CNC4=O)nc1C(=O)NC1CCCC1		CHEMBL1933142	>=	Inhibition	%	80.0	CHEMBL3587	Homo sapiens	INH	%	80.0
	7989264	CHEMBL1936348	Inhibition of human MEK1 at 3 uM	B	Cc1cc(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)on1		CHEMBL1933143	<	Inhibition	%	80.0	CHEMBL3587	Homo sapiens	INH	%	80.0
	7989265	CHEMBL1936348	Inhibition of human MEK1 at 3 uM	B	Cn1cc(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)cn1		CHEMBL1933148	<	Inhibition	%	80.0	CHEMBL3587	Homo sapiens	INH	%	80.0
	7989266	CHEMBL1936348	Inhibition of human MEK1 at 3 uM	B	Cn1c(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)nc2ccccc21		CHEMBL1933279	<	Inhibition	%	80.0	CHEMBL3587	Homo sapiens	INH	%	80.0
	7992199	CHEMBL1935879	Inhibition of MAP2K1 at 1 uM	B	CN(c1ccccc1-c1cc(Cl)c2cnc(Nc3ccc(C4CCN(CC(N)=O)CC4)cc3)nn12)S(C)(=O)=O		CHEMBL1934353	=	Inhibition	%	67.0	CHEMBL3587	Homo sapiens	INH	%	67.0
	8004268	CHEMBL1942771	Inhibition of human MAP2K1 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940980	<	Inhibition	%	35.0	CHEMBL3587	Homo sapiens	INH	%	35.0
	8004269	CHEMBL1942771	Inhibition of human MAP2K1 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940981	<	Inhibition	%	35.0	CHEMBL3587	Homo sapiens	INH	%	35.0
	8004270	CHEMBL1942771	Inhibition of human MAP2K1 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940987	<	Inhibition	%	35.0	CHEMBL3587	Homo sapiens	INH	%	35.0
	8004271	CHEMBL1942771	Inhibition of human MAP2K1 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940990	<	Inhibition	%	35.0	CHEMBL3587	Homo sapiens	INH	%	35.0
	8018831	CHEMBL1948949	Inhibition of MEK1 assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CC1CCOCC1		CHEMBL1945953	=	Activity	%	84.0	CHEMBL3587	Homo sapiens	Activity	%	84.0
	8018832	CHEMBL1948949	Inhibition of MEK1 assessed as activity remaining at 10 uM	B	CC(C)(O)c1ccc(-c2cnc3[nH]c(=O)n(CC4CCCCC4)c3n2)cc1		CHEMBL1945950	=	Activity	%	82.0	CHEMBL3587	Homo sapiens	Activity	%	82.0
	8018833	CHEMBL1948949	Inhibition of MEK1 assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc4[nH]cnc4c3)nc2n1CC1CCCCC1		CHEMBL1946262	=	Activity	%	79.0	CHEMBL3587	Homo sapiens	Activity	%	79.0
	8047368	CHEMBL1959026	Inhibition of MEK1	B	C[C@@H](c1ccccc1)[C@@H](C(=O)Nc1ccc(I)cc1F)N1C(=O)N[C@H](c2ccc(OC[C@H](O)CO)cc2)C1=O		CHEMBL1956073	=	IC50	nM	25.0	CHEMBL3587	Homo sapiens	IC50	uM	0.025
	8047369	CHEMBL1959027	Inhibition of MEK1 in human LOX cells assessed as inhibition of ERK phosphorylation by Western blot analysis	B	C[C@@H](c1ccccc1)[C@@H](C(=O)Nc1ccc(I)cc1F)N1C(=O)N[C@H](c2ccc(OC[C@H](O)CO)cc2)C1=O		CHEMBL1956073	=	IC50	nM	22.0	CHEMBL3587	Homo sapiens	IC50	uM	0.022
	8047370	CHEMBL1959028	Inhibition of MEK1 in human HT-29 cells assessed as inhibition of ERK phosphorylation by Western blot analysis	B	C[C@@H](c1ccccc1)[C@@H](C(=O)Nc1ccc(I)cc1F)N1C(=O)N[C@H](c2ccc(OC[C@H](O)CO)cc2)C1=O		CHEMBL1956073	=	IC50	nM	12.0	CHEMBL3587	Homo sapiens	IC50	uM	0.012
	8047371	CHEMBL1959029	Inhibition of MEK1 in human H460 cells assessed as inhibition of ERK phosphorylation by Western blot analysis	B	C[C@@H](c1ccccc1)[C@@H](C(=O)Nc1ccc(I)cc1F)N1C(=O)N[C@H](c2ccc(OC[C@H](O)CO)cc2)C1=O		CHEMBL1956073	=	IC50	nM	82.0	CHEMBL3587	Homo sapiens	IC50	uM	0.082
	8047372	CHEMBL1959030	Inhibition of MEK1 in human MIA PaCa-2 cells assessed as inhibition of ERK phosphorylation by Western blot analysis	B	C[C@@H](c1ccccc1)[C@@H](C(=O)Nc1ccc(I)cc1F)N1C(=O)N[C@H](c2ccc(OC[C@H](O)CO)cc2)C1=O		CHEMBL1956073	=	IC50	nM	69.0	CHEMBL3587	Homo sapiens	IC50	uM	0.069
	8049830	CHEMBL1959615	Inhibition of MEK1 at 5 to 10 uM	B	CS(=O)(=O)N1CCN(Cc2cn3cc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL1957497	=	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	8049831	CHEMBL1959615	Inhibition of MEK1 at 5 to 10 uM	B	CS(=O)(=O)N1CCN(Cc2nc3c(N4CCOCC4)nc(-c4cccc5[nH]ncc45)cn3c2Br)CC1		CHEMBL1957498	=	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	8049832	CHEMBL1959615	Inhibition of MEK1 at 5 to 10 uM	B	CS(=O)(=O)N1CCN(Cc2cn3c(C#N)c(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL1957499	=	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	8049833	CHEMBL1959615	Inhibition of MEK1 at 5 to 10 uM	B	CS(=O)(=O)N1CCN(Cc2cn3c(Cl)c(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL1957500	=	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	8049834	CHEMBL1959615	Inhibition of MEK1 at 5 to 10 uM	B	CNC(=O)c1cn2cc(-c3cccc4[nH]ncc34)nc(N3CCOCC3)c2n1		CHEMBL1957502	=	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	8049835	CHEMBL1959615	Inhibition of MEK1 at 5 to 10 uM	B	O=C(NCCN1CCOCC1)c1cn2cc(-c3cccc4[nH]ncc34)nc(N3CCOCC3)c2n1		CHEMBL1957504	=	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	8049836	CHEMBL1959615	Inhibition of MEK1 at 5 to 10 uM	B	CN(C)CCCNC(=O)c1cn2cc(-c3cccc4[nH]ncc34)nc(N3CCOCC3)c2n1		CHEMBL1957505	=	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	8049837	CHEMBL1959615	Inhibition of MEK1 at 5 to 10 uM	B	COCCCNC(=O)c1cn2cc(-c3cccc4[nH]ncc34)nc(N3CCOCC3)c2n1		CHEMBL1957508	=	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	8061337	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	0.8	CHEMBL3587	Homo sapiens	Inhibition	%	0.8
	8061514	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-4.65	CHEMBL3587	Homo sapiens	Inhibition	%	-4.65
	8061845	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	4.26	CHEMBL3587	Homo sapiens	Inhibition	%	4.26
	8062036	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	2.69	CHEMBL3587	Homo sapiens	Inhibition	%	2.69
	8062376	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	4.67	CHEMBL3587	Homo sapiens	Inhibition	%	4.67
	8062538	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	5.03	CHEMBL3587	Homo sapiens	Inhibition	%	5.03
	8062860	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	1.41	CHEMBL3587	Homo sapiens	Inhibition	%	1.41
	8063216	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	2.23	CHEMBL3587	Homo sapiens	Inhibition	%	2.23
	8063383	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	2.33	CHEMBL3587	Homo sapiens	Inhibition	%	2.33
	8063715	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	3.95	CHEMBL3587	Homo sapiens	Inhibition	%	3.95
	8063897	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	7.29	CHEMBL3587	Homo sapiens	Inhibition	%	7.29
	8064236	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	4.45	CHEMBL3587	Homo sapiens	Inhibition	%	4.45
	8064446	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	-0.21	CHEMBL3587	Homo sapiens	Inhibition	%	-0.21
	8064808	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	0.51	CHEMBL3587	Homo sapiens	Inhibition	%	0.51
	8064974	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	1.56	CHEMBL3587	Homo sapiens	Inhibition	%	1.56
	8065198	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	2.82	CHEMBL3587	Homo sapiens	Inhibition	%	2.82
	8065314	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	3.52	CHEMBL3587	Homo sapiens	Inhibition	%	3.52
	8065489	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	2.31	CHEMBL3587	Homo sapiens	Inhibition	%	2.31
	8065713	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	4.08	CHEMBL3587	Homo sapiens	Inhibition	%	4.08
	8065828	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	1.11	CHEMBL3587	Homo sapiens	Inhibition	%	1.11
	8066038	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.83	CHEMBL3587	Homo sapiens	Inhibition	%	0.83
	8066262	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	1.12	CHEMBL3587	Homo sapiens	Inhibition	%	1.12
	8066398	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	2.06	CHEMBL3587	Homo sapiens	Inhibition	%	2.06
	8066788	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	2.1	CHEMBL3587	Homo sapiens	Inhibition	%	2.1
	8066912	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	5.03	CHEMBL3587	Homo sapiens	Inhibition	%	5.03
	8067311	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.83	CHEMBL3587	Homo sapiens	Inhibition	%	2.83
	8067432	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	2.61	CHEMBL3587	Homo sapiens	Inhibition	%	2.61
	8067656	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.23	CHEMBL3587	Homo sapiens	Inhibition	%	1.23
	8067866	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	1.54	CHEMBL3587	Homo sapiens	Inhibition	%	1.54
	8068001	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	3.92	CHEMBL3587	Homo sapiens	Inhibition	%	3.92
	8068225	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	26.43	CHEMBL3587	Homo sapiens	Inhibition	%	26.43
	8068389	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	2.21	CHEMBL3587	Homo sapiens	Inhibition	%	2.21
	8068514	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	4.0	CHEMBL3587	Homo sapiens	Inhibition	%	4.0
	8068738	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.23	CHEMBL3587	Homo sapiens	Inhibition	%	1.23
	8068912	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.72	CHEMBL3587	Homo sapiens	Inhibition	%	2.72
	8069261	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	2.3	CHEMBL3587	Homo sapiens	Inhibition	%	2.3
	8069556	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	4.56	CHEMBL3587	Homo sapiens	Inhibition	%	4.56
	8069717	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	2.12	CHEMBL3587	Homo sapiens	Inhibition	%	2.12
	8070067	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.68	CHEMBL3587	Homo sapiens	Inhibition	%	1.68
	8070239	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	4.05	CHEMBL3587	Homo sapiens	Inhibition	%	4.05
	8070588	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.36	CHEMBL3587	Homo sapiens	Inhibition	%	0.36
	8070886	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	17.84	CHEMBL3587	Homo sapiens	Inhibition	%	17.84
	8071043	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	3.39	CHEMBL3587	Homo sapiens	Inhibition	%	3.39
	8071267	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	2.09	CHEMBL3587	Homo sapiens	Inhibition	%	2.09
	8071393	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	1.75	CHEMBL3587	Homo sapiens	Inhibition	%	1.75
	8071566	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	3.39	CHEMBL3587	Homo sapiens	Inhibition	%	3.39
	8071790	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	3.9	CHEMBL3587	Homo sapiens	Inhibition	%	3.9
	8071915	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	2.47	CHEMBL3587	Homo sapiens	Inhibition	%	2.47
	8072229	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.59	CHEMBL3587	Homo sapiens	Inhibition	%	0.59
	8072610	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	3.88	CHEMBL3587	Homo sapiens	Inhibition	%	3.88
	8072735	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	1.88	CHEMBL3587	Homo sapiens	Inhibition	%	1.88
	8073126	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	3.63	CHEMBL3587	Homo sapiens	Inhibition	%	3.63
	8073251	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	0.28	CHEMBL3587	Homo sapiens	Inhibition	%	0.28
	8073475	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	1.52	CHEMBL3587	Homo sapiens	Inhibition	%	1.52
	8073594	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	0.13	CHEMBL3587	Homo sapiens	Inhibition	%	0.13
	8073827	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.38	CHEMBL3587	Homo sapiens	Inhibition	%	0.38
	8074203	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	2.45	CHEMBL3587	Homo sapiens	Inhibition	%	2.45
	8074333	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.8	CHEMBL3587	Homo sapiens	Inhibition	%	0.8
	8074557	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	1.58	CHEMBL3587	Homo sapiens	Inhibition	%	1.58
	8074714	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	2.01	CHEMBL3587	Homo sapiens	Inhibition	%	2.01
	8075065	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-1.29	CHEMBL3587	Homo sapiens	Inhibition	%	-1.29
	8075176	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	1.05	CHEMBL3587	Homo sapiens	Inhibition	%	1.05
	8075413	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	0.73	CHEMBL3587	Homo sapiens	Inhibition	%	0.73
	8075637	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-0.46	CHEMBL3587	Homo sapiens	Inhibition	%	-0.46
	8075778	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	5.3	CHEMBL3587	Homo sapiens	Inhibition	%	5.3
	8076144	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	0.25	CHEMBL3587	Homo sapiens	Inhibition	%	0.25
	8076292	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	2.53	CHEMBL3587	Homo sapiens	Inhibition	%	2.53
	8076650	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.07	CHEMBL3587	Homo sapiens	Inhibition	%	0.07
	8076752	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.25	CHEMBL3587	Homo sapiens	Inhibition	%	-0.25
	8076976	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	0.32	CHEMBL3587	Homo sapiens	Inhibition	%	0.32
	8077223	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-0.01	CHEMBL3587	Homo sapiens	Inhibition	%	-0.01
	8077351	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	2.84	CHEMBL3587	Homo sapiens	Inhibition	%	2.84
	8077726	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.57	CHEMBL3587	Homo sapiens	Inhibition	%	-0.57
	8077869	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	3.24	CHEMBL3587	Homo sapiens	Inhibition	%	3.24
	8078093	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	2.39	CHEMBL3587	Homo sapiens	Inhibition	%	2.39
	8078232	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-2.69	CHEMBL3587	Homo sapiens	Inhibition	%	-2.69
	8078558	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	0.2	CHEMBL3587	Homo sapiens	Inhibition	%	0.2
	8078808	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	6.28	CHEMBL3587	Homo sapiens	Inhibition	%	6.28
	8078924	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	2.51	CHEMBL3587	Homo sapiens	Inhibition	%	2.51
	8079148	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	1.55	CHEMBL3587	Homo sapiens	Inhibition	%	1.55
	8079306	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-0.54	CHEMBL3587	Homo sapiens	Inhibition	%	-0.54
	8079672	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	2.4	CHEMBL3587	Homo sapiens	Inhibition	%	2.4
	8079811	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-3.65	CHEMBL3587	Homo sapiens	Inhibition	%	-3.65
	8080140	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	2.1	CHEMBL3587	Homo sapiens	Inhibition	%	2.1
	8080392	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	3.79	CHEMBL3587	Homo sapiens	Inhibition	%	3.79
	8080731	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	3.95	CHEMBL3587	Homo sapiens	Inhibition	%	3.95
	8080895	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	0.3	CHEMBL3587	Homo sapiens	Inhibition	%	0.3
	8081254	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	3.03	CHEMBL3587	Homo sapiens	Inhibition	%	3.03
	8081398	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	9.27	CHEMBL3587	Homo sapiens	Inhibition	%	9.27
	8081622	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	37.68	CHEMBL3587	Homo sapiens	Inhibition	%	37.68
	8081725	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	0.81	CHEMBL3587	Homo sapiens	Inhibition	%	0.81
	8081977	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	33.67	CHEMBL3587	Homo sapiens	Inhibition	%	33.67
	8082314	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	2.41	CHEMBL3587	Homo sapiens	Inhibition	%	2.41
	8082487	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-1.59	CHEMBL3587	Homo sapiens	Inhibition	%	-1.59
	8082711	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.41	CHEMBL3587	Homo sapiens	Inhibition	%	1.41
	8082834	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	2.81	CHEMBL3587	Homo sapiens	Inhibition	%	2.81
	8083214	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	10.69	CHEMBL3587	Homo sapiens	Inhibition	%	10.69
	8083313	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	7.65	CHEMBL3587	Homo sapiens	Inhibition	%	7.65
	8083537	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.37	CHEMBL3587	Homo sapiens	Inhibition	%	0.37
	8083567	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	0.13	CHEMBL3587	Homo sapiens	Inhibition	%	0.13
	8083791	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	7.67	CHEMBL3587	Homo sapiens	Inhibition	%	7.67
	8083901	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	3.26	CHEMBL3587	Homo sapiens	Inhibition	%	3.26
	8084310	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	14.27	CHEMBL3587	Homo sapiens	Inhibition	%	14.27
	8084428	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	2.71	CHEMBL3587	Homo sapiens	Inhibition	%	2.71
	8084813	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	38.01	CHEMBL3587	Homo sapiens	Inhibition	%	38.01
	8085135	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.96	CHEMBL3587	Homo sapiens	Inhibition	%	0.96
	8085391	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-3.29	CHEMBL3587	Homo sapiens	Inhibition	%	-3.29
	8085499	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	3.41	CHEMBL3587	Homo sapiens	Inhibition	%	3.41
	8085723	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	3.25	CHEMBL3587	Homo sapiens	Inhibition	%	3.25
	8085912	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	61.11	CHEMBL3587	Homo sapiens	Inhibition	%	61.11
	8086027	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	3.44	CHEMBL3587	Homo sapiens	Inhibition	%	3.44
	8086251	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	2.77	CHEMBL3587	Homo sapiens	Inhibition	%	2.77
	8086413	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	6.37	CHEMBL3587	Homo sapiens	Inhibition	%	6.37
	8086736	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	2.48	CHEMBL3587	Homo sapiens	Inhibition	%	2.48
	8086947	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	1.66	CHEMBL3587	Homo sapiens	Inhibition	%	1.66
	8087329	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	3.72	CHEMBL3587	Homo sapiens	Inhibition	%	3.72
	8087443	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	5.1	CHEMBL3587	Homo sapiens	Inhibition	%	5.1
	8087667	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	4.67	CHEMBL3587	Homo sapiens	Inhibition	%	4.67
	8087805	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.91	CHEMBL3587	Homo sapiens	Inhibition	%	3.91
	8088171	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	4.93	CHEMBL3587	Homo sapiens	Inhibition	%	4.93
	8088319	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	3.57	CHEMBL3587	Homo sapiens	Inhibition	%	3.57
	8088671	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	4.3	CHEMBL3587	Homo sapiens	Inhibition	%	4.3
	8088988	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	4.74	CHEMBL3587	Homo sapiens	Inhibition	%	4.74
	8089116	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	0.84	CHEMBL3587	Homo sapiens	Inhibition	%	0.84
	8089488	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	0.02	CHEMBL3587	Homo sapiens	Inhibition	%	0.02
	8089608	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-0.29	CHEMBL3587	Homo sapiens	Inhibition	%	-0.29
	8089832	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	-0.28	CHEMBL3587	Homo sapiens	Inhibition	%	-0.28
	8090012	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.93	CHEMBL3587	Homo sapiens	Inhibition	%	0.93
	8090177	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	0.13	CHEMBL3587	Homo sapiens	Inhibition	%	0.13
	8090401	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	4.11	CHEMBL3587	Homo sapiens	Inhibition	%	4.11
	8090568	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.79	CHEMBL3587	Homo sapiens	Inhibition	%	2.79
	8090707	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	0.44	CHEMBL3587	Homo sapiens	Inhibition	%	0.44
	8090931	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	3.84	CHEMBL3587	Homo sapiens	Inhibition	%	3.84
	8091136	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	2.75	CHEMBL3587	Homo sapiens	Inhibition	%	2.75
	8091273	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	1.76	CHEMBL3587	Homo sapiens	Inhibition	%	1.76
	8091497	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	7.02	CHEMBL3587	Homo sapiens	Inhibition	%	7.02
	8091652	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	2.87	CHEMBL3587	Homo sapiens	Inhibition	%	2.87
	8091992	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	3.89	CHEMBL3587	Homo sapiens	Inhibition	%	3.89
	8092129	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.34	CHEMBL3587	Homo sapiens	Inhibition	%	1.34
	8092504	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	4.54	CHEMBL3587	Homo sapiens	Inhibition	%	4.54
	8092652	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	2.74	CHEMBL3587	Homo sapiens	Inhibition	%	2.74
	8092876	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	2.3	CHEMBL3587	Homo sapiens	Inhibition	%	2.3
	8093005	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	3.99	CHEMBL3587	Homo sapiens	Inhibition	%	3.99
	8093317	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	1.92	CHEMBL3587	Homo sapiens	Inhibition	%	1.92
	8093457	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	20.62	CHEMBL3587	Homo sapiens	Inhibition	%	20.62
	8093681	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-0.93	CHEMBL3587	Homo sapiens	Inhibition	%	-0.93
	8093820	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	2.23	CHEMBL3587	Homo sapiens	Inhibition	%	2.23
	8094164	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	0.4	CHEMBL3587	Homo sapiens	Inhibition	%	0.4
	8094344	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	3.02	CHEMBL3587	Homo sapiens	Inhibition	%	3.02
	8094743	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	2.21	CHEMBL3587	Homo sapiens	Inhibition	%	2.21
	8094899	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	4.46	CHEMBL3587	Homo sapiens	Inhibition	%	4.46
	8095263	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	13.69	CHEMBL3587	Homo sapiens	Inhibition	%	13.69
	8095466	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	2.72	CHEMBL3587	Homo sapiens	Inhibition	%	2.72
	8095831	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	28.7	CHEMBL3587	Homo sapiens	Inhibition	%	28.7
	8095979	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	3.32	CHEMBL3587	Homo sapiens	Inhibition	%	3.32
	8096320	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	5.6	CHEMBL3587	Homo sapiens	Inhibition	%	5.6
	8096459	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	3.93	CHEMBL3587	Homo sapiens	Inhibition	%	3.93
	8096683	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	2.1	CHEMBL3587	Homo sapiens	Inhibition	%	2.1
	8096839	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	5.74	CHEMBL3587	Homo sapiens	Inhibition	%	5.74
	8097210	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	4.0	CHEMBL3587	Homo sapiens	Inhibition	%	4.0
	8097297	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	2.76	CHEMBL3587	Homo sapiens	Inhibition	%	2.76
	8097517	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	7.22	CHEMBL3587	Homo sapiens	Inhibition	%	7.22
	8097891	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	3.8	CHEMBL3587	Homo sapiens	Inhibition	%	3.8
	8098024	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	0.36	CHEMBL3587	Homo sapiens	Inhibition	%	0.36
	8098368	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.36	CHEMBL3587	Homo sapiens	Inhibition	%	0.36
	8098548	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	3.14	CHEMBL3587	Homo sapiens	Inhibition	%	3.14
	8098772	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.63	CHEMBL3587	Homo sapiens	Inhibition	%	1.63
	8098957	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	15.61	CHEMBL3587	Homo sapiens	Inhibition	%	15.61
	8099101	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	2.33	CHEMBL3587	Homo sapiens	Inhibition	%	2.33
	8099467	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	3.88	CHEMBL3587	Homo sapiens	Inhibition	%	3.88
	8099661	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.85	CHEMBL3587	Homo sapiens	Inhibition	%	0.85
	8100032	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	4.05	CHEMBL3587	Homo sapiens	Inhibition	%	4.05
	8100178	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	2.12	CHEMBL3587	Homo sapiens	Inhibition	%	2.12
	8100402	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	2.18	CHEMBL3587	Homo sapiens	Inhibition	%	2.18
	8100518	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	5.27	CHEMBL3587	Homo sapiens	Inhibition	%	5.27
	8100882	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	3.29	CHEMBL3587	Homo sapiens	Inhibition	%	3.29
	8101042	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	4.89	CHEMBL3587	Homo sapiens	Inhibition	%	4.89
	8101408	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-0.87	CHEMBL3587	Homo sapiens	Inhibition	%	-0.87
	8101593	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	2.51	CHEMBL3587	Homo sapiens	Inhibition	%	2.51
	8101846	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	1.76	CHEMBL3587	Homo sapiens	Inhibition	%	1.76
	8102225	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-4.0	CHEMBL3587	Homo sapiens	Inhibition	%	-4.0
	8102356	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	0.97	CHEMBL3587	Homo sapiens	Inhibition	%	0.97
	8102580	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	-0.08	CHEMBL3587	Homo sapiens	Inhibition	%	-0.08
	8102700	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.58	CHEMBL3587	Homo sapiens	Inhibition	%	0.58
	8103102	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.55	CHEMBL3587	Homo sapiens	Inhibition	%	1.55
	8103298	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	2.26	CHEMBL3587	Homo sapiens	Inhibition	%	2.26
	8103436	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	3.36	CHEMBL3587	Homo sapiens	Inhibition	%	3.36
	8103660	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	-0.23	CHEMBL3587	Homo sapiens	Inhibition	%	-0.23
	8103810	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	3.7	CHEMBL3587	Homo sapiens	Inhibition	%	3.7
	8103995	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	3.35	CHEMBL3587	Homo sapiens	Inhibition	%	3.35
	8104219	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	1.15	CHEMBL3587	Homo sapiens	Inhibition	%	1.15
	8104367	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	3.78	CHEMBL3587	Homo sapiens	Inhibition	%	3.78
	8104737	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	5.31	CHEMBL3587	Homo sapiens	Inhibition	%	5.31
	8104851	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	4.35	CHEMBL3587	Homo sapiens	Inhibition	%	4.35
	8105075	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	3.84	CHEMBL3587	Homo sapiens	Inhibition	%	3.84
	8105215	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	1.79	CHEMBL3587	Homo sapiens	Inhibition	%	1.79
	8105381	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	4.05	CHEMBL3587	Homo sapiens	Inhibition	%	4.05
	8105605	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	1.83	CHEMBL3587	Homo sapiens	Inhibition	%	1.83
	8105743	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	0.69	CHEMBL3587	Homo sapiens	Inhibition	%	0.69
	8106023	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	2.07	CHEMBL3587	Homo sapiens	Inhibition	%	2.07
	8106188	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	6.21	CHEMBL3587	Homo sapiens	Inhibition	%	6.21
	8106412	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	1.86	CHEMBL3587	Homo sapiens	Inhibition	%	1.86
	8106568	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	0.69	CHEMBL3587	Homo sapiens	Inhibition	%	0.69
	8106921	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	0.32	CHEMBL3587	Homo sapiens	Inhibition	%	0.32
	8107042	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	0.08	CHEMBL3587	Homo sapiens	Inhibition	%	0.08
	8107266	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	1.59	CHEMBL3587	Homo sapiens	Inhibition	%	1.59
	8107438	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	2.56	CHEMBL3587	Homo sapiens	Inhibition	%	2.56
	8107639	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	4.39	CHEMBL3587	Homo sapiens	Inhibition	%	4.39
	8107998	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	1.42	CHEMBL3587	Homo sapiens	Inhibition	%	1.42
	8108156	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	3.14	CHEMBL3587	Homo sapiens	Inhibition	%	3.14
	8108555	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.9	CHEMBL3587	Homo sapiens	Inhibition	%	0.9
	8108702	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	6.35	CHEMBL3587	Homo sapiens	Inhibition	%	6.35
	8109068	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	2.11	CHEMBL3587	Homo sapiens	Inhibition	%	2.11
	8109406	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	3.52	CHEMBL3587	Homo sapiens	Inhibition	%	3.52
	8109536	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	3.05	CHEMBL3587	Homo sapiens	Inhibition	%	3.05
	8109931	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	2.54	CHEMBL3587	Homo sapiens	Inhibition	%	2.54
	8110063	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	4.41	CHEMBL3587	Homo sapiens	Inhibition	%	4.41
	8110342	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	3.13	CHEMBL3587	Homo sapiens	Inhibition	%	3.13
	8110732	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	2.52	CHEMBL3587	Homo sapiens	Inhibition	%	2.52
	8110890	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-2.28	CHEMBL3587	Homo sapiens	Inhibition	%	-2.28
	8111237	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	1.28	CHEMBL3587	Homo sapiens	Inhibition	%	1.28
	8111588	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	1.6	CHEMBL3587	Homo sapiens	Inhibition	%	1.6
	8111754	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.52	CHEMBL3587	Homo sapiens	Inhibition	%	1.52
	8111959	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	2.53	CHEMBL3587	Homo sapiens	Inhibition	%	2.53
	8112183	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	2.53	CHEMBL3587	Homo sapiens	Inhibition	%	2.53
	8112320	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-0.14	CHEMBL3587	Homo sapiens	Inhibition	%	-0.14
	8112488	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	3.6	CHEMBL3587	Homo sapiens	Inhibition	%	3.6
	8112712	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	3.89	CHEMBL3587	Homo sapiens	Inhibition	%	3.89
	8112884	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	1.46	CHEMBL3587	Homo sapiens	Inhibition	%	1.46
	8113036	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	5.61	CHEMBL3587	Homo sapiens	Inhibition	%	5.61
	8113260	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	3.55	CHEMBL3587	Homo sapiens	Inhibition	%	3.55
	8113396	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	3.33	CHEMBL3587	Homo sapiens	Inhibition	%	3.33
	8113744	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	4.43	CHEMBL3587	Homo sapiens	Inhibition	%	4.43
	8113860	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-1.47	CHEMBL3587	Homo sapiens	Inhibition	%	-1.47
	8114084	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	0.22	CHEMBL3587	Homo sapiens	Inhibition	%	0.22
	8114260	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	3.29	CHEMBL3587	Homo sapiens	Inhibition	%	3.29
	8114392	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	3.91	CHEMBL3587	Homo sapiens	Inhibition	%	3.91
	8114616	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	5.47	CHEMBL3587	Homo sapiens	Inhibition	%	5.47
	8114668	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	4.37	CHEMBL3587	Homo sapiens	Inhibition	%	4.37
	8114892	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	4.68	CHEMBL3587	Homo sapiens	Inhibition	%	4.68
	8115058	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	1.15	CHEMBL3587	Homo sapiens	Inhibition	%	1.15
	8115223	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-2.9	CHEMBL3587	Homo sapiens	Inhibition	%	-2.9
	8115447	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-0.39	CHEMBL3587	Homo sapiens	Inhibition	%	-0.39
	8115567	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	1.44	CHEMBL3587	Homo sapiens	Inhibition	%	1.44
	8115924	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	0.19	CHEMBL3587	Homo sapiens	Inhibition	%	0.19
	8116083	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	6.31	CHEMBL3587	Homo sapiens	Inhibition	%	6.31
	8116510	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	1.98	CHEMBL3587	Homo sapiens	Inhibition	%	1.98
	8116644	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-0.11	CHEMBL3587	Homo sapiens	Inhibition	%	-0.11
	8117040	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	6.87	CHEMBL3587	Homo sapiens	Inhibition	%	6.87
	8117211	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	2.49	CHEMBL3587	Homo sapiens	Inhibition	%	2.49
	8117593	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	3.92	CHEMBL3587	Homo sapiens	Inhibition	%	3.92
	8117723	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	1.17	CHEMBL3587	Homo sapiens	Inhibition	%	1.17
	8118085	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	3.03	CHEMBL3587	Homo sapiens	Inhibition	%	3.03
	8118425	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	3.99	CHEMBL3587	Homo sapiens	Inhibition	%	3.99
	8118597	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	5.38	CHEMBL3587	Homo sapiens	Inhibition	%	5.38
	8118957	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	3.29	CHEMBL3587	Homo sapiens	Inhibition	%	3.29
	8119228	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	3.12	CHEMBL3587	Homo sapiens	Inhibition	%	3.12
	8119387	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	2.3	CHEMBL3587	Homo sapiens	Inhibition	%	2.3
	8119778	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-1.7	CHEMBL3587	Homo sapiens	Inhibition	%	-1.7
	8119897	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.19	CHEMBL3587	Homo sapiens	Inhibition	%	1.19
	8120121	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	2.66	CHEMBL3587	Homo sapiens	Inhibition	%	2.66
	8120260	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.89	CHEMBL3587	Homo sapiens	Inhibition	%	1.89
	8120420	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	43.14	CHEMBL3587	Homo sapiens	Inhibition	%	43.14
	8120644	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-0.35	CHEMBL3587	Homo sapiens	Inhibition	%	-0.35
	8120845	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	3.44	CHEMBL3587	Homo sapiens	Inhibition	%	3.44
	8120973	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.83	CHEMBL3587	Homo sapiens	Inhibition	%	0.83
	8121197	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	1.72	CHEMBL3587	Homo sapiens	Inhibition	%	1.72
	8121369	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	1.32	CHEMBL3587	Homo sapiens	Inhibition	%	1.32
	8121536	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	1.96	CHEMBL3587	Homo sapiens	Inhibition	%	1.96
	8121760	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	3.3	CHEMBL3587	Homo sapiens	Inhibition	%	3.3
	8121923	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	3.81	CHEMBL3587	Homo sapiens	Inhibition	%	3.81
	8122044	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	1.86	CHEMBL3587	Homo sapiens	Inhibition	%	1.86
	8122268	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-1.72	CHEMBL3587	Homo sapiens	Inhibition	%	-1.72
	8122406	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	3.8	CHEMBL3587	Homo sapiens	Inhibition	%	3.8
	8122750	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	3.65	CHEMBL3587	Homo sapiens	Inhibition	%	3.65
	8122917	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	3.69	CHEMBL3587	Homo sapiens	Inhibition	%	3.69
	8123283	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	2.39	CHEMBL3587	Homo sapiens	Inhibition	%	2.39
	8123561	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	6.41	CHEMBL3587	Homo sapiens	Inhibition	%	6.41
	8123711	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	1.68	CHEMBL3587	Homo sapiens	Inhibition	%	1.68
	8123935	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	1.06	CHEMBL3587	Homo sapiens	Inhibition	%	1.06
	8124102	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-0.13	CHEMBL3587	Homo sapiens	Inhibition	%	-0.13
	8124445	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	3.11	CHEMBL3587	Homo sapiens	Inhibition	%	3.11
	8124584	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.58	CHEMBL3587	Homo sapiens	Inhibition	%	1.58
	8124973	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-0.55	CHEMBL3587	Homo sapiens	Inhibition	%	-0.55
	8125174	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	3.92	CHEMBL3587	Homo sapiens	Inhibition	%	3.92
	8125528	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.74	CHEMBL3587	Homo sapiens	Inhibition	%	0.74
	8125696	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	1.73	CHEMBL3587	Homo sapiens	Inhibition	%	1.73
	8126084	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	2.15	CHEMBL3587	Homo sapiens	Inhibition	%	2.15
	8126248	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	4.35	CHEMBL3587	Homo sapiens	Inhibition	%	4.35
	8126587	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	0.44	CHEMBL3587	Homo sapiens	Inhibition	%	0.44
	8126723	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	8.75	CHEMBL3587	Homo sapiens	Inhibition	%	8.75
	8126947	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	42.86	CHEMBL3587	Homo sapiens	Inhibition	%	42.86
	8127069	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	4.35	CHEMBL3587	Homo sapiens	Inhibition	%	4.35
	8127236	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	5.25	CHEMBL3587	Homo sapiens	Inhibition	%	5.25
	8127460	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	4.98	CHEMBL3587	Homo sapiens	Inhibition	%	4.98
	8127602	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	2.9	CHEMBL3587	Homo sapiens	Inhibition	%	2.9
	8127890	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	2.88	CHEMBL3587	Homo sapiens	Inhibition	%	2.88
	8128266	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	2.74	CHEMBL3587	Homo sapiens	Inhibition	%	2.74
	8128433	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-0.71	CHEMBL3587	Homo sapiens	Inhibition	%	-0.71
	8128776	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	29.08	CHEMBL3587	Homo sapiens	Inhibition	%	29.08
	8128913	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	2.59	CHEMBL3587	Homo sapiens	Inhibition	%	2.59
	8129137	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	2.69	CHEMBL3587	Homo sapiens	Inhibition	%	2.69
	8129308	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	1.44	CHEMBL3587	Homo sapiens	Inhibition	%	1.44
	8129497	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	8.98	CHEMBL3587	Homo sapiens	Inhibition	%	8.98
	8129860	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	3.42	CHEMBL3587	Homo sapiens	Inhibition	%	3.42
	8130021	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	1.61	CHEMBL3587	Homo sapiens	Inhibition	%	1.61
	8130245	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.41	CHEMBL3587	Homo sapiens	Inhibition	%	2.41
	8130417	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	2.0	CHEMBL3587	Homo sapiens	Inhibition	%	2.0
	8130577	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	3.09	CHEMBL3587	Homo sapiens	Inhibition	%	3.09
	8130917	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	4.29	CHEMBL3587	Homo sapiens	Inhibition	%	4.29
	8131280	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	4.01	CHEMBL3587	Homo sapiens	Inhibition	%	4.01
	8131400	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	7.53	CHEMBL3587	Homo sapiens	Inhibition	%	7.53
	8131791	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	5.0	CHEMBL3587	Homo sapiens	Inhibition	%	5.0
	8131932	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	4.53	CHEMBL3587	Homo sapiens	Inhibition	%	4.53
	8132156	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	4.91	CHEMBL3587	Homo sapiens	Inhibition	%	4.91
	8132218	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	9.12	CHEMBL3587	Homo sapiens	Inhibition	%	9.12
	8132589	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	2.6	CHEMBL3587	Homo sapiens	Inhibition	%	2.6
	8132757	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	-0.39	CHEMBL3587	Homo sapiens	Inhibition	%	-0.39
	8132981	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	2.24	CHEMBL3587	Homo sapiens	Inhibition	%	2.24
	8133102	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	0.08	CHEMBL3587	Homo sapiens	Inhibition	%	0.08
	8133464	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	2.23	CHEMBL3587	Homo sapiens	Inhibition	%	2.23
	8133636	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	2.23	CHEMBL3587	Homo sapiens	Inhibition	%	2.23
	8133816	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	1.05	CHEMBL3587	Homo sapiens	Inhibition	%	1.05
	8134040	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	10.8	CHEMBL3587	Homo sapiens	Inhibition	%	10.8
	8134188	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.07	CHEMBL3587	Homo sapiens	Inhibition	%	-0.07
	8134572	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	2.89	CHEMBL3587	Homo sapiens	Inhibition	%	2.89
	8134756	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-3.18	CHEMBL3587	Homo sapiens	Inhibition	%	-3.18
	8134916	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	13.13	CHEMBL3587	Homo sapiens	Inhibition	%	13.13
	8135140	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	3.04	CHEMBL3587	Homo sapiens	Inhibition	%	3.04
	8135255	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	4.33	CHEMBL3587	Homo sapiens	Inhibition	%	4.33
	8135620	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	4.05	CHEMBL3587	Homo sapiens	Inhibition	%	4.05
	8135741	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	1.76	CHEMBL3587	Homo sapiens	Inhibition	%	1.76
	8135965	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	2.77	CHEMBL3587	Homo sapiens	Inhibition	%	2.77
	8136133	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	3.68	CHEMBL3587	Homo sapiens	Inhibition	%	3.68
	8136501	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	4.99	CHEMBL3587	Homo sapiens	Inhibition	%	4.99
	8136567	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	2.7	CHEMBL3587	Homo sapiens	Inhibition	%	2.7
	8136791	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	4.56	CHEMBL3587	Homo sapiens	Inhibition	%	4.56
	8136926	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	4.74	CHEMBL3587	Homo sapiens	Inhibition	%	4.74
	8137313	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	1.7	CHEMBL3587	Homo sapiens	Inhibition	%	1.7
	8137433	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	2.12	CHEMBL3587	Homo sapiens	Inhibition	%	2.12
	8137805	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	2.45	CHEMBL3587	Homo sapiens	Inhibition	%	2.45
	8137971	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	0.34	CHEMBL3587	Homo sapiens	Inhibition	%	0.34
	8138374	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	1.13	CHEMBL3587	Homo sapiens	Inhibition	%	1.13
	8138522	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	1.35	CHEMBL3587	Homo sapiens	Inhibition	%	1.35
	8138904	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	2.27	CHEMBL3587	Homo sapiens	Inhibition	%	2.27
	8139089	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-0.2	CHEMBL3587	Homo sapiens	Inhibition	%	-0.2
	8139472	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	4.93	CHEMBL3587	Homo sapiens	Inhibition	%	4.93
	8139586	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	3.83	CHEMBL3587	Homo sapiens	Inhibition	%	3.83
	8139810	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	3.81	CHEMBL3587	Homo sapiens	Inhibition	%	3.81
	8139951	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	5.35	CHEMBL3587	Homo sapiens	Inhibition	%	5.35
	8140298	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	3.94	CHEMBL3587	Homo sapiens	Inhibition	%	3.94
	8140457	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	2.66	CHEMBL3587	Homo sapiens	Inhibition	%	2.66
	8140824	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	8.82	CHEMBL3587	Homo sapiens	Inhibition	%	8.82
	8141126	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.49	CHEMBL3587	Homo sapiens	Inhibition	%	1.49
	8141256	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	30.46	CHEMBL3587	Homo sapiens	Inhibition	%	30.46
	8141640	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	2.07	CHEMBL3587	Homo sapiens	Inhibition	%	2.07
	8141759	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-0.07	CHEMBL3587	Homo sapiens	Inhibition	%	-0.07
	8141983	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	0.41	CHEMBL3587	Homo sapiens	Inhibition	%	0.41
	8142144	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	0.5	CHEMBL3587	Homo sapiens	Inhibition	%	0.5
	8142312	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.71	CHEMBL3587	Homo sapiens	Inhibition	%	-0.71
	8142536	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-0.27	CHEMBL3587	Homo sapiens	Inhibition	%	-0.27
	8142712	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	0.13	CHEMBL3587	Homo sapiens	Inhibition	%	0.13
	8142861	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-2.99	CHEMBL3587	Homo sapiens	Inhibition	%	-2.99
	8143085	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-1.83	CHEMBL3587	Homo sapiens	Inhibition	%	-1.83
	8143240	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	2.6	CHEMBL3587	Homo sapiens	Inhibition	%	2.6
	8143427	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	3.38	CHEMBL3587	Homo sapiens	Inhibition	%	3.38
	8143651	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	3.62	CHEMBL3587	Homo sapiens	Inhibition	%	3.62
	8143810	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	5.35	CHEMBL3587	Homo sapiens	Inhibition	%	5.35
	8144148	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	1.96	CHEMBL3587	Homo sapiens	Inhibition	%	1.96
	8144287	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	4.93	CHEMBL3587	Homo sapiens	Inhibition	%	4.93
	8144641	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	4.58	CHEMBL3587	Homo sapiens	Inhibition	%	4.58
	8144794	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.79	CHEMBL3587	Homo sapiens	Inhibition	%	2.79
	8145018	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	4.52	CHEMBL3587	Homo sapiens	Inhibition	%	4.52
	8145155	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	6.48	CHEMBL3587	Homo sapiens	Inhibition	%	6.48
	8145468	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	2.14	CHEMBL3587	Homo sapiens	Inhibition	%	2.14
	8145592	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	-0.04	CHEMBL3587	Homo sapiens	Inhibition	%	-0.04
	8145816	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	0.75	CHEMBL3587	Homo sapiens	Inhibition	%	0.75
	8145977	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	5.73	CHEMBL3587	Homo sapiens	Inhibition	%	5.73
	8146321	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	-0.42	CHEMBL3587	Homo sapiens	Inhibition	%	-0.42
	8146481	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	1.59	CHEMBL3587	Homo sapiens	Inhibition	%	1.59
	8146872	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	0.01	CHEMBL3587	Homo sapiens	Inhibition	%	0.01
	8147041	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	2.39	CHEMBL3587	Homo sapiens	Inhibition	%	2.39
	8147407	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	2.8	CHEMBL3587	Homo sapiens	Inhibition	%	2.8
	8147560	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	3.23	CHEMBL3587	Homo sapiens	Inhibition	%	3.23
	8147971	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	3.31	CHEMBL3587	Homo sapiens	Inhibition	%	3.31
	8148129	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	7.59	CHEMBL3587	Homo sapiens	Inhibition	%	7.59
	8148467	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	1.78	CHEMBL3587	Homo sapiens	Inhibition	%	1.78
	8148606	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	4.73	CHEMBL3587	Homo sapiens	Inhibition	%	4.73
	8148830	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	12.56	CHEMBL3587	Homo sapiens	Inhibition	%	12.56
	8148968	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	4.51	CHEMBL3587	Homo sapiens	Inhibition	%	4.51
	8149351	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	2.47	CHEMBL3587	Homo sapiens	Inhibition	%	2.47
	8149485	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	5.62	CHEMBL3587	Homo sapiens	Inhibition	%	5.62
	8149807	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	2.97	CHEMBL3587	Homo sapiens	Inhibition	%	2.97
	8150156	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	0.55	CHEMBL3587	Homo sapiens	Inhibition	%	0.55
	8150316	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	5.34	CHEMBL3587	Homo sapiens	Inhibition	%	5.34
	8150660	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.12	CHEMBL3587	Homo sapiens	Inhibition	%	0.12
	8150825	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-3.96	CHEMBL3587	Homo sapiens	Inhibition	%	-3.96
	8151049	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-5.54	CHEMBL3587	Homo sapiens	Inhibition	%	-5.54
	8151212	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-3.43	CHEMBL3587	Homo sapiens	Inhibition	%	-3.43
	8151389	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	2.15	CHEMBL3587	Homo sapiens	Inhibition	%	2.15
	8151613	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	2.65	CHEMBL3587	Homo sapiens	Inhibition	%	2.65
	8151751	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	3.14	CHEMBL3587	Homo sapiens	Inhibition	%	3.14
	8151905	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	1.9	CHEMBL3587	Homo sapiens	Inhibition	%	1.9
	8152129	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	2.55	CHEMBL3587	Homo sapiens	Inhibition	%	2.55
	8152317	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	5.79	CHEMBL3587	Homo sapiens	Inhibition	%	5.79
	8152475	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	5.07	CHEMBL3587	Homo sapiens	Inhibition	%	5.07
	8152699	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	4.19	CHEMBL3587	Homo sapiens	Inhibition	%	4.19
	8152813	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	4.63	CHEMBL3587	Homo sapiens	Inhibition	%	4.63
	8153176	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.63	CHEMBL3587	Homo sapiens	Inhibition	%	3.63
	8153313	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	4.62	CHEMBL3587	Homo sapiens	Inhibition	%	4.62
	8153537	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	5.61	CHEMBL3587	Homo sapiens	Inhibition	%	5.61
	8153694	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	0.44	CHEMBL3587	Homo sapiens	Inhibition	%	0.44
	8153827	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	4.81	CHEMBL3587	Homo sapiens	Inhibition	%	4.81
	8154051	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	3.62	CHEMBL3587	Homo sapiens	Inhibition	%	3.62
	8154148	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	4.15	CHEMBL3587	Homo sapiens	Inhibition	%	4.15
	8154372	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	4.06	CHEMBL3587	Homo sapiens	Inhibition	%	4.06
	8154498	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	1.24	CHEMBL3587	Homo sapiens	Inhibition	%	1.24
	8154657	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.1	CHEMBL3587	Homo sapiens	Inhibition	%	0.1
	8154881	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.05	CHEMBL3587	Homo sapiens	Inhibition	%	1.05
	8155001	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-0.68	CHEMBL3587	Homo sapiens	Inhibition	%	-0.68
	8155401	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	1.8	CHEMBL3587	Homo sapiens	Inhibition	%	1.8
	8155562	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-3.98	CHEMBL3587	Homo sapiens	Inhibition	%	-3.98
	8155964	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	2.39	CHEMBL3587	Homo sapiens	Inhibition	%	2.39
	8156102	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	2.29	CHEMBL3587	Homo sapiens	Inhibition	%	2.29
	8156314	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	4.4	CHEMBL3587	Homo sapiens	Inhibition	%	4.4
	8156538	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	3.02	CHEMBL3587	Homo sapiens	Inhibition	%	3.02
	8156688	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	2.6	CHEMBL3587	Homo sapiens	Inhibition	%	2.6
	8157055	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	2.12	CHEMBL3587	Homo sapiens	Inhibition	%	2.12
	8157175	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	6.17	CHEMBL3587	Homo sapiens	Inhibition	%	6.17
	8157540	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	4.45	CHEMBL3587	Homo sapiens	Inhibition	%	4.45
	8157894	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	4.12	CHEMBL3587	Homo sapiens	Inhibition	%	4.12
	8158055	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	0.97	CHEMBL3587	Homo sapiens	Inhibition	%	0.97
	8158305	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	4.97	CHEMBL3587	Homo sapiens	Inhibition	%	4.97
	8158687	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	5.8	CHEMBL3587	Homo sapiens	Inhibition	%	5.8
	8158856	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	4.62	CHEMBL3587	Homo sapiens	Inhibition	%	4.62
	8159215	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	6.24	CHEMBL3587	Homo sapiens	Inhibition	%	6.24
	8159335	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	35.54	CHEMBL3587	Homo sapiens	Inhibition	%	35.54
	8159559	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	3.75	CHEMBL3587	Homo sapiens	Inhibition	%	3.75
	8159690	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	5.67	CHEMBL3587	Homo sapiens	Inhibition	%	5.67
	8160055	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.68	CHEMBL3587	Homo sapiens	Inhibition	%	1.68
	8160192	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	6.12	CHEMBL3587	Homo sapiens	Inhibition	%	6.12
	8160566	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-3.17	CHEMBL3587	Homo sapiens	Inhibition	%	-3.17
	8160860	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	3.21	CHEMBL3587	Homo sapiens	Inhibition	%	3.21
	8161010	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	5.04	CHEMBL3587	Homo sapiens	Inhibition	%	5.04
	8161377	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	7.35	CHEMBL3587	Homo sapiens	Inhibition	%	7.35
	8161502	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	36.49	CHEMBL3587	Homo sapiens	Inhibition	%	36.49
	8161726	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.44	CHEMBL3587	Homo sapiens	Inhibition	%	1.44
	8161864	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	10.65	CHEMBL3587	Homo sapiens	Inhibition	%	10.65
	8162218	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	3.81	CHEMBL3587	Homo sapiens	Inhibition	%	3.81
	8162378	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	2.3	CHEMBL3587	Homo sapiens	Inhibition	%	2.3
	8162631	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	6.85	CHEMBL3587	Homo sapiens	Inhibition	%	6.85
	8162855	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	6.13	CHEMBL3587	Homo sapiens	Inhibition	%	6.13
	8163003	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	17.49	CHEMBL3587	Homo sapiens	Inhibition	%	17.49
	8163172	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	4.19	CHEMBL3587	Homo sapiens	Inhibition	%	4.19
	8163396	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	3.76	CHEMBL3587	Homo sapiens	Inhibition	%	3.76
	8163530	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	5.74	CHEMBL3587	Homo sapiens	Inhibition	%	5.74
	8163877	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	4.29	CHEMBL3587	Homo sapiens	Inhibition	%	4.29
	8164011	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	9.59	CHEMBL3587	Homo sapiens	Inhibition	%	9.59
	8164235	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	33.41	CHEMBL3587	Homo sapiens	Inhibition	%	33.41
	8164375	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.4	CHEMBL3587	Homo sapiens	Inhibition	%	1.4
	8164530	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	5.95	CHEMBL3587	Homo sapiens	Inhibition	%	5.95
	8164754	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	19.49	CHEMBL3587	Homo sapiens	Inhibition	%	19.49
	8164898	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-3.2	CHEMBL3587	Homo sapiens	Inhibition	%	-3.2
	8165192	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	3.03	CHEMBL3587	Homo sapiens	Inhibition	%	3.03
	8165333	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	7.12	CHEMBL3587	Homo sapiens	Inhibition	%	7.12
	8165557	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	4.15	CHEMBL3587	Homo sapiens	Inhibition	%	4.15
	8165700	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	27.75	CHEMBL3587	Homo sapiens	Inhibition	%	27.75
	8166050	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.89	CHEMBL3587	Homo sapiens	Inhibition	%	1.89
	8166188	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	5.05	CHEMBL3587	Homo sapiens	Inhibition	%	5.05
	8166412	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	3.82	CHEMBL3587	Homo sapiens	Inhibition	%	3.82
	8166542	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	5.08	CHEMBL3587	Homo sapiens	Inhibition	%	5.08
	8166867	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	4.1	CHEMBL3587	Homo sapiens	Inhibition	%	4.1
	8167179	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	3.5	CHEMBL3587	Homo sapiens	Inhibition	%	3.5
	8167320	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	68.35	CHEMBL3587	Homo sapiens	Inhibition	%	68.35
	8167708	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	3.46	CHEMBL3587	Homo sapiens	Inhibition	%	3.46
	8167841	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	9.94	CHEMBL3587	Homo sapiens	Inhibition	%	9.94
	8168189	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	2.25	CHEMBL3587	Homo sapiens	Inhibition	%	2.25
	8168554	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	6.94	CHEMBL3587	Homo sapiens	Inhibition	%	6.94
	8168690	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.04	CHEMBL3587	Homo sapiens	Inhibition	%	1.04
	8169078	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	63.04	CHEMBL3587	Homo sapiens	Inhibition	%	63.04
	8169220	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	3.68	CHEMBL3587	Homo sapiens	Inhibition	%	3.68
	8169524	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	3.53	CHEMBL3587	Homo sapiens	Inhibition	%	3.53
	8169882	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	4.62	CHEMBL3587	Homo sapiens	Inhibition	%	4.62
	8170027	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	0.93	CHEMBL3587	Homo sapiens	Inhibition	%	0.93
	8170251	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	3.12	CHEMBL3587	Homo sapiens	Inhibition	%	3.12
	8170376	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	2.57	CHEMBL3587	Homo sapiens	Inhibition	%	2.57
	8170740	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	5.08	CHEMBL3587	Homo sapiens	Inhibition	%	5.08
	8170875	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	4.94	CHEMBL3587	Homo sapiens	Inhibition	%	4.94
	8171072	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	1.94	CHEMBL3587	Homo sapiens	Inhibition	%	1.94
	8171296	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	2.25	CHEMBL3587	Homo sapiens	Inhibition	%	2.25
	8171513	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	3.8	CHEMBL3587	Homo sapiens	Inhibition	%	3.8
	8171654	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	6.86	CHEMBL3587	Homo sapiens	Inhibition	%	6.86
	8171878	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	12.29	CHEMBL3587	Homo sapiens	Inhibition	%	12.29
	8172031	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	3.46	CHEMBL3587	Homo sapiens	Inhibition	%	3.46
	8172163	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	7.03	CHEMBL3587	Homo sapiens	Inhibition	%	7.03
	8172387	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	8.19	CHEMBL3587	Homo sapiens	Inhibition	%	8.19
	8172515	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	5.95	CHEMBL3587	Homo sapiens	Inhibition	%	5.95
	8172881	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	13.18	CHEMBL3587	Homo sapiens	Inhibition	%	13.18
	8173017	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-1.43	CHEMBL3587	Homo sapiens	Inhibition	%	-1.43
	8173241	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	2.83	CHEMBL3587	Homo sapiens	Inhibition	%	2.83
	8173406	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	7.89	CHEMBL3587	Homo sapiens	Inhibition	%	7.89
	8173547	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	2.95	CHEMBL3587	Homo sapiens	Inhibition	%	2.95
	8173771	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	4.59	CHEMBL3587	Homo sapiens	Inhibition	%	4.59
	8173858	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	6.81	CHEMBL3587	Homo sapiens	Inhibition	%	6.81
	8174082	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	16.33	CHEMBL3587	Homo sapiens	Inhibition	%	16.33
	8174214	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	4.72	CHEMBL3587	Homo sapiens	Inhibition	%	4.72
	8174586	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	3.01	CHEMBL3587	Homo sapiens	Inhibition	%	3.01
	8174708	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	1.95	CHEMBL3587	Homo sapiens	Inhibition	%	1.95
	8175075	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	4.1	CHEMBL3587	Homo sapiens	Inhibition	%	4.1
	8175211	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	2.79	CHEMBL3587	Homo sapiens	Inhibition	%	2.79
	8175435	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	9.57	CHEMBL3587	Homo sapiens	Inhibition	%	9.57
	8175467	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	6.13	CHEMBL3587	Homo sapiens	Inhibition	%	6.13
	8175691	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	6.15	CHEMBL3587	Homo sapiens	Inhibition	%	6.15
	8175854	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	3.83	CHEMBL3587	Homo sapiens	Inhibition	%	3.83
	8176231	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	8.09	CHEMBL3587	Homo sapiens	Inhibition	%	8.09
	8176380	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	3.27	CHEMBL3587	Homo sapiens	Inhibition	%	3.27
	8176736	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	6.88	CHEMBL3587	Homo sapiens	Inhibition	%	6.88
	8176866	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	5.95	CHEMBL3587	Homo sapiens	Inhibition	%	5.95
	8177090	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	2.45	CHEMBL3587	Homo sapiens	Inhibition	%	2.45
	8177232	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	6.51	CHEMBL3587	Homo sapiens	Inhibition	%	6.51
	8177594	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	4.86	CHEMBL3587	Homo sapiens	Inhibition	%	4.86
	8177758	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	7.23	CHEMBL3587	Homo sapiens	Inhibition	%	7.23
	8178122	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	5.62	CHEMBL3587	Homo sapiens	Inhibition	%	5.62
	8178434	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.29	CHEMBL3587	Homo sapiens	Inhibition	%	1.29
	8178561	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	4.21	CHEMBL3587	Homo sapiens	Inhibition	%	4.21
	8178934	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	1.66	CHEMBL3587	Homo sapiens	Inhibition	%	1.66
	8179057	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	2.35	CHEMBL3587	Homo sapiens	Inhibition	%	2.35
	8179281	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.8	CHEMBL3587	Homo sapiens	Inhibition	%	1.8
	8179425	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	15.56	CHEMBL3587	Homo sapiens	Inhibition	%	15.56
	8179786	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.53	CHEMBL3587	Homo sapiens	Inhibition	%	1.53
	8180043	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	6.89	CHEMBL3587	Homo sapiens	Inhibition	%	6.89
	8180197	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	4.09	CHEMBL3587	Homo sapiens	Inhibition	%	4.09
	8180577	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	8.5	CHEMBL3587	Homo sapiens	Inhibition	%	8.5
	8180725	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	2.52	CHEMBL3587	Homo sapiens	Inhibition	%	2.52
	8180949	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	6.25	CHEMBL3587	Homo sapiens	Inhibition	%	6.25
	8181082	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	7.84	CHEMBL3587	Homo sapiens	Inhibition	%	7.84
	8181437	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-1.13	CHEMBL3587	Homo sapiens	Inhibition	%	-1.13
	8181577	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	5.24	CHEMBL3587	Homo sapiens	Inhibition	%	5.24
	8181940	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	7.06	CHEMBL3587	Homo sapiens	Inhibition	%	7.06
	8182103	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	6.1	CHEMBL3587	Homo sapiens	Inhibition	%	6.1
	8182327	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	4.31	CHEMBL3587	Homo sapiens	Inhibition	%	4.31
	8182467	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	3.85	CHEMBL3587	Homo sapiens	Inhibition	%	3.85
	8182783	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.35	CHEMBL3587	Homo sapiens	Inhibition	%	2.35
	8182905	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	4.9	CHEMBL3587	Homo sapiens	Inhibition	%	4.9
	8183129	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	3.13	CHEMBL3587	Homo sapiens	Inhibition	%	3.13
	8183278	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	2.58	CHEMBL3587	Homo sapiens	Inhibition	%	2.58
	8183631	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	1.64	CHEMBL3587	Homo sapiens	Inhibition	%	1.64
	8183773	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	57.6	CHEMBL3587	Homo sapiens	Inhibition	%	57.6
	8184133	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.76	CHEMBL3587	Homo sapiens	Inhibition	%	1.76
	8184399	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	5.56	CHEMBL3587	Homo sapiens	Inhibition	%	5.56
	8184546	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	3.99	CHEMBL3587	Homo sapiens	Inhibition	%	3.99
	8184770	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	3.24	CHEMBL3587	Homo sapiens	Inhibition	%	3.24
	8184927	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	5.8	CHEMBL3587	Homo sapiens	Inhibition	%	5.8
	8185300	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	1.45	CHEMBL3587	Homo sapiens	Inhibition	%	1.45
	8185431	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	8.37	CHEMBL3587	Homo sapiens	Inhibition	%	8.37
	8185786	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	0.96	CHEMBL3587	Homo sapiens	Inhibition	%	0.96
	8185925	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	4.67	CHEMBL3587	Homo sapiens	Inhibition	%	4.67
	8186149	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	3.62	CHEMBL3587	Homo sapiens	Inhibition	%	3.62
	8186290	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	6.07	CHEMBL3587	Homo sapiens	Inhibition	%	6.07
	8186678	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	5.11	CHEMBL3587	Homo sapiens	Inhibition	%	5.11
	8186817	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	3.88	CHEMBL3587	Homo sapiens	Inhibition	%	3.88
	8187139	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	2.17	CHEMBL3587	Homo sapiens	Inhibition	%	2.17
	8187487	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	6.37	CHEMBL3587	Homo sapiens	Inhibition	%	6.37
	8187635	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	3.57	CHEMBL3587	Homo sapiens	Inhibition	%	3.57
	8187988	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	-1.13	CHEMBL3587	Homo sapiens	Inhibition	%	-1.13
	8188131	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	5.27	CHEMBL3587	Homo sapiens	Inhibition	%	5.27
	8188355	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	5.11	CHEMBL3587	Homo sapiens	Inhibition	%	5.11
	8188490	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	1.79	CHEMBL3587	Homo sapiens	Inhibition	%	1.79
	8188764	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	7.76	CHEMBL3587	Homo sapiens	Inhibition	%	7.76
	8189136	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	2.16	CHEMBL3587	Homo sapiens	Inhibition	%	2.16
	8189292	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	11.66	CHEMBL3587	Homo sapiens	Inhibition	%	11.66
	8189665	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	1.08	CHEMBL3587	Homo sapiens	Inhibition	%	1.08
	8189797	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	6.88	CHEMBL3587	Homo sapiens	Inhibition	%	6.88
	8190021	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	4.96	CHEMBL3587	Homo sapiens	Inhibition	%	4.96
	8190153	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	6.54	CHEMBL3587	Homo sapiens	Inhibition	%	6.54
	8190517	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	6.3	CHEMBL3587	Homo sapiens	Inhibition	%	6.3
	8190654	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	3.87	CHEMBL3587	Homo sapiens	Inhibition	%	3.87
	8191042	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	4.03	CHEMBL3587	Homo sapiens	Inhibition	%	4.03
	8191180	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	4.9	CHEMBL3587	Homo sapiens	Inhibition	%	4.9
	8191404	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	4.12	CHEMBL3587	Homo sapiens	Inhibition	%	4.12
	8191500	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	3.39	CHEMBL3587	Homo sapiens	Inhibition	%	3.39
	8191846	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	6.2	CHEMBL3587	Homo sapiens	Inhibition	%	6.2
	8191995	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	2.63	CHEMBL3587	Homo sapiens	Inhibition	%	2.63
	8192219	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	2.68	CHEMBL3587	Homo sapiens	Inhibition	%	2.68
	8192348	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	3.35	CHEMBL3587	Homo sapiens	Inhibition	%	3.35
	8192716	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	6.36	CHEMBL3587	Homo sapiens	Inhibition	%	6.36
	8192852	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	1.58	CHEMBL3587	Homo sapiens	Inhibition	%	1.58
	8193076	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	0.11	CHEMBL3587	Homo sapiens	Inhibition	%	0.11
	8193124	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	8.23	CHEMBL3587	Homo sapiens	Inhibition	%	8.23
	8193348	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	5.61	CHEMBL3587	Homo sapiens	Inhibition	%	5.61
	8193493	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	1.21	CHEMBL3587	Homo sapiens	Inhibition	%	1.21
	8193650	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	4.87	CHEMBL3587	Homo sapiens	Inhibition	%	4.87
	8193874	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	5.35	CHEMBL3587	Homo sapiens	Inhibition	%	5.35
	8194023	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-2.28	CHEMBL3587	Homo sapiens	Inhibition	%	-2.28
	8194378	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	6.11	CHEMBL3587	Homo sapiens	Inhibition	%	6.11
	8194509	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	5.7	CHEMBL3587	Homo sapiens	Inhibition	%	5.7
	8194733	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	5.02	CHEMBL3587	Homo sapiens	Inhibition	%	5.02
	8194876	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	5.89	CHEMBL3587	Homo sapiens	Inhibition	%	5.89
	8195009	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	4.13	CHEMBL3587	Homo sapiens	Inhibition	%	4.13
	8195233	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	5.25	CHEMBL3587	Homo sapiens	Inhibition	%	5.25
	8195397	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	2.93	CHEMBL3587	Homo sapiens	Inhibition	%	2.93
	8195760	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	5.12	CHEMBL3587	Homo sapiens	Inhibition	%	5.12
	8195858	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	-0.07	CHEMBL3587	Homo sapiens	Inhibition	%	-0.07
	8196082	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	3.43	CHEMBL3587	Homo sapiens	Inhibition	%	3.43
	8196199	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	2.72	CHEMBL3587	Homo sapiens	Inhibition	%	2.72
	8196573	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	4.55	CHEMBL3587	Homo sapiens	Inhibition	%	4.55
	8196701	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	0.16	CHEMBL3587	Homo sapiens	Inhibition	%	0.16
	8196925	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	3.5	CHEMBL3587	Homo sapiens	Inhibition	%	3.5
	8197066	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	5.22	CHEMBL3587	Homo sapiens	Inhibition	%	5.22
	8197427	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	0.8	CHEMBL3587	Homo sapiens	Inhibition	%	0.8
	8197702	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	3.83	CHEMBL3587	Homo sapiens	Inhibition	%	3.83
	8197842	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	2.14	CHEMBL3587	Homo sapiens	Inhibition	%	2.14
	8198223	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	5.23	CHEMBL3587	Homo sapiens	Inhibition	%	5.23
	8198361	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-2.11	CHEMBL3587	Homo sapiens	Inhibition	%	-2.11
	8198715	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	5.54	CHEMBL3587	Homo sapiens	Inhibition	%	5.54
	8199070	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	5.22	CHEMBL3587	Homo sapiens	Inhibition	%	5.22
	8199218	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	6.17	CHEMBL3587	Homo sapiens	Inhibition	%	6.17
	8199576	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	6.0	CHEMBL3587	Homo sapiens	Inhibition	%	6.0
	8199739	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	9.42	CHEMBL3587	Homo sapiens	Inhibition	%	9.42
	8200101	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	4.13	CHEMBL3587	Homo sapiens	Inhibition	%	4.13
	8200429	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	1.32	CHEMBL3587	Homo sapiens	Inhibition	%	1.32
	8200544	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	2.98	CHEMBL3587	Homo sapiens	Inhibition	%	2.98
	8200768	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	3.54	CHEMBL3587	Homo sapiens	Inhibition	%	3.54
	8200918	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	10.82	CHEMBL3587	Homo sapiens	Inhibition	%	10.82
	8201272	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	2.83	CHEMBL3587	Homo sapiens	Inhibition	%	2.83
	8201407	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	4.49	CHEMBL3587	Homo sapiens	Inhibition	%	4.49
	8201764	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-0.9	CHEMBL3587	Homo sapiens	Inhibition	%	-0.9
	8202043	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	5.38	CHEMBL3587	Homo sapiens	Inhibition	%	5.38
	8202183	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	2.16	CHEMBL3587	Homo sapiens	Inhibition	%	2.16
	8202407	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-1.03	CHEMBL3587	Homo sapiens	Inhibition	%	-1.03
	8202574	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	5.11	CHEMBL3587	Homo sapiens	Inhibition	%	5.11
	8202699	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	5.25	CHEMBL3587	Homo sapiens	Inhibition	%	5.25
	8202923	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	3.85	CHEMBL3587	Homo sapiens	Inhibition	%	3.85
	8203053	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	6.95	CHEMBL3587	Homo sapiens	Inhibition	%	6.95
	8203408	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	6.31	CHEMBL3587	Homo sapiens	Inhibition	%	6.31
	8203554	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	5.42	CHEMBL3587	Homo sapiens	Inhibition	%	5.42
	8203778	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	4.91	CHEMBL3587	Homo sapiens	Inhibition	%	4.91
	8203912	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	4.44	CHEMBL3587	Homo sapiens	Inhibition	%	4.44
	8204078	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	4.02	CHEMBL3587	Homo sapiens	Inhibition	%	4.02
	8204302	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	3.99	CHEMBL3587	Homo sapiens	Inhibition	%	3.99
	8204439	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	6.05	CHEMBL3587	Homo sapiens	Inhibition	%	6.05
	8204768	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	2.28	CHEMBL3587	Homo sapiens	Inhibition	%	2.28
	8205107	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	3.75	CHEMBL3587	Homo sapiens	Inhibition	%	3.75
	8205256	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	4.84	CHEMBL3587	Homo sapiens	Inhibition	%	4.84
	8205616	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	3.44	CHEMBL3587	Homo sapiens	Inhibition	%	3.44
	8205755	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	3.72	CHEMBL3587	Homo sapiens	Inhibition	%	3.72
	8205979	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	3.69	CHEMBL3587	Homo sapiens	Inhibition	%	3.69
	8206111	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-1.09	CHEMBL3587	Homo sapiens	Inhibition	%	-1.09
	8206387	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	4.64	CHEMBL3587	Homo sapiens	Inhibition	%	4.64
	8206754	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-1.25	CHEMBL3587	Homo sapiens	Inhibition	%	-1.25
	8206934	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	4.6	CHEMBL3587	Homo sapiens	Inhibition	%	4.6
	8207284	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	5.85	CHEMBL3587	Homo sapiens	Inhibition	%	5.85
	8207414	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	5.61	CHEMBL3587	Homo sapiens	Inhibition	%	5.61
	8207638	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	7.68	CHEMBL3587	Homo sapiens	Inhibition	%	7.68
	8207770	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	10.73	CHEMBL3587	Homo sapiens	Inhibition	%	10.73
	8208139	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	3.9	CHEMBL3587	Homo sapiens	Inhibition	%	3.9
	8208271	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	6.36	CHEMBL3587	Homo sapiens	Inhibition	%	6.36
	8208661	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	8.09	CHEMBL3587	Homo sapiens	Inhibition	%	8.09
	8208794	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	4.87	CHEMBL3587	Homo sapiens	Inhibition	%	4.87
	8209018	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.0	CHEMBL3587	Homo sapiens	Inhibition	%	3.0
	8209123	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	-1.1	CHEMBL3587	Homo sapiens	Inhibition	%	-1.1
	8209463	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	2.95	CHEMBL3587	Homo sapiens	Inhibition	%	2.95
	8209613	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	9.33	CHEMBL3587	Homo sapiens	Inhibition	%	9.33
	8209837	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.7	CHEMBL3587	Homo sapiens	Inhibition	%	1.7
	8209973	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	3.14	CHEMBL3587	Homo sapiens	Inhibition	%	3.14
	8210338	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	2.73	CHEMBL3587	Homo sapiens	Inhibition	%	2.73
	8210474	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-3.83	CHEMBL3587	Homo sapiens	Inhibition	%	-3.83
	8210733	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	6.35	CHEMBL3587	Homo sapiens	Inhibition	%	6.35
	8211101	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	5.37	CHEMBL3587	Homo sapiens	Inhibition	%	5.37
	8211271	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	3.75	CHEMBL3587	Homo sapiens	Inhibition	%	3.75
	8211618	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	5.35	CHEMBL3587	Homo sapiens	Inhibition	%	5.35
	8211971	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	8.1	CHEMBL3587	Homo sapiens	Inhibition	%	8.1
	8212103	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	5.91	CHEMBL3587	Homo sapiens	Inhibition	%	5.91
	8212468	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	3.48	CHEMBL3587	Homo sapiens	Inhibition	%	3.48
	8212601	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	4.25	CHEMBL3587	Homo sapiens	Inhibition	%	4.25
	8212825	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	8.77	CHEMBL3587	Homo sapiens	Inhibition	%	8.77
	8212995	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	44.42	CHEMBL3587	Homo sapiens	Inhibition	%	44.42
	8213348	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	6.15	CHEMBL3587	Homo sapiens	Inhibition	%	6.15
	8213452	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	-0.23	CHEMBL3587	Homo sapiens	Inhibition	%	-0.23
	8213676	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-2.44	CHEMBL3587	Homo sapiens	Inhibition	%	-2.44
	8213789	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	2.78	CHEMBL3587	Homo sapiens	Inhibition	%	2.78
	8214160	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	2.0	CHEMBL3587	Homo sapiens	Inhibition	%	2.0
	8214297	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	4.68	CHEMBL3587	Homo sapiens	Inhibition	%	4.68
	8214655	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	4.22	CHEMBL3587	Homo sapiens	Inhibition	%	4.22
	8214807	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-4.66	CHEMBL3587	Homo sapiens	Inhibition	%	-4.66
	8215031	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-0.91	CHEMBL3587	Homo sapiens	Inhibition	%	-0.91
	8215058	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	4.13	CHEMBL3587	Homo sapiens	Inhibition	%	4.13
	8215282	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	5.23	CHEMBL3587	Homo sapiens	Inhibition	%	5.23
	8215435	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	4.96	CHEMBL3587	Homo sapiens	Inhibition	%	4.96
	8215599	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	5.1	CHEMBL3587	Homo sapiens	Inhibition	%	5.1
	8215823	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	5.26	CHEMBL3587	Homo sapiens	Inhibition	%	5.26
	8215942	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	6.5	CHEMBL3587	Homo sapiens	Inhibition	%	6.5
	8216285	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	4.95	CHEMBL3587	Homo sapiens	Inhibition	%	4.95
	8216421	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	5.86	CHEMBL3587	Homo sapiens	Inhibition	%	5.86
	8216645	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	7.68	CHEMBL3587	Homo sapiens	Inhibition	%	7.68
	8216783	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	3.42	CHEMBL3587	Homo sapiens	Inhibition	%	3.42
	8217141	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	4.7	CHEMBL3587	Homo sapiens	Inhibition	%	4.7
	8217315	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.88	CHEMBL3587	Homo sapiens	Inhibition	%	0.88
	8217670	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	3.78	CHEMBL3587	Homo sapiens	Inhibition	%	3.78
	8217995	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-3.36	CHEMBL3587	Homo sapiens	Inhibition	%	-3.36
	8218110	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	4.37	CHEMBL3587	Homo sapiens	Inhibition	%	4.37
	8218461	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	2.77	CHEMBL3587	Homo sapiens	Inhibition	%	2.77
	8218604	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	4.4	CHEMBL3587	Homo sapiens	Inhibition	%	4.4
	8218828	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	6.74	CHEMBL3587	Homo sapiens	Inhibition	%	6.74
	8218959	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	4.94	CHEMBL3587	Homo sapiens	Inhibition	%	4.94
	8219343	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-0.3	CHEMBL3587	Homo sapiens	Inhibition	%	-0.3
	8219593	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	4.45	CHEMBL3587	Homo sapiens	Inhibition	%	4.45
	8219754	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	5.34	CHEMBL3587	Homo sapiens	Inhibition	%	5.34
	8220147	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	6.04	CHEMBL3587	Homo sapiens	Inhibition	%	6.04
	8220276	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	5.77	CHEMBL3587	Homo sapiens	Inhibition	%	5.77
	8220500	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	6.44	CHEMBL3587	Homo sapiens	Inhibition	%	6.44
	8220614	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	5.45	CHEMBL3587	Homo sapiens	Inhibition	%	5.45
	8220976	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	9.97	CHEMBL3587	Homo sapiens	Inhibition	%	9.97
	8221112	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.58	CHEMBL3587	Homo sapiens	Inhibition	%	3.58
	8221469	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	4.86	CHEMBL3587	Homo sapiens	Inhibition	%	4.86
	8221634	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.76	CHEMBL3587	Homo sapiens	Inhibition	%	1.76
	8221858	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.76	CHEMBL3587	Homo sapiens	Inhibition	%	0.76
	8221989	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	7.23	CHEMBL3587	Homo sapiens	Inhibition	%	7.23
	8222311	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	3.55	CHEMBL3587	Homo sapiens	Inhibition	%	3.55
	8222445	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	3.23	CHEMBL3587	Homo sapiens	Inhibition	%	3.23
	8222669	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	2.3	CHEMBL3587	Homo sapiens	Inhibition	%	2.3
	8222787	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	4.04	CHEMBL3587	Homo sapiens	Inhibition	%	4.04
	8223155	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	7.26	CHEMBL3587	Homo sapiens	Inhibition	%	7.26
	8223284	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	2.91	CHEMBL3587	Homo sapiens	Inhibition	%	2.91
	8223508	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	2.61	CHEMBL3587	Homo sapiens	Inhibition	%	2.61
	8223669	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	1.66	CHEMBL3587	Homo sapiens	Inhibition	%	1.66
	8223919	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	6.08	CHEMBL3587	Homo sapiens	Inhibition	%	6.08
	8224081	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	5.29	CHEMBL3587	Homo sapiens	Inhibition	%	5.29
	8224305	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	5.95	CHEMBL3587	Homo sapiens	Inhibition	%	5.95
	8224475	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	5.49	CHEMBL3587	Homo sapiens	Inhibition	%	5.49
	8224834	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	5.16	CHEMBL3587	Homo sapiens	Inhibition	%	5.16
	8224948	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	9.84	CHEMBL3587	Homo sapiens	Inhibition	%	9.84
	8225306	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	7.97	CHEMBL3587	Homo sapiens	Inhibition	%	7.97
	8225444	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	7.11	CHEMBL3587	Homo sapiens	Inhibition	%	7.11
	8225668	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.98	CHEMBL3587	Homo sapiens	Inhibition	%	1.98
	8225803	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	2.88	CHEMBL3587	Homo sapiens	Inhibition	%	2.88
	8226185	CHEMBL1962207	GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	5.84	CHEMBL3587	Homo sapiens	Inhibition	%	5.84
	8226310	CHEMBL1962206	GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	2.67	CHEMBL3587	Homo sapiens	Inhibition	%	2.67
active	9511771	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC(C)(C)CCOc1cc(-c2ccc(C(N)=O)cc2)cc2[nH]nc(N)c12		CHEMBL2001398	=	Ki	nM	2511.89	CHEMBL3587	Homo sapiens	pKi		5.6
inactive	9511772	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCOCCO)c2)n1		CHEMBL1978271	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9511773	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc(OCCCn4cccc4)c4[nH]nc(N)c34)cc2)c1		CHEMBL2007266	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9511774	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	=	Ki	nM	158.49	CHEMBL3587	Homo sapiens	pKi		6.8
inactive	9511775	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9511776	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C(CCC(=O)Nc1cc(C(F)(F)F)ccc1Cl)NN=Cc1c[nH]c2ccccc12		CHEMBL1994308	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9511777	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9511778	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Nc1nc(=O)[nH]c2sccc12		CHEMBL2007097	=	Ki	nM	50118.72	CHEMBL3587	Homo sapiens	pKi		4.3
inactive	9511779	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9511780	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9511781	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCN1CCN(c2ccc(Nc3ncc(C#N)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1973516	=	Ki	nM	794.33	CHEMBL3587	Homo sapiens	pKi		6.1
active	9511782	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	=	Ki	nM	501.19	CHEMBL3587	Homo sapiens	pKi		6.3
active	9511783	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Ki	nM	794.33	CHEMBL3587	Homo sapiens	pKi		6.1
active	9511784	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccc[nH]2)C(=O)N3)c1)Cc1ccccc1		CHEMBL1980407	=	Ki	nM	316.23	CHEMBL3587	Homo sapiens	pKi		6.5
inactive	9511785	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CN(C)CCCN(C)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1964948	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9511786	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C1NCc2ccc(-c3ccc(Cl)cc3)cc21		CHEMBL2002202	=	Ki	nM	79432.82	CHEMBL3587	Homo sapiens	pKi		4.1
inactive	9511787	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1cnc(Nc2nc(NC(C)C)ncc2Br)s1		CHEMBL1973013	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9511788	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	<	Ki	nM	2511.89	CHEMBL3587	Homo sapiens	pKi		5.6
inactive	9511789	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCCc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1987430	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9511790	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1ccccc1		CHEMBL1993413	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9511791	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9511792	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1ccc(-n2ccc3cnc(Nc4cc(OC)c(OC)c(OC)c4)nc32)cc1		CHEMBL1975927	=	Ki	nM	1000.0	CHEMBL3587	Homo sapiens	pKi		6.0
active	9511793	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	31.62	CHEMBL3587	Homo sapiens	pKi		7.5
active	9511794	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	c1ccc(Nc2ncnc3ccccc23)cc1		CHEMBL289959	=	Ki	nM	63095.73	CHEMBL3587	Homo sapiens	pKi		4.2
active	9511795	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Nc1ncc2cccc(-c3ccccc3)n12		CHEMBL1997119	=	Ki	nM	31622.78	CHEMBL3587	Homo sapiens	pKi		4.5
active	9511796	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC(Nc1cncc(-n2cnc3ccc(C#N)cc32)n1)c1ccccc1F		CHEMBL1977138	=	Ki	nM	1995.26	CHEMBL3587	Homo sapiens	pKi		5.7
active	9511797	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	c1ccc(C2CCc3[nH]ncc3C2)cc1		CHEMBL2000879	=	Ki	nM	39810.72	CHEMBL3587	Homo sapiens	pKi		4.4
inactive	9511798	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9511799	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C1Nc2cc(-c3ccc(O)cc3)ccc2C1=Cc1ccc[nH]1		CHEMBL1980329	=	Ki	nM	1258.93	CHEMBL3587	Homo sapiens	pKi		5.9
active	9511800	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	c1nc(-c2ccc3c(c2)OCO3)c2cc[nH]c2n1		CHEMBL2004515	=	Ki	nM	1258.93	CHEMBL3587	Homo sapiens	pKi		5.9
active	9511801	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C(Nc1cccc(C2Nc3ccc4ccccc4c3C3C=CCC32)c1)c1ccc(F)cc1		CHEMBL1992042	=	Ki	nM	1000.0	CHEMBL3587	Homo sapiens	pKi		6.0
inactive	9511802	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C(O)C1CN(Cc2ccc(OCc3cccc(C(F)(F)F)c3)cc2Cl)C1		CHEMBL1986265	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9511803	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Fc1ccc(-c2ccc3nccn3n2)cn1		CHEMBL1967211	=	Ki	nM	79432.82	CHEMBL3587	Homo sapiens	pKi		4.1
active	9511804	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CN1c2ccc(N)cc2C(c2ccccc2)c2cc(N)ccc21		CHEMBL1991734	=	Ki	nM	794.33	CHEMBL3587	Homo sapiens	pKi		6.1
active	9511805	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Ki	nM	100.0	CHEMBL3587	Homo sapiens	pKi		7.0
inactive	9511806	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)s2)c1		CHEMBL1994724	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9511807	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1cc(-c2csc3c(C=CC(=O)NCCN(C)C)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1989267	=	Ki	nM	125.89	CHEMBL3587	Homo sapiens	pKi		6.9
inactive	9511808	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9511809	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C1NCc2c1cccc2-c1cccs1		CHEMBL1991782	<	Ki	nM	63095.73	CHEMBL3587	Homo sapiens	pKi		4.2
active	9511810	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Nc1n[nH]c2ncc(Br)cc12		CHEMBL2002105	=	Ki	nM	19952.62	CHEMBL3587	Homo sapiens	pKi		4.7
inactive	9511811	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9511812	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCCCN(CCC#N)C(=O)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1983348	=	Ki	nM	251.19	CHEMBL3587	Homo sapiens	pKi		6.6
active	9511813	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CN(C)Cc1ccc2c(c1)NC(=O)C1CCCN21		CHEMBL539660	=	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9511814	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCN(CC)CCNC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1970290	=	Ki	nM	1995.26	CHEMBL3587	Homo sapiens	pKi		5.7
inactive	9511815	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9511816	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Ki	nM	630.96	CHEMBL3587	Homo sapiens	pKi		6.2
active	9511817	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	C#Cc1cn(C2CCCC2)c2ncnc(N)c12		CHEMBL1993877	=	Ki	nM	501.19	CHEMBL3587	Homo sapiens	pKi		6.3
active	9511818	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCOC(=O)Cc1nc2c3cc(Br)ccc3[nH]c(=O)n2n1		CHEMBL1974480	=	Ki	nM	1995.26	CHEMBL3587	Homo sapiens	pKi		5.7
inactive	9511819	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL2000934	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9511820	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9511821	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Nc1ncnc2c1C(=O)Nc1ccccc1N2		CHEMBL1980671	=	Ki	nM	31622.78	CHEMBL3587	Homo sapiens	pKi		4.5
active	9511822	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1cccc(NC(=O)N2CCC(c3nc4c(C(N)=O)cccc4[nH]3)CC2)c1		CHEMBL1973363	=	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9511823	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C(Nc1cccc(Cl)c1)Nc1nc(CCNc2ncnc3ccsc23)cs1		CHEMBL1986177	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9511824	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	251.19	CHEMBL3587	Homo sapiens	pKi		6.6
inactive	9511825	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9511826	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(Cl)ccc12		CHEMBL1981744	=	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9511827	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	c1ccc2c(c1)Cc1c[nH]nc1-2		CHEMBL1989423	=	Ki	nM	39810.72	CHEMBL3587	Homo sapiens	pKi		4.4
active	9511828	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1ccnc(Nc2cc(C)nc(-c3ccccc3)n2)c1		CHEMBL1985367	=	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9511829	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	<	Ki	nM	1995.26	CHEMBL3587	Homo sapiens	pKi		5.7
active	9511830	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1nc(N2CCNCC2)nc2ccccc12		CHEMBL1996510	=	Ki	nM	794.33	CHEMBL3587	Homo sapiens	pKi		6.1
inactive	9511831	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1ccccc1-c1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL2000029	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9511832	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9511833	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cn1cc(-c2cccc(NC(=O)c3ccc(C(C)(C)C)cc3)c2CO)cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c1=O		CHEMBL2001584	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9511834	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL1973961	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9511835	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=CN(O)C(CS(=O)(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)cc1)c1ccc(O)cc1		CHEMBL1971227	=	Ki	nM	1258.93	CHEMBL3587	Homo sapiens	pKi		5.9
active	9511836	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1967998	=	Ki	nM	125.89	CHEMBL3587	Homo sapiens	pKi		6.9
active	9511837	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(C#N)ccc21		CHEMBL1978562	=	Ki	nM	1000.0	CHEMBL3587	Homo sapiens	pKi		6.0
inactive	9511838	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCCO)c2)n1		CHEMBL1994977	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9511839	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Oc1ccc2nc(-c3ccc(Sc4ccc(-c5nc6ccc(O)cc6[nH]5)cc4)cc3)[nH]c2c1		CHEMBL2001149	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9511840	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1ccc2c(c1)c(-c1cc3nc(Br)cnc3[nH]1)cn2C		CHEMBL2005478	=	Ki	nM	398.11	CHEMBL3587	Homo sapiens	pKi		6.4
active	9511841	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1cccc(OC)c1CNc1nc(NC2CCCCC2)nc2ccc(Cl)cc12		CHEMBL1996646	=	Ki	nM	1000.0	CHEMBL3587	Homo sapiens	pKi		6.0
inactive	9511842	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1979773	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9511843	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1ccnc2[nH]c3cc(C(C)C)ccc3c(=O)c12		CHEMBL1989471	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9511844	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	<	Ki	nM	2511.89	CHEMBL3587	Homo sapiens	pKi		5.6
active	9511845	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	c1ccc(-c2cccc3nccn23)cc1		CHEMBL1992723	=	Ki	nM	63095.73	CHEMBL3587	Homo sapiens	pKi		4.2
inactive	9511846	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCCN(C)C)cc2NC3=O)ccc1O		CHEMBL1996702	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9511847	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	1258.93	CHEMBL3587	Homo sapiens	pKi		5.9
inactive	9511848	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C(Nc1ccc(-c2ccc(=O)[nH]n2)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL2007124	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9511849	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	NC(=O)c1cc2c(-c3ccc(Br)cc3)cncc2s1		CHEMBL1978195	=	Ki	nM	501.19	CHEMBL3587	Homo sapiens	pKi		6.3
inactive	9511850	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9511851	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	=	Ki	nM	199.53	CHEMBL3587	Homo sapiens	pKi		6.7
active	9511852	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	N#Cc1ccc2c(c1)C(c1ccc3c(n1)CCCC3O)C(=O)N2		CHEMBL1985681	=	Ki	nM	1000.0	CHEMBL3587	Homo sapiens	pKi		6.0
inactive	9511853	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	<	Ki	nM	2511.89	CHEMBL3587	Homo sapiens	pKi		5.6
inactive	9511854	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9511855	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	=	Ki	nM	31.62	CHEMBL3587	Homo sapiens	pKi		7.5
active	9511856	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	=	Ki	nM	398.11	CHEMBL3587	Homo sapiens	pKi		6.4
active	9511857	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Nc1ncnc2c1N=C(c1ccccc1)CCN2		CHEMBL262623	=	Ki	nM	5011.87	CHEMBL3587	Homo sapiens	pKi		5.3
inactive	9511858	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC(C)COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1984842	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9511859	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL2004118	=	Ki	nM	2511.89	CHEMBL3587	Homo sapiens	pKi		5.6
active	9511860	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCN1CCN(c2ccc(Nc3ncc(C#N)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1973516	=	Ki	nM	630.96	CHEMBL3587	Homo sapiens	pKi		6.2
inactive	9511861	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	N#Cc1ccc2nc(N)n(-c3nc4c(s3)CCCC4)c2c1		CHEMBL1996345	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9511862	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COCOc1cccc(OCOC)c1-c1ccc(NS(C)(=O)=O)cc1C(=O)OC		CHEMBL2004025	=	Ki	nM	794.33	CHEMBL3587	Homo sapiens	pKi		6.1
active	9511863	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1ccc(-c2cc3c(NCCN)ccc(C(N)=O)c3[nH]2)cc1		CHEMBL1996048	=	Ki	nM	794.33	CHEMBL3587	Homo sapiens	pKi		6.1
inactive	9511864	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9511865	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC(C)(C)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1995211	=	Ki	nM	1000.0	CHEMBL3587	Homo sapiens	pKi		6.0
inactive	9511866	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1		CHEMBL1965033	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9511867	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL461876	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9511868	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	<	Ki	nM	1995.26	CHEMBL3587	Homo sapiens	pKi		5.7
active	9511869	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	NC(=O)c1ccc(NC2CCCCC2N)nc1Nc1cccc(Cl)c1		CHEMBL1982753	=	Ki	nM	1000.0	CHEMBL3587	Homo sapiens	pKi		6.0
inactive	9511870	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1cccc(CNC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2006299	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9511871	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Oc1cc(O)cc(C=Cc2ccc(O)c(O)c2)c1		CHEMBL1972346	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9511872	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Nc1n[nH]c2cccc(-c3ccc(F)cc3)c12		CHEMBL1971519	=	Ki	nM	251.19	CHEMBL3587	Homo sapiens	pKi		6.6
inactive	9515780	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1ccc(C2=NNc3cccc4c(OC)ccc2c34)cc1OC		CHEMBL1997335	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515781	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1ccc(-c2cc3nc(Br)cnc3[nH]2)cc1		CHEMBL1965169	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515782	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Ki	nM	398.11	CHEMBL3587	Homo sapiens	pKi		6.4
active	9515783	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(O)CO)c5)cnc(N)c34)cc2)cc1		CHEMBL1965170	=	Ki	nM	1000.0	CHEMBL3587	Homo sapiens	pKi		6.0
active	9515784	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1nnc(-c2ccccc2)c(C#N)n1		CHEMBL1994808	=	Ki	nM	79432.82	CHEMBL3587	Homo sapiens	pKi		4.1
inactive	9515785	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2005792	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515786	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1c(-c2nc3ccccc3[nH]2)c(O)cc2oc(C)cc(=O)c12		CHEMBL1972355	=	Ki	nM	630.96	CHEMBL3587	Homo sapiens	pKi		6.2
inactive	9515787	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)c(Cl)c1		CHEMBL1997892	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515788	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC(C)(O)c1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL2001641	=	Ki	nM	19952.62	CHEMBL3587	Homo sapiens	pKi		4.7
inactive	9515789	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1ccc(-c2cc(-c3cc(Br)ccc3O)[nH]c(=O)c2C#N)s1		CHEMBL1997193	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515790	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)O)c2)n1		CHEMBL1964902	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515791	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Oc1cnc2ccc(-c3ccncc3)cc2c1		CHEMBL1973868	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515792	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCCCC#Cc1ccc(CN2CC(C(=O)O)C2)cc1		CHEMBL1972462	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515793	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515794	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Ki	nM	1000.0	CHEMBL3587	Homo sapiens	pKi		6.0
inactive	9515795	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515796	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)n2)s1		CHEMBL1983715	=	Ki	nM	398.11	CHEMBL3587	Homo sapiens	pKi		6.4
inactive	9515797	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C1NCc2c(Br)cccc21		CHEMBL1984500	<	Ki	nM	63095.73	CHEMBL3587	Homo sapiens	pKi		4.2
inactive	9515798	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515799	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	<	Ki	nM	2511.89	CHEMBL3587	Homo sapiens	pKi		5.6
inactive	9515800	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCCCNC(=O)c1cn(C(CC)CC)c(=O)c2cc(OC)c(OC)cc12		CHEMBL1982700	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515801	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515802	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC(C)Cc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL1980763	=	Ki	nM	1995.26	CHEMBL3587	Homo sapiens	pKi		5.7
inactive	9515803	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(N)=O)cc2)n1		CHEMBL1977634	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515804	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC(=O)c1ccccc1-c1ncnc2[nH]ccc12		CHEMBL1977931	=	Ki	nM	79432.82	CHEMBL3587	Homo sapiens	pKi		4.1
active	9515805	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Nc1nccc2cnc(-c3ccccc3)n12		CHEMBL1969156	=	Ki	nM	5011.87	CHEMBL3587	Homo sapiens	pKi		5.3
inactive	9515806	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	1995.26	CHEMBL3587	Homo sapiens	pKi		5.7
inactive	9515807	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCCCNc1nc(N)c(C(=O)c2ccccc2)s1		CHEMBL2007479	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515808	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	c1ccc(-c2c[nH]c3ncnc(N4CCCCC4)c23)cc1		CHEMBL1998953	=	Ki	nM	316.23	CHEMBL3587	Homo sapiens	pKi		6.5
inactive	9515809	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2)c1		CHEMBL1971606	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515810	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515811	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC(C)c1cc(=O)[nH]c2[nH][nH]c(=O)c12		CHEMBL1999120	=	Ki	nM	100000.0	CHEMBL3587	Homo sapiens	pKi		4.0
active	9515812	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4ccc(OC(F)F)cc4)cc3)c12		CHEMBL1972220	=	Ki	nM	50.12	CHEMBL3587	Homo sapiens	pKi		7.3
active	9515813	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	NC(=O)c1cnn2c(-c3ccccc3)ccnc12		CHEMBL1972583	=	Ki	nM	50118.72	CHEMBL3587	Homo sapiens	pKi		4.3
inactive	9515814	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(OC(F)F)ccc12		CHEMBL1981215	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515815	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Fc1cccc(CNc2ncnc3[nH]cnc23)c1		CHEMBL2003785	=	Ki	nM	10000.0	CHEMBL3587	Homo sapiens	pKi		5.0
active	9515816	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	19.95	CHEMBL3587	Homo sapiens	pKi		7.7
inactive	9515817	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515818	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1999414	=	Ki	nM	1000.0	CHEMBL3587	Homo sapiens	pKi		6.0
inactive	9515819	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cc(F)cc12		CHEMBL1967336	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515820	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C1Nc2cc(CCOc3ccc(N4CCOCC4)cc3)ccc2Nc2cc(-c3cn(Cc4cc(F)c(F)c(F)c4)c4cnccc34)ccc21		CHEMBL2001923	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515821	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C1CN=C(c2ccc(F)cc2)c2cn[nH]c2N1		CHEMBL1994056	=	Ki	nM	79432.82	CHEMBL3587	Homo sapiens	pKi		4.1
inactive	9515822	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCOc1ccccc1-c1cccc(-c2n[nH]c3nc(O)cc(C)c23)c1		CHEMBL1983070	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515823	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2003514	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515824	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515825	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	=	Ki	nM	1584.89	CHEMBL3587	Homo sapiens	pKi		5.8
inactive	9515826	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	N#Cc1ccc(-c2ccncc2)cc1NCc1ccccc1		CHEMBL1967992	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515827	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515828	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4c(Cl)cccc4Cl)s3)cc2)CC1		CHEMBL1989043	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515829	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515830	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL2006450	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515831	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1nn(C)c2sc3c(=O)[nH]cnc3c12		CHEMBL1967538	=	Ki	nM	100000.0	CHEMBL3587	Homo sapiens	pKi		4.0
inactive	9515832	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)ccc(F)c12		CHEMBL2001987	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515833	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCc1c(-c2ccc(C(C)=O)cc2)[nH]c2nccnc12		CHEMBL1994555	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515834	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515835	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515836	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515837	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3coc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1983640	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515838	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCOC(=O)c1nc2c(=O)[nH]c3cc([N+](=O)[O-])c(NC(C)=O)cc3n2c1C		CHEMBL1997611	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515839	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	<	Ki	nM	2511.89	CHEMBL3587	Homo sapiens	pKi		5.6
active	9515840	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC(=O)Nc1ccc(-n2nc3ccc(N)nc3n2)cc1		CHEMBL2002723	=	Ki	nM	2511.89	CHEMBL3587	Homo sapiens	pKi		5.6
active	9515841	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	19.95	CHEMBL3587	Homo sapiens	pKi		7.7
inactive	9515842	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Brc1ccc2cnc(Nc3ccncn3)cc2c1		CHEMBL1984686	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515843	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515844	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=S(=O)(Nc1ccc2c(c1)C(=NO)c1ccccc1-2)c1cccc(Br)c1		CHEMBL1973793	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515845	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515846	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	=	Ki	nM	50.12	CHEMBL3587	Homo sapiens	pKi		7.3
inactive	9515847	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCC1CC(NS(=O)(=O)C2CC2)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1992073	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515848	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515849	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C(NC(CCO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1986143	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515850	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Nc1ncnc2sccc12		CHEMBL1972934	=	Ki	nM	15848.93	CHEMBL3587	Homo sapiens	pKi		4.8
inactive	9515851	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3sccc3n2)cc1		CHEMBL2007559	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515852	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C(Cc1ccc(-c2cccnc2)cc1)Nc1ccc(SC(F)F)cc1		CHEMBL1992581	=	Ki	nM	501.19	CHEMBL3587	Homo sapiens	pKi		6.3
active	9515853	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	=	Ki	nM	1258.93	CHEMBL3587	Homo sapiens	pKi		5.9
active	9515854	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=c1[nH]c2cc(Br)cnc2[nH]1		CHEMBL1975921	=	Ki	nM	50118.72	CHEMBL3587	Homo sapiens	pKi		4.3
active	9515855	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	C=Cc1ccc(-c2cccc3nnc(N)n23)cc1		CHEMBL1983573	=	Ki	nM	12589.25	CHEMBL3587	Homo sapiens	pKi		4.9
active	9515856	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=c1[nH]n2ccccc2c1Br		CHEMBL2004033	=	Ki	nM	2511.89	CHEMBL3587	Homo sapiens	pKi		5.6
inactive	9515857	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC(CCC(=O)O)(c1ccc(O)c(N)c1)c1ccc(O)c(N)c1		CHEMBL1975923	<	Ki	nM	1584.89	CHEMBL3587	Homo sapiens	pKi		5.8
inactive	9515858	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC(=O)OCCn1nc(-c2cccc(Br)c2)c2c(C(F)(F)F)cc(=O)[nH]c21		CHEMBL1984847	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515859	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1cc(Nc2nc(Cl)cc(NCc3ccccc3)n2)n[nH]1		CHEMBL2005449	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515860	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C(Cc1ccc(OC(F)(F)F)cc1)N1CCC2(CC1)NCCc1c2[nH]c2ccccc12		CHEMBL1996576	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515861	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515862	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C(O)C1CN(Cc2ccc(OCc3ccccc3)cc2Cl)C1		CHEMBL1987998	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515863	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	NC(=O)c1cc2ccncc2s1		CHEMBL1971534	=	Ki	nM	10000.0	CHEMBL3587	Homo sapiens	pKi		5.0
inactive	9515864	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515865	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc([N+](=O)[O-])cc2)n1		CHEMBL242865	=	Ki	nM	1258.93	CHEMBL3587	Homo sapiens	pKi		5.9
inactive	9515866	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	<	Ki	nM	1995.26	CHEMBL3587	Homo sapiens	pKi		5.7
inactive	9515867	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1cc2ncc3c(N)nc4c(C)c(N)ccc4c3c2cc1OC		CHEMBL235157	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515868	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	<	Ki	nM	1995.26	CHEMBL3587	Homo sapiens	pKi		5.7
inactive	9515869	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1cccc(CNC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2004159	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515870	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	N#CC1=C(c2ccccc2)CC(c2ccc(Cl)cc2)C(C(=O)c2ccccc2)C1=O		CHEMBL1978371	=	Ki	nM	1000.0	CHEMBL3587	Homo sapiens	pKi		6.0
inactive	9515871	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515872	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	[2H]C([2H])([2H])Oc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1998110	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515873	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	501.19	CHEMBL3587	Homo sapiens	pKi		6.3
inactive	9515874	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1cc(O)nc2[nH]nc(-c3cccc(-c4ccc(Cl)cc4)c3)c12		CHEMBL1990590	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515875	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1nn(C)c2c1c(=O)c1cc(Cl)ccc1n2OCC(C)C		CHEMBL1977814	=	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515876	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	OCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1974617	=	Ki	nM	10000.0	CHEMBL3587	Homo sapiens	pKi		5.0
active	9515877	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	=	Ki	nM	794.33	CHEMBL3587	Homo sapiens	pKi		6.1
active	9515878	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	1995.26	CHEMBL3587	Homo sapiens	pKi		5.7
active	9515879	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1cc(Nc2ncnc(N3CCCc4cc(C)ccc43)n2)cc(OC)c1OC		CHEMBL1992125	=	Ki	nM	1258.93	CHEMBL3587	Homo sapiens	pKi		5.9
inactive	9515880	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC1CCN(C(=O)CC#N)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1966175	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515881	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC#Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL2007375	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515882	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21		CHEMBL379975	=	Ki	nM	25.12	CHEMBL3587	Homo sapiens	pKi		7.6
inactive	9515883	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CS(=O)(=O)c1cccc(C(=O)Nc2nc3ccccc3n2CCCO)c1		CHEMBL1973016	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515884	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Nc1n[nH]c2c(OCCCn3cccc3)ccc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL1965387	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515885	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	c1cc2c(s1)CCc1cn[nH]c1-2		CHEMBL2001539	=	Ki	nM	31622.78	CHEMBL3587	Homo sapiens	pKi		4.5
active	9515886	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	=	Ki	nM	6.31	CHEMBL3587	Homo sapiens	pKi		8.2
active	9515887	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1cc(-c2ncnc3[nH]ccc23)ccc1F		CHEMBL1997041	=	Ki	nM	1258.93	CHEMBL3587	Homo sapiens	pKi		5.9
inactive	9515888	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1cc(-c2ccc3c(c2)Nc2c(O)cccc2NC3=O)ccc1O		CHEMBL550418	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515889	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515890	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515891	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCOc1ccc(C=C2SC(=N)NC2=O)c(O)c1		CHEMBL1971289	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515892	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	<	Ki	nM	2511.89	CHEMBL3587	Homo sapiens	pKi		5.6
inactive	9515893	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2ccc(F)cc12		CHEMBL2007603	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515894	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C(Cc1cccs1)Nc1nc2ccccc2s1		CHEMBL1421720	=	Ki	nM	1995.26	CHEMBL3587	Homo sapiens	pKi		5.7
inactive	9515895	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1ccc2c(c1)c(-c1cc3nccnc3[nH]1)cn2C		CHEMBL1233887	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515896	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Nc1nnc2cncc(Cl)n12		CHEMBL1968130	=	Ki	nM	79432.82	CHEMBL3587	Homo sapiens	pKi		4.1
inactive	9515897	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCCC(=O)O)cc2)n1		CHEMBL2003689	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515898	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1996649	=	Ki	nM	1000.0	CHEMBL3587	Homo sapiens	pKi		6.0
inactive	9515899	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1986756	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515900	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	<	Ki	nM	1995.26	CHEMBL3587	Homo sapiens	pKi		5.7
active	9515901	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=c1[nH]cnc2c(Cl)cccc12		CHEMBL1949855	=	Ki	nM	50118.72	CHEMBL3587	Homo sapiens	pKi		4.3
active	9515902	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	=	Ki	nM	39.81	CHEMBL3587	Homo sapiens	pKi		7.4
inactive	9515903	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1cc(OCc2ccc(Cl)c(Cl)c2)ccc1CN1CC(C(=O)O)C1		CHEMBL1990223	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515904	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12		CHEMBL2004438	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515905	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC(C)(c1cc(Br)c(O)c(I)c1)c1cc(Br)c(O)c(I)c1		CHEMBL1964382	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515906	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CN(C)CC(O)COc1ccc(Nc2nccc(Nc3cc(Cl)ccc3Cl)n2)cc1		CHEMBL101311	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515907	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Ki	nM	1995.26	CHEMBL3587	Homo sapiens	pKi		5.7
active	9515908	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	NC(=O)c1ccc2nc(-c3ccc([N+](=O)[O-])o3)cn2c1		CHEMBL1973359	=	Ki	nM	1584.89	CHEMBL3587	Homo sapiens	pKi		5.8
active	9515909	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1cc(=O)n2ccc(CN(C)C)c(O)c2n1		CHEMBL1988581	=	Ki	nM	100.0	CHEMBL3587	Homo sapiens	pKi		7.0
inactive	9515910	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(=O)O)cc2)n1		CHEMBL2005699	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515911	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCN(C(C)=O)c1ccc(Nc2nc(NC3CC3)c3nc[nH]c3n2)cc1		CHEMBL2006564	=	Ki	nM	79.43	CHEMBL3587	Homo sapiens	pKi		7.1
active	9515912	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	31.62	CHEMBL3587	Homo sapiens	pKi		7.5
active	9515913	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1979690	=	Ki	nM	125.89	CHEMBL3587	Homo sapiens	pKi		6.9
inactive	9515914	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515915	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	501.19	CHEMBL3587	Homo sapiens	pKi		6.3
inactive	9515916	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2ccccc21		CHEMBL1978167	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515917	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515918	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Ki	nM	125.89	CHEMBL3587	Homo sapiens	pKi		6.9
inactive	9515919	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515920	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC(=O)c1cccc(-c2ccc3nccn3n2)c1		CHEMBL1994159	=	Ki	nM	39810.72	CHEMBL3587	Homo sapiens	pKi		4.4
active	9515921	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Nc1ncnc2c1c(-c1ccc(Oc3ccc(CO)cc3)cc1)cn2C1CCOC1		CHEMBL1976376	=	Ki	nM	5.012	CHEMBL3587	Homo sapiens	pKi		8.3
active	9515922	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C(NN=Cc1cc(Br)c(O)c(Br)c1)Nc1ccccc1		CHEMBL1983575	=	Ki	nM	10.0	CHEMBL3587	Homo sapiens	pKi		8.0
inactive	9515923	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	N#Cc1cccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)n1		CHEMBL1968868	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515924	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515925	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1998470	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515926	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C(Nc1ccc([N+](=O)[O-])cc1)N1CCc2[nH]c3c(Cl)cc(Cl)cc3c2C1		CHEMBL1976196	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515927	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1ccccc1CNC(=N)Nc1nccc(-c2cccs2)n1		CHEMBL1997197	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515928	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1ccccc1-c1ccnc(Nc2cccc(S(C)(=O)=O)c2)n1		CHEMBL1975903	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515929	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C1Cc2cc(-c3ccccc3)cnc2N1		CHEMBL1983630	=	Ki	nM	79432.82	CHEMBL3587	Homo sapiens	pKi		4.1
active	9515930	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	N#Cc1ccc2nc(N)n(-c3nccs3)c2c1		CHEMBL1988805	=	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515931	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515932	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C(Nc1ccc(-c2ccc3cn[nH]c3c2)cc1)Nc1cccc(F)c1		CHEMBL1969942	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515933	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515934	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1978567	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515935	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	=	Ki	nM	1258.93	CHEMBL3587	Homo sapiens	pKi		5.9
active	9515936	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Nc1cc(=O)[nH]n1-c1ccccn1		CHEMBL1995765	=	Ki	nM	79432.82	CHEMBL3587	Homo sapiens	pKi		4.1
active	9515937	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCCNC(=O)c1ccc(Nc2nc(CCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL1984760	=	Ki	nM	1995.26	CHEMBL3587	Homo sapiens	pKi		5.7
active	9515938	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	=	Ki	nM	251.19	CHEMBL3587	Homo sapiens	pKi		6.6
inactive	9515939	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515940	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515941	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CN(C)CC1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL360847	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515942	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cc(F)ccc1F		CHEMBL1995811	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515943	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL49120	=	Ki	nM	50.12	CHEMBL3587	Homo sapiens	pKi		7.3
active	9515944	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Ki	nM	100.0	CHEMBL3587	Homo sapiens	pKi		7.0
active	9515945	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCC(=O)Nc1ccc(C(=O)N2CCNCC2)c(O)c1		CHEMBL1988141	=	Ki	nM	398.11	CHEMBL3587	Homo sapiens	pKi		6.4
inactive	9515946	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	<	Ki	nM	2511.89	CHEMBL3587	Homo sapiens	pKi		5.6
active	9515947	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	NC(=O)c1cccc2cn[nH]c12		CHEMBL451401	=	Ki	nM	7943.28	CHEMBL3587	Homo sapiens	pKi		5.1
inactive	9515948	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)cnc2c(-c3ccc4c(c3)OCO4)cnn12		CHEMBL1977134	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515949	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COCC#Cc1cccc2c1Cc1c(-c3cccs3)n[nH]c1-2		CHEMBL1985206	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515950	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515951	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	=	Ki	nM	1258.93	CHEMBL3587	Homo sapiens	pKi		5.9
inactive	9515952	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	C=CCc1cccc2c(=NO)cc(-c3ccccc3)oc12		CHEMBL1977749	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515953	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Nc1ncnc2scc(-c3ccccc3)c12		CHEMBL1975212	=	Ki	nM	794.33	CHEMBL3587	Homo sapiens	pKi		6.1
active	9515954	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=c1[nH][nH]c2ccc(Br)cc12		CHEMBL2001613	=	Ki	nM	25118.86	CHEMBL3587	Homo sapiens	pKi		4.6
inactive	9515955	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515956	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	=	Ki	nM	501.19	CHEMBL3587	Homo sapiens	pKi		6.3
active	9515957	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	=	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515958	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	NC(=O)c1cc2c(-c3ccc(Nc4nc5ccccc5o4)cc3)cnc(N)c2s1		CHEMBL1993904	=	Ki	nM	1000.0	CHEMBL3587	Homo sapiens	pKi		6.0
active	9515959	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1ccc2[nH]cc(C=C3C(=O)Nc4ccccc43)c2c1		CHEMBL1997275	=	Ki	nM	1000.0	CHEMBL3587	Homo sapiens	pKi		6.0
inactive	9515960	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2ccc(Cl)cc12		CHEMBL1967513	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515961	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1cccc(-c2cccc3onc(N)c23)c1		CHEMBL1980376	=	Ki	nM	1995.26	CHEMBL3587	Homo sapiens	pKi		5.7
inactive	9515962	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1cc(O)nc2[nH]nc(-c3cccc(-c4ccc(C#N)cc4)c3)c12		CHEMBL2000724	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515963	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515964	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	1995.26	CHEMBL3587	Homo sapiens	pKi		5.7
active	9515965	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CN(Cc1cc(Cl)c(O)c2ncccc12)C1CCCCC1		CHEMBL1982413	=	Ki	nM	1258.93	CHEMBL3587	Homo sapiens	pKi		5.9
active	9515966	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C(NCCc1cccs1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1987535	=	Ki	nM	2511.89	CHEMBL3587	Homo sapiens	pKi		5.6
inactive	9515967	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C(Nc1cccc(F)c1)Nc1cccc(-c2ccc3cn[nH]c3c2)c1		CHEMBL1983393	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515968	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(F)c(F)cc12		CHEMBL1981792	=	Ki	nM	1584.89	CHEMBL3587	Homo sapiens	pKi		5.8
active	9515969	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Clc1cc(Nc2nc(NC3CC3)c3sccc3n2)ccc1N1CCOCC1		CHEMBL2002586	=	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515970	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	NC(=O)c1cc(-c2cccs2)n2nccc2n1		CHEMBL1987815	=	Ki	nM	3981.07	CHEMBL3587	Homo sapiens	pKi		5.4
inactive	9515971	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCCC3CCO)nc12		CHEMBL2006674	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515972	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1981133	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515973	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C(Nc1cnccn1)Nc1cccc2c(O)cccc12		CHEMBL1992371	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515974	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CN(C)c1ccc(Nc2cc(-c3csc(Br)c3)[nH]n2)cc1		CHEMBL1984236	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515975	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC(C)Oc1cc(Nc2nc(NC(C)c3ccc(F)cn3)ncc2Cl)n[nH]1		CHEMBL2007421	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515976	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c(=O)n(C)c1		CHEMBL1973138	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515977	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(N3CC4COCC4C3)cc12		CHEMBL2002599	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515978	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=c1[nH]c2ccc(Cl)cc2c2ncnn12		CHEMBL1992673	=	Ki	nM	50118.72	CHEMBL3587	Homo sapiens	pKi		4.3
inactive	9515979	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515980	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CN(C)C1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1969151	=	Ki	nM	199.53	CHEMBL3587	Homo sapiens	pKi		6.7
active	9515981	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1n[nH]c2ccc(-c3cccnc3)cc12		CHEMBL1967252	=	Ki	nM	10000.0	CHEMBL3587	Homo sapiens	pKi		5.0
active	9515982	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(F)ccc21		CHEMBL1993335	=	Ki	nM	398.11	CHEMBL3587	Homo sapiens	pKi		6.4
active	9515983	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COC(=O)c1c(N)nc2ccccn12		CHEMBL1981492	=	Ki	nM	31622.78	CHEMBL3587	Homo sapiens	pKi		4.5
active	9515984	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Nc1nc(Cl)cc(-c2c[nH]c3ncccc23)n1		CHEMBL2007574	=	Ki	nM	398.11	CHEMBL3587	Homo sapiens	pKi		6.4
active	9515985	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC(C)NC1=NNC(=O)C1=Cc1cc2ccccc2[nH]1		CHEMBL1988692	=	Ki	nM	794.33	CHEMBL3587	Homo sapiens	pKi		6.1
active	9515986	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL2004637	=	Ki	nM	2511.89	CHEMBL3587	Homo sapiens	pKi		5.6
inactive	9515987	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC(C)C(C)Nc1ncc(Cl)c(Nc2nccs2)n1		CHEMBL1993374	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515988	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC(C)N(CCCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1994318	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515989	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)NCCO)c2)n1		CHEMBL1998680	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515990	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515991	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCCC(=O)O)c2)n1		CHEMBL1999506	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515992	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1970317	=	Ki	nM	1258.93	CHEMBL3587	Homo sapiens	pKi		5.9
inactive	9515993	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515994	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCCNC(=O)c1ccc(Nc2nc(CC)c3cc[nH]c3n2)cc1		CHEMBL1997007	=	Ki	nM	2511.89	CHEMBL3587	Homo sapiens	pKi		5.6
inactive	9515995	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCOC(=O)c1c(C)n(-c2ccc(I)cc2)c2c1cc(O)c1ccccc12		CHEMBL1970352	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515996	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1964444	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9515997	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C(Nc1nc2c(O)cccc2s1)Nc1ccccc1-c1ccccc1		CHEMBL2002690	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9515998	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CN(C)c1ccc(-c2cc(-c3ccc([N+](=O)[O-])cc3)nc(NS(=O)(=O)c3ccc(N)cc3)n2)cc1		CHEMBL1980167	=	Ki	nM	1584.89	CHEMBL3587	Homo sapiens	pKi		5.8
inactive	9515999	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9516000	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9516001	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	<	Ki	nM	1995.26	CHEMBL3587	Homo sapiens	pKi		5.7
active	9516002	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	=	Ki	nM	63.1	CHEMBL3587	Homo sapiens	pKi		7.2
active	9516003	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C1Nc2ccccc2C1=Cc1c[nH]c2ccccc12		CHEMBL1986590	=	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9516004	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCC(N)C3)c21		CHEMBL1870106	<	Ki	nM	2511.89	CHEMBL3587	Homo sapiens	pKi		5.6
active	9516005	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Ki	nM	251.19	CHEMBL3587	Homo sapiens	pKi		6.6
inactive	9516006	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	NCc1cc(Nc2ncnc(-c3ccccc3)n2)ccc1O		CHEMBL1980246	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9516007	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(-c3ccc(CO)cc3)s1)CC2		CHEMBL1983980	=	Ki	nM	1000.0	CHEMBL3587	Homo sapiens	pKi		6.0
active	9516008	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	Ki	nM	100.0	CHEMBL3587	Homo sapiens	pKi		7.0
active	9516009	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	c1ccc(-c2ccnc3[nH]ccc23)cc1		CHEMBL482538	=	Ki	nM	630.96	CHEMBL3587	Homo sapiens	pKi		6.2
active	9516010	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCNCC4)cc3)n2)s1		CHEMBL1999484	=	Ki	nM	794.33	CHEMBL3587	Homo sapiens	pKi		6.1
active	9516011	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	NC(=O)c1csc2c1NCCC2=O		CHEMBL1973399	=	Ki	nM	79432.82	CHEMBL3587	Homo sapiens	pKi		4.1
inactive	9516012	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1ccc(C)c(NC(=O)c2cc(-c3ccco3)nc3ccccc23)c1		CHEMBL1984296	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9516013	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1ccc(NCc2ccc(-c3ccc(F)cc3)nc2)cc1		CHEMBL1986899	=	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9516014	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	Cc1nn(C)c2sc(C(N)=O)c(N)c12		CHEMBL1996837	=	Ki	nM	10000.0	CHEMBL3587	Homo sapiens	pKi		5.0
inactive	9516015	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9516016	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	=	Ki	nM	63.1	CHEMBL3587	Homo sapiens	pKi		7.2
inactive	9516017	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	<	Ki	nM	2511.89	CHEMBL3587	Homo sapiens	pKi		5.6
inactive	9516018	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	CNCC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1964441	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
inactive	9516019	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1c(F)cccc1F		CHEMBL1991410	<	Ki	nM	3162.28	CHEMBL3587	Homo sapiens	pKi		5.5
active	9519922	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	=	Ki	nM	1995.26	CHEMBL3587	Homo sapiens	pKi		5.7
active	9519923	CHEMBL1963692	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP2K1	F	ON=C(c1nc2ccccc2[nH]1)c1nc2ccccc2[nH]1		CHEMBL546797	=	Ki	nM	1000.0	CHEMBL3587	Homo sapiens	pKi		6.0
	10838720	CHEMBL2014946	Inhibition of MAP2K1 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	16.0	CHEMBL3587	Homo sapiens	INH	%	16.0
	10839608	CHEMBL2015158	Inhibition of MKK1 assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	30.0	CHEMBL3587	Homo sapiens	Activity	%	30.0
	10840363	CHEMBL2016290	Inhibition of MKK1 assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	91.0	CHEMBL3587	Homo sapiens	Activity	%	91.0
Active	10842811	CHEMBL2016338	Inhibition of MEK1-mediated Erk1/2 phosphorylation in human HT-29 cells at 3 mg/kg plasma concentration measured after 4 hrs by in vivo pharmacodynamic model	B	Cc1c(Nc2ccc(I)cc2F)c(C(=O)NOCCO)c2n(c1=O)CCC2		CHEMBL2012908		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Active	10842812	CHEMBL2016337	Inhibition of MEK1-mediated Erk1/2 phosphorylation in human HT-29 cells at 30 mg/kg measured after 4 hrs by in vivo pharmacodynamic model	B	C#Cc1ccc(Nc2c(C(=O)NOCCO)c3c(n2C)C(=O)CCC3)c(F)c1		CHEMBL2012899		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
	10843531	CHEMBL2016104	Inhibition of MEK1-mediated ERK1 phosphorylation using IPTTPITTYFFFK-5FAM-COOH as substrate by fluorescent polarization assay	B	O=C(NOCCO)c1c(Nc2ccc(I)cc2F)c(Cl)c(=O)n2c1CCC2		CHEMBL2012909	=	IC50	nM	109.0	CHEMBL3587	Homo sapiens	IC50	nM	109.0
	10843532	CHEMBL2016104	Inhibition of MEK1-mediated ERK1 phosphorylation using IPTTPITTYFFFK-5FAM-COOH as substrate by fluorescent polarization assay	B	Cc1c(Nc2ccc(I)cc2F)c(C(=O)NOCCO)c2n(c1=O)CCC2		CHEMBL2012908	=	IC50	nM	38.0	CHEMBL3587	Homo sapiens	IC50	nM	38.0
	10843533	CHEMBL2016104	Inhibition of MEK1-mediated ERK1 phosphorylation using IPTTPITTYFFFK-5FAM-COOH as substrate by fluorescent polarization assay	B	O=C(NOCCO)c1c(Nc2ccc(I)cc2F)cc(=O)n2c1CCC2		CHEMBL2012907	=	IC50	nM	29.0	CHEMBL3587	Homo sapiens	IC50	nM	29.0
	10843534	CHEMBL2016104	Inhibition of MEK1-mediated ERK1 phosphorylation using IPTTPITTYFFFK-5FAM-COOH as substrate by fluorescent polarization assay	B	C#Cc1ccc(Nc2c(C(=O)NOCCO)c3n(c(=O)c2F)CCC3)c(F)c1		CHEMBL2012906	=	IC50	nM	69.0	CHEMBL3587	Homo sapiens	IC50	nM	69.0
	10843535	CHEMBL2016104	Inhibition of MEK1-mediated ERK1 phosphorylation using IPTTPITTYFFFK-5FAM-COOH as substrate by fluorescent polarization assay	B	O=C(NOC[C@H](O)CO)c1c(Nc2ccc(I)cc2F)c(F)c(=O)n2c1CCC2		CHEMBL2012905	=	IC50	nM	39.0	CHEMBL3587	Homo sapiens	IC50	nM	39.0
	10843536	CHEMBL2016104	Inhibition of MEK1-mediated ERK1 phosphorylation using IPTTPITTYFFFK-5FAM-COOH as substrate by fluorescent polarization assay	B	O=C(NOC[C@@H](O)CO)c1c(Nc2ccc(I)cc2F)c(F)c(=O)n2c1CCC2		CHEMBL2012904	=	IC50	nM	94.0	CHEMBL3587	Homo sapiens	IC50	nM	94.0
	10843537	CHEMBL2016104	Inhibition of MEK1-mediated ERK1 phosphorylation using IPTTPITTYFFFK-5FAM-COOH as substrate by fluorescent polarization assay	B	O=C(NOCCO)c1c(Nc2ccc(I)cc2F)c(F)c(=O)n2c1CCCC2		CHEMBL2012903	=	IC50	nM	57.0	CHEMBL3587	Homo sapiens	IC50	nM	57.0
	10843538	CHEMBL2016104	Inhibition of MEK1-mediated ERK1 phosphorylation using IPTTPITTYFFFK-5FAM-COOH as substrate by fluorescent polarization assay	B	O=C(NOCCO)c1c(Nc2ccc(I)cc2F)c(F)c(=O)n2c1CCC2		CHEMBL2012902	=	IC50	nM	25.0	CHEMBL3587	Homo sapiens	IC50	nM	25.0
	10843539	CHEMBL2016104	Inhibition of MEK1-mediated ERK1 phosphorylation using IPTTPITTYFFFK-5FAM-COOH as substrate by fluorescent polarization assay	B	C#Cc1ccc(Nc2c(C(=O)NOCCO)c3c(n2C)C(=O)CC3)c(F)c1		CHEMBL2012901	=	IC50	nM	36.0	CHEMBL3587	Homo sapiens	IC50	nM	36.0
	10843540	CHEMBL2016104	Inhibition of MEK1-mediated ERK1 phosphorylation using IPTTPITTYFFFK-5FAM-COOH as substrate by fluorescent polarization assay	B	C#Cc1ccc(Nc2c(C(=O)NOC[C@H](O)CO)c3c(n2C)C(=O)CCC3)c(F)c1		CHEMBL2012900	=	IC50	nM	41.0	CHEMBL3587	Homo sapiens	IC50	nM	41.0
	10843541	CHEMBL2016104	Inhibition of MEK1-mediated ERK1 phosphorylation using IPTTPITTYFFFK-5FAM-COOH as substrate by fluorescent polarization assay	B	C#Cc1ccc(Nc2c(C(=O)NOCCO)c3c(n2C)C(=O)CCC3)c(F)c1		CHEMBL2012899	=	IC50	nM	32.0	CHEMBL3587	Homo sapiens	IC50	nM	32.0
	10843542	CHEMBL2016104	Inhibition of MEK1-mediated ERK1 phosphorylation using IPTTPITTYFFFK-5FAM-COOH as substrate by fluorescent polarization assay	B	Cn1c(Nc2ccc(Br)cc2F)c(C(=O)NOC[C@H](O)CO)c2c1C(=O)CCC2		CHEMBL2012898	=	IC50	nM	52.0	CHEMBL3587	Homo sapiens	IC50	nM	52.0
	10843543	CHEMBL2016104	Inhibition of MEK1-mediated ERK1 phosphorylation using IPTTPITTYFFFK-5FAM-COOH as substrate by fluorescent polarization assay	B	Cn1c(Nc2ccc(Br)cc2F)c(C(=O)NOC[C@@H](O)CO)c2c1C(=O)CCC2		CHEMBL2012897	=	IC50	nM	76.0	CHEMBL3587	Homo sapiens	IC50	nM	76.0
	10843544	CHEMBL2016104	Inhibition of MEK1-mediated ERK1 phosphorylation using IPTTPITTYFFFK-5FAM-COOH as substrate by fluorescent polarization assay	B	Cn1c(Nc2ccc(Br)cc2F)c(C(=O)NOCCO)c2c1C(=O)CCC2		CHEMBL2012896	=	IC50	nM	18.0	CHEMBL3587	Homo sapiens	IC50	nM	18.0
	10843545	CHEMBL2016104	Inhibition of MEK1-mediated ERK1 phosphorylation using IPTTPITTYFFFK-5FAM-COOH as substrate by fluorescent polarization assay	B	Cn1c(Nc2ccc(I)cc2F)c(C(=O)NOC[C@H](O)CO)c2c1C(=O)CC2		CHEMBL2012895	=	IC50	nM	54.0	CHEMBL3587	Homo sapiens	IC50	nM	54.0
	10843546	CHEMBL2016104	Inhibition of MEK1-mediated ERK1 phosphorylation using IPTTPITTYFFFK-5FAM-COOH as substrate by fluorescent polarization assay	B	Cn1c(Nc2ccc(I)cc2F)c(C(=O)NOC[C@@H](O)CO)c2c1C(=O)CC2		CHEMBL2012894	=	IC50	nM	11.0	CHEMBL3587	Homo sapiens	IC50	nM	11.0
	10843547	CHEMBL2016104	Inhibition of MEK1-mediated ERK1 phosphorylation using IPTTPITTYFFFK-5FAM-COOH as substrate by fluorescent polarization assay	B	Cn1c(Nc2ccc(I)cc2F)c(C(=O)NOCCO)c2c1C(=O)CC2		CHEMBL2012893	=	IC50	nM	8.9	CHEMBL3587	Homo sapiens	IC50	nM	8.9
	10843548	CHEMBL2016104	Inhibition of MEK1-mediated ERK1 phosphorylation using IPTTPITTYFFFK-5FAM-COOH as substrate by fluorescent polarization assay	B	Cn1c(Nc2ccc(I)cc2F)c(C(=O)NOC[C@H](O)CO)c2c1C(=O)CCC2		CHEMBL2012892	=	IC50	nM	20.0	CHEMBL3587	Homo sapiens	IC50	nM	20.0
	10843549	CHEMBL2016104	Inhibition of MEK1-mediated ERK1 phosphorylation using IPTTPITTYFFFK-5FAM-COOH as substrate by fluorescent polarization assay	B	Cn1c(Nc2ccc(I)cc2F)c(C(=O)NOC[C@@H](O)CO)c2c1C(=O)CCC2		CHEMBL2012891	=	IC50	nM	17.0	CHEMBL3587	Homo sapiens	IC50	nM	17.0
	10843550	CHEMBL2016104	Inhibition of MEK1-mediated ERK1 phosphorylation using IPTTPITTYFFFK-5FAM-COOH as substrate by fluorescent polarization assay	B	Cn1c(Nc2ccc(I)cc2F)c(C(=O)NOCCO)c2c1C(=O)CCC2		CHEMBL2012890	=	IC50	nM	14.0	CHEMBL3587	Homo sapiens	IC50	nM	14.0
	10843551	CHEMBL2016104	Inhibition of MEK1-mediated ERK1 phosphorylation using IPTTPITTYFFFK-5FAM-COOH as substrate by fluorescent polarization assay	B	CC(=O)c1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n1C		CHEMBL1169814	=	IC50	nM	18.0	CHEMBL3587	Homo sapiens	IC50	nM	18.0
	10849607	CHEMBL2019650	Inhibition of MEK1 assessed as remaining activity at 0.1 uM by radiolabeled kinase assay relative to control	B	CCCCCCNc1ncnc2c1ncn2[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O		CHEMBL2017007	=	Activity	%	122.89	CHEMBL3587	Homo sapiens	Activity	%	122.89
	10867530	CHEMBL2027420	Inhibition of Mek1 at 2 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Inhibition	%	5.0	CHEMBL3587	Homo sapiens	INH	%	5.0
	10886515	CHEMBL2033420	Inhibition of MEK1 in human HEK293 cells after 1 hr by competition binding assay	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	=	Kd	nM	7100.0	CHEMBL3587	Homo sapiens	Kd	nM	7100.0
	10896870	CHEMBL2039244	Inhibition of MEK1 at 3 uM	B	C=CC(=O)NCc1coc(-c2c(N)ncnc2Nc2ccc(OCc3ccccn3)c(Cl)c2)n1		CHEMBL2035810	=	Inhibition	%	14.0	CHEMBL3587	Homo sapiens	INH	%	14.0
	10896888	CHEMBL2039262	Inhibition of MEK1	B	C=CC(=O)NCc1coc(-c2c(N)ncnc2Nc2ccc(OCc3ccccn3)c(Cl)c2)n1		CHEMBL2035810	>	IC50	nM	3000.0	CHEMBL3587	Homo sapiens	IC50	uM	3.0
	10921384	CHEMBL2046188	Inhibition of MEK1 at 1 uM	B	CCN1C(=O)CCCc2c1ccc(Nc1ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n1)c2OC		CHEMBL2042829	=	Inhibition	%	91.0	CHEMBL3587	Homo sapiens	INH	%	91.0
	10921385	CHEMBL2046189	Inhibition of MEK1 at 0.1 uM	B	CCN1C(=O)CCCc2c1ccc(Nc1ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n1)c2OC		CHEMBL2042829	<	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	10926106	CHEMBL2046202	Inhibition of human MEK1 assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	CC(C)Nc1cc(-c2oc3ccccc3c(=O)c2-c2ccc(F)cc2)ccn1		CHEMBL2041958	=	Activity	%	99.0	CHEMBL3587	Homo sapiens	Activity	%	99.0
	10926107	CHEMBL2046202	Inhibition of human MEK1 assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	O=c1c(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)oc2ccccc12		CHEMBL2041962	=	Activity	%	104.0	CHEMBL3587	Homo sapiens	Activity	%	104.0
	10949784	CHEMBL2050659	Inhibition of N-terminus GST -fused MEK1 expressed using baculovirus infection system using [gamma-33P]ATP preincubated with compound for 5 mins measured after 30 mins by scintillation counting	B	CC(C)(N)C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc5sncc45)c(Cl)c3)c21		CHEMBL2048912	=	IC50	nM	2100.0	CHEMBL3587	Homo sapiens	IC50	nM	2100.0
	10955088	CHEMBL2059996	Inhibition of MEK1 at 10 uM using [gamma32P]ATP by radiometric kinase assay	B	N=C1/C(=C\c2ccc(O)c(O)c2)C(=O)N=C2SC(c3ccc(O)cc3)=NN12		CHEMBL2057830	>	Inhibition	%	30.0	CHEMBL3587	Homo sapiens	INH	%	30.0
	10955089	CHEMBL2059996	Inhibition of MEK1 at 10 uM using [gamma32P]ATP by radiometric kinase assay	B	N=C1/C(=C\c2coc3ccccc3c2=O)C(=O)N=C2SC(c3ccc(O)cc3)=NN12		CHEMBL2057831	>	Inhibition	%	30.0	CHEMBL3587	Homo sapiens	INH	%	30.0
	10955090	CHEMBL2059996	Inhibition of MEK1 at 10 uM using [gamma32P]ATP by radiometric kinase assay	B	OCCNc1ncnc2oc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL189434	>	Inhibition	%	30.0	CHEMBL3587	Homo sapiens	INH	%	30.0
	10955091	CHEMBL2059996	Inhibition of MEK1 at 10 uM using [gamma32P]ATP by radiometric kinase assay	B	O=C(O)c1cccc(N2C(=O)/C(=C\c3cnc4ccccc4n3)SC2=S)c1		CHEMBL2057832	>	Inhibition	%	30.0	CHEMBL3587	Homo sapiens	INH	%	30.0
	10955092	CHEMBL2059997	Inhibition of MEK1 using [gamma32P]ATP by radiometric kinase assay	B	N=C1/C(=C\c2ccc(O)c(O)c2)C(=O)N=C2SC(c3ccc(O)cc3)=NN12		CHEMBL2057830	=	IC50	nM	2200.0	CHEMBL3587	Homo sapiens	IC50	uM	2.2
	10955093	CHEMBL2059997	Inhibition of MEK1 using [gamma32P]ATP by radiometric kinase assay	B	N=C1/C(=C\c2coc3ccccc3c2=O)C(=O)N=C2SC(c3ccc(O)cc3)=NN12		CHEMBL2057831	=	IC50	nM	8500.0	CHEMBL3587	Homo sapiens	IC50	uM	8.5
	10955094	CHEMBL2059997	Inhibition of MEK1 using [gamma32P]ATP by radiometric kinase assay	B	OCCNc1ncnc2oc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL189434	=	IC50	nM	12300.0	CHEMBL3587	Homo sapiens	IC50	uM	12.3
	10955095	CHEMBL2059997	Inhibition of MEK1 using [gamma32P]ATP by radiometric kinase assay	B	O=C(O)c1cccc(N2C(=O)/C(=C\c3cnc4ccccc4n3)SC2=S)c1		CHEMBL2057832	=	IC50	nM	23100.0	CHEMBL3587	Homo sapiens	IC50	uM	23.1
Not Active	10986543	CHEMBL2072220	Inhibition of MEK1 at 10 uM	B	NS(=O)(=O)c1cc(-c2nc3ccccc3s2)cs1		CHEMBL2069711		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
	11015839	CHEMBL2092007	Inhibition of MEK1-mediated ERK1 phosphorylation after 30 mins by HTRF assay	B	O=C(NOCCO)c1ccc2[nH]ncc2c1Nc1ccc(I)cc1F		CHEMBL2087076	=	IC50	nM	13.0	CHEMBL3587	Homo sapiens	IC50	nM	13.0
	11015840	CHEMBL2092007	Inhibition of MEK1-mediated ERK1 phosphorylation after 30 mins by HTRF assay	B	O=C(NOC[C@H](O)CO)c1oc2ccncc2c1Nc1ccc(I)cc1F		CHEMBL2087077	=	IC50	nM	25.0	CHEMBL3587	Homo sapiens	IC50	nM	25.0
	11015841	CHEMBL2092007	Inhibition of MEK1-mediated ERK1 phosphorylation after 30 mins by HTRF assay	B	C[C@H](O)CONC(=O)c1oc2c(F)cncc2c1Nc1ccc(I)cc1F		CHEMBL2087078	=	IC50	nM	35.0	CHEMBL3587	Homo sapiens	IC50	nM	35.0
	11015842	CHEMBL2092007	Inhibition of MEK1-mediated ERK1 phosphorylation after 30 mins by HTRF assay	B	O=C(NOCCO)c1ccc2[nH]ncc2c1Nc1ccc(Br)cc1F		CHEMBL2087079	=	IC50	nM	125.0	CHEMBL3587	Homo sapiens	IC50	nM	125.0
	11015843	CHEMBL2092007	Inhibition of MEK1-mediated ERK1 phosphorylation after 30 mins by HTRF assay	B	O=C(NOC[C@H](O)CO)c1ccc2[nH]ncc2c1Nc1ccc(I)cc1F		CHEMBL2087080	=	IC50	nM	15.0	CHEMBL3587	Homo sapiens	IC50	nM	15.0
	11015844	CHEMBL2092007	Inhibition of MEK1-mediated ERK1 phosphorylation after 30 mins by HTRF assay	B	O=C(NOCC1CC1)c1ccc2[nH]ncc2c1Nc1ccc(I)cc1F		CHEMBL2087081	=	IC50	nM	79.0	CHEMBL3587	Homo sapiens	IC50	nM	79.0
	11015845	CHEMBL2092007	Inhibition of MEK1-mediated ERK1 phosphorylation after 30 mins by HTRF assay	B	CCONC(=O)c1ccc2[nH]ncc2c1Nc1ccc(I)cc1F		CHEMBL2087082	=	IC50	nM	93.0	CHEMBL3587	Homo sapiens	IC50	nM	93.0
	11015846	CHEMBL2092007	Inhibition of MEK1-mediated ERK1 phosphorylation after 30 mins by HTRF assay	B	O=C(NCCCO)c1ccc2[nH]ncc2c1Nc1ccc(I)cc1F		CHEMBL2087083	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	nM	10000.0
	11015847	CHEMBL2092007	Inhibition of MEK1-mediated ERK1 phosphorylation after 30 mins by HTRF assay	B	O=C(c1ccc2[nH]ncc2c1Nc1ccc(I)cc1F)N1CC(O)C1		CHEMBL2087460	=	IC50	nM	4546.0	CHEMBL3587	Homo sapiens	IC50	nM	4546.0
	11015848	CHEMBL2092007	Inhibition of MEK1-mediated ERK1 phosphorylation after 30 mins by HTRF assay	B	O=C(NOCCO)c1ccc2cnsc2c1Nc1ccc(I)cc1F		CHEMBL2087461	=	IC50	nM	15.0	CHEMBL3587	Homo sapiens	IC50	nM	15.0
	11015849	CHEMBL2092007	Inhibition of MEK1-mediated ERK1 phosphorylation after 30 mins by HTRF assay	B	O=C(NOC[C@H](O)CO)c1ccc2cnsc2c1Nc1ccc(I)cc1F		CHEMBL2087462	=	IC50	nM	20.0	CHEMBL3587	Homo sapiens	IC50	nM	20.0
	11015850	CHEMBL2091986	Inhibition of MEK1-mediated ERK1 phosphorylation in human HCT116 cells after 2 hrs by immunoblotting method	B	O=C(NOCCO)c1ccc2[nH]ncc2c1Nc1ccc(I)cc1F		CHEMBL2087076	=	EC50	nM	0.2	CHEMBL3587	Homo sapiens	EC50	nM	0.2
	11015851	CHEMBL2091986	Inhibition of MEK1-mediated ERK1 phosphorylation in human HCT116 cells after 2 hrs by immunoblotting method	B	O=C(NOC[C@H](O)CO)c1oc2ccncc2c1Nc1ccc(I)cc1F		CHEMBL2087077	=	EC50	nM	6.3	CHEMBL3587	Homo sapiens	EC50	nM	6.3
	11015852	CHEMBL2091986	Inhibition of MEK1-mediated ERK1 phosphorylation in human HCT116 cells after 2 hrs by immunoblotting method	B	C[C@H](O)CONC(=O)c1oc2c(F)cncc2c1Nc1ccc(I)cc1F		CHEMBL2087078	=	EC50	nM	4.0	CHEMBL3587	Homo sapiens	EC50	nM	4.0
	11015853	CHEMBL2091986	Inhibition of MEK1-mediated ERK1 phosphorylation in human HCT116 cells after 2 hrs by immunoblotting method	B	O=C(NOCCO)c1ccc2[nH]ncc2c1Nc1ccc(Br)cc1F		CHEMBL2087079	=	EC50	nM	3.4	CHEMBL3587	Homo sapiens	EC50	nM	3.4
	11015854	CHEMBL2091986	Inhibition of MEK1-mediated ERK1 phosphorylation in human HCT116 cells after 2 hrs by immunoblotting method	B	O=C(NOC[C@H](O)CO)c1ccc2[nH]ncc2c1Nc1ccc(I)cc1F		CHEMBL2087080	=	EC50	nM	0.4	CHEMBL3587	Homo sapiens	EC50	nM	0.4
	11015855	CHEMBL2091986	Inhibition of MEK1-mediated ERK1 phosphorylation in human HCT116 cells after 2 hrs by immunoblotting method	B	O=C(NOCC1CC1)c1ccc2[nH]ncc2c1Nc1ccc(I)cc1F		CHEMBL2087081	=	EC50	nM	1.5	CHEMBL3587	Homo sapiens	EC50	nM	1.5
	11015856	CHEMBL2091986	Inhibition of MEK1-mediated ERK1 phosphorylation in human HCT116 cells after 2 hrs by immunoblotting method	B	CCONC(=O)c1ccc2[nH]ncc2c1Nc1ccc(I)cc1F		CHEMBL2087082	=	EC50	nM	1.3	CHEMBL3587	Homo sapiens	EC50	nM	1.3
	11015857	CHEMBL2091986	Inhibition of MEK1-mediated ERK1 phosphorylation in human HCT116 cells after 2 hrs by immunoblotting method	B	O=C(NOCCO)c1ccc2cnsc2c1Nc1ccc(I)cc1F		CHEMBL2087461	=	EC50	nM	0.6	CHEMBL3587	Homo sapiens	EC50	nM	0.6
	11015858	CHEMBL2091986	Inhibition of MEK1-mediated ERK1 phosphorylation in human HCT116 cells after 2 hrs by immunoblotting method	B	O=C(NOC[C@H](O)CO)c1ccc2cnsc2c1Nc1ccc(I)cc1F		CHEMBL2087462	=	EC50	nM	0.9	CHEMBL3587	Homo sapiens	EC50	nM	0.9
	11015859	CHEMBL2092012	Inhibition of MEK1-mediated ERK1 phosphorylation in human A375 cells after 2 hrs by immunoblotting method	B	O=C(NOCCO)c1ccc2[nH]ncc2c1Nc1ccc(I)cc1F		CHEMBL2087076	=	EC50	nM	0.4	CHEMBL3587	Homo sapiens	EC50	nM	0.4
	11015860	CHEMBL2092012	Inhibition of MEK1-mediated ERK1 phosphorylation in human A375 cells after 2 hrs by immunoblotting method	B	O=C(NOC[C@H](O)CO)c1oc2ccncc2c1Nc1ccc(I)cc1F		CHEMBL2087077	=	EC50	nM	34.0	CHEMBL3587	Homo sapiens	EC50	nM	34.0
	11015861	CHEMBL2092012	Inhibition of MEK1-mediated ERK1 phosphorylation in human A375 cells after 2 hrs by immunoblotting method	B	C[C@H](O)CONC(=O)c1oc2c(F)cncc2c1Nc1ccc(I)cc1F		CHEMBL2087078	=	EC50	nM	7.2	CHEMBL3587	Homo sapiens	EC50	nM	7.2
	11015862	CHEMBL2092012	Inhibition of MEK1-mediated ERK1 phosphorylation in human A375 cells after 2 hrs by immunoblotting method	B	O=C(NOCCO)c1ccc2[nH]ncc2c1Nc1ccc(Br)cc1F		CHEMBL2087079	=	EC50	nM	6.4	CHEMBL3587	Homo sapiens	EC50	nM	6.4
	11015863	CHEMBL2092012	Inhibition of MEK1-mediated ERK1 phosphorylation in human A375 cells after 2 hrs by immunoblotting method	B	O=C(NOC[C@H](O)CO)c1ccc2[nH]ncc2c1Nc1ccc(I)cc1F		CHEMBL2087080	=	EC50	nM	3.7	CHEMBL3587	Homo sapiens	EC50	nM	3.7
	11015864	CHEMBL2092012	Inhibition of MEK1-mediated ERK1 phosphorylation in human A375 cells after 2 hrs by immunoblotting method	B	O=C(NOCC1CC1)c1ccc2[nH]ncc2c1Nc1ccc(I)cc1F		CHEMBL2087081	=	EC50	nM	1.5	CHEMBL3587	Homo sapiens	EC50	nM	1.5
	11015865	CHEMBL2092012	Inhibition of MEK1-mediated ERK1 phosphorylation in human A375 cells after 2 hrs by immunoblotting method	B	CCONC(=O)c1ccc2[nH]ncc2c1Nc1ccc(I)cc1F		CHEMBL2087082	=	EC50	nM	2.4	CHEMBL3587	Homo sapiens	EC50	nM	2.4
	11015866	CHEMBL2092012	Inhibition of MEK1-mediated ERK1 phosphorylation in human A375 cells after 2 hrs by immunoblotting method	B	O=C(NOCCO)c1ccc2cnsc2c1Nc1ccc(I)cc1F		CHEMBL2087461	=	EC50	nM	0.9	CHEMBL3587	Homo sapiens	EC50	nM	0.9
	11015867	CHEMBL2092012	Inhibition of MEK1-mediated ERK1 phosphorylation in human A375 cells after 2 hrs by immunoblotting method	B	O=C(NOC[C@H](O)CO)c1ccc2cnsc2c1Nc1ccc(I)cc1F		CHEMBL2087462	=	EC50	nM	1.1	CHEMBL3587	Homo sapiens	EC50	nM	1.1
	11016474	CHEMBL2092355	Inhibition of MEK1 at 1 uM	B	CS(=O)(=O)N1CCN(Cc2cn3cc(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1		CHEMBL2087474	<	Inhibition	%	30.0	CHEMBL3587	Homo sapiens	INH	%	30.0
	11016475	CHEMBL2092355	Inhibition of MEK1 at 1 uM	B	Cc1nc(N)ncc1-c1cn2cc(CN3CCN(S(C)(=O)=O)CC3)nc2c(N2CCOCC2)n1		CHEMBL2087480	<	Inhibition	%	30.0	CHEMBL3587	Homo sapiens	INH	%	30.0
	11016476	CHEMBL2092355	Inhibition of MEK1 at 1 uM	B	CS(=O)(=O)N1CCN(Cc2nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn3c2Br)CC1		CHEMBL2087491	<	Inhibition	%	30.0	CHEMBL3587	Homo sapiens	INH	%	30.0
	11016477	CHEMBL2092355	Inhibition of MEK1 at 1 uM	B	Cc1c(CN2CCN(S(C)(=O)=O)CC2)nc2c(N3CCOCC3)nc(-c3cnc(N)nc3)cn12		CHEMBL2087492	<	Inhibition	%	30.0	CHEMBL3587	Homo sapiens	INH	%	30.0
	11016478	CHEMBL2092355	Inhibition of MEK1 at 1 uM	B	CS(=O)(=O)N1CCN(Cc2cn3c(Cl)c(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1		CHEMBL2087493	<	Inhibition	%	30.0	CHEMBL3587	Homo sapiens	INH	%	30.0
	11016607	CHEMBL2090019	Inhibition of MEK1 fused with GST by autoradiography	B	CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1		CHEMBL189584	>	IC50	nM	50000.0	CHEMBL3587	Homo sapiens	IC50	uM	50.0
	11017023	CHEMBL2092429	Inhibition of MEK1 at 5 uM	B	CS(=O)(=O)N1CCN(Cc2cn3cc(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1		CHEMBL2087474	<	Inhibition	%	30.0	CHEMBL3587	Homo sapiens	INH	%	30.0
	11017024	CHEMBL2092429	Inhibition of MEK1 at 5 uM	B	Cc1nc(N)ncc1-c1cn2cc(CN3CCN(S(C)(=O)=O)CC3)nc2c(N2CCOCC2)n1		CHEMBL2087480	<	Inhibition	%	30.0	CHEMBL3587	Homo sapiens	INH	%	30.0
	11017025	CHEMBL2092429	Inhibition of MEK1 at 5 uM	B	CS(=O)(=O)N1CCN(Cc2nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn3c2Br)CC1		CHEMBL2087491	<	Inhibition	%	30.0	CHEMBL3587	Homo sapiens	INH	%	30.0
	11017026	CHEMBL2092429	Inhibition of MEK1 at 5 uM	B	Cc1c(CN2CCN(S(C)(=O)=O)CC2)nc2c(N3CCOCC3)nc(-c3cnc(N)nc3)cn12		CHEMBL2087492	<	Inhibition	%	30.0	CHEMBL3587	Homo sapiens	INH	%	30.0
	11017027	CHEMBL2092429	Inhibition of MEK1 at 5 uM	B	CS(=O)(=O)N1CCN(Cc2cn3c(Cl)c(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1		CHEMBL2087493	<	Inhibition	%	30.0	CHEMBL3587	Homo sapiens	INH	%	30.0
	12036415	CHEMBL2150622	Inhibition of N-terminal GST-tagged MEK1 after 5 mins by scintillation counter	B	CC(C)(C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(Cl)c4)c(Cl)c3)c21)S(C)(=O)=O.Cc1ccc(S(=O)(=O)O)cc1		CHEMBL2148053	=	IC50	nM	980.0	CHEMBL3587	Homo sapiens	IC50	nM	980.0
	12041220	CHEMBL2149502	Inhibition of MEK1-mediated ERK2 T202/Y204 phosphorylation using biotinylated MBP as substrate preincubated for 30 mins measured after 100 mins by cRAF-MEK-ERK enzyme coupled assay	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	=	IC50	nM	0.9	CHEMBL3587	Homo sapiens	IC50	nM	0.9
	12041221	CHEMBL2149502	Inhibition of MEK1-mediated ERK2 T202/Y204 phosphorylation using biotinylated MBP as substrate preincubated for 30 mins measured after 100 mins by cRAF-MEK-ERK enzyme coupled assay	B	O=C(NOCC(O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL450775	=	IC50	nM	0.6	CHEMBL3587	Homo sapiens	IC50	nM	0.6
	12041222	CHEMBL2149502	Inhibition of MEK1-mediated ERK2 T202/Y204 phosphorylation using biotinylated MBP as substrate preincubated for 30 mins measured after 100 mins by cRAF-MEK-ERK enzyme coupled assay	B	O=C(NCCC(O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL2146884	=	IC50	nM	801.0	CHEMBL3587	Homo sapiens	IC50	nM	801.0
	12041223	CHEMBL2149502	Inhibition of MEK1-mediated ERK2 T202/Y204 phosphorylation using biotinylated MBP as substrate preincubated for 30 mins measured after 100 mins by cRAF-MEK-ERK enzyme coupled assay	B	O=C(O)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL2146885	=	IC50	nM	19.5	CHEMBL3587	Homo sapiens	IC50	nM	19.5
	12041224	CHEMBL2149502	Inhibition of MEK1-mediated ERK2 T202/Y204 phosphorylation using biotinylated MBP as substrate preincubated for 30 mins measured after 100 mins by cRAF-MEK-ERK enzyme coupled assay	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CCC1		CHEMBL2146886	=	IC50	nM	535.0	CHEMBL3587	Homo sapiens	IC50	nM	535.0
	12041225	CHEMBL2149502	Inhibition of MEK1-mediated ERK2 T202/Y204 phosphorylation using biotinylated MBP as substrate preincubated for 30 mins measured after 100 mins by cRAF-MEK-ERK enzyme coupled assay	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)C1		CHEMBL2146887	=	IC50	nM	44.0	CHEMBL3587	Homo sapiens	IC50	nM	44.0
	12041226	CHEMBL2149502	Inhibition of MEK1-mediated ERK2 T202/Y204 phosphorylation using biotinylated MBP as substrate preincubated for 30 mins measured after 100 mins by cRAF-MEK-ERK enzyme coupled assay	B	NCC1(O)CN(C(=O)c2ccc(F)c(F)c2Nc2ccc(I)cc2F)C1		CHEMBL2146888	=	IC50	nM	6.6	CHEMBL3587	Homo sapiens	IC50	nM	6.6
	12041227	CHEMBL2149502	Inhibition of MEK1-mediated ERK2 T202/Y204 phosphorylation using biotinylated MBP as substrate preincubated for 30 mins measured after 100 mins by cRAF-MEK-ERK enzyme coupled assay	B	CC1(O)CN(C(=O)c2ccc(F)c(F)c2Nc2ccc(I)cc2F)C1		CHEMBL2146889	=	IC50	nM	82.0	CHEMBL3587	Homo sapiens	IC50	nM	82.0
	12041228	CHEMBL2149502	Inhibition of MEK1-mediated ERK2 T202/Y204 phosphorylation using biotinylated MBP as substrate preincubated for 30 mins measured after 100 mins by cRAF-MEK-ERK enzyme coupled assay	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)(CO)C1		CHEMBL2146890	=	IC50	nM	27.0	CHEMBL3587	Homo sapiens	IC50	nM	27.0
	12041229	CHEMBL2149502	Inhibition of MEK1-mediated ERK2 T202/Y204 phosphorylation using biotinylated MBP as substrate preincubated for 30 mins measured after 100 mins by cRAF-MEK-ERK enzyme coupled assay	B	NC(=O)C1(O)CN(C(=O)c2ccc(F)c(F)c2Nc2ccc(I)cc2F)C1		CHEMBL2146891	=	IC50	nM	220.0	CHEMBL3587	Homo sapiens	IC50	nM	220.0
	12041230	CHEMBL2149502	Inhibition of MEK1-mediated ERK2 T202/Y204 phosphorylation using biotinylated MBP as substrate preincubated for 30 mins measured after 100 mins by cRAF-MEK-ERK enzyme coupled assay	B	CCNCC1(O)CN(C(=O)c2ccc(F)c(F)c2Nc2ccc(I)cc2F)C1		CHEMBL2146892	=	IC50	nM	7.2	CHEMBL3587	Homo sapiens	IC50	nM	7.2
	12041231	CHEMBL2149502	Inhibition of MEK1-mediated ERK2 T202/Y204 phosphorylation using biotinylated MBP as substrate preincubated for 30 mins measured after 100 mins by cRAF-MEK-ERK enzyme coupled assay	B	CC(C)NCC1(O)CN(C(=O)c2ccc(F)c(F)c2Nc2ccc(I)cc2F)C1		CHEMBL2146893	=	IC50	nM	1.8	CHEMBL3587	Homo sapiens	IC50	nM	1.8
	12041232	CHEMBL2149502	Inhibition of MEK1-mediated ERK2 T202/Y204 phosphorylation using biotinylated MBP as substrate preincubated for 30 mins measured after 100 mins by cRAF-MEK-ERK enzyme coupled assay	B	CC(C)(C)NCC1(O)CN(C(=O)c2ccc(F)c(F)c2Nc2ccc(I)cc2F)C1		CHEMBL2146894	=	IC50	nM	4.8	CHEMBL3587	Homo sapiens	IC50	nM	4.8
	12041233	CHEMBL2149502	Inhibition of MEK1-mediated ERK2 T202/Y204 phosphorylation using biotinylated MBP as substrate preincubated for 30 mins measured after 100 mins by cRAF-MEK-ERK enzyme coupled assay	B	CN(C)CC1(O)CN(C(=O)c2ccc(F)c(F)c2Nc2ccc(I)cc2F)C1		CHEMBL2146895	=	IC50	nM	5.1	CHEMBL3587	Homo sapiens	IC50	nM	5.1
	12041234	CHEMBL2149502	Inhibition of MEK1-mediated ERK2 T202/Y204 phosphorylation using biotinylated MBP as substrate preincubated for 30 mins measured after 100 mins by cRAF-MEK-ERK enzyme coupled assay	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)(CN2CCCC2)C1		CHEMBL2146896	=	IC50	nM	7.6	CHEMBL3587	Homo sapiens	IC50	nM	7.6
	12041235	CHEMBL2149502	Inhibition of MEK1-mediated ERK2 T202/Y204 phosphorylation using biotinylated MBP as substrate preincubated for 30 mins measured after 100 mins by cRAF-MEK-ERK enzyme coupled assay	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)(CN2CCOCC2)C1		CHEMBL2146897	=	IC50	nM	1708.0	CHEMBL3587	Homo sapiens	IC50	nM	1708.0
	12041236	CHEMBL2149502	Inhibition of MEK1-mediated ERK2 T202/Y204 phosphorylation using biotinylated MBP as substrate preincubated for 30 mins measured after 100 mins by cRAF-MEK-ERK enzyme coupled assay	B	C[C@H](N)C1(O)CN(C(=O)c2ccc(F)c(F)c2Nc2ccc(I)cc2F)C1		CHEMBL2146898	=	IC50	nM	5.2	CHEMBL3587	Homo sapiens	IC50	nM	5.2
	12041237	CHEMBL2149502	Inhibition of MEK1-mediated ERK2 T202/Y204 phosphorylation using biotinylated MBP as substrate preincubated for 30 mins measured after 100 mins by cRAF-MEK-ERK enzyme coupled assay	B	C[C@@H](N)C1(O)CN(C(=O)c2ccc(F)c(F)c2Nc2ccc(I)cc2F)C1		CHEMBL2146899	=	IC50	nM	16.0	CHEMBL3587	Homo sapiens	IC50	nM	16.0
	12046358	CHEMBL2157285	Inhibition of MEK1 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	6.0	CHEMBL3587	Homo sapiens	INH	%	6.0
	12060929	CHEMBL2157038	Binding affinity to MEK1 at 1 uM by high throughput binding assay relative to control	B	Nc1cc(NS(=O)(=O)c2cccc(C(F)(F)F)c2)cc(-c2cnc3[nH]cc(-c4ccncc4)c3c2)c1		CHEMBL2152288	=	Activity	%	100.0	CHEMBL3587	Homo sapiens	Activity	%	100.0
	12068077	CHEMBL2162580	Inhibition of MAP2K1 at 0.1 uM	B	Cc1nc2cnc3[nH]ccc3c2n1[C@@H]1CCC[C@@H](O)C1		CHEMBL2159210	=	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	12074684	CHEMBL2161405	Inhibition of MEK1 at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	12094393	CHEMBL2166398	Inhibition of human MEK1 at 10 uM	B	CCOc1ccc(Nc2c(C)c(N[C@H]3CCCNC3)nc3ccnn23)cc1		CHEMBL1235213	=	Inhibition	%	19.0	CHEMBL3587	Homo sapiens	INH	%	19.0
	12094408	CHEMBL2166400	Inhibition of MEK1	B	N[C@H]1CC[C@H](Nc2cc(Nc3ccc(F)c(Cl)c3)n3nccc3n2)CC1		CHEMBL2163999	=	IC50	nM	4900.0	CHEMBL3587	Homo sapiens	IC50	uM	4.9
	12170780	CHEMBL2209907	Inhibition of MKK1 assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	77.0	CHEMBL3587	Homo sapiens	Activity	%	77.0
	12170911	CHEMBL2213469	Inhibition of MKK1 assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	98.0	CHEMBL3587	Homo sapiens	Activity	%	98.0
	12172355	CHEMBL2210621	Inhibition of MEK1 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL3587	Homo sapiens	Activity	%	100.0
	12175178	CHEMBL2210705	Inhibition of MEK1	B	CN(c1ccc(F)c(NC(=O)c2cccc(OC(C)(C)C#N)c2Cl)c1)c1ccc2nc(NC(=O)C3CC3)sc2n1		CHEMBL2204532	=	IC50	nM	1000.0	CHEMBL3587	Homo sapiens	IC50	nM	1000.0
	12183868	CHEMBL2211520	Inhibition of MAP2K1	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	pIC50		5.0
	12205217	CHEMBL2217250	Inhibition of MEK1	B	CCNc1cc(O)c2c(c1)/C=C/C[C@@H](O)[C@H](O)C(=O)/C=C\[C@H](C)[C@H](C)OC2=O		CHEMBL2216826	=	IC50	nM	5.2	CHEMBL3587	Homo sapiens	IC50	nM	5.2
	12205218	CHEMBL2217250	Inhibition of MEK1	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	IC50	nM	6.0	CHEMBL3587	Homo sapiens	IC50	nM	6.0
	12209837	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	113.0	CHEMBL3587	Homo sapiens	Residual Activity	%	113.0
	12209838	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	34.0	CHEMBL3587	Homo sapiens	Residual Activity	%	34.0
	12209839	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	78.0	CHEMBL3587	Homo sapiens	Residual Activity	%	78.0
	12209840	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	75.0	CHEMBL3587	Homo sapiens	Residual Activity	%	75.0
	12209841	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	84.0	CHEMBL3587	Homo sapiens	Residual Activity	%	84.0
	12209842	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	104.0	CHEMBL3587	Homo sapiens	Residual Activity	%	104.0
	12209843	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	42.0	CHEMBL3587	Homo sapiens	Residual Activity	%	42.0
	12209844	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	114.0	CHEMBL3587	Homo sapiens	Residual Activity	%	114.0
	12209845	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	120.0	CHEMBL3587	Homo sapiens	Residual Activity	%	120.0
	12209846	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	91.0	CHEMBL3587	Homo sapiens	Residual Activity	%	91.0
	12209847	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	111.0	CHEMBL3587	Homo sapiens	Residual Activity	%	111.0
	12209848	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	66.0	CHEMBL3587	Homo sapiens	Residual Activity	%	66.0
	12209849	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	93.0	CHEMBL3587	Homo sapiens	Residual Activity	%	93.0
	12209850	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	94.0	CHEMBL3587	Homo sapiens	Residual Activity	%	94.0
	12209851	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	73.0	CHEMBL3587	Homo sapiens	Residual Activity	%	73.0
	12209852	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	102.0	CHEMBL3587	Homo sapiens	Residual Activity	%	102.0
	12209853	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	138.0	CHEMBL3587	Homo sapiens	Residual Activity	%	138.0
	12209854	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	125.0	CHEMBL3587	Homo sapiens	Residual Activity	%	125.0
	12209855	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	120.0	CHEMBL3587	Homo sapiens	Residual Activity	%	120.0
	12209856	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	66.0	CHEMBL3587	Homo sapiens	Residual Activity	%	66.0
	12209857	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	93.0	CHEMBL3587	Homo sapiens	Residual Activity	%	93.0
	12209858	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	109.0	CHEMBL3587	Homo sapiens	Residual Activity	%	109.0
	12209859	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	127.0	CHEMBL3587	Homo sapiens	Residual Activity	%	127.0
	12209860	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	103.0	CHEMBL3587	Homo sapiens	Residual Activity	%	103.0
	12209861	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	121.0	CHEMBL3587	Homo sapiens	Residual Activity	%	121.0
	12209862	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	117.0	CHEMBL3587	Homo sapiens	Residual Activity	%	117.0
	12209863	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	80.0	CHEMBL3587	Homo sapiens	Residual Activity	%	80.0
	12209864	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	119.0	CHEMBL3587	Homo sapiens	Residual Activity	%	119.0
	12209865	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	115.0	CHEMBL3587	Homo sapiens	Residual Activity	%	115.0
	12209866	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	104.0	CHEMBL3587	Homo sapiens	Residual Activity	%	104.0
	12209867	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	114.0	CHEMBL3587	Homo sapiens	Residual Activity	%	114.0
	12209868	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	62.0	CHEMBL3587	Homo sapiens	Residual Activity	%	62.0
	12209869	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	127.0	CHEMBL3587	Homo sapiens	Residual Activity	%	127.0
	12209870	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	114.0	CHEMBL3587	Homo sapiens	Residual Activity	%	114.0
	12209871	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	100.0	CHEMBL3587	Homo sapiens	Residual Activity	%	100.0
	12209872	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	107.0	CHEMBL3587	Homo sapiens	Residual Activity	%	107.0
	12209873	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	108.0	CHEMBL3587	Homo sapiens	Residual Activity	%	108.0
	12209874	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	132.0	CHEMBL3587	Homo sapiens	Residual Activity	%	132.0
	12209875	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	122.0	CHEMBL3587	Homo sapiens	Residual Activity	%	122.0
	12209876	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	87.0	CHEMBL3587	Homo sapiens	Residual Activity	%	87.0
	12209877	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	117.0	CHEMBL3587	Homo sapiens	Residual Activity	%	117.0
	12209878	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	102.0	CHEMBL3587	Homo sapiens	Residual Activity	%	102.0
	12209879	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	36.0	CHEMBL3587	Homo sapiens	Residual Activity	%	36.0
	12209880	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	9.0	CHEMBL3587	Homo sapiens	Residual Activity	%	9.0
	12209881	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	86.0	CHEMBL3587	Homo sapiens	Residual Activity	%	86.0
	12209882	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	87.0	CHEMBL3587	Homo sapiens	Residual Activity	%	87.0
	12209883	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	103.0	CHEMBL3587	Homo sapiens	Residual Activity	%	103.0
	12209884	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	41.0	CHEMBL3587	Homo sapiens	Residual Activity	%	41.0
	12209885	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	99.0	CHEMBL3587	Homo sapiens	Residual Activity	%	99.0
	12209886	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	102.0	CHEMBL3587	Homo sapiens	Residual Activity	%	102.0
	12209887	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	102.0	CHEMBL3587	Homo sapiens	Residual Activity	%	102.0
	12209888	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	48.0	CHEMBL3587	Homo sapiens	Residual Activity	%	48.0
	12209889	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	15.0	CHEMBL3587	Homo sapiens	Residual Activity	%	15.0
	12209890	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	102.0	CHEMBL3587	Homo sapiens	Residual Activity	%	102.0
	12209891	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	98.0	CHEMBL3587	Homo sapiens	Residual Activity	%	98.0
	12209892	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	105.0	CHEMBL3587	Homo sapiens	Residual Activity	%	105.0
	12209893	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	119.0	CHEMBL3587	Homo sapiens	Residual Activity	%	119.0
	12209894	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	98.0	CHEMBL3587	Homo sapiens	Residual Activity	%	98.0
	12209895	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	112.0	CHEMBL3587	Homo sapiens	Residual Activity	%	112.0
	12209896	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	103.0	CHEMBL3587	Homo sapiens	Residual Activity	%	103.0
	12209897	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	99.0	CHEMBL3587	Homo sapiens	Residual Activity	%	99.0
	12209898	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	74.0	CHEMBL3587	Homo sapiens	Residual Activity	%	74.0
	12209899	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	104.0	CHEMBL3587	Homo sapiens	Residual Activity	%	104.0
	12209900	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	80.0	CHEMBL3587	Homo sapiens	Residual Activity	%	80.0
	12209901	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	108.0	CHEMBL3587	Homo sapiens	Residual Activity	%	108.0
	12209902	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	114.0	CHEMBL3587	Homo sapiens	Residual Activity	%	114.0
	12209903	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	102.0	CHEMBL3587	Homo sapiens	Residual Activity	%	102.0
	12209904	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	99.0	CHEMBL3587	Homo sapiens	Residual Activity	%	99.0
	12209905	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	108.0	CHEMBL3587	Homo sapiens	Residual Activity	%	108.0
	12209906	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	89.0	CHEMBL3587	Homo sapiens	Residual Activity	%	89.0
	12209907	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	112.0	CHEMBL3587	Homo sapiens	Residual Activity	%	112.0
	12209908	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	106.0	CHEMBL3587	Homo sapiens	Residual Activity	%	106.0
	12209909	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	109.0	CHEMBL3587	Homo sapiens	Residual Activity	%	109.0
	12209910	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	115.0	CHEMBL3587	Homo sapiens	Residual Activity	%	115.0
	12209911	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	113.0	CHEMBL3587	Homo sapiens	Residual Activity	%	113.0
	12209912	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	43.0	CHEMBL3587	Homo sapiens	Residual Activity	%	43.0
	12209913	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	114.0	CHEMBL3587	Homo sapiens	Residual Activity	%	114.0
	12209914	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	21.0	CHEMBL3587	Homo sapiens	Residual Activity	%	21.0
	12209915	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	114.0	CHEMBL3587	Homo sapiens	Residual Activity	%	114.0
	12209916	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	6.0	CHEMBL3587	Homo sapiens	Residual Activity	%	6.0
	12209917	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	107.0	CHEMBL3587	Homo sapiens	Residual Activity	%	107.0
	12209918	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	73.0	CHEMBL3587	Homo sapiens	Residual Activity	%	73.0
	12209919	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	75.0	CHEMBL3587	Homo sapiens	Residual Activity	%	75.0
	12209920	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	104.0	CHEMBL3587	Homo sapiens	Residual Activity	%	104.0
	12209921	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	101.0	CHEMBL3587	Homo sapiens	Residual Activity	%	101.0
	12209922	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	103.0	CHEMBL3587	Homo sapiens	Residual Activity	%	103.0
	12209923	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	100.0	CHEMBL3587	Homo sapiens	Residual Activity	%	100.0
	12209924	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	113.0	CHEMBL3587	Homo sapiens	Residual Activity	%	113.0
	12209925	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	111.0	CHEMBL3587	Homo sapiens	Residual Activity	%	111.0
	12209926	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	64.0	CHEMBL3587	Homo sapiens	Residual Activity	%	64.0
	12209927	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	114.0	CHEMBL3587	Homo sapiens	Residual Activity	%	114.0
	12209928	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	89.0	CHEMBL3587	Homo sapiens	Residual Activity	%	89.0
	12209929	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	88.0	CHEMBL3587	Homo sapiens	Residual Activity	%	88.0
	12209930	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	125.0	CHEMBL3587	Homo sapiens	Residual Activity	%	125.0
	12209931	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	111.0	CHEMBL3587	Homo sapiens	Residual Activity	%	111.0
	12209932	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	107.0	CHEMBL3587	Homo sapiens	Residual Activity	%	107.0
	12209933	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	116.0	CHEMBL3587	Homo sapiens	Residual Activity	%	116.0
	12209934	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	105.0	CHEMBL3587	Homo sapiens	Residual Activity	%	105.0
	12209935	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	99.0	CHEMBL3587	Homo sapiens	Residual Activity	%	99.0
	12209936	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	104.0	CHEMBL3587	Homo sapiens	Residual Activity	%	104.0
	12209937	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	59.0	CHEMBL3587	Homo sapiens	Residual Activity	%	59.0
	12209938	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	0.0	CHEMBL3587	Homo sapiens	Residual Activity	%	0.0
	12209939	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	103.0	CHEMBL3587	Homo sapiens	Residual Activity	%	103.0
	12209940	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	40.0	CHEMBL3587	Homo sapiens	Residual Activity	%	40.0
	12209941	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	103.0	CHEMBL3587	Homo sapiens	Residual Activity	%	103.0
	12209942	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	103.0	CHEMBL3587	Homo sapiens	Residual Activity	%	103.0
	12209943	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	97.0	CHEMBL3587	Homo sapiens	Residual Activity	%	97.0
	12209944	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	97.0	CHEMBL3587	Homo sapiens	Residual Activity	%	97.0
	12209945	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	104.0	CHEMBL3587	Homo sapiens	Residual Activity	%	104.0
	12209946	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	107.0	CHEMBL3587	Homo sapiens	Residual Activity	%	107.0
	12209947	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	109.0	CHEMBL3587	Homo sapiens	Residual Activity	%	109.0
	12209948	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	105.0	CHEMBL3587	Homo sapiens	Residual Activity	%	105.0
	12209949	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	114.0	CHEMBL3587	Homo sapiens	Residual Activity	%	114.0
	12209950	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	101.0	CHEMBL3587	Homo sapiens	Residual Activity	%	101.0
	12209951	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	91.0	CHEMBL3587	Homo sapiens	Residual Activity	%	91.0
	12209952	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	96.0	CHEMBL3587	Homo sapiens	Residual Activity	%	96.0
	12209953	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	44.0	CHEMBL3587	Homo sapiens	Residual Activity	%	44.0
	12209954	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	97.0	CHEMBL3587	Homo sapiens	Residual Activity	%	97.0
	12209955	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	109.0	CHEMBL3587	Homo sapiens	Residual Activity	%	109.0
	12209956	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	104.0	CHEMBL3587	Homo sapiens	Residual Activity	%	104.0
	12209957	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	109.0	CHEMBL3587	Homo sapiens	Residual Activity	%	109.0
	12209958	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	87.0	CHEMBL3587	Homo sapiens	Residual Activity	%	87.0
	12209959	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	81.0	CHEMBL3587	Homo sapiens	Residual Activity	%	81.0
	12209960	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	69.0	CHEMBL3587	Homo sapiens	Residual Activity	%	69.0
	12209961	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	26.0	CHEMBL3587	Homo sapiens	Residual Activity	%	26.0
	12209962	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	32.0	CHEMBL3587	Homo sapiens	Residual Activity	%	32.0
	12209963	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	111.0	CHEMBL3587	Homo sapiens	Residual Activity	%	111.0
	12209964	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	106.0	CHEMBL3587	Homo sapiens	Residual Activity	%	106.0
	12209965	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	140.0	CHEMBL3587	Homo sapiens	Residual Activity	%	140.0
	12209966	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	16.0	CHEMBL3587	Homo sapiens	Residual Activity	%	16.0
	12209967	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	103.0	CHEMBL3587	Homo sapiens	Residual Activity	%	103.0
	12209968	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	98.0	CHEMBL3587	Homo sapiens	Residual Activity	%	98.0
	12209969	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	75.0	CHEMBL3587	Homo sapiens	Residual Activity	%	75.0
	12209970	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	107.0	CHEMBL3587	Homo sapiens	Residual Activity	%	107.0
	12209971	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	94.0	CHEMBL3587	Homo sapiens	Residual Activity	%	94.0
	12209972	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	99.0	CHEMBL3587	Homo sapiens	Residual Activity	%	99.0
	12209973	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	87.0	CHEMBL3587	Homo sapiens	Residual Activity	%	87.0
	12209974	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	48.0	CHEMBL3587	Homo sapiens	Residual Activity	%	48.0
	12209975	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	71.0	CHEMBL3587	Homo sapiens	Residual Activity	%	71.0
	12209976	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	95.0	CHEMBL3587	Homo sapiens	Residual Activity	%	95.0
	12209977	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	104.0	CHEMBL3587	Homo sapiens	Residual Activity	%	104.0
	12209978	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	102.0	CHEMBL3587	Homo sapiens	Residual Activity	%	102.0
	12209979	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	94.0	CHEMBL3587	Homo sapiens	Residual Activity	%	94.0
	12209980	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	123.0	CHEMBL3587	Homo sapiens	Residual Activity	%	123.0
	12209981	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	102.0	CHEMBL3587	Homo sapiens	Residual Activity	%	102.0
	12209982	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	82.0	CHEMBL3587	Homo sapiens	Residual Activity	%	82.0
	12209983	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	98.0	CHEMBL3587	Homo sapiens	Residual Activity	%	98.0
	12209984	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	91.0	CHEMBL3587	Homo sapiens	Residual Activity	%	91.0
	12209985	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	60.0	CHEMBL3587	Homo sapiens	Residual Activity	%	60.0
	12209986	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	92.0	CHEMBL3587	Homo sapiens	Residual Activity	%	92.0
	12209987	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	62.0	CHEMBL3587	Homo sapiens	Residual Activity	%	62.0
	12209988	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	106.0	CHEMBL3587	Homo sapiens	Residual Activity	%	106.0
	12209989	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	103.0	CHEMBL3587	Homo sapiens	Residual Activity	%	103.0
	12209990	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	89.0	CHEMBL3587	Homo sapiens	Residual Activity	%	89.0
	12209991	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	105.0	CHEMBL3587	Homo sapiens	Residual Activity	%	105.0
	12209992	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	99.0	CHEMBL3587	Homo sapiens	Residual Activity	%	99.0
	12209993	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	90.0	CHEMBL3587	Homo sapiens	Residual Activity	%	90.0
	12209994	CHEMBL2219261	Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	91.0	CHEMBL3587	Homo sapiens	Residual Activity	%	91.0
	12209995	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	96.0	CHEMBL3587	Homo sapiens	Residual Activity	%	96.0
	12209996	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	7.0	CHEMBL3587	Homo sapiens	Residual Activity	%	7.0
	12209997	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	88.0	CHEMBL3587	Homo sapiens	Residual Activity	%	88.0
	12209998	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	86.0	CHEMBL3587	Homo sapiens	Residual Activity	%	86.0
	12209999	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	53.0	CHEMBL3587	Homo sapiens	Residual Activity	%	53.0
	12210000	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	79.0	CHEMBL3587	Homo sapiens	Residual Activity	%	79.0
	12210001	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	19.0	CHEMBL3587	Homo sapiens	Residual Activity	%	19.0
	12210002	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	71.0	CHEMBL3587	Homo sapiens	Residual Activity	%	71.0
	12210003	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	91.0	CHEMBL3587	Homo sapiens	Residual Activity	%	91.0
	12210004	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	88.0	CHEMBL3587	Homo sapiens	Residual Activity	%	88.0
	12210005	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	103.0	CHEMBL3587	Homo sapiens	Residual Activity	%	103.0
	12210006	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	81.0	CHEMBL3587	Homo sapiens	Residual Activity	%	81.0
	12210007	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	92.0	CHEMBL3587	Homo sapiens	Residual Activity	%	92.0
	12210008	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	63.0	CHEMBL3587	Homo sapiens	Residual Activity	%	63.0
	12210009	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	25.0	CHEMBL3587	Homo sapiens	Residual Activity	%	25.0
	12210010	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	93.0	CHEMBL3587	Homo sapiens	Residual Activity	%	93.0
	12210011	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	95.0	CHEMBL3587	Homo sapiens	Residual Activity	%	95.0
	12210012	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	119.0	CHEMBL3587	Homo sapiens	Residual Activity	%	119.0
	12210013	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	101.0	CHEMBL3587	Homo sapiens	Residual Activity	%	101.0
	12210014	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	20.0	CHEMBL3587	Homo sapiens	Residual Activity	%	20.0
	12210015	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	100.0	CHEMBL3587	Homo sapiens	Residual Activity	%	100.0
	12210016	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	122.0	CHEMBL3587	Homo sapiens	Residual Activity	%	122.0
	12210017	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	120.0	CHEMBL3587	Homo sapiens	Residual Activity	%	120.0
	12210018	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	108.0	CHEMBL3587	Homo sapiens	Residual Activity	%	108.0
	12210019	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	101.0	CHEMBL3587	Homo sapiens	Residual Activity	%	101.0
	12210020	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	50.0	CHEMBL3587	Homo sapiens	Residual Activity	%	50.0
	12210021	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	26.0	CHEMBL3587	Homo sapiens	Residual Activity	%	26.0
	12210022	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	80.0	CHEMBL3587	Homo sapiens	Residual Activity	%	80.0
	12210023	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	94.0	CHEMBL3587	Homo sapiens	Residual Activity	%	94.0
	12212859	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	39.0	CHEMBL3587	Homo sapiens	Residual Activity	%	39.0
	12212860	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	84.0	CHEMBL3587	Homo sapiens	Residual Activity	%	84.0
	12212861	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	20.0	CHEMBL3587	Homo sapiens	Residual Activity	%	20.0
	12212862	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	62.0	CHEMBL3587	Homo sapiens	Residual Activity	%	62.0
	12212863	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	92.0	CHEMBL3587	Homo sapiens	Residual Activity	%	92.0
	12212864	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	90.0	CHEMBL3587	Homo sapiens	Residual Activity	%	90.0
	12212865	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	91.0	CHEMBL3587	Homo sapiens	Residual Activity	%	91.0
	12212866	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	88.0	CHEMBL3587	Homo sapiens	Residual Activity	%	88.0
	12212867	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	97.0	CHEMBL3587	Homo sapiens	Residual Activity	%	97.0
	12212868	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	96.0	CHEMBL3587	Homo sapiens	Residual Activity	%	96.0
	12212869	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	60.0	CHEMBL3587	Homo sapiens	Residual Activity	%	60.0
	12212870	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	115.0	CHEMBL3587	Homo sapiens	Residual Activity	%	115.0
	12212871	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	104.0	CHEMBL3587	Homo sapiens	Residual Activity	%	104.0
	12212872	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	34.0	CHEMBL3587	Homo sapiens	Residual Activity	%	34.0
	12212873	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	5.0	CHEMBL3587	Homo sapiens	Residual Activity	%	5.0
	12212874	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	68.0	CHEMBL3587	Homo sapiens	Residual Activity	%	68.0
	12212875	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	75.0	CHEMBL3587	Homo sapiens	Residual Activity	%	75.0
	12212876	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	89.0	CHEMBL3587	Homo sapiens	Residual Activity	%	89.0
	12212877	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	31.0	CHEMBL3587	Homo sapiens	Residual Activity	%	31.0
	12212878	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	119.0	CHEMBL3587	Homo sapiens	Residual Activity	%	119.0
	12212879	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	112.0	CHEMBL3587	Homo sapiens	Residual Activity	%	112.0
	12212880	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	75.0	CHEMBL3587	Homo sapiens	Residual Activity	%	75.0
	12212881	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	24.0	CHEMBL3587	Homo sapiens	Residual Activity	%	24.0
	12212882	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	1.0	CHEMBL3587	Homo sapiens	Residual Activity	%	1.0
	12212883	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	103.0	CHEMBL3587	Homo sapiens	Residual Activity	%	103.0
	12212884	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	117.0	CHEMBL3587	Homo sapiens	Residual Activity	%	117.0
	12212885	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	75.0	CHEMBL3587	Homo sapiens	Residual Activity	%	75.0
	12212886	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	80.0	CHEMBL3587	Homo sapiens	Residual Activity	%	80.0
	12212887	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	92.0	CHEMBL3587	Homo sapiens	Residual Activity	%	92.0
	12212888	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	92.0	CHEMBL3587	Homo sapiens	Residual Activity	%	92.0
	12212889	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	81.0	CHEMBL3587	Homo sapiens	Residual Activity	%	81.0
	12212890	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	49.0	CHEMBL3587	Homo sapiens	Residual Activity	%	49.0
	12212891	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	56.0	CHEMBL3587	Homo sapiens	Residual Activity	%	56.0
	12212892	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	103.0	CHEMBL3587	Homo sapiens	Residual Activity	%	103.0
	12212893	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	90.0	CHEMBL3587	Homo sapiens	Residual Activity	%	90.0
	12212894	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	94.0	CHEMBL3587	Homo sapiens	Residual Activity	%	94.0
	12212895	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	73.0	CHEMBL3587	Homo sapiens	Residual Activity	%	73.0
	12212896	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	95.0	CHEMBL3587	Homo sapiens	Residual Activity	%	95.0
	12212897	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	89.0	CHEMBL3587	Homo sapiens	Residual Activity	%	89.0
	12212898	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	84.0	CHEMBL3587	Homo sapiens	Residual Activity	%	84.0
	12212899	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	38.0	CHEMBL3587	Homo sapiens	Residual Activity	%	38.0
	12212900	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	90.0	CHEMBL3587	Homo sapiens	Residual Activity	%	90.0
	12212901	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	77.0	CHEMBL3587	Homo sapiens	Residual Activity	%	77.0
	12212902	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	52.0	CHEMBL3587	Homo sapiens	Residual Activity	%	52.0
	12212903	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	84.0	CHEMBL3587	Homo sapiens	Residual Activity	%	84.0
	12212904	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	92.0	CHEMBL3587	Homo sapiens	Residual Activity	%	92.0
	12212905	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	29.0	CHEMBL3587	Homo sapiens	Residual Activity	%	29.0
	12212906	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	109.0	CHEMBL3587	Homo sapiens	Residual Activity	%	109.0
	12212907	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	8.0	CHEMBL3587	Homo sapiens	Residual Activity	%	8.0
	12212908	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	92.0	CHEMBL3587	Homo sapiens	Residual Activity	%	92.0
	12212909	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	1.0	CHEMBL3587	Homo sapiens	Residual Activity	%	1.0
	12212910	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	114.0	CHEMBL3587	Homo sapiens	Residual Activity	%	114.0
	12212911	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	64.0	CHEMBL3587	Homo sapiens	Residual Activity	%	64.0
	12212912	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	98.0	CHEMBL3587	Homo sapiens	Residual Activity	%	98.0
	12212913	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	106.0	CHEMBL3587	Homo sapiens	Residual Activity	%	106.0
	12212914	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	83.0	CHEMBL3587	Homo sapiens	Residual Activity	%	83.0
	12212915	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	111.0	CHEMBL3587	Homo sapiens	Residual Activity	%	111.0
	12212916	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	107.0	CHEMBL3587	Homo sapiens	Residual Activity	%	107.0
	12212917	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	110.0	CHEMBL3587	Homo sapiens	Residual Activity	%	110.0
	12212918	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	104.0	CHEMBL3587	Homo sapiens	Residual Activity	%	104.0
	12212919	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	55.0	CHEMBL3587	Homo sapiens	Residual Activity	%	55.0
	12212920	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	110.0	CHEMBL3587	Homo sapiens	Residual Activity	%	110.0
	12212921	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	38.0	CHEMBL3587	Homo sapiens	Residual Activity	%	38.0
	12212922	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	67.0	CHEMBL3587	Homo sapiens	Residual Activity	%	67.0
	12212923	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	95.0	CHEMBL3587	Homo sapiens	Residual Activity	%	95.0
	12212924	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	102.0	CHEMBL3587	Homo sapiens	Residual Activity	%	102.0
	12212925	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	106.0	CHEMBL3587	Homo sapiens	Residual Activity	%	106.0
	12212926	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	120.0	CHEMBL3587	Homo sapiens	Residual Activity	%	120.0
	12212927	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	95.0	CHEMBL3587	Homo sapiens	Residual Activity	%	95.0
	12212928	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	116.0	CHEMBL3587	Homo sapiens	Residual Activity	%	116.0
	12212929	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	109.0	CHEMBL3587	Homo sapiens	Residual Activity	%	109.0
	12212930	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	67.0	CHEMBL3587	Homo sapiens	Residual Activity	%	67.0
	12212931	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	0.0	CHEMBL3587	Homo sapiens	Residual Activity	%	0.0
	12212932	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	111.0	CHEMBL3587	Homo sapiens	Residual Activity	%	111.0
	12212933	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	51.0	CHEMBL3587	Homo sapiens	Residual Activity	%	51.0
	12212934	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	129.0	CHEMBL3587	Homo sapiens	Residual Activity	%	129.0
	12212935	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	110.0	CHEMBL3587	Homo sapiens	Residual Activity	%	110.0
	12212936	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	116.0	CHEMBL3587	Homo sapiens	Residual Activity	%	116.0
	12212937	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	110.0	CHEMBL3587	Homo sapiens	Residual Activity	%	110.0
	12212938	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	114.0	CHEMBL3587	Homo sapiens	Residual Activity	%	114.0
	12212939	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	82.0	CHEMBL3587	Homo sapiens	Residual Activity	%	82.0
	12212940	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	127.0	CHEMBL3587	Homo sapiens	Residual Activity	%	127.0
	12212941	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	106.0	CHEMBL3587	Homo sapiens	Residual Activity	%	106.0
	12212942	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	106.0	CHEMBL3587	Homo sapiens	Residual Activity	%	106.0
	12212943	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	109.0	CHEMBL3587	Homo sapiens	Residual Activity	%	109.0
	12212944	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	111.0	CHEMBL3587	Homo sapiens	Residual Activity	%	111.0
	12212945	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	117.0	CHEMBL3587	Homo sapiens	Residual Activity	%	117.0
	12212946	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	34.0	CHEMBL3587	Homo sapiens	Residual Activity	%	34.0
	12212947	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	79.0	CHEMBL3587	Homo sapiens	Residual Activity	%	79.0
	12212948	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	119.0	CHEMBL3587	Homo sapiens	Residual Activity	%	119.0
	12212949	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	120.0	CHEMBL3587	Homo sapiens	Residual Activity	%	120.0
	12212950	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	87.0	CHEMBL3587	Homo sapiens	Residual Activity	%	87.0
	12212951	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	25.0	CHEMBL3587	Homo sapiens	Residual Activity	%	25.0
	12212952	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	91.0	CHEMBL3587	Homo sapiens	Residual Activity	%	91.0
	12212953	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	77.0	CHEMBL3587	Homo sapiens	Residual Activity	%	77.0
	12212954	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	21.0	CHEMBL3587	Homo sapiens	Residual Activity	%	21.0
	12212955	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	7.0	CHEMBL3587	Homo sapiens	Residual Activity	%	7.0
	12212956	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	104.0	CHEMBL3587	Homo sapiens	Residual Activity	%	104.0
	12212957	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	112.0	CHEMBL3587	Homo sapiens	Residual Activity	%	112.0
	12212958	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	112.0	CHEMBL3587	Homo sapiens	Residual Activity	%	112.0
	12212959	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	6.0	CHEMBL3587	Homo sapiens	Residual Activity	%	6.0
	12212960	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	120.0	CHEMBL3587	Homo sapiens	Residual Activity	%	120.0
	12212961	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	120.0	CHEMBL3587	Homo sapiens	Residual Activity	%	120.0
	12212962	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	50.0	CHEMBL3587	Homo sapiens	Residual Activity	%	50.0
	12212963	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	67.0	CHEMBL3587	Homo sapiens	Residual Activity	%	67.0
	12212964	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	102.0	CHEMBL3587	Homo sapiens	Residual Activity	%	102.0
	12212965	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	103.0	CHEMBL3587	Homo sapiens	Residual Activity	%	103.0
	12212966	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	85.0	CHEMBL3587	Homo sapiens	Residual Activity	%	85.0
	12212967	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	48.0	CHEMBL3587	Homo sapiens	Residual Activity	%	48.0
	12212968	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	107.0	CHEMBL3587	Homo sapiens	Residual Activity	%	107.0
	12212969	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	91.0	CHEMBL3587	Homo sapiens	Residual Activity	%	91.0
	12212970	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	101.0	CHEMBL3587	Homo sapiens	Residual Activity	%	101.0
	12212971	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	85.0	CHEMBL3587	Homo sapiens	Residual Activity	%	85.0
	12212972	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	97.0	CHEMBL3587	Homo sapiens	Residual Activity	%	97.0
	12212973	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	117.0	CHEMBL3587	Homo sapiens	Residual Activity	%	117.0
	12212974	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	100.0	CHEMBL3587	Homo sapiens	Residual Activity	%	100.0
	12212975	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	117.0	CHEMBL3587	Homo sapiens	Residual Activity	%	117.0
	12212976	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	113.0	CHEMBL3587	Homo sapiens	Residual Activity	%	113.0
	12212977	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	83.0	CHEMBL3587	Homo sapiens	Residual Activity	%	83.0
	12212978	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	23.0	CHEMBL3587	Homo sapiens	Residual Activity	%	23.0
	12212979	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	119.0	CHEMBL3587	Homo sapiens	Residual Activity	%	119.0
	12212980	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	11.0	CHEMBL3587	Homo sapiens	Residual Activity	%	11.0
	12212981	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	65.0	CHEMBL3587	Homo sapiens	Residual Activity	%	65.0
	12212982	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	120.0	CHEMBL3587	Homo sapiens	Residual Activity	%	120.0
	12212983	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	109.0	CHEMBL3587	Homo sapiens	Residual Activity	%	109.0
	12212984	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	117.0	CHEMBL3587	Homo sapiens	Residual Activity	%	117.0
	12212985	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	101.0	CHEMBL3587	Homo sapiens	Residual Activity	%	101.0
	12212986	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	104.0	CHEMBL3587	Homo sapiens	Residual Activity	%	104.0
	12212987	CHEMBL2219262	Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	91.0	CHEMBL3587	Homo sapiens	Residual Activity	%	91.0
	12626712	CHEMBL2316988	Inhibition of MEK1 (unknown origin) at 1 uM	B	COc1cc(Nc2ncc(Cl)c(-c3cccc(CC#N)c3)n2)ccc1N1CCN(C)CC1		CHEMBL2312140	>=	Inhibition	%	80.0	CHEMBL3587	Homo sapiens	INH	%	80.0
	12628454	CHEMBL2321177	Inhibition of MKK1 (unknown origin) at 10 uM	B	N#Cc1c(N)nc2sc(C(=O)c3cccc(Cl)c3)c(N)c2c1-c1ccccc1Cl		CHEMBL2313853	>	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	12660676	CHEMBL2330666	Inhibition of MKK1 (unknown origin) at 1 uM	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Inhibition	%	75.0	CHEMBL3587	Homo sapiens	INH	%	75.0
	12672983	CHEMBL2339718	Inhibition of recombinant MKK1 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	28.0	CHEMBL3587	Homo sapiens	Activity	%	28.0
	12672984	CHEMBL2339718	Inhibition of recombinant MKK1 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	41.0	CHEMBL3587	Homo sapiens	Activity	%	41.0
	12674230	CHEMBL2344633	Inhibition of human MKK1 using [gamma-33P]ATP assessed as residual activity at 3 uM after 30 mins by radiometric assay	B	CCCCn1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333603	=	Activity	%	56.0	CHEMBL3587	Homo sapiens	Activity	%	56.0
	12675466	CHEMBL2344387	Inhibition of MEK1 (unknown origin)	B	O=C(Nc1ccc(Oc2ncnc3[nH]ncc23)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL2332840	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	12676867	CHEMBL2341896	Inhibition of MEK1 (unknown origin)	B	O=C(NOCCO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL244488	=	IC50	nM	2.0	CHEMBL3587	Homo sapiens	IC50	uM	0.002
	12676868	CHEMBL2341896	Inhibition of MEK1 (unknown origin)	B	O=C(NOCCO)c1ccc(F)c(F)c1Nc1ccc(Br)cc1F		CHEMBL2335186	=	IC50	nM	7.7	CHEMBL3587	Homo sapiens	IC50	uM	0.0077
	12676869	CHEMBL2341896	Inhibition of MEK1 (unknown origin)	B	O=C(NOCCO)c1ccc(F)c(F)c1Nc1ccc(Cl)cc1F		CHEMBL2335185	=	IC50	nM	26.0	CHEMBL3587	Homo sapiens	IC50	uM	0.026
	12693283	CHEMBL2344412	Inhibition of MEK1 (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	3500.0	CHEMBL3587	Homo sapiens	IC50	nM	3500.0
	12700055	CHEMBL2344116	Inhibition of recombinant MEK1 (unknown origin) by cascade reaction assay	B	CN1C/C(=C\c2ccccn2)C(=O)[C@@H](Cc2ccccn2)C1		CHEMBL2338335	>	IC50	nM	100000.0	CHEMBL3587	Homo sapiens	IC50	uM	100.0
	12700067	CHEMBL2344116	Inhibition of recombinant MEK1 (unknown origin) by cascade reaction assay	B	CN1C/C(=C\c2ccccn2)C(=O)[C@H](Cc2ccccn2)C1		CHEMBL2338334	>	IC50	nM	100000.0	CHEMBL3587	Homo sapiens	IC50	uM	100.0
	12700079	CHEMBL2344116	Inhibition of recombinant MEK1 (unknown origin) by cascade reaction assay	B	O=C1/C(=C/c2ccccn2)CSC/C1=C\c1ccccn1		CHEMBL2036343	=	IC50	nM	30000.0	CHEMBL3587	Homo sapiens	IC50	uM	30.0
	12700091	CHEMBL2344116	Inhibition of recombinant MEK1 (unknown origin) by cascade reaction assay	B	CN1C/C(=C\c2ccccn2)C(=O)/C(=C/c2ccccn2)C1		CHEMBL2338333	=	IC50	nM	9000.0	CHEMBL3587	Homo sapiens	IC50	uM	9.0
	12700104	CHEMBL2344116	Inhibition of recombinant MEK1 (unknown origin) by cascade reaction assay	B	O=C1/C(=C/c2ccccn2)CNC/C1=C\c1ccccn1		CHEMBL574646	=	IC50	nM	1100.0	CHEMBL3587	Homo sapiens	IC50	uM	1.1
	12700166	CHEMBL2344116	Inhibition of recombinant MEK1 (unknown origin) by cascade reaction assay	B	O=C1/C(=C/c2ccccc2F)CNC/C1=C\c1ccccc1F		CHEMBL379849	=	IC50	nM	12800.0	CHEMBL3587	Homo sapiens	IC50	uM	12.8
	12705255	CHEMBL2345795	Inhibition of MEK1 (unknown origin)	B	CN1c2ccc(NCc3ccc(C(C)(C)C)cc3)cc2-c2c(cnn2C)S1(=O)=O		CHEMBL2333444	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	12705256	CHEMBL2345795	Inhibition of MEK1 (unknown origin)	B	CCc1ccc(-c2ccc3c(c2)-c2c(cnn2C)S(=O)(=O)N3C)cc1		CHEMBL2333435	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	12705257	CHEMBL2345795	Inhibition of MEK1 (unknown origin)	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	IC50	nM	8600.0	CHEMBL3587	Homo sapiens	IC50	uM	8.6
	12721810	CHEMBL2353795	Inhibition of MEK1 (unknown origin) at 1 uM relative to control	B	CCNC(=O)Nc1nc2ccc(-c3ccccc3OC)cc2s1		CHEMBL2347710	=	Inhibition	%	100.0	CHEMBL3587	Homo sapiens	INH	%	100.0
	12727733	CHEMBL2351168	Inhibition of MEK1 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	90.0	CHEMBL3587	Homo sapiens	Activity	%	90.0
	12728086	CHEMBL2351301	Inhibition of N-terminal GST-fused MEK1 (unknown origin) incubated for 5 mins prior to [gamma-33P]ATP addition measured after 20 mins by scintillation counting analysis	B	O=C(NCCO)C1=Cc2c(ncnc2Nc2ccc(Oc3cccc4sccc34)c(Cl)c2)NCC1		CHEMBL2348417	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	nM	10000.0
	12729021	CHEMBL2351667	Inhibition of MEK1 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	91.0	CHEMBL3587	Homo sapiens	Activity	%	91.0
	12729907	CHEMBL2349811	Inhibition of MEK1 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	93.0	CHEMBL3587	Homo sapiens	Activity	%	93.0
	12730164	CHEMBL2351168	Inhibition of MEK1 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	105.0	CHEMBL3587	Homo sapiens	Activity	%	105.0
	13294074	CHEMBL2379959	Inhibition of MEK1 (unknown origin) after 2 hrs by fluorescence assay	B	NC(=O)c1c(Nc2ccc(I)cc2F)cc(F)cc1Oc1cccc(CS(N)(=O)=O)c1		CHEMBL2376667	=	IC50	nM	32.0	CHEMBL3587	Homo sapiens	IC50	nM	32.0
	13294075	CHEMBL2379959	Inhibition of MEK1 (unknown origin) after 2 hrs by fluorescence assay	B	NC(=O)c1c(Nc2ccc(I)cc2F)cc(F)cc1Oc1cccc(NS(N)(=O)=O)c1		CHEMBL2376666	=	IC50	nM	14.0	CHEMBL3587	Homo sapiens	IC50	nM	14.0
	13294076	CHEMBL2379959	Inhibition of MEK1 (unknown origin) after 2 hrs by fluorescence assay	B	CNS(=O)(=O)Nc1cccc(Oc2cc(F)cc(Nc3ccc(I)cc3F)c2C(N)=O)c1		CHEMBL2376665	=	IC50	nM	22.0	CHEMBL3587	Homo sapiens	IC50	nM	22.0
	13294077	CHEMBL2379959	Inhibition of MEK1 (unknown origin) after 2 hrs by fluorescence assay	B	NC(=O)c1c(Nc2ccc(I)cc2F)cc(F)cc1Oc1cccc(NS(=O)(=O)N2CCCC2)c1		CHEMBL2376664	=	IC50	nM	21.0	CHEMBL3587	Homo sapiens	IC50	nM	21.0
	13294078	CHEMBL2379959	Inhibition of MEK1 (unknown origin) after 2 hrs by fluorescence assay	B	CN(C)S(=O)(=O)Nc1cccc(Oc2cc(F)cc(Nc3ccc(I)cc3F)c2C(N)=O)c1		CHEMBL2376663	=	IC50	nM	21.0	CHEMBL3587	Homo sapiens	IC50	nM	21.0
	13294079	CHEMBL2379959	Inhibition of MEK1 (unknown origin) after 2 hrs by fluorescence assay	B	CC(C)S(=O)(=O)Nc1cccc(Oc2cc(F)cc(Nc3ccc(I)cc3F)c2C(N)=O)c1		CHEMBL2376662	=	IC50	nM	18.0	CHEMBL3587	Homo sapiens	IC50	nM	18.0
	13294080	CHEMBL2379959	Inhibition of MEK1 (unknown origin) after 2 hrs by fluorescence assay	B	CCS(=O)(=O)Nc1cccc(Oc2cc(F)cc(Nc3ccc(I)cc3F)c2C(N)=O)c1		CHEMBL2376661	=	IC50	nM	15.0	CHEMBL3587	Homo sapiens	IC50	nM	15.0
	13294081	CHEMBL2379959	Inhibition of MEK1 (unknown origin) after 2 hrs by fluorescence assay	B	CS(=O)(=O)Nc1cccc(Oc2cc(F)cc(Nc3ccc(I)cc3F)c2C(N)=O)c1		CHEMBL2375372	=	IC50	nM	21.0	CHEMBL3587	Homo sapiens	IC50	nM	21.0
	13294082	CHEMBL2379959	Inhibition of MEK1 (unknown origin) after 2 hrs by fluorescence assay	B	NC(=O)c1c(Nc2ccc(I)cc2F)cc(F)cc1Oc1ccc2oc(=O)[nH]c2c1		CHEMBL2376660	=	IC50	nM	36.0	CHEMBL3587	Homo sapiens	IC50	nM	36.0
	13294083	CHEMBL2379959	Inhibition of MEK1 (unknown origin) after 2 hrs by fluorescence assay	B	CC(C)C(=O)Nc1cccc(Oc2cc(F)cc(Nc3ccc(I)cc3F)c2C(N)=O)c1		CHEMBL2376686	=	IC50	nM	48.0	CHEMBL3587	Homo sapiens	IC50	nM	48.0
	13294084	CHEMBL2379959	Inhibition of MEK1 (unknown origin) after 2 hrs by fluorescence assay	B	CC(=O)Nc1ccc(Oc2cc(F)cc(Nc3ccc(I)cc3F)c2C(N)=O)cc1		CHEMBL2376685	=	IC50	nM	539.0	CHEMBL3587	Homo sapiens	IC50	nM	539.0
	13294085	CHEMBL2379959	Inhibition of MEK1 (unknown origin) after 2 hrs by fluorescence assay	B	CC(=O)Nc1cccc(Oc2cc(F)cc(Nc3ccc(I)cc3F)c2C(N)=O)c1		CHEMBL2376684	=	IC50	nM	28.0	CHEMBL3587	Homo sapiens	IC50	nM	28.0
	13294086	CHEMBL2379959	Inhibition of MEK1 (unknown origin) after 2 hrs by fluorescence assay	B	NC(=O)c1c(Nc2ccc(I)cc2F)cc(F)cc1Oc1ccc2cn[nH]c2c1		CHEMBL2376683	=	IC50	nM	54.0	CHEMBL3587	Homo sapiens	IC50	nM	54.0
	13294087	CHEMBL2379959	Inhibition of MEK1 (unknown origin) after 2 hrs by fluorescence assay	B	NC(=O)c1c(Nc2ccc(I)cc2F)cc(F)cc1Oc1cccnc1		CHEMBL2376682	=	IC50	nM	76.0	CHEMBL3587	Homo sapiens	IC50	nM	76.0
	13294088	CHEMBL2379959	Inhibition of MEK1 (unknown origin) after 2 hrs by fluorescence assay	B	NC(=O)c1c(Nc2ccc(I)cc2F)cc(F)cc1Oc1ccccc1		CHEMBL2376681	=	IC50	nM	99.0	CHEMBL3587	Homo sapiens	IC50	nM	99.0
	13294089	CHEMBL2379959	Inhibition of MEK1 (unknown origin) after 2 hrs by fluorescence assay	B	NC(=O)c1c(Nc2ccc(I)cc2F)cc(F)cc1OC[C@@H]1CCCN1S(N)(=O)=O		CHEMBL2376680	=	IC50	nM	73.0	CHEMBL3587	Homo sapiens	IC50	nM	73.0
	13294090	CHEMBL2379959	Inhibition of MEK1 (unknown origin) after 2 hrs by fluorescence assay	B	CN(C)S(=O)(=O)N1CCC[C@H]1COc1cc(F)cc(Nc2ccc(I)cc2F)c1C(N)=O		CHEMBL2376679	=	IC50	nM	1000.0	CHEMBL3587	Homo sapiens	IC50	nM	1000.0
	13294091	CHEMBL2379959	Inhibition of MEK1 (unknown origin) after 2 hrs by fluorescence assay	B	CCS(=O)(=O)N1CCC[C@H]1COc1cc(F)cc(Nc2ccc(I)cc2F)c1C(N)=O		CHEMBL2376678	=	IC50	nM	96.0	CHEMBL3587	Homo sapiens	IC50	nM	96.0
	13294092	CHEMBL2379959	Inhibition of MEK1 (unknown origin) after 2 hrs by fluorescence assay	B	CN1CCC[C@H]1COc1cc(F)cc(Nc2ccc(I)cc2F)c1C(N)=O		CHEMBL2376677	=	IC50	nM	182.0	CHEMBL3587	Homo sapiens	IC50	nM	182.0
	13294093	CHEMBL2379959	Inhibition of MEK1 (unknown origin) after 2 hrs by fluorescence assay	B	NC(=O)c1c(Nc2ccc(I)cc2F)cc(F)cc1OC[C@@H]1CCCN1		CHEMBL2376676	=	IC50	nM	26.0	CHEMBL3587	Homo sapiens	IC50	nM	26.0
	13294094	CHEMBL2379959	Inhibition of MEK1 (unknown origin) after 2 hrs by fluorescence assay	B	NC(=O)c1c(Nc2ccc(I)cc2F)cc(F)cc1OCC[C@@H](O)Cn1ccnc1		CHEMBL2376675	=	IC50	nM	16.0	CHEMBL3587	Homo sapiens	IC50	nM	16.0
	13294095	CHEMBL2379959	Inhibition of MEK1 (unknown origin) after 2 hrs by fluorescence assay	B	NC(=O)c1c(Nc2ccc(I)cc2F)cc(F)cc1OCC[C@@H](O)Cn1cccn1		CHEMBL2376674	=	IC50	nM	13.0	CHEMBL3587	Homo sapiens	IC50	nM	13.0
	13294096	CHEMBL2379959	Inhibition of MEK1 (unknown origin) after 2 hrs by fluorescence assay	B	CC(C)(O)C(O)CCOc1cc(F)cc(Nc2ccc(I)cc2F)c1C(N)=O		CHEMBL2376673	=	IC50	nM	43.0	CHEMBL3587	Homo sapiens	IC50	nM	43.0
	13294097	CHEMBL2379959	Inhibition of MEK1 (unknown origin) after 2 hrs by fluorescence assay	B	CC(O)(CO)CCOc1cc(F)cc(Nc2ccc(I)cc2F)c1C(N)=O		CHEMBL2376672	=	IC50	nM	69.0	CHEMBL3587	Homo sapiens	IC50	nM	69.0
	13294098	CHEMBL2379959	Inhibition of MEK1 (unknown origin) after 2 hrs by fluorescence assay	B	NC(=O)c1c(Nc2ccc(I)cc2F)cc(F)cc1OC[C@H](O)CCO		CHEMBL2376671	=	IC50	nM	63.0	CHEMBL3587	Homo sapiens	IC50	nM	63.0
	13294099	CHEMBL2379959	Inhibition of MEK1 (unknown origin) after 2 hrs by fluorescence assay	B	NC(=O)c1c(Nc2ccc(I)cc2F)cc(F)cc1OCC[C@H](O)CO		CHEMBL2376670	=	IC50	nM	96.0	CHEMBL3587	Homo sapiens	IC50	nM	96.0
	13294100	CHEMBL2379959	Inhibition of MEK1 (unknown origin) after 2 hrs by fluorescence assay	B	COc1cc(F)cc(Nc2ccc(I)cc2F)c1C(N)=O		CHEMBL2376669	=	IC50	nM	74.0	CHEMBL3587	Homo sapiens	IC50	nM	74.0
	13294101	CHEMBL2379959	Inhibition of MEK1 (unknown origin) after 2 hrs by fluorescence assay	B	NC(=O)c1c(Nc2ccc(I)cc2F)cc(F)cc1OCC[C@@H](O)CO		CHEMBL2376668	=	IC50	nM	63.0	CHEMBL3587	Homo sapiens	IC50	nM	63.0
	13294102	CHEMBL2379959	Inhibition of MEK1 (unknown origin) after 2 hrs by fluorescence assay	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	=	IC50	nM	80.0	CHEMBL3587	Homo sapiens	IC50	nM	80.0
	13294103	CHEMBL2379959	Inhibition of MEK1 (unknown origin) after 2 hrs by fluorescence assay	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	IC50	nM	7.0	CHEMBL3587	Homo sapiens	IC50	nM	7.0
	13295006	CHEMBL2379196	Inhibition of MEK1 (unknown origin)	B	Nc1nc(C2CCNC(=O)c3[nH]c(Br)c(Br)c32)c[nH]1		CHEMBL151430	=	IC50	nM	6.0	CHEMBL3587	Homo sapiens	IC50	nM	6.0
Active	13300207	CHEMBL2384450	Inhibition of human MKK1 at 1 uM	B	CC(C)CCNc1ccc(-c2cnc3ccc(NC4CCN(C)CC4)nn23)cn1		CHEMBL2380687		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
	13327655	CHEMBL2389823	Inhibition of MAP2K1 (unknown origin) at 1 uM	B	CC(C)(C)c1cc(NC(=O)NCc2ccc(-c3cc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)[nH]n3)cc2)no1		CHEMBL2386802	=	Inhibition	%	13.0	CHEMBL3587	Homo sapiens	INH	%	13.0
	13327656	CHEMBL2389823	Inhibition of MAP2K1 (unknown origin) at 1 uM	B	Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1NC(=O)Nc1cc(C(C)(C)C)on1		CHEMBL2386796	=	Inhibition	%	5.0	CHEMBL3587	Homo sapiens	INH	%	5.0
	13341022	CHEMBL2395228	Binding affinity to MEK1 (unknown origin) at 200 uM by SPR analysis	B	O=c1[nH]ccc2cc(O[C@@H]3CCCNC3)c(Cl)cc12		CHEMBL2391617	=	RU		0.3	CHEMBL3587	Homo sapiens	RU		0.3
	13341023	CHEMBL2395228	Binding affinity to MEK1 (unknown origin) at 200 uM by SPR analysis	B	O=c1[nH]ccc2cc(O[C@@H]3CCNC3)c(Cl)cc12		CHEMBL2391616	=	RU		0.7	CHEMBL3587	Homo sapiens	RU		0.7
	13341024	CHEMBL2395228	Binding affinity to MEK1 (unknown origin) at 200 uM by SPR analysis	B	O=c1[nH]ccc2cc(OC[C@@H]3CCNC3)c(Cl)cc12		CHEMBL2391618	=	RU		1.9	CHEMBL3587	Homo sapiens	RU		1.9
	13341025	CHEMBL2395228	Binding affinity to MEK1 (unknown origin) at 200 uM by SPR analysis	B	N#Cc1cccc2[nH]nc(N)c12		CHEMBL2391619	=	RU		0.3	CHEMBL3587	Homo sapiens	RU		0.3
	13341614	CHEMBL2395228	Binding affinity to MEK1 (unknown origin) at 200 uM by SPR analysis	B	COC(=O)c1c[nH]c2ncccc12		CHEMBL2391621	=	RU		0.7	CHEMBL3587	Homo sapiens	RU		0.7
	13341615	CHEMBL2395228	Binding affinity to MEK1 (unknown origin) at 200 uM by SPR analysis	B	O=c1[nH]ccc2cc(O[C@H]3CCNC3)c(Cl)cc12		CHEMBL2391620	=	RU		1.4	CHEMBL3587	Homo sapiens	RU		1.4
	13341616	CHEMBL2395230	Binding affinity to MEK1 (unknown origin) assessed as fluorescence intensity every 0.2 degC at 500 uM at 20 degC to 90 degC by differential screening fluorimetry analysis	B	O=c1[nH]ccc2cc(O[C@@H]3CCCNC3)c(Cl)cc12		CHEMBL2391617	=	Delta Tm	degrees C	0.2	CHEMBL3587	Homo sapiens	deltaTm	degrees C	0.2
	13341617	CHEMBL2395230	Binding affinity to MEK1 (unknown origin) assessed as fluorescence intensity every 0.2 degC at 500 uM at 20 degC to 90 degC by differential screening fluorimetry analysis	B	O=c1[nH]ccc2cc(O[C@@H]3CCNC3)c(Cl)cc12		CHEMBL2391616	=	Delta Tm	degrees C	0.4	CHEMBL3587	Homo sapiens	deltaTm	degrees C	0.4
	13341618	CHEMBL2395230	Binding affinity to MEK1 (unknown origin) assessed as fluorescence intensity every 0.2 degC at 500 uM at 20 degC to 90 degC by differential screening fluorimetry analysis	B	O=c1[nH]ccc2cc(OC[C@@H]3CCNC3)c(Cl)cc12		CHEMBL2391618	=	Delta Tm	degrees C	0.8	CHEMBL3587	Homo sapiens	deltaTm	degrees C	0.8
	13341619	CHEMBL2395230	Binding affinity to MEK1 (unknown origin) assessed as fluorescence intensity every 0.2 degC at 500 uM at 20 degC to 90 degC by differential screening fluorimetry analysis	B	N#Cc1cccc2[nH]nc(N)c12		CHEMBL2391619	=	Delta Tm	degrees C	2.0	CHEMBL3587	Homo sapiens	deltaTm	degrees C	2.0
	13341620	CHEMBL2395230	Binding affinity to MEK1 (unknown origin) assessed as fluorescence intensity every 0.2 degC at 500 uM at 20 degC to 90 degC by differential screening fluorimetry analysis	B	COC(=O)c1c[nH]c2ncccc12		CHEMBL2391621	=	Delta Tm	degrees C	1.8	CHEMBL3587	Homo sapiens	deltaTm	degrees C	1.8
	13341621	CHEMBL2395230	Binding affinity to MEK1 (unknown origin) assessed as fluorescence intensity every 0.2 degC at 500 uM at 20 degC to 90 degC by differential screening fluorimetry analysis	B	CC1(O)CCN2C(=O)CCc3cccc1c32		CHEMBL1702690	=	Delta Tm	degrees C	3.8	CHEMBL3587	Homo sapiens	deltaTm	degrees C	3.8
	13341622	CHEMBL2395230	Binding affinity to MEK1 (unknown origin) assessed as fluorescence intensity every 0.2 degC at 500 uM at 20 degC to 90 degC by differential screening fluorimetry analysis	B	O=c1[nH]ccc2cc(O[C@H]3CCNC3)c(Cl)cc12		CHEMBL2391620	=	Delta Tm	degrees C	2.6	CHEMBL3587	Homo sapiens	deltaTm	degrees C	2.6
	13341623	CHEMBL2395229	Inhibition of MEK1 (unknown origin) using ATP and ERK2 K54R as substrate after 60 to 80 mins by HTRF assay	B	O=c1[nH]ccc2cc(OC[C@@H]3CCCNC3)ccc12		CHEMBL2391615	=	IC50	nM	491000.0	CHEMBL3587	Homo sapiens	IC50	uM	491.0
	13341624	CHEMBL2395229	Inhibition of MEK1 (unknown origin) using ATP and ERK2 K54R as substrate after 60 to 80 mins by HTRF assay	B	O=c1[nH]ccc2cc(OC[C@@H]3CCNC3)c(Cl)cc12		CHEMBL2391618	=	IC50	nM	157000.0	CHEMBL3587	Homo sapiens	IC50	uM	157.0
	13341625	CHEMBL2395229	Inhibition of MEK1 (unknown origin) using ATP and ERK2 K54R as substrate after 60 to 80 mins by HTRF assay	B	N#Cc1cccc2[nH]nc(N)c12		CHEMBL2391619	=	IC50	nM	300000.0	CHEMBL3587	Homo sapiens	IC50	uM	300.0
	13341626	CHEMBL2395229	Inhibition of MEK1 (unknown origin) using ATP and ERK2 K54R as substrate after 60 to 80 mins by HTRF assay	B	COC(=O)c1c[nH]c2ncccc12		CHEMBL2391621	=	IC50	nM	39400.0	CHEMBL3587	Homo sapiens	IC50	uM	39.4
	13341627	CHEMBL2395229	Inhibition of MEK1 (unknown origin) using ATP and ERK2 K54R as substrate after 60 to 80 mins by HTRF assay	B	CC1(O)CCN2C(=O)CCc3cccc1c32		CHEMBL1702690	=	IC50	nM	18100.0	CHEMBL3587	Homo sapiens	IC50	uM	18.1
	13341628	CHEMBL2395229	Inhibition of MEK1 (unknown origin) using ATP and ERK2 K54R as substrate after 60 to 80 mins by HTRF assay	B	O=c1[nH]ccc2cc(O[C@H]3CCNC3)c(Cl)cc12		CHEMBL2391620	=	IC50	nM	1100.0	CHEMBL3587	Homo sapiens	IC50	uM	1.1
	13341629	CHEMBL2395231	Inhibition of MEK1 (unknown origin) using ATP and ERK2 K54R as substrate at 530 uM after 60 to 80 mins by HTRF assay	B	O=c1[nH]ccc2cc(O[C@@H]3CCCNC3)c(Cl)cc12		CHEMBL2391617	=	Inhibition	%	100.0	CHEMBL3587	Homo sapiens	INH	%	100.0
	13341630	CHEMBL2395231	Inhibition of MEK1 (unknown origin) using ATP and ERK2 K54R as substrate at 530 uM after 60 to 80 mins by HTRF assay	B	O=c1[nH]ccc2cc(O[C@@H]3CCNC3)c(Cl)cc12		CHEMBL2391616	=	Inhibition	%	100.0	CHEMBL3587	Homo sapiens	INH	%	100.0
	13341631	CHEMBL2395231	Inhibition of MEK1 (unknown origin) using ATP and ERK2 K54R as substrate at 530 uM after 60 to 80 mins by HTRF assay	B	O=c1[nH]ccc2cc(OC[C@@H]3CCCNC3)ccc12		CHEMBL2391615	=	Inhibition	%	95.0	CHEMBL3587	Homo sapiens	INH	%	95.0
	13341632	CHEMBL2395231	Inhibition of MEK1 (unknown origin) using ATP and ERK2 K54R as substrate at 530 uM after 60 to 80 mins by HTRF assay	B	O=c1[nH]ccc2cc(OC[C@@H]3CCNC3)c(Cl)cc12		CHEMBL2391618	=	Inhibition	%	81.0	CHEMBL3587	Homo sapiens	INH	%	81.0
	13341633	CHEMBL2395231	Inhibition of MEK1 (unknown origin) using ATP and ERK2 K54R as substrate at 530 uM after 60 to 80 mins by HTRF assay	B	N#Cc1cccc2[nH]nc(N)c12		CHEMBL2391619	=	Inhibition	%	85.0	CHEMBL3587	Homo sapiens	INH	%	85.0
	13341634	CHEMBL2395231	Inhibition of MEK1 (unknown origin) using ATP and ERK2 K54R as substrate at 530 uM after 60 to 80 mins by HTRF assay	B	COC(=O)c1c[nH]c2ncccc12		CHEMBL2391621	=	Inhibition	%	99.0	CHEMBL3587	Homo sapiens	INH	%	99.0
	13341635	CHEMBL2395231	Inhibition of MEK1 (unknown origin) using ATP and ERK2 K54R as substrate at 530 uM after 60 to 80 mins by HTRF assay	B	CC1(O)CCN2C(=O)CCc3cccc1c32		CHEMBL1702690	=	Inhibition	%	92.0	CHEMBL3587	Homo sapiens	INH	%	92.0
	13341636	CHEMBL2395231	Inhibition of MEK1 (unknown origin) using ATP and ERK2 K54R as substrate at 530 uM after 60 to 80 mins by HTRF assay	B	O=c1[nH]ccc2cc(O[C@H]3CCNC3)c(Cl)cc12		CHEMBL2391620	=	Inhibition	%	100.0	CHEMBL3587	Homo sapiens	INH	%	100.0
	13351575	CHEMBL2399783	Inhibition of human MEK1 at 10 uM relative to control	B	Cl.O=c1[nH]nc2c(NCCCc3ccncc3)cc(Cl)cn12		CHEMBL2397859	=	Inhibition	%	9.0	CHEMBL3587	Homo sapiens	INH	%	9.0
	13352868	CHEMBL2399311	Inhibition of MEK1 (unknown origin)	B	C[C@@H](c1ccccc1)[C@@H](C(=O)Nc1ccc(I)cc1F)N1C(=O)N[C@H](c2ccc(OC[C@H](C)CO)cc2)C1=O		CHEMBL2396995	=	IC50	nM	25.0	CHEMBL3587	Homo sapiens	IC50	uM	0.025
	13352872	CHEMBL2399315	Non-competitive inhibition of MEK1 (unknown origin) kinase activity using fluorescent peptide as substrate by fluorescence assay in presence of ATP	B	CCC(=O)c1csc(NC(=O)[C@H]([C@@H](C)c2ccccc2)N2C(=O)N[C@H](c3ccc(OCCO)cc3)C2=O)n1		CHEMBL2396994	=	IC50	nM	23.0	CHEMBL3587	Homo sapiens	IC50	nM	23.0
	13375815	CHEMBL2404328	Inhibition of MEK1 S218D/S222D double mutant (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	10.0	CHEMBL3587	Homo sapiens	INH	%	10.0
	13375816	CHEMBL2404327	Inhibition of MEK1 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	-2.0	CHEMBL3587	Homo sapiens	INH	%	-2.0
	13436386	CHEMBL2422257	Inhibition of MAP2K1 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(Cc2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420551	<	Inhibition	%	35.0	CHEMBL3587	Homo sapiens	INH	%	35.0
	13436387	CHEMBL2422257	Inhibition of MAP2K1 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420555	<	Inhibition	%	35.0	CHEMBL3587	Homo sapiens	INH	%	35.0
	13436388	CHEMBL2422257	Inhibition of MAP2K1 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CCC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420573	<	Inhibition	%	35.0	CHEMBL3587	Homo sapiens	INH	%	35.0
	13436389	CHEMBL2422257	Inhibition of MAP2K1 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420572	<	Inhibition	%	35.0	CHEMBL3587	Homo sapiens	INH	%	35.0
	13436390	CHEMBL2422257	Inhibition of MAP2K1 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC(C)(NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420570	<	Inhibition	%	35.0	CHEMBL3587	Homo sapiens	INH	%	35.0
	13436391	CHEMBL2422257	Inhibition of MAP2K1 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CCC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420565	<	Inhibition	%	35.0	CHEMBL3587	Homo sapiens	INH	%	35.0
	13436392	CHEMBL2422257	Inhibition of MAP2K1 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(N[C@H](CO)c1ccccc1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420564	<	Inhibition	%	35.0	CHEMBL3587	Homo sapiens	INH	%	35.0
	13436393	CHEMBL2422257	Inhibition of MAP2K1 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420562	<	Inhibition	%	35.0	CHEMBL3587	Homo sapiens	INH	%	35.0
	13436394	CHEMBL2422257	Inhibition of MAP2K1 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420560	<	Inhibition	%	35.0	CHEMBL3587	Homo sapiens	INH	%	35.0
	13436395	CHEMBL2422257	Inhibition of MAP2K1 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420556	<	Inhibition	%	35.0	CHEMBL3587	Homo sapiens	INH	%	35.0
	13436396	CHEMBL2422257	Inhibition of MAP2K1 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420587	<	Inhibition	%	35.0	CHEMBL3587	Homo sapiens	INH	%	35.0
	13436397	CHEMBL2422257	Inhibition of MAP2K1 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420585	<	Inhibition	%	35.0	CHEMBL3587	Homo sapiens	INH	%	35.0
	13439817	CHEMBL2426962	Competitive binding affinity to MEK1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	13440851	CHEMBL2429594	Inhibition of MKK1 (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc4c(N)ncnc43)cc2)cc1	Outside typical range	CHEMBL2425144	=	Inhibition	%	-43.0	CHEMBL3587	Homo sapiens	INH	%	-43.0
	13445650	CHEMBL2426962	Competitive binding affinity to MEK1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	13451637	CHEMBL2426962	Competitive binding affinity to MEK1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	13453029	CHEMBL2429594	Inhibition of MKK1 (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-c3cccnc3)cc2)cc1		CHEMBL2425156	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	INH	%	0.0
	13453077	CHEMBL2429594	Inhibition of MKK1 (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc(C)c3)cc2)cc1		CHEMBL2425145	=	Inhibition	%	5.0	CHEMBL3587	Homo sapiens	INH	%	5.0
Not Active	13508508	CHEMBL2447619	Inhibition of MEK1 (unknown origin) at 30 uM	B	O=C(Nc1ccc2c(c1)B(O)OC2)c1c(C(F)(F)F)ccc(Cl)c1F		CHEMBL2441375		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
	13836339	CHEMBL3090923	Inhibition of MEK1 S218E/S222E mutant (unknown origin) using inactive MAP kinase 2/Erk2 and FAM-Erktide as substrate assessed as inhibition of FAM-Erktide phosphorylation preincubated with inactive MAP kinase 2/Erk2 for 30 mins followed by FAM-Erktide addition measured after 90 mins by IMAP fluorescence polarization assay	B	Cc1c(Cc2cccc(NS(N)(=O)=O)c2F)c(=O)oc2cc(OC(=O)N(C)C)c(F)cc12		CHEMBL3086078	=	IC50	nM	9.0	CHEMBL3587	Homo sapiens	IC50	nM	9.0
	13836340	CHEMBL3090923	Inhibition of MEK1 S218E/S222E mutant (unknown origin) using inactive MAP kinase 2/Erk2 and FAM-Erktide as substrate assessed as inhibition of FAM-Erktide phosphorylation preincubated with inactive MAP kinase 2/Erk2 for 30 mins followed by FAM-Erktide addition measured after 90 mins by IMAP fluorescence polarization assay	B	Cc1c(Cc2cccc(NS(=O)(=O)N3CCN(C)CC3)c2)c(=O)oc2cc(OC(=O)N(C)C)c(Cl)cc12		CHEMBL3086076	=	IC50	nM	35.0	CHEMBL3587	Homo sapiens	IC50	nM	35.0
	13836341	CHEMBL3090923	Inhibition of MEK1 S218E/S222E mutant (unknown origin) using inactive MAP kinase 2/Erk2 and FAM-Erktide as substrate assessed as inhibition of FAM-Erktide phosphorylation preincubated with inactive MAP kinase 2/Erk2 for 30 mins followed by FAM-Erktide addition measured after 90 mins by IMAP fluorescence polarization assay	B	COCCNS(=O)(=O)Nc1cccc(Cc2c(C)c3cc(Cl)c(OC(=O)N(C)C)cc3oc2=O)c1		CHEMBL3086075	=	IC50	nM	47.0	CHEMBL3587	Homo sapiens	IC50	nM	47.0
	13836342	CHEMBL3090923	Inhibition of MEK1 S218E/S222E mutant (unknown origin) using inactive MAP kinase 2/Erk2 and FAM-Erktide as substrate assessed as inhibition of FAM-Erktide phosphorylation preincubated with inactive MAP kinase 2/Erk2 for 30 mins followed by FAM-Erktide addition measured after 90 mins by IMAP fluorescence polarization assay	B	Cc1c(Cc2cccc(NS(=O)(=O)NCCO)c2)c(=O)oc2cc(OC(=O)N(C)C)c(Cl)cc12		CHEMBL3086074	=	IC50	nM	46.0	CHEMBL3587	Homo sapiens	IC50	nM	46.0
	13836343	CHEMBL3090923	Inhibition of MEK1 S218E/S222E mutant (unknown origin) using inactive MAP kinase 2/Erk2 and FAM-Erktide as substrate assessed as inhibition of FAM-Erktide phosphorylation preincubated with inactive MAP kinase 2/Erk2 for 30 mins followed by FAM-Erktide addition measured after 90 mins by IMAP fluorescence polarization assay	B	Cc1c(Cc2cccc(NS(=O)(=O)NCCC#N)c2)c(=O)oc2cc(OC(=O)N(C)C)c(Cl)cc12		CHEMBL3086073	=	IC50	nM	36.0	CHEMBL3587	Homo sapiens	IC50	nM	36.0
	13836344	CHEMBL3090923	Inhibition of MEK1 S218E/S222E mutant (unknown origin) using inactive MAP kinase 2/Erk2 and FAM-Erktide as substrate assessed as inhibition of FAM-Erktide phosphorylation preincubated with inactive MAP kinase 2/Erk2 for 30 mins followed by FAM-Erktide addition measured after 90 mins by IMAP fluorescence polarization assay	B	Cc1c(Cc2cccc(NS(=O)(=O)NCCN)c2)c(=O)oc2cc(OC(=O)N(C)C)c(Cl)cc12.Cl		CHEMBL3086072	=	IC50	nM	5.0	CHEMBL3587	Homo sapiens	IC50	nM	5.0
	13836345	CHEMBL3090923	Inhibition of MEK1 S218E/S222E mutant (unknown origin) using inactive MAP kinase 2/Erk2 and FAM-Erktide as substrate assessed as inhibition of FAM-Erktide phosphorylation preincubated with inactive MAP kinase 2/Erk2 for 30 mins followed by FAM-Erktide addition measured after 90 mins by IMAP fluorescence polarization assay	B	Cc1c(Cc2cccc(NS(=O)(=O)NCC(F)(F)F)c2)c(=O)oc2cc(OC(=O)N(C)C)c(Cl)cc12		CHEMBL3086071	=	IC50	nM	65.0	CHEMBL3587	Homo sapiens	IC50	nM	65.0
	13836346	CHEMBL3090923	Inhibition of MEK1 S218E/S222E mutant (unknown origin) using inactive MAP kinase 2/Erk2 and FAM-Erktide as substrate assessed as inhibition of FAM-Erktide phosphorylation preincubated with inactive MAP kinase 2/Erk2 for 30 mins followed by FAM-Erktide addition measured after 90 mins by IMAP fluorescence polarization assay	B	CONS(=O)(=O)Nc1cccc(Cc2c(C)c3cc(Cl)c(OC(=O)N(C)C)cc3oc2=O)c1		CHEMBL3086070	=	IC50	nM	58.0	CHEMBL3587	Homo sapiens	IC50	nM	58.0
	13836347	CHEMBL3090923	Inhibition of MEK1 S218E/S222E mutant (unknown origin) using inactive MAP kinase 2/Erk2 and FAM-Erktide as substrate assessed as inhibition of FAM-Erktide phosphorylation preincubated with inactive MAP kinase 2/Erk2 for 30 mins followed by FAM-Erktide addition measured after 90 mins by IMAP fluorescence polarization assay	B	CCS(=O)(=O)Nc1cccc(Cc2c(C)c3cc(Cl)c(OC(=O)N(C)C)cc3oc2=O)c1		CHEMBL3086069	=	IC50	nM	21.0	CHEMBL3587	Homo sapiens	IC50	nM	21.0
	13836348	CHEMBL3090923	Inhibition of MEK1 S218E/S222E mutant (unknown origin) using inactive MAP kinase 2/Erk2 and FAM-Erktide as substrate assessed as inhibition of FAM-Erktide phosphorylation preincubated with inactive MAP kinase 2/Erk2 for 30 mins followed by FAM-Erktide addition measured after 90 mins by IMAP fluorescence polarization assay	B	Cc1c(Cc2cccc(NS(C)(=O)=O)c2)c(=O)oc2cc(OC(=O)N(C)C)c(Cl)cc12		CHEMBL3086068	=	IC50	nM	29.0	CHEMBL3587	Homo sapiens	IC50	nM	29.0
	13836349	CHEMBL3090923	Inhibition of MEK1 S218E/S222E mutant (unknown origin) using inactive MAP kinase 2/Erk2 and FAM-Erktide as substrate assessed as inhibition of FAM-Erktide phosphorylation preincubated with inactive MAP kinase 2/Erk2 for 30 mins followed by FAM-Erktide addition measured after 90 mins by IMAP fluorescence polarization assay	B	Cc1c(Cc2cccc(NC(=O)N(C)C)c2)c(=O)oc2cc(OC(=O)N(C)C)c(Cl)cc12		CHEMBL3086067	=	IC50	nM	500.0	CHEMBL3587	Homo sapiens	IC50	nM	500.0
	13836350	CHEMBL3090923	Inhibition of MEK1 S218E/S222E mutant (unknown origin) using inactive MAP kinase 2/Erk2 and FAM-Erktide as substrate assessed as inhibition of FAM-Erktide phosphorylation preincubated with inactive MAP kinase 2/Erk2 for 30 mins followed by FAM-Erktide addition measured after 90 mins by IMAP fluorescence polarization assay	B	CC(=O)Nc1cccc(Cc2c(C)c3cc(Cl)c(OC(=O)N(C)C)cc3oc2=O)c1		CHEMBL81277	=	IC50	nM	96.0	CHEMBL3587	Homo sapiens	IC50	nM	96.0
	13836351	CHEMBL3090923	Inhibition of MEK1 S218E/S222E mutant (unknown origin) using inactive MAP kinase 2/Erk2 and FAM-Erktide as substrate assessed as inhibition of FAM-Erktide phosphorylation preincubated with inactive MAP kinase 2/Erk2 for 30 mins followed by FAM-Erktide addition measured after 90 mins by IMAP fluorescence polarization assay	B	Cc1c(Cc2cccc(NS(=O)(=O)N(C)C)c2)c(=O)oc2cc(OC(=O)N(C)C)c(Cl)cc12		CHEMBL3086066	=	IC50	nM	11.0	CHEMBL3587	Homo sapiens	IC50	nM	11.0
	13836352	CHEMBL3090923	Inhibition of MEK1 S218E/S222E mutant (unknown origin) using inactive MAP kinase 2/Erk2 and FAM-Erktide as substrate assessed as inhibition of FAM-Erktide phosphorylation preincubated with inactive MAP kinase 2/Erk2 for 30 mins followed by FAM-Erktide addition measured after 90 mins by IMAP fluorescence polarization assay	B	CNS(=O)(=O)Nc1cccc(Cc2c(C)c3cc(Cl)c(OC(=O)N(C)C)cc3oc2=O)c1		CHEMBL3086065	=	IC50	nM	7.0	CHEMBL3587	Homo sapiens	IC50	nM	7.0
	13836353	CHEMBL3090923	Inhibition of MEK1 S218E/S222E mutant (unknown origin) using inactive MAP kinase 2/Erk2 and FAM-Erktide as substrate assessed as inhibition of FAM-Erktide phosphorylation preincubated with inactive MAP kinase 2/Erk2 for 30 mins followed by FAM-Erktide addition measured after 90 mins by IMAP fluorescence polarization assay	B	Cc1c(Cc2cccc(NS(N)(=O)=O)c2)c(=O)oc2cc(OC(=O)N(C)C)c(Cl)cc12		CHEMBL3086064	=	IC50	nM	28.0	CHEMBL3587	Homo sapiens	IC50	nM	28.0
	13836354	CHEMBL3090923	Inhibition of MEK1 S218E/S222E mutant (unknown origin) using inactive MAP kinase 2/Erk2 and FAM-Erktide as substrate assessed as inhibition of FAM-Erktide phosphorylation preincubated with inactive MAP kinase 2/Erk2 for 30 mins followed by FAM-Erktide addition measured after 90 mins by IMAP fluorescence polarization assay	B	Cc1c(Cc2cccc(N)c2)c(=O)oc2cc(OC(=O)N(C)C)c(Cl)cc12		CHEMBL3086063	=	IC50	nM	56.0	CHEMBL3587	Homo sapiens	IC50	nM	56.0
	13836355	CHEMBL3090923	Inhibition of MEK1 S218E/S222E mutant (unknown origin) using inactive MAP kinase 2/Erk2 and FAM-Erktide as substrate assessed as inhibition of FAM-Erktide phosphorylation preincubated with inactive MAP kinase 2/Erk2 for 30 mins followed by FAM-Erktide addition measured after 90 mins by IMAP fluorescence polarization assay	B	Cc1c(Cc2ccccc2N)c(=O)oc2cc(OC(=O)N(C)C)c(Cl)cc12		CHEMBL3086062	=	IC50	nM	210.0	CHEMBL3587	Homo sapiens	IC50	nM	210.0
	13849975	CHEMBL3096357	Inhibition of MEK1 (unknown origin) assessed as phosphorylation of Erk2 preincubated for 30 mins followed by FAM-Erktide addition measured after 60 mins by IMAP fluorescence polarization assay	B	CNS(=O)(=O)Nc1cccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1C		CHEMBL3092177	=	IC50	nM	4200.0	CHEMBL3587	Homo sapiens	IC50	nM	4200.0
	13849977	CHEMBL3096357	Inhibition of MEK1 (unknown origin) assessed as phosphorylation of Erk2 preincubated for 30 mins followed by FAM-Erktide addition measured after 60 mins by IMAP fluorescence polarization assay	B	CNS(=O)(=O)Nc1ccc(F)c(Cc2c(C)c3ccc(OC(=O)N(C)C)cc3oc2=O)c1		CHEMBL3092190	=	IC50	nM	2900.0	CHEMBL3587	Homo sapiens	IC50	nM	2900.0
	13849982	CHEMBL3096357	Inhibition of MEK1 (unknown origin) assessed as phosphorylation of Erk2 preincubated for 30 mins followed by FAM-Erktide addition measured after 60 mins by IMAP fluorescence polarization assay	B	Cc1c(Cc2cc(NS(N)(=O)=O)ccc2F)c(=O)oc2cc(OC(=O)N(C)C)ccc12		CHEMBL3092183	=	IC50	nM	940.0	CHEMBL3587	Homo sapiens	IC50	nM	940.0
	13849984	CHEMBL3096357	Inhibition of MEK1 (unknown origin) assessed as phosphorylation of Erk2 preincubated for 30 mins followed by FAM-Erktide addition measured after 60 mins by IMAP fluorescence polarization assay	B	CNS(=O)(=O)Nc1cccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1		CHEMBL3092194	=	IC50	nM	810.0	CHEMBL3587	Homo sapiens	IC50	nM	810.0
	13849993	CHEMBL3096357	Inhibition of MEK1 (unknown origin) assessed as phosphorylation of Erk2 preincubated for 30 mins followed by FAM-Erktide addition measured after 60 mins by IMAP fluorescence polarization assay	B	Cc1c(Cc2cccc(NS(N)(=O)=O)c2)c(=O)oc2c(F)c(OC(=O)N(C)C)ccc12		CHEMBL3092187	=	IC50	nM	240.0	CHEMBL3587	Homo sapiens	IC50	nM	240.0
	13849994	CHEMBL3096357	Inhibition of MEK1 (unknown origin) assessed as phosphorylation of Erk2 preincubated for 30 mins followed by FAM-Erktide addition measured after 60 mins by IMAP fluorescence polarization assay	B	Cc1c(Cc2cccc(NS(N)(=O)=O)c2)c(=O)oc2cc(OC(=O)N(C)C)ccc12		CHEMBL3092182	=	IC50	nM	230.0	CHEMBL3587	Homo sapiens	IC50	nM	230.0
	13850009	CHEMBL3096357	Inhibition of MEK1 (unknown origin) assessed as phosphorylation of Erk2 preincubated for 30 mins followed by FAM-Erktide addition measured after 60 mins by IMAP fluorescence polarization assay	B	CNS(=O)(=O)Nc1cccc(Cc2c(C)c3ccc(OC(=O)N(C)C)cc3oc2=O)c1		CHEMBL3092189	=	IC50	nM	110.0	CHEMBL3587	Homo sapiens	IC50	nM	110.0
	13850010	CHEMBL3096357	Inhibition of MEK1 (unknown origin) assessed as phosphorylation of Erk2 preincubated for 30 mins followed by FAM-Erktide addition measured after 60 mins by IMAP fluorescence polarization assay	B	Cc1c(Cc2cccc(NS(N)(=O)=O)c2)c(=O)oc2cc(OC(=O)N(C)C)c(F)cc12		CHEMBL3092186	=	IC50	nM	110.0	CHEMBL3587	Homo sapiens	IC50	nM	110.0
	13850013	CHEMBL3096357	Inhibition of MEK1 (unknown origin) assessed as phosphorylation of Erk2 preincubated for 30 mins followed by FAM-Erktide addition measured after 60 mins by IMAP fluorescence polarization assay	B	C#Cc1cc2c(C)c(Cc3cccc(NS(=O)(=O)NC)c3)c(=O)oc2cc1OC(=O)N(C)C		CHEMBL3092180	=	IC50	nM	100.0	CHEMBL3587	Homo sapiens	IC50	nM	100.0
	13850015	CHEMBL3096357	Inhibition of MEK1 (unknown origin) assessed as phosphorylation of Erk2 preincubated for 30 mins followed by FAM-Erktide addition measured after 60 mins by IMAP fluorescence polarization assay	B	CNS(=O)(=O)Nc1cccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3092195	=	IC50	nM	97.0	CHEMBL3587	Homo sapiens	IC50	nM	97.0
	13850019	CHEMBL3096357	Inhibition of MEK1 (unknown origin) assessed as phosphorylation of Erk2 preincubated for 30 mins followed by FAM-Erktide addition measured after 60 mins by IMAP fluorescence polarization assay	B	CNS(=O)(=O)Nc1cccc(Cc2c(C)c3cc(C#N)c(OC(=O)N(C)C)cc3oc2=O)c1		CHEMBL3092181	=	IC50	nM	85.0	CHEMBL3587	Homo sapiens	IC50	nM	85.0
	13850031	CHEMBL3096357	Inhibition of MEK1 (unknown origin) assessed as phosphorylation of Erk2 preincubated for 30 mins followed by FAM-Erktide addition measured after 60 mins by IMAP fluorescence polarization assay	B	CNS(=O)(=O)Nc1cccc(Cc2c(CF)c3ccc(OC(=O)N(C)C)cc3oc2=O)c1		CHEMBL3092193	=	IC50	nM	66.0	CHEMBL3587	Homo sapiens	IC50	nM	66.0
	13850032	CHEMBL3096357	Inhibition of MEK1 (unknown origin) assessed as phosphorylation of Erk2 preincubated for 30 mins followed by FAM-Erktide addition measured after 60 mins by IMAP fluorescence polarization assay	B	CNS(=O)(=O)Nc1cccc(Cc2c(C)c3cc(F)c(OC(=O)N(C)C)cc3oc2=O)c1		CHEMBL3092192	=	IC50	nM	64.0	CHEMBL3587	Homo sapiens	IC50	nM	64.0
	13850035	CHEMBL3096357	Inhibition of MEK1 (unknown origin) assessed as phosphorylation of Erk2 preincubated for 30 mins followed by FAM-Erktide addition measured after 60 mins by IMAP fluorescence polarization assay	B	CN(C)C(=O)Oc1ccc2c(CF)c(Cc3cccc(NS(N)(=O)=O)c3)c(=O)oc2c1		CHEMBL3092188	=	IC50	nM	60.0	CHEMBL3587	Homo sapiens	IC50	nM	60.0
	13850037	CHEMBL3096357	Inhibition of MEK1 (unknown origin) assessed as phosphorylation of Erk2 preincubated for 30 mins followed by FAM-Erktide addition measured after 60 mins by IMAP fluorescence polarization assay	B	CNS(=O)(=O)Nc1cccc(Cc2c(C)c3ccc(Oc4nccs4)cc3oc2=O)c1		CHEMBL3092196	=	IC50	nM	59.0	CHEMBL3587	Homo sapiens	IC50	nM	59.0
	13850040	CHEMBL3096357	Inhibition of MEK1 (unknown origin) assessed as phosphorylation of Erk2 preincubated for 30 mins followed by FAM-Erktide addition measured after 60 mins by IMAP fluorescence polarization assay	B	Cc1c(Cc2cccc(NS(N)(=O)=O)c2F)c(=O)oc2cc(OC(=O)N(C)C)ccc12		CHEMBL3092185	=	IC50	nM	53.0	CHEMBL3587	Homo sapiens	IC50	nM	53.0
	13850043	CHEMBL3096357	Inhibition of MEK1 (unknown origin) assessed as phosphorylation of Erk2 preincubated for 30 mins followed by FAM-Erktide addition measured after 60 mins by IMAP fluorescence polarization assay	B	Cc1c(Cc2ccc(F)c(NS(N)(=O)=O)c2)c(=O)oc2cc(OC(=O)N(C)C)ccc12		CHEMBL3092184	=	IC50	nM	44.0	CHEMBL3587	Homo sapiens	IC50	nM	44.0
	13850048	CHEMBL3096357	Inhibition of MEK1 (unknown origin) assessed as phosphorylation of Erk2 preincubated for 30 mins followed by FAM-Erktide addition measured after 60 mins by IMAP fluorescence polarization assay	B	CNS(=O)(=O)Nc1cccc(Cc2c(C)c3ccc(OC(=O)N(C)C)cc3oc2=O)c1F		CHEMBL3092191	=	IC50	nM	38.0	CHEMBL3587	Homo sapiens	IC50	nM	38.0
	13850055	CHEMBL3096357	Inhibition of MEK1 (unknown origin) assessed as phosphorylation of Erk2 preincubated for 30 mins followed by FAM-Erktide addition measured after 60 mins by IMAP fluorescence polarization assay	B	CNS(=O)(=O)Nc1cccc(Cc2c(C)c3cc(C)c(OC(=O)N(C)C)cc3oc2=O)c1		CHEMBL3092179	=	IC50	nM	29.0	CHEMBL3587	Homo sapiens	IC50	nM	29.0
	13850056	CHEMBL3096357	Inhibition of MEK1 (unknown origin) assessed as phosphorylation of Erk2 preincubated for 30 mins followed by FAM-Erktide addition measured after 60 mins by IMAP fluorescence polarization assay	B	CNS(=O)(=O)Nc1cccc(Cc2c(C)c3ccc(Oc4nccs4)cc3oc2=O)c1F		CHEMBL3092176	=	IC50	nM	26.0	CHEMBL3587	Homo sapiens	IC50	nM	26.0
	13850096	CHEMBL3096357	Inhibition of MEK1 (unknown origin) assessed as phosphorylation of Erk2 preincubated for 30 mins followed by FAM-Erktide addition measured after 60 mins by IMAP fluorescence polarization assay	B	CNS(=O)(=O)Nc1cccc(Cc2c(C)c3cc(Cl)c(OC(=O)N(C)C)cc3oc2=O)c1		CHEMBL3086065	=	IC50	nM	7.0	CHEMBL3587	Homo sapiens	IC50	nM	7.0
	13850115	CHEMBL3096357	Inhibition of MEK1 (unknown origin) assessed as phosphorylation of Erk2 preincubated for 30 mins followed by FAM-Erktide addition measured after 60 mins by IMAP fluorescence polarization assay	B	CNS(=O)(=O)Nc1cccc(Cc2c(C)c3cc(I)c(OC(=O)N(C)C)cc3oc2=O)c1		CHEMBL3092178	=	IC50	nM	5.0	CHEMBL3587	Homo sapiens	IC50	nM	5.0
	13863632	CHEMBL3102608	Inhibition of recombinant MEK1 (unknown origin) expressed in Escherichia coli	B	CC(C)n1cc(C2=C(c3nn(CCCN4CCOCC4)c4ncccc34)C(=O)NC2=O)c2ccccc21		CHEMBL3099835	>	IC50	nM	40000.0	CHEMBL3587	Homo sapiens	IC50	uM	40.0
	13863633	CHEMBL3102608	Inhibition of recombinant MEK1 (unknown origin) expressed in Escherichia coli	B	Cn1cc(C2=C(c3nn(CCN4CCOCC4)c4ncccc34)C(=O)NC2=O)c2ccccc21		CHEMBL3099832	>	IC50	nM	40000.0	CHEMBL3587	Homo sapiens	IC50	uM	40.0
	13863634	CHEMBL3102608	Inhibition of recombinant MEK1 (unknown origin) expressed in Escherichia coli	B	Cn1cc(C2=C(c3nn(CCn4ccnc4)c4ncccc34)C(=O)NC2=O)c2ccccc21		CHEMBL563560	>	IC50	nM	40000.0	CHEMBL3587	Homo sapiens	IC50	uM	40.0
	13863635	CHEMBL3102608	Inhibition of recombinant MEK1 (unknown origin) expressed in Escherichia coli	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	670.0	CHEMBL3587	Homo sapiens	IC50	uM	0.67
	13872103	CHEMBL3101410	Inhibition of human MEK1 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	96.0	CHEMBL3587	Homo sapiens	Activity	%	96.0
	13878400	CHEMBL3108324	Inhibition of wild type MEK1 (unknown origin)	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	13878401	CHEMBL3108324	Inhibition of wild type MEK1 (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	300.0	CHEMBL3587	Homo sapiens	IC50	uM	0.3
	13878402	CHEMBL3108324	Inhibition of wild type MEK1 (unknown origin)	B	Cc1c(O)c(O)c(O)c(C=O)c1-c1cc2c(C=O)c(C)c(O)c(O)c2o1		CHEMBL3104855	>	IC50	nM	30000.0	CHEMBL3587	Homo sapiens	IC50	uM	30.0
	13878403	CHEMBL3108324	Inhibition of wild type MEK1 (unknown origin)	B	Cc1c(O)c(O)c(O)c2c1COC2=O		CHEMBL3104854	>	IC50	nM	100000.0	CHEMBL3587	Homo sapiens	IC50	uM	100.0
	13878404	CHEMBL3108324	Inhibition of wild type MEK1 (unknown origin)	B	COCc1c(C)c(O)c(O)c(O)c1C=O		CHEMBL3104853	>	IC50	nM	30000.0	CHEMBL3587	Homo sapiens	IC50	uM	30.0
	13878405	CHEMBL3108324	Inhibition of wild type MEK1 (unknown origin)	B	COC1OC(=O)c2c(O)c(O)c(O)c(C)c21		CHEMBL3104852	>	IC50	nM	30000.0	CHEMBL3587	Homo sapiens	IC50	uM	30.0
	13878406	CHEMBL3108324	Inhibition of wild type MEK1 (unknown origin)	B	Cc1c(O)c(O)c2c(c1C=O)[C@@H]1O[C@H](O2)c2c(C)c(O)c(O)c(O)c2C1=O		CHEMBL3104851	>	IC50	nM	30000.0	CHEMBL3587	Homo sapiens	IC50	uM	30.0
	13897457	CHEMBL3111642	Inhibition of wild type MEK1 (unknown origin) assessed as incorporation of [gamma-33P]-ATP into substrate by radiometric assay	B	COC(=O)c1cc(O)c(O)c(C[C@]2(C)[C@@H](C)CC[C@@]3(C)C(C)=CCC[C@H]32)c1		CHEMBL3109404	>	IC50	nM	100000.0	CHEMBL3587	Homo sapiens	IC50	uM	100.0
	13897458	CHEMBL3111642	Inhibition of wild type MEK1 (unknown origin) assessed as incorporation of [gamma-33P]-ATP into substrate by radiometric assay	B	COc1cc2nc(C)oc2c(C[C@]2(C)[C@@H](C)CC[C@@]3(C)C(C)=CCC[C@H]32)c1O		CHEMBL3109402	>	IC50	nM	100000.0	CHEMBL3587	Homo sapiens	IC50	uM	100.0
	13897459	CHEMBL3111642	Inhibition of wild type MEK1 (unknown origin) assessed as incorporation of [gamma-33P]-ATP into substrate by radiometric assay	B	CC1=CCC[C@@H]2[C@@]1(C)CC[C@H](C)[C@@]2(C)CC1=C(O)C(=O)C=C(NCCC(C)C)C1=O		CHEMBL3109401	>	IC50	nM	100000.0	CHEMBL3587	Homo sapiens	IC50	uM	100.0
	13948191	CHEMBL3132598	Inhibition of N-terminal GST-tagged MEK1 (unknown origin) expressed in 293 cells using GST-ERK1(K71A) as substrate after 20 mins	B	N#Cc1c(Oc2ccc(F)c(NC(=O)Cc3cccc(C(F)(F)F)c3)c2)ccc2nc(NC(=O)C3CC3)sc12		CHEMBL3125890	=	IC50	nM	3700.0	CHEMBL3587	Homo sapiens	IC50	nmol/L	3700.0
	13953345	CHEMBL3130914	Inhibition of human MEK1 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	90.0	CHEMBL3587	Homo sapiens	Activity	%	90.0
	13953352	CHEMBL3130914	Inhibition of human MEK1 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	89.0	CHEMBL3587	Homo sapiens	Activity	%	89.0
	13953363	CHEMBL3130914	Inhibition of human MEK1 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	86.0	CHEMBL3587	Homo sapiens	Activity	%	86.0
	13972311	CHEMBL3136009	Inhibition of B-Raf activated MEK1 (unknown origin) assessed as ERK2-mediated MBP phosphorylation after 30 mins by ELISA	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	=	IC50	nM	3.4	CHEMBL3587	Homo sapiens	IC50	nM	3.4
	14527026	CHEMBL3226581	Inhibition of MEK1 (unknown origin)	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	IC50	nM	4000.0	CHEMBL3587	Homo sapiens	IC50	uM	4.0
	14553638	CHEMBL3225778	Inhibition of MEK1 (unknown origin) at 10 uM assessed as residual enzyme activity	B	COc1ccc(-c2n[nH]c3ncc(-c4ccc(Cl)cc4N)cc23)cc1		CHEMBL3220823	=	Activity	%	102.4	CHEMBL3587	Homo sapiens	Activity	%	102.4
	14582548	CHEMBL3242549	Inhibition of human MEK1 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	97.0	CHEMBL3587	Homo sapiens	Activity	%	97.0
	14648042	CHEMBL3265831	Inhibition of human MKK1 at 1 uM relative to control	B	CC(C)CCNc1ccc(-c2cnc3ccc(NC4CCN(C)CC4)nn23)cn1		CHEMBL2380687	=	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	14648043	CHEMBL3265831	Inhibition of human MKK1 at 1 uM relative to control	B	N[C@H]1CC[C@H](Nc2ccc3ncc(-c4cnc(Nc5ncccc5F)nc4)n3n2)CC1		CHEMBL3264059	>	Inhibition	%	80.0	CHEMBL3587	Homo sapiens	INH	%	80.0
	14653725	CHEMBL3267831	Inhibition of constitutively active MEK1 S218E,S222E mutant (unknown origin) assessed as MAP kinase 2/Erk2-mediated FAM-Erktide phosphorylation using MAP kinase 2/Erk2 as substrate preincubated for 30 mins by IMAP fluorescence polarization assay	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	=	IC50	nM	160.0	CHEMBL3587	Homo sapiens	IC50	nM	160.0
	14653726	CHEMBL3267831	Inhibition of constitutively active MEK1 S218E,S222E mutant (unknown origin) assessed as MAP kinase 2/Erk2-mediated FAM-Erktide phosphorylation using MAP kinase 2/Erk2 as substrate preincubated for 30 mins by IMAP fluorescence polarization assay	B	CNS(=O)(=O)Nc1cccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3092195	=	IC50	nM	97.0	CHEMBL3587	Homo sapiens	IC50	nM	97.0
	14653727	CHEMBL3267831	Inhibition of constitutively active MEK1 S218E,S222E mutant (unknown origin) assessed as MAP kinase 2/Erk2-mediated FAM-Erktide phosphorylation using MAP kinase 2/Erk2 as substrate preincubated for 30 mins by IMAP fluorescence polarization assay	B	CNS(=O)(=O)Nc1cccc(Cc2c(C)c3ccc(OC(=O)N(C)C)cc3oc2=O)c1		CHEMBL3092189	=	IC50	nM	110.0	CHEMBL3587	Homo sapiens	IC50	nM	110.0
	14653728	CHEMBL3267831	Inhibition of constitutively active MEK1 S218E,S222E mutant (unknown origin) assessed as MAP kinase 2/Erk2-mediated FAM-Erktide phosphorylation using MAP kinase 2/Erk2 as substrate preincubated for 30 mins by IMAP fluorescence polarization assay	B	CNS(=O)(=O)Nc1cccc(Cc2c(C)c3ccc(OC(=O)N(C)C)nc3oc2=O)c1		CHEMBL3263994	=	IC50	nM	440.0	CHEMBL3587	Homo sapiens	IC50	nM	440.0
	14653729	CHEMBL3267831	Inhibition of constitutively active MEK1 S218E,S222E mutant (unknown origin) assessed as MAP kinase 2/Erk2-mediated FAM-Erktide phosphorylation using MAP kinase 2/Erk2 as substrate preincubated for 30 mins by IMAP fluorescence polarization assay	B	CNS(=O)(=O)Nc1cccc(Cc2c(C)c3ccc(OC(=O)N(C)C)cc3oc2=O)n1		CHEMBL3263995	=	IC50	nM	110.0	CHEMBL3587	Homo sapiens	IC50	nM	110.0
	14653730	CHEMBL3267831	Inhibition of constitutively active MEK1 S218E,S222E mutant (unknown origin) assessed as MAP kinase 2/Erk2-mediated FAM-Erktide phosphorylation using MAP kinase 2/Erk2 as substrate preincubated for 30 mins by IMAP fluorescence polarization assay	B	CNS(=O)(=O)Nc1cc(Cc2c(C)c3ccc(OC(=O)N(C)C)cc3oc2=O)ccn1		CHEMBL3263996	=	IC50	nM	99.0	CHEMBL3587	Homo sapiens	IC50	nM	99.0
	14653731	CHEMBL3267831	Inhibition of constitutively active MEK1 S218E,S222E mutant (unknown origin) assessed as MAP kinase 2/Erk2-mediated FAM-Erktide phosphorylation using MAP kinase 2/Erk2 as substrate preincubated for 30 mins by IMAP fluorescence polarization assay	B	CNS(=O)(=O)Nc1cncc(Cc2c(C)c3ccc(OC(=O)N(C)C)cc3oc2=O)c1		CHEMBL3263997	>	IC50	nM	50000.0	CHEMBL3587	Homo sapiens	IC50	nM	50000.0
	14653732	CHEMBL3267831	Inhibition of constitutively active MEK1 S218E,S222E mutant (unknown origin) assessed as MAP kinase 2/Erk2-mediated FAM-Erktide phosphorylation using MAP kinase 2/Erk2 as substrate preincubated for 30 mins by IMAP fluorescence polarization assay	B	CNS(=O)(=O)Nc1cccc(Cc2c(C)c3cc(C)c(OC(=O)N(C)C)cc3oc2=O)c1		CHEMBL3092179	=	IC50	nM	29.0	CHEMBL3587	Homo sapiens	IC50	nM	29.0
	14653733	CHEMBL3267831	Inhibition of constitutively active MEK1 S218E,S222E mutant (unknown origin) assessed as MAP kinase 2/Erk2-mediated FAM-Erktide phosphorylation using MAP kinase 2/Erk2 as substrate preincubated for 30 mins by IMAP fluorescence polarization assay	B	CNS(=O)(=O)Nc1ccnc(Cc2c(C)c3cc(C)c(OC(=O)N(C)C)cc3oc2=O)c1		CHEMBL3263998	=	IC50	nM	37000.0	CHEMBL3587	Homo sapiens	IC50	nM	37000.0
	14653734	CHEMBL3267831	Inhibition of constitutively active MEK1 S218E,S222E mutant (unknown origin) assessed as MAP kinase 2/Erk2-mediated FAM-Erktide phosphorylation using MAP kinase 2/Erk2 as substrate preincubated for 30 mins by IMAP fluorescence polarization assay	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ccccc4)cc3oc2=O)c1F		CHEMBL3263999	=	IC50	nM	76.0	CHEMBL3587	Homo sapiens	IC50	nM	76.0
	14653735	CHEMBL3267831	Inhibition of constitutively active MEK1 S218E,S222E mutant (unknown origin) assessed as MAP kinase 2/Erk2-mediated FAM-Erktide phosphorylation using MAP kinase 2/Erk2 as substrate preincubated for 30 mins by IMAP fluorescence polarization assay	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ccccn4)cc3oc2=O)c1F		CHEMBL3264000	=	IC50	nM	190.0	CHEMBL3587	Homo sapiens	IC50	nM	190.0
	14653736	CHEMBL3267831	Inhibition of constitutively active MEK1 S218E,S222E mutant (unknown origin) assessed as MAP kinase 2/Erk2-mediated FAM-Erktide phosphorylation using MAP kinase 2/Erk2 as substrate preincubated for 30 mins by IMAP fluorescence polarization assay	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4cnccn4)cc3oc2=O)c1F		CHEMBL3264001	=	IC50	nM	650.0	CHEMBL3587	Homo sapiens	IC50	nM	650.0
	14653737	CHEMBL3267831	Inhibition of constitutively active MEK1 S218E,S222E mutant (unknown origin) assessed as MAP kinase 2/Erk2-mediated FAM-Erktide phosphorylation using MAP kinase 2/Erk2 as substrate preincubated for 30 mins by IMAP fluorescence polarization assay	B	CNS(=O)(=O)Nc1cccc(Nc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1		CHEMBL3264003	>	IC50	nM	50000.0	CHEMBL3587	Homo sapiens	IC50	nM	50000.0
	14666136	CHEMBL3266112	Inhibition of MEK1 (unknown origin)	B	O=c1c2c(Nc3ccc(I)cc3F)cncc2cnn1C[C@H](O)CO		CHEMBL3261161	=	IC50	nM	1.63	CHEMBL3587	Homo sapiens	IC50	nM	1.63
	14666137	CHEMBL3266112	Inhibition of MEK1 (unknown origin)	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	=	IC50	nM	1.79	CHEMBL3587	Homo sapiens	IC50	nM	1.79
	14666138	CHEMBL3266112	Inhibition of MEK1 (unknown origin)	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	=	IC50	nM	3.39	CHEMBL3587	Homo sapiens	IC50	nM	3.39
	14666139	CHEMBL3266112	Inhibition of MEK1 (unknown origin)	B	O=C(NC[C@H](O)CO)c1ncncc1Nc1ccc(I)cc1F		CHEMBL3261144	=	IC50	nM	5.37	CHEMBL3587	Homo sapiens	IC50	nM	5.37
	14666140	CHEMBL3266112	Inhibition of MEK1 (unknown origin)	B	Cc1nn(C[C@H](O)CO)c(=O)c2c(Nc3ccc(I)cc3F)cncc12		CHEMBL3261162	=	IC50	nM	11.4	CHEMBL3587	Homo sapiens	IC50	nM	11.4
	14666141	CHEMBL3266112	Inhibition of MEK1 (unknown origin)	B	O=c1c2c(Nc3ccc(I)cc3F)cncc2ncn1C[C@H](O)CO		CHEMBL3261157	=	IC50	nM	12.3	CHEMBL3587	Homo sapiens	IC50	nM	12.3
	14666142	CHEMBL3266112	Inhibition of MEK1 (unknown origin)	B	O=C(NC[C@H](O)CO)c1nc(Cl)ncc1Nc1ccc(I)cc1F		CHEMBL3261153	=	IC50	nM	13.0	CHEMBL3587	Homo sapiens	IC50	nM	13.0
	14666143	CHEMBL3266112	Inhibition of MEK1 (unknown origin)	B	O=C(NC[C@@H](O)CO)c1ncncc1Nc1ccc(I)cc1F		CHEMBL3259833	=	IC50	nM	30.2	CHEMBL3587	Homo sapiens	IC50	nM	30.2
	14666144	CHEMBL3266112	Inhibition of MEK1 (unknown origin)	B	O=C(NC(CO)CO)c1ncncc1Nc1ccc(I)cc1F		CHEMBL3261150	=	IC50	nM	31.3	CHEMBL3587	Homo sapiens	IC50	nM	31.3
	14666145	CHEMBL3266112	Inhibition of MEK1 (unknown origin)	B	O=c1c2c(Nc3ccc(I)cc3F)cncc2ncn1C[C@@H](O)CO		CHEMBL3261158	=	IC50	nM	33.6	CHEMBL3587	Homo sapiens	IC50	nM	33.6
	14666146	CHEMBL3266112	Inhibition of MEK1 (unknown origin)	B	O=C(NCCO)c1ncncc1Nc1ccc(I)cc1F		CHEMBL3261145	=	IC50	nM	49.6	CHEMBL3587	Homo sapiens	IC50	nM	49.6
	14666147	CHEMBL3266112	Inhibition of MEK1 (unknown origin)	B	O=C(NCCCO)c1ncncc1Nc1ccc(I)cc1F		CHEMBL3261146	=	IC50	nM	60.1	CHEMBL3587	Homo sapiens	IC50	nM	60.1
	14666148	CHEMBL3266112	Inhibition of MEK1 (unknown origin)	B	O=c1c2c(Nc3ccc(I)cc3F)cncc2c(I)nn1C[C@H](O)CO		CHEMBL3261164	=	IC50	nM	95.0	CHEMBL3587	Homo sapiens	IC50	nM	95.0
	14666149	CHEMBL3266112	Inhibition of MEK1 (unknown origin)	B	O=c1c2c(Nc3ccc(I)cc3F)cnc(Cl)c2ncn1C[C@H](O)CO		CHEMBL3261159	=	IC50	nM	112.0	CHEMBL3587	Homo sapiens	IC50	nM	112.0
	14666150	CHEMBL3266112	Inhibition of MEK1 (unknown origin)	B	Cc1ncc2ncn(C[C@H](O)CO)c(=O)c2c1Nc1ccc(I)cc1F		CHEMBL3261160	=	IC50	nM	123.0	CHEMBL3587	Homo sapiens	IC50	nM	123.0
	14666151	CHEMBL3266112	Inhibition of MEK1 (unknown origin)	B	Cc1ncc(Nc2ccc(I)cc2F)c(C(=O)NC[C@H](O)CO)n1		CHEMBL3261151	=	IC50	nM	138.5	CHEMBL3587	Homo sapiens	IC50	nM	138.5
	14666152	CHEMBL3266112	Inhibition of MEK1 (unknown origin)	B	Cc1ncnc(C(=O)NC[C@H](O)CO)c1Nc1ccc(I)cc1F		CHEMBL3261154	=	IC50	nM	314.0	CHEMBL3587	Homo sapiens	IC50	nM	314.0
	14666153	CHEMBL3266112	Inhibition of MEK1 (unknown origin)	B	Cc1nn(C[C@@H](O)CO)c(=O)c2c(Nc3ccc(I)cc3F)cncc12		CHEMBL3261163	=	IC50	nM	326.0	CHEMBL3587	Homo sapiens	IC50	nM	326.0
	14666154	CHEMBL3266112	Inhibition of MEK1 (unknown origin)	B	O=C(NOC[C@@H](O)CO)c1ncncc1Nc1ccc(I)cc1F		CHEMBL3261149	=	IC50	nM	411.0	CHEMBL3587	Homo sapiens	IC50	nM	411.0
	14666155	CHEMBL3266112	Inhibition of MEK1 (unknown origin)	B	O=C(NOCCO)c1ncncc1Nc1ccc(I)cc1F		CHEMBL3261147	=	IC50	nM	513.2	CHEMBL3587	Homo sapiens	IC50	nM	513.2
	14666156	CHEMBL3266112	Inhibition of MEK1 (unknown origin)	B	O=C(NOC[C@H](O)CO)c1ncncc1Nc1ccc(I)cc1F		CHEMBL3261148	=	IC50	nM	559.0	CHEMBL3587	Homo sapiens	IC50	nM	559.0
	14666157	CHEMBL3266112	Inhibition of MEK1 (unknown origin)	B	Cc1ncc(Nc2ccc(I)cc2F)c(C(=O)N[C@@H]2CCC[C@@H](O)[C@H]2O)n1		CHEMBL3261155	=	IC50	nM	773.0	CHEMBL3587	Homo sapiens	IC50	nM	773.0
	14666158	CHEMBL3266112	Inhibition of MEK1 (unknown origin)	B	Cc1ncc(Nc2ccc(I)cc2F)c(C(=O)NC[C@@H](O)CO)n1		CHEMBL3261152	>	IC50	nM	1000.0	CHEMBL3587	Homo sapiens	IC50	nM	1000.0
	14666159	CHEMBL3266112	Inhibition of MEK1 (unknown origin)	B	O=C(NC[C@H](O)CO)c1ncncc1Nc1ccccc1F		CHEMBL3261156	>	IC50	nM	1000.0	CHEMBL3587	Homo sapiens	IC50	nM	1000.0
	14666160	CHEMBL3266113	Inhibition of MEK1 in human COLO205 cells	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	=	IC50	nM	1.81	CHEMBL3587	Homo sapiens	IC50	nM	1.81
	14666161	CHEMBL3266113	Inhibition of MEK1 in human COLO205 cells	B	O=c1c2c(Nc3ccc(I)cc3F)cncc2cnn1C[C@H](O)CO		CHEMBL3261161	=	IC50	nM	1.95	CHEMBL3587	Homo sapiens	IC50	nM	1.95
	14666162	CHEMBL3266113	Inhibition of MEK1 in human COLO205 cells	B	O=C(NC[C@H](O)CO)c1ncncc1Nc1ccc(I)cc1F		CHEMBL3261144	=	IC50	nM	3.41	CHEMBL3587	Homo sapiens	IC50	nM	3.41
	14666163	CHEMBL3266113	Inhibition of MEK1 in human COLO205 cells	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	=	IC50	nM	6.92	CHEMBL3587	Homo sapiens	IC50	nM	6.92
	14666164	CHEMBL3266113	Inhibition of MEK1 in human COLO205 cells	B	Cc1nn(C[C@H](O)CO)c(=O)c2c(Nc3ccc(I)cc3F)cncc12		CHEMBL3261162	=	IC50	nM	13.9	CHEMBL3587	Homo sapiens	IC50	nM	13.9
	14666165	CHEMBL3266113	Inhibition of MEK1 in human COLO205 cells	B	O=C(NC[C@H](O)CO)c1nc(Cl)ncc1Nc1ccc(I)cc1F		CHEMBL3261153	=	IC50	nM	44.3	CHEMBL3587	Homo sapiens	IC50	nM	44.3
	14666166	CHEMBL3266113	Inhibition of MEK1 in human COLO205 cells	B	O=C(NC(CO)CO)c1ncncc1Nc1ccc(I)cc1F		CHEMBL3261150	=	IC50	nM	55.2	CHEMBL3587	Homo sapiens	IC50	nM	55.2
	14666167	CHEMBL3266113	Inhibition of MEK1 in human COLO205 cells	B	O=C(NC[C@@H](O)CO)c1ncncc1Nc1ccc(I)cc1F		CHEMBL3259833	=	IC50	nM	56.6	CHEMBL3587	Homo sapiens	IC50	nM	56.6
	14666168	CHEMBL3266113	Inhibition of MEK1 in human COLO205 cells	B	O=C(NCCCO)c1ncncc1Nc1ccc(I)cc1F		CHEMBL3261146	=	IC50	nM	101.4	CHEMBL3587	Homo sapiens	IC50	nM	101.4
	14666169	CHEMBL3266113	Inhibition of MEK1 in human COLO205 cells	B	O=C(NCCO)c1ncncc1Nc1ccc(I)cc1F		CHEMBL3261145	=	IC50	nM	101.6	CHEMBL3587	Homo sapiens	IC50	nM	101.6
	14666170	CHEMBL3266113	Inhibition of MEK1 in human COLO205 cells	B	O=c1c2c(Nc3ccc(I)cc3F)cncc2ncn1C[C@H](O)CO		CHEMBL3261157	=	IC50	nM	108.0	CHEMBL3587	Homo sapiens	IC50	nM	108.0
	14666171	CHEMBL3266113	Inhibition of MEK1 in human COLO205 cells	B	O=c1c2c(Nc3ccc(I)cc3F)cncc2ncn1C[C@@H](O)CO		CHEMBL3261158	=	IC50	nM	142.0	CHEMBL3587	Homo sapiens	IC50	nM	142.0
Not Determined	14666172	CHEMBL3266113	Inhibition of MEK1 in human COLO205 cells	B	O=C(NOCCO)c1ncncc1Nc1ccc(I)cc1F		CHEMBL3261147		IC50			CHEMBL3587	Homo sapiens	IC50		
Not Determined	14666173	CHEMBL3266113	Inhibition of MEK1 in human COLO205 cells	B	O=C(NOC[C@H](O)CO)c1ncncc1Nc1ccc(I)cc1F		CHEMBL3261148		IC50			CHEMBL3587	Homo sapiens	IC50		
Not Determined	14666174	CHEMBL3266113	Inhibition of MEK1 in human COLO205 cells	B	O=C(NOC[C@@H](O)CO)c1ncncc1Nc1ccc(I)cc1F		CHEMBL3261149		IC50			CHEMBL3587	Homo sapiens	IC50		
Not Determined	14666175	CHEMBL3266113	Inhibition of MEK1 in human COLO205 cells	B	Cc1ncc(Nc2ccc(I)cc2F)c(C(=O)NC[C@H](O)CO)n1		CHEMBL3261151		IC50			CHEMBL3587	Homo sapiens	IC50		
Not Determined	14666176	CHEMBL3266113	Inhibition of MEK1 in human COLO205 cells	B	Cc1ncc(Nc2ccc(I)cc2F)c(C(=O)NC[C@@H](O)CO)n1		CHEMBL3261152		IC50			CHEMBL3587	Homo sapiens	IC50		
Not Determined	14666177	CHEMBL3266113	Inhibition of MEK1 in human COLO205 cells	B	Cc1ncnc(C(=O)NC[C@H](O)CO)c1Nc1ccc(I)cc1F		CHEMBL3261154		IC50			CHEMBL3587	Homo sapiens	IC50		
Not Determined	14666178	CHEMBL3266113	Inhibition of MEK1 in human COLO205 cells	B	Cc1ncc(Nc2ccc(I)cc2F)c(C(=O)N[C@@H]2CCC[C@@H](O)[C@H]2O)n1		CHEMBL3261155		IC50			CHEMBL3587	Homo sapiens	IC50		
Not Determined	14666179	CHEMBL3266113	Inhibition of MEK1 in human COLO205 cells	B	O=C(NC[C@H](O)CO)c1ncncc1Nc1ccccc1F		CHEMBL3261156		IC50			CHEMBL3587	Homo sapiens	IC50		
Not Determined	14666180	CHEMBL3266113	Inhibition of MEK1 in human COLO205 cells	B	O=c1c2c(Nc3ccc(I)cc3F)cnc(Cl)c2ncn1C[C@H](O)CO		CHEMBL3261159		IC50			CHEMBL3587	Homo sapiens	IC50		
Not Determined	14666181	CHEMBL3266113	Inhibition of MEK1 in human COLO205 cells	B	Cc1ncc2ncn(C[C@H](O)CO)c(=O)c2c1Nc1ccc(I)cc1F		CHEMBL3261160		IC50			CHEMBL3587	Homo sapiens	IC50		
Not Determined	14666182	CHEMBL3266113	Inhibition of MEK1 in human COLO205 cells	B	Cc1nn(C[C@@H](O)CO)c(=O)c2c(Nc3ccc(I)cc3F)cncc12		CHEMBL3261163		IC50			CHEMBL3587	Homo sapiens	IC50		
Not Determined	14666183	CHEMBL3266113	Inhibition of MEK1 in human COLO205 cells	B	O=c1c2c(Nc3ccc(I)cc3F)cncc2c(I)nn1C[C@H](O)CO		CHEMBL3261164		IC50			CHEMBL3587	Homo sapiens	IC50		
	14666184	CHEMBL3266114	Inhibition of MEK1 in human HCT116 cells	B	O=c1c2c(Nc3ccc(I)cc3F)cncc2cnn1C[C@H](O)CO		CHEMBL3261161	=	IC50	nM	35.5	CHEMBL3587	Homo sapiens	IC50	nM	35.5
	14666185	CHEMBL3266115	Inhibition of MEK1 in human A549 cells	B	O=c1c2c(Nc3ccc(I)cc3F)cncc2cnn1C[C@H](O)CO		CHEMBL3261161	=	IC50	nM	58.0	CHEMBL3587	Homo sapiens	IC50	nM	58.0
	14983189	CHEMBL3385010	Inhibition of MEK1 (unknown origin) at 1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	20.0	CHEMBL3587	Homo sapiens	INH	%	20.0
	14984431	CHEMBL3382496	Inhibition of MEK1 (unknown origin) at 0.1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	-10.0	CHEMBL3587	Homo sapiens	INH	%	-10.0
	14991962	CHEMBL3373545	Inhibition of MAP2K1 (unknown origin) using unphosphorylated GST-tagged ERK2 substrate protein assessed as phosphorylation by ELISA	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	IC50	nM	80.0	CHEMBL3587	Homo sapiens	IC50	uM	0.08
	15008060	CHEMBL3369097	Inhibition of human MEK1 at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)Cc4ccccc4)cc23)c1		CHEMBL3330255	=	Inhibition	%	54.0	CHEMBL3587	Homo sapiens	INH	%	54.0
	15008061	CHEMBL3369097	Inhibition of human MEK1 at 1 uM by radiometric Assay	B	COC(C(=O)Nc1ccc2[nH]nc(-c3cccc(S(N)(=O)=O)c3)c2c1)c1ccccc1		CHEMBL3330401	=	Inhibition	%	26.0	CHEMBL3587	Homo sapiens	INH	%	26.0
	15008062	CHEMBL3369097	Inhibition of human MEK1 at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)C(c4ccsc4)N4CCCC4)cc23)c1		CHEMBL3330410	=	Inhibition	%	13.0	CHEMBL3587	Homo sapiens	INH	%	13.0
	15009767	CHEMBL3361639	Inhibition of MEK1 (unknown origin) at 10 uM	B	C[C@H](O)CNc1nccc(-n2ccnc2Cc2cccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c2)n1		CHEMBL3309549	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	INH	%	0.0
Active	15017653	CHEMBL3361508	Inhibition of MEK1 (unknown origin) at 1 uM	B	COc1cccc(-c2cc(=O)c3cc(Cl)cc(NCCCO)c3o2)c1N		CHEMBL3326325		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
	15018635	CHEMBL3361527	Inhibition of MEK1 (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	2.8	CHEMBL3587	Homo sapiens	INH	%	2.8
	15019181	CHEMBL3364374	Inhibition of MEK1 (unknown origin) at 1 uM in presence of 100 uM ATP	B	C=CC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C		CHEMBL3298512	=	Inhibition	%	5.0	CHEMBL3587	Homo sapiens	INH	%	5.0
	15022499	CHEMBL3371353	Inhibition of MEK1/MAP2K1 (unknown origin) at 1 uM	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(C(=O)NCCN3CCCC3)c2C)c(F)c1		CHEMBL3329684	=	Inhibition	%	38.0	CHEMBL3587	Homo sapiens	INH	%	38.0
	15025414	CHEMBL3365916	Inhibition of Mek1 (unknown origin) at 1 uM by radioisotope-based P81 filter-binding assay	B	O=C1Nc2cc(NC(=O)c3c[nH]cc(-c4ccccc4F)c3=O)ccc2/C1=C/c1ccc[nH]1		CHEMBL3322590	=	Inhibition	%	0.6	CHEMBL3587	Homo sapiens	INH	%	0.6
	15037283	CHEMBL3368566	Inhibition of MEK1 (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2cnc3[nH]cc(-c4ccc(OC)c(OC)c4)c3c2)cc1OC		CHEMBL3102948	=	Inhibition	%	74.0	CHEMBL3587	Homo sapiens	INH	%	74.0
	15037284	CHEMBL3368566	Inhibition of MEK1 (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1cc(-c2c[nH]c3ncc(-c4cccc(N)c4)cc23)cc(OC)c1OC		CHEMBL3319457	=	Inhibition	%	85.0	CHEMBL3587	Homo sapiens	INH	%	85.0
	15037285	CHEMBL3368566	Inhibition of MEK1 (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2c[nH]c3ncc(-c4ccc(C(=O)N5CCOCC5)c(N)c4)cc23)cc1OC		CHEMBL3319467	=	Inhibition	%	59.0	CHEMBL3587	Homo sapiens	INH	%	59.0
	15037286	CHEMBL3368566	Inhibition of MEK1 (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2c[nH]c3ncc(-c4cc(OC)c(OC)c(OC)c4)cc23)cc1OC		CHEMBL3319468	=	Inhibition	%	78.0	CHEMBL3587	Homo sapiens	INH	%	78.0
	15037287	CHEMBL3368566	Inhibition of MEK1 (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2cnc3[nH]cc(-c4ccc(OC)c(OC)c4)c3c2)cc1N		CHEMBL3319470	=	Inhibition	%	76.0	CHEMBL3587	Homo sapiens	INH	%	76.0
	15072497	CHEMBL3379498	Inhibition of MKK1 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	95.0	CHEMBL3587	Homo sapiens	Activity	%	95.0
Active	15092943	CHEMBL3381906	Inhibition of MEK1 in human A2780 cells assessed as reduction of MEK1 phosphorylation at 100 to 1000 nM after 24 hrs by Western blotting analysis	B	Cc1cc(=O)oc2cc(OCCOc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)ccc12		CHEMBL3358557		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Active	15092944	CHEMBL3381907	Inhibition of MEK1 in human A2780 cells assessed as reduction of ERK1 phosphorylation at 100 to 1000 nM after 24 hrs by Western blotting analysis	B	Cc1cc(=O)oc2cc(OCCOc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)ccc12		CHEMBL3358557		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
	15092945	CHEMBL3381908	Inhibition of MEK-1 (unknown origin) at 5 uM after 120 mins by mobility shift assay	B	Cc1cc(=O)oc2cc(Sc3cccc(Cl)n3)ccc12		CHEMBL1946665	=	Inhibition	%	1.6	CHEMBL3587	Homo sapiens	INH	%	1.6
	15092946	CHEMBL3381908	Inhibition of MEK-1 (unknown origin) at 5 uM after 120 mins by mobility shift assay	B	O=c1ccc2ccc(Oc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)cc2o1		CHEMBL3358553	=	Inhibition	%	8.4	CHEMBL3587	Homo sapiens	INH	%	8.4
	15092947	CHEMBL3381908	Inhibition of MEK-1 (unknown origin) at 5 uM after 120 mins by mobility shift assay	B	Cc1cc(=O)oc2cc(Oc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)ccc12		CHEMBL3358554	=	Inhibition	%	10.0	CHEMBL3587	Homo sapiens	INH	%	10.0
	15092948	CHEMBL3381908	Inhibition of MEK-1 (unknown origin) at 5 uM after 120 mins by mobility shift assay	B	Cc1cc(=O)oc2c(C)c(Oc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)ccc12		CHEMBL3358555	=	Inhibition	%	11.3	CHEMBL3587	Homo sapiens	INH	%	11.3
	15092949	CHEMBL3381908	Inhibition of MEK-1 (unknown origin) at 5 uM after 120 mins by mobility shift assay	B	O=c1ccc2ccc(OCCOc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)cc2o1		CHEMBL3358556	=	Inhibition	%	22.7	CHEMBL3587	Homo sapiens	INH	%	22.7
	15092950	CHEMBL3381908	Inhibition of MEK-1 (unknown origin) at 5 uM after 120 mins by mobility shift assay	B	Cc1cc(=O)oc2cc(OCCOc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)ccc12		CHEMBL3358557	=	Inhibition	%	35.2	CHEMBL3587	Homo sapiens	INH	%	35.2
	15092951	CHEMBL3381908	Inhibition of MEK-1 (unknown origin) at 5 uM after 120 mins by mobility shift assay	B	Cc1cc(=O)oc2cc(SCCOc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)ccc12		CHEMBL3358558	=	Inhibition	%	53.4	CHEMBL3587	Homo sapiens	INH	%	53.4
	15092952	CHEMBL3381908	Inhibition of MEK-1 (unknown origin) at 5 uM after 120 mins by mobility shift assay	B	Cc1cc(=O)oc2cc(OCCCOc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)ccc12		CHEMBL3358559	=	Inhibition	%	31.6	CHEMBL3587	Homo sapiens	INH	%	31.6
	15092953	CHEMBL3381908	Inhibition of MEK-1 (unknown origin) at 5 uM after 120 mins by mobility shift assay	B	Cc1cc(=O)oc2cc(OCCCCOc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)ccc12		CHEMBL3358560	=	Inhibition	%	43.0	CHEMBL3587	Homo sapiens	INH	%	43.0
	15092954	CHEMBL3381908	Inhibition of MEK-1 (unknown origin) at 5 uM after 120 mins by mobility shift assay	B	Cc1cc(=O)oc2c(C)c(OCCOc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)ccc12		CHEMBL3358561	=	Inhibition	%	48.1	CHEMBL3587	Homo sapiens	INH	%	48.1
	15092955	CHEMBL3381908	Inhibition of MEK-1 (unknown origin) at 5 uM after 120 mins by mobility shift assay	B	Cc1cc(=O)oc2cc(NCCOc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)ccc12		CHEMBL3359125	=	Inhibition	%	5.7	CHEMBL3587	Homo sapiens	INH	%	5.7
	15092956	CHEMBL3381908	Inhibition of MEK-1 (unknown origin) at 5 uM after 120 mins by mobility shift assay	B	Cc1cc(=O)oc2cc(N(C)CCOc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)ccc12		CHEMBL3359126	=	Inhibition	%	47.6	CHEMBL3587	Homo sapiens	INH	%	47.6
	15092957	CHEMBL3381908	Inhibition of MEK-1 (unknown origin) at 5 uM after 120 mins by mobility shift assay	B	O=C(COc1ccc2ccc(=O)oc2c1)OCCOc1no[n+]([O-])c1S(=O)(=O)c1ccccc1		CHEMBL3359127	=	Inhibition	%	16.4	CHEMBL3587	Homo sapiens	INH	%	16.4
	15092958	CHEMBL3381908	Inhibition of MEK-1 (unknown origin) at 5 uM after 120 mins by mobility shift assay	B	Cc1cc(=O)oc2cc(OCC(=O)OCCOc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)ccc12		CHEMBL3359128	=	Inhibition	%	14.4	CHEMBL3587	Homo sapiens	INH	%	14.4
	15092959	CHEMBL3381908	Inhibition of MEK-1 (unknown origin) at 5 uM after 120 mins by mobility shift assay	B	CCc1cc(=O)c2ccc(Oc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)cc2o1		CHEMBL3359129	=	Inhibition	%	10.9	CHEMBL3587	Homo sapiens	INH	%	10.9
	15092960	CHEMBL3381908	Inhibition of MEK-1 (unknown origin) at 5 uM after 120 mins by mobility shift assay	B	CCc1cc(=O)c2ccc(OCCOc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)cc2o1		CHEMBL3359130	=	Inhibition	%	29.8	CHEMBL3587	Homo sapiens	INH	%	29.8
	15092961	CHEMBL3381908	Inhibition of MEK-1 (unknown origin) at 5 uM after 120 mins by mobility shift assay	B	CCc1cc(=O)c2ccc(OCCCOc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)cc2o1		CHEMBL3359131	=	Inhibition	%	20.4	CHEMBL3587	Homo sapiens	INH	%	20.4
	15092962	CHEMBL3381909	Inhibition of MEK-1 (unknown origin) after 120 mins by mobility shift assay	B	O=c1ccc2ccc(Oc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)cc2o1		CHEMBL3358553	<	IC50	nM	1000.0	CHEMBL3587	Homo sapiens	IC50	uM	1.0
	15092963	CHEMBL3381909	Inhibition of MEK-1 (unknown origin) after 120 mins by mobility shift assay	B	Cc1cc(=O)oc2cc(Oc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)ccc12		CHEMBL3358554	<	IC50	nM	1000.0	CHEMBL3587	Homo sapiens	IC50	uM	1.0
	15092964	CHEMBL3381909	Inhibition of MEK-1 (unknown origin) after 120 mins by mobility shift assay	B	Cc1cc(=O)oc2c(C)c(Oc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)ccc12		CHEMBL3358555	<	IC50	nM	1000.0	CHEMBL3587	Homo sapiens	IC50	uM	1.0
	15092965	CHEMBL3381909	Inhibition of MEK-1 (unknown origin) after 120 mins by mobility shift assay	B	Cc1cc(=O)oc2cc(NCCOc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)ccc12		CHEMBL3359125	<	IC50	nM	1000.0	CHEMBL3587	Homo sapiens	IC50	uM	1.0
	15092966	CHEMBL3381909	Inhibition of MEK-1 (unknown origin) after 120 mins by mobility shift assay	B	O=C(COc1ccc2ccc(=O)oc2c1)OCCOc1no[n+]([O-])c1S(=O)(=O)c1ccccc1		CHEMBL3359127	<	IC50	nM	1000.0	CHEMBL3587	Homo sapiens	IC50	uM	1.0
	15092967	CHEMBL3381909	Inhibition of MEK-1 (unknown origin) after 120 mins by mobility shift assay	B	Cc1cc(=O)oc2cc(OCC(=O)OCCOc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)ccc12		CHEMBL3359128	<	IC50	nM	1000.0	CHEMBL3587	Homo sapiens	IC50	uM	1.0
	15092968	CHEMBL3381909	Inhibition of MEK-1 (unknown origin) after 120 mins by mobility shift assay	B	CCc1cc(=O)c2ccc(Oc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)cc2o1		CHEMBL3359129	<	IC50	nM	1000.0	CHEMBL3587	Homo sapiens	IC50	uM	1.0
Not Active	15107521	CHEMBL3375317	Inhibition of human MEK1 assessed as enzyme activity at 10 uM	B	CN(CCc1c[nH]c2ccccc12)C(=O)c1ccc(-c2ccccc2)cc1		CHEMBL213805		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
	15116505	CHEMBL3377059	Inhibition of MEK1 (unknown origin)	B	CC(=O)c1ccc(N2CCN(C(=O)CN3CC[C@@H](C(=O)Nc4ccc(O)c(Cl)c4)C3)CC2)cc1		CHEMBL3356117	>	IC50	nM	20000.0	CHEMBL3587	Homo sapiens	IC50	uM	20.0
	15118738	CHEMBL3377160	Inhibition of MEK1 (unknown origin) by HTRF assay	B	O=C(NOCCO)c1ccc2cnsc2c1Nc1ccc(I)cc1F		CHEMBL2087461	=	IC50	nM	12.0	CHEMBL3587	Homo sapiens	IC50	uM	0.012
	15118739	CHEMBL3377160	Inhibition of MEK1 (unknown origin) by HTRF assay	B	O=C(NOCCO)c1oc2ccncc2c1Nc1ccc(I)cc1F		CHEMBL3330649	=	IC50	nM	12.0	CHEMBL3587	Homo sapiens	IC50	uM	0.012
	15137699	CHEMBL3385156	Inhibition of MKK1 (unknown origin) assessed as residual enzyme activity at 10 uM	B	CO[C@H]1CC[C@H](NC(=O)c2n[nH]cc2NC(=O)c2ccccc2)CC1		CHEMBL3335124	=	Activity	%	54.0	CHEMBL3587	Homo sapiens	Activity	%	54.0
	15137700	CHEMBL3385156	Inhibition of MKK1 (unknown origin) assessed as residual enzyme activity at 10 uM	B	COc1cccc(OC)c1C(=O)Nc1c[nH]nc1C(=O)N[C@H]1CC[C@H](OC)CC1		CHEMBL3335141	=	Activity	%	83.0	CHEMBL3587	Homo sapiens	Activity	%	83.0
	15137701	CHEMBL3385156	Inhibition of MKK1 (unknown origin) assessed as residual enzyme activity at 10 uM	B	CO[C@H]1CC[C@H](NC(=O)c2n[nH]cc2NC(=O)c2ccc(-c3ccccc3)o2)CC1		CHEMBL3335153	=	Activity	%	17.0	CHEMBL3587	Homo sapiens	Activity	%	17.0
	15137702	CHEMBL3385156	Inhibition of MKK1 (unknown origin) assessed as residual enzyme activity at 10 uM	B	COc1cccc(OC)c1C(=O)Nc1c[nH]nc1C(=O)NCc1ccccc1		CHEMBL3335161	=	Activity	%	76.0	CHEMBL3587	Homo sapiens	Activity	%	76.0
	15169317	CHEMBL3406331	Inhibition of MEK1 (unknown origin) at 1 ug/ml relative to control	B	CN(C(=O)c1ccccc1)c1ccc2[nH]c(-c3n[nH]c4ccccc34)cc2n1		CHEMBL3403010	=	Inhibition	%	3.85	CHEMBL3587	Homo sapiens	INH	%	3.85
	15169318	CHEMBL3406331	Inhibition of MEK1 (unknown origin) at 1 ug/ml relative to control	B	CN(C(=O)c1ccc(Cl)cc1)c1ccc2[nH]c(-c3n[nH]c4ccccc34)cc2n1		CHEMBL3403013	=	Inhibition	%	1.98	CHEMBL3587	Homo sapiens	INH	%	1.98
	15169319	CHEMBL3406331	Inhibition of MEK1 (unknown origin) at 1 ug/ml relative to control	B	CN(C(=O)Nc1ccccc1)c1ccc2[nH]c(-c3n[nH]c4ccccc34)cc2n1		CHEMBL3403031	=	Inhibition	%	6.64	CHEMBL3587	Homo sapiens	INH	%	6.64
Active	15183834	CHEMBL3406108	Inhibition of MEK1 in human PANC1 cells assessed as reduction in pErk1/2 level at 10 uM after 1 hr by Western blotting analysis	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Active	15183835	CHEMBL3406108	Inhibition of MEK1 in human PANC1 cells assessed as reduction in pErk1/2 level at 10 uM after 1 hr by Western blotting analysis	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Not Active	15183836	CHEMBL3406108	Inhibition of MEK1 in human PANC1 cells assessed as reduction in pErk1/2 level at 10 uM after 1 hr by Western blotting analysis	B	FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL586702		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Active	15183840	CHEMBL3406106	Inhibition of MEK1 in human PANC1 cells assessed as reduction in pErk1/2 level at 25 uM after 1 hr by Western blotting analysis	B	Cc1c(Cc2cccc(N(C)S(=O)(=O)CCCNCCCCCC(=O)N3CCN(c4nc(N5CCOCC5)nc(-n5c(C(F)F)nc6ccccc65)n4)CC3)c2)c(=O)oc2cc(OC(=O)N(C)C)ccc12		CHEMBL3400291		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Dose-dependent effect	15183842	CHEMBL3406104	Inhibition of MEK1 in human PANC1 cells assessed as reduction in pErk1/2 level after 1 hr by Western blotting analysis	B	Cc1c(Cc2cccc(N(C)S(=O)(=O)CCCNCCCCCC(=O)N3CCN(c4nc(N5CCOCC5)nc(-n5c(C(F)F)nc6ccccc65)n4)CC3)c2)c(=O)oc2cc(OC(=O)N(C)C)ccc12		CHEMBL3400291		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
	15184734	CHEMBL3406097	Inhibition of MEK1 (unknown origin)	B	Cc1c(Cc2cccc(N(C)S(=O)(=O)CCCNCCCCCC(=O)N3CCN(c4nc(N5CCOCC5)nc(-n5c(C(F)F)nc6ccccc65)n4)CC3)c2)c(=O)oc2cc(OC(=O)N(C)C)ccc12		CHEMBL3400291	=	IC50	nM	473.0	CHEMBL3587	Homo sapiens	IC50	nM	473.0
	15184735	CHEMBL3406097	Inhibition of MEK1 (unknown origin)	B	Cc1c(Cc2cccc(N3CCCS3(=O)=O)c2)c(=O)oc2cc(OC(=O)N(C)C)ccc12		CHEMBL3400287	=	IC50	nM	27.1	CHEMBL3587	Homo sapiens	IC50	nM	27.1
	15184736	CHEMBL3406097	Inhibition of MEK1 (unknown origin)	B	Cc1c(Cc2cccc(N(C)S(=O)(=O)CCCCl)c2)c(=O)oc2cc(OC(=O)N(C)C)ccc12		CHEMBL3400286	=	IC50	nM	57.5	CHEMBL3587	Homo sapiens	IC50	nM	57.5
	15184737	CHEMBL3406097	Inhibition of MEK1 (unknown origin)	B	Cc1c(Cc2cccc(NS(=O)(=O)CCCCl)c2)c(=O)oc2cc(OC(=O)N(C)C)ccc12		CHEMBL3400285	=	IC50	nM	39.2	CHEMBL3587	Homo sapiens	IC50	nM	39.2
	15184738	CHEMBL3406097	Inhibition of MEK1 (unknown origin)	B	Cc1c(Cc2cccc(N)c2)c(=O)oc2cc(OC(=O)N(C)C)ccc12		CHEMBL3402994	=	IC50	nM	1190.0	CHEMBL3587	Homo sapiens	IC50	nM	1190.0
	15184739	CHEMBL3406097	Inhibition of MEK1 (unknown origin)	B	Cc1c(Cc2cccc([N+](=O)[O-])c2)c(=O)oc2cc(OC(=O)N(C)C)ccc12		CHEMBL3402993	=	IC50	nM	27.7	CHEMBL3587	Homo sapiens	IC50	nM	27.7
Dose-dependent effect	15184740	CHEMBL3406110	Inhibition of MEK1 in human A549 cells assessed as reduction in pErk1/2 level after 1 hr by Western blotting analysis	B	Cc1c(Cc2cccc(N(C)S(=O)(=O)CCCNCCCCCC(=O)N3CCN(c4nc(N5CCOCC5)nc(-n5c(C(F)F)nc6ccccc65)n4)CC3)c2)c(=O)oc2cc(OC(=O)N(C)C)ccc12		CHEMBL3400291		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Active	15184742	CHEMBL3406291	Inhibition of MEK1 in human A549 cells assessed as reduction in pErk1/2 level at 25 uM after 1 hr by Western blotting analysis	B	Cc1c(Cc2cccc(N(C)S(=O)(=O)CCCNCCCCCC(=O)N3CCN(c4nc(N5CCOCC5)nc(-n5c(C(F)F)nc6ccccc65)n4)CC3)c2)c(=O)oc2cc(OC(=O)N(C)C)ccc12		CHEMBL3400291		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Not Active	15184753	CHEMBL3406293	Inhibition of MEK1 in human A549 cells assessed as reduction in pErk1/2 level at 10 uM after 1 hr by Western blotting analysis	B	FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL586702		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Active	15184754	CHEMBL3406293	Inhibition of MEK1 in human A549 cells assessed as reduction in pErk1/2 level at 10 uM after 1 hr by Western blotting analysis	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Active	15184755	CHEMBL3406293	Inhibition of MEK1 in human A549 cells assessed as reduction in pErk1/2 level at 10 uM after 1 hr by Western blotting analysis	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
	15251844	CHEMBL3428237	Inhibition of MKK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Activity	%	51.0	CHEMBL3587	Homo sapiens	Activity	%	51.0
	15251953	CHEMBL3428237	Inhibition of MKK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427170	=	Activity	%	37.0	CHEMBL3587	Homo sapiens	Activity	%	37.0
	15252055	CHEMBL3428237	Inhibition of MKK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427171	=	Activity	%	92.0	CHEMBL3587	Homo sapiens	Activity	%	92.0
	15252700	CHEMBL3428237	Inhibition of MKK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427172	=	Activity	%	85.0	CHEMBL3587	Homo sapiens	Activity	%	85.0
	15252802	CHEMBL3428237	Inhibition of MKK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1		CHEMBL3427173	=	Activity	%	83.0	CHEMBL3587	Homo sapiens	Activity	%	83.0
	15252904	CHEMBL3428237	Inhibition of MKK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1		CHEMBL3427174	=	Activity	%	95.0	CHEMBL3587	Homo sapiens	Activity	%	95.0
	15253205	CHEMBL3430005	Inhibition of human MEK1	B	CCn1nc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)ccc2C)c2c(N)ncnc21		CHEMBL3426225	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	15253578	CHEMBL3428237	Inhibition of MKK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427175	=	Activity	%	77.0	CHEMBL3587	Homo sapiens	Activity	%	77.0
	15253680	CHEMBL3428237	Inhibition of MKK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427176	=	Activity	%	88.0	CHEMBL3587	Homo sapiens	Activity	%	88.0
	15253782	CHEMBL3428237	Inhibition of MKK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427177	=	Activity	%	88.0	CHEMBL3587	Homo sapiens	Activity	%	88.0
	15254448	CHEMBL3428237	Inhibition of MKK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427178	=	Activity	%	82.0	CHEMBL3587	Homo sapiens	Activity	%	82.0
	15254550	CHEMBL3428237	Inhibition of MKK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O		CHEMBL3427179	=	Activity	%	71.0	CHEMBL3587	Homo sapiens	Activity	%	71.0
	15254652	CHEMBL3428237	Inhibition of MKK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O		CHEMBL3427180	=	Activity	%	60.0	CHEMBL3587	Homo sapiens	Activity	%	60.0
	15255343	CHEMBL3428237	Inhibition of MKK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Activity	%	92.0	CHEMBL3587	Homo sapiens	Activity	%	92.0
	15255445	CHEMBL3428237	Inhibition of MKK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427182	=	Activity	%	69.0	CHEMBL3587	Homo sapiens	Activity	%	69.0
	15256177	CHEMBL3428237	Inhibition of MKK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Activity	%	89.0	CHEMBL3587	Homo sapiens	Activity	%	89.0
	15256279	CHEMBL3428237	Inhibition of MKK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427184	=	Activity	%	83.0	CHEMBL3587	Homo sapiens	Activity	%	83.0
	15461649	CHEMBL3536064	Inhibition of MEK1 (unknown origin)	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	=	IC50	nM	4.2	CHEMBL3587	Homo sapiens	IC50	nM	4.2
	15637155	CHEMBL3593139	Inhibition of MEK1 (unknown origin) autophosphorylation incubated with enzyme for 20 mins prior to ATP addition by ADP Glo kinase assay in presence of ATP at Km concentration	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	15637156	CHEMBL3593139	Inhibition of MEK1 (unknown origin) autophosphorylation incubated with enzyme for 20 mins prior to ATP addition by ADP Glo kinase assay in presence of ATP at Km concentration	B	O=C(Nc1ccc2[nH]nc(-c3ccncc3)c2c1)[C@@H]1CCN(CC(=O)N2CCN(c3ccc(-c4ncccn4)cc3)CC2)C1		CHEMBL3590107	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	15637157	CHEMBL3593139	Inhibition of MEK1 (unknown origin) autophosphorylation incubated with enzyme for 20 mins prior to ATP addition by ADP Glo kinase assay in presence of ATP at Km concentration	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@@H](O)C(=O)/C=C/C[C@H](C)OC2=O		CHEMBL3590108	=	IC50	nM	3400.0	CHEMBL3587	Homo sapiens	IC50	uM	3.4
	15637158	CHEMBL3593139	Inhibition of MEK1 (unknown origin) autophosphorylation incubated with enzyme for 20 mins prior to ATP addition by ADP Glo kinase assay in presence of ATP at Km concentration	B	C=CS(=O)(=O)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3590109	>	IC50	nM	1000.0	CHEMBL3587	Homo sapiens	IC50	uM	1.0
	15637159	CHEMBL3593139	Inhibition of MEK1 (unknown origin) autophosphorylation incubated with enzyme for 20 mins prior to ATP addition by ADP Glo kinase assay in presence of ATP at Km concentration	B	C=CS(=O)(=O)Nc1ccc2[nH]nc(-c3ccncc3)c2c1		CHEMBL3590110	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	15637160	CHEMBL3593139	Inhibition of MEK1 (unknown origin) autophosphorylation incubated with enzyme for 20 mins prior to ATP addition by ADP Glo kinase assay in presence of ATP at Km concentration	B	C=CS(=O)(=O)N1CCc2[nH]nc(-c3ccnc(C)c3)c2C1		CHEMBL3590111	=	IC50	nM	4900.0	CHEMBL3587	Homo sapiens	IC50	uM	4.9
	15637161	CHEMBL3593139	Inhibition of MEK1 (unknown origin) autophosphorylation incubated with enzyme for 20 mins prior to ATP addition by ADP Glo kinase assay in presence of ATP at Km concentration	B	CNC(=O)c1ccc(F)cc1Nc1cc(Nc2cc(C)nn2C)ncc1C(F)(F)F		CHEMBL3590114	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	15637162	CHEMBL3593139	Inhibition of MEK1 (unknown origin) autophosphorylation incubated with enzyme for 20 mins prior to ATP addition by ADP Glo kinase assay in presence of ATP at Km concentration	B	CNC(=O)c1ccccc1Nc1cc(NC2CCOCC2)ncc1Cl		CHEMBL3590115	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	15637163	CHEMBL3593139	Inhibition of MEK1 (unknown origin) autophosphorylation incubated with enzyme for 20 mins prior to ATP addition by ADP Glo kinase assay in presence of ATP at Km concentration	B	CNC(=O)c1ccc(F)cc1Nc1cc(NC2CCOCC2)ncc1C(F)(F)F		CHEMBL3590116	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	15637164	CHEMBL3593139	Inhibition of MEK1 (unknown origin) autophosphorylation incubated with enzyme for 20 mins prior to ATP addition by ADP Glo kinase assay in presence of ATP at Km concentration	B	C=CC(=O)Nc1ccccc1Nc1cc(NC2CCOCC2)ncc1Cl		CHEMBL3590117	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	15637165	CHEMBL3593139	Inhibition of MEK1 (unknown origin) autophosphorylation incubated with enzyme for 20 mins prior to ATP addition by ADP Glo kinase assay in presence of ATP at Km concentration	B	C=CC(=O)Nc1ccccc1Nc1nc(NC2CCOCC2)ncc1Cl		CHEMBL3590118	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	15637166	CHEMBL3593139	Inhibition of MEK1 (unknown origin) autophosphorylation incubated with enzyme for 20 mins prior to ATP addition by ADP Glo kinase assay in presence of ATP at Km concentration	B	C=CC(=O)Nc1cnccc1Nc1nc(NC2CCOCC2)ncc1Cl		CHEMBL3590120	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	15637167	CHEMBL3593139	Inhibition of MEK1 (unknown origin) autophosphorylation incubated with enzyme for 20 mins prior to ATP addition by ADP Glo kinase assay in presence of ATP at Km concentration	B	C=CC(=O)Nc1ccccc1Nc1nc(NC2CCOCC2)ncc1C(F)(F)F		CHEMBL3590121	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	15637168	CHEMBL3593139	Inhibition of MEK1 (unknown origin) autophosphorylation incubated with enzyme for 20 mins prior to ATP addition by ADP Glo kinase assay in presence of ATP at Km concentration	B	C=CC(=O)Nc1ccccc1Nc1nc(NC2CCOCC2)ncc1C		CHEMBL3590122	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	15637169	CHEMBL3593139	Inhibition of MEK1 (unknown origin) autophosphorylation incubated with enzyme for 20 mins prior to ATP addition by ADP Glo kinase assay in presence of ATP at Km concentration	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccnn2C)ncc1Cl		CHEMBL3590123	=	IC50	nM	120.0	CHEMBL3587	Homo sapiens	IC50	uM	0.12
	15637170	CHEMBL3593139	Inhibition of MEK1 (unknown origin) autophosphorylation incubated with enzyme for 20 mins prior to ATP addition by ADP Glo kinase assay in presence of ATP at Km concentration	B	C=CC(=O)Nc1ccccc1Nc1nc(N[C@H]2CC[C@H](N(C)C)CC2)ncc1Cl		CHEMBL3590124	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	15637171	CHEMBL3593139	Inhibition of MEK1 (unknown origin) autophosphorylation incubated with enzyme for 20 mins prior to ATP addition by ADP Glo kinase assay in presence of ATP at Km concentration	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccnn2C)ncc1C		CHEMBL3590125	=	IC50	nM	260.0	CHEMBL3587	Homo sapiens	IC50	uM	0.26
	15649115	CHEMBL3595100	Inhibition of MEK1 (unknown origin)	B	N#Cc1ccc(N2CC[C@@H](Nc3c(C(N)=O)cnc4[nH]ccc34)[C@@H](F)C2)nc1		CHEMBL3593777	>	IC50	nM	1000.0	CHEMBL3587	Homo sapiens	IC50	nM	1000.0
	15650138	CHEMBL3595404	Inhibition of human MEK1 at 0.1 uM relative to control	B	CCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(CC)CC5)nc(C)n4)s3)cc2)no1		CHEMBL3593290	=	Inhibition	%	41.0	CHEMBL3587	Homo sapiens	INH	%	41.0
	15665868	CHEMBL3602864	Inhibition of recombinant MEK1 (unknown origin) at 1 uM after 3 hrs	B	CS(=O)(=O)NCc1ccc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nn12		CHEMBL3601472	=	Inhibition	%	-1.0	CHEMBL3587	Homo sapiens	INH	%	-1.0
	15686160	CHEMBL3606884	Inhibition of MKK1 (unknown origin) at 2 uM by radioactive filter-binding assay	B	NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I		CHEMBL3605056	>=	Inhibition	%	80.0	CHEMBL3587	Homo sapiens	INH	%	80.0
	15723405	CHEMBL3620007	Inhibition of MEK1 (unknown origin) at 10 uM after 40 mins by scintillation counting analysis	B	Cc1ccc(NC(=O)c2cc(N3CCN(C)CC3)cc(C(F)(F)F)c2)cc1NC(=O)c1cnoc1C		CHEMBL3616960	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	INH	%	0.0
Not Active	15723406	CHEMBL3620007	Inhibition of MEK1 (unknown origin) at 10 uM after 40 mins by scintillation counting analysis	B	Cc1ccccc1C(=O)Nc1cnoc1C		CHEMBL3616990		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
	15723447	CHEMBL3620300	Inhibition of MEK1 (unknown origin) after 40 mins by scintillation counting analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	12.1	CHEMBL3587	Homo sapiens	IC50	nM	12.1
	15735991	CHEMBL3624357	Inhibition of human recombinant MEK1	B	CN(C)CCCNC(=O)c1csc2nc(-c3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)cn12		CHEMBL3623375	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	15753838	CHEMBL3630471	Inhibition of human MEK1 by kinase inhibition assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	24.0	CHEMBL3587	Homo sapiens	IC50	10'-8M	2.4
	15753840	CHEMBL3630461	Inhibition of human MEK1 at 10 uM by kinase inhibition assay	B	COc1ccc2c(c1)SCc1cnc(-c3ccccc3)nc1-2		CHEMBL481789	=	Inhibition	%	14.6	CHEMBL3587	Homo sapiens	INH	%	14.6
	15753901	CHEMBL3630461	Inhibition of human MEK1 at 10 uM by kinase inhibition assay	B	Clc1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2SC3)cc1		CHEMBL3628818	=	Inhibition	%	5.9	CHEMBL3587	Homo sapiens	INH	%	5.9
	15753983	CHEMBL3630461	Inhibition of human MEK1 at 10 uM by kinase inhibition assay	B	COc1ccc(Nc2ncc3c(n2)-c2ccccc2SC3)cc1		CHEMBL3628537	=	Inhibition	%	21.6	CHEMBL3587	Homo sapiens	INH	%	21.6
	15754248	CHEMBL3631173	Inhibition of MEK1 (unknown origin) at 1 uM by FRET method	B	N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)n(C3CCCC3)n2)c1		CHEMBL3629013	=	Inhibition	%	4.0	CHEMBL3587	Homo sapiens	INH	%	4.0
	15755900	CHEMBL3630843	Inhibition of MEK1 (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control	B	O=C1c2ccccc2-c2c1oc1ccccc1c2=O		CHEMBL3629616	=	Activity	%	85.0	CHEMBL3587	Homo sapiens	Activity	%	85.0
	15756922	CHEMBL3631288	Inhibition of MEK1 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	22.04	CHEMBL3587	Homo sapiens	INH	%	22.04
	15757801	CHEMBL3631288	Inhibition of MEK1 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	72.49	CHEMBL3587	Homo sapiens	INH	%	72.49
	15758780	CHEMBL3631288	Inhibition of MEK1 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC	Outside typical range	CHEMBL3628628	=	Inhibition	%	-16.97	CHEMBL3587	Homo sapiens	INH	%	-16.97
278884	16263248	CHEMBL3707981	Radioactive Kinase Assay: The ATP-KM value of the complex is 61 uM. The kinase assays are run in the presence of 100 uM ATP using 10 uM of a substrate peptide. pAUB-IN847 was used to transform the E. coli strain BL21 (DE3) containing the pUBS520 helper plasmid. Both proteins and their mutants are expressed and purified under essentially identical conditions. Protein expression is induced with 0.3 mM IPTG at an OD6oo of 0.45-0.7. Expression is then continued for about 12-16 hours at 23-25 C with agitation. Bacterial cells are harvested by centrifugation at 4000 rpm x 15 min in a Beckman JLA 8.1 rotor, and the pellets resuspended in lysis buffer (50 mM Tris HCI pH 7.6, 300 mM NaCI, 1 mM DTT, 1 mM EDTA, 5 % glycerol, Roche Complete protease inhibitor tablets). 20-30 ml lysis buffer are used per liter of E. coli culture. Cells are lysed by sonication, and the lysates cleared by centrifugation at 12000 rpm for 45-60 min on a JA20 rotor.	B	CN(C)Cc1ccc(N/C(=C2\C(=O)Nc3cc(C#CC(=O)NCC(F)F)ccc32)c2ccccc2)cc1		CHEMBL3699138	=	IC50	nM	6.0	CHEMBL3587	Homo sapiens	IC50	nM	6.0
278886	16269123	CHEMBL3707981	Radioactive Kinase Assay: The ATP-KM value of the complex is 61 uM. The kinase assays are run in the presence of 100 uM ATP using 10 uM of a substrate peptide. pAUB-IN847 was used to transform the E. coli strain BL21 (DE3) containing the pUBS520 helper plasmid. Both proteins and their mutants are expressed and purified under essentially identical conditions. Protein expression is induced with 0.3 mM IPTG at an OD6oo of 0.45-0.7. Expression is then continued for about 12-16 hours at 23-25 C with agitation. Bacterial cells are harvested by centrifugation at 4000 rpm x 15 min in a Beckman JLA 8.1 rotor, and the pellets resuspended in lysis buffer (50 mM Tris HCI pH 7.6, 300 mM NaCI, 1 mM DTT, 1 mM EDTA, 5 % glycerol, Roche Complete protease inhibitor tablets). 20-30 ml lysis buffer are used per liter of E. coli culture. Cells are lysed by sonication, and the lysates cleared by centrifugation at 12000 rpm for 45-60 min on a JA20 rotor.	B	O=C(C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCC2)cc1)c1ccccc1)NCCF		CHEMBL3699140	=	IC50	nM	6.0	CHEMBL3587	Homo sapiens	IC50	nM	6.0
278888	16299022	CHEMBL3707981	Radioactive Kinase Assay: The ATP-KM value of the complex is 61 uM. The kinase assays are run in the presence of 100 uM ATP using 10 uM of a substrate peptide. pAUB-IN847 was used to transform the E. coli strain BL21 (DE3) containing the pUBS520 helper plasmid. Both proteins and their mutants are expressed and purified under essentially identical conditions. Protein expression is induced with 0.3 mM IPTG at an OD6oo of 0.45-0.7. Expression is then continued for about 12-16 hours at 23-25 C with agitation. Bacterial cells are harvested by centrifugation at 4000 rpm x 15 min in a Beckman JLA 8.1 rotor, and the pellets resuspended in lysis buffer (50 mM Tris HCI pH 7.6, 300 mM NaCI, 1 mM DTT, 1 mM EDTA, 5 % glycerol, Roche Complete protease inhibitor tablets). 20-30 ml lysis buffer are used per liter of E. coli culture. Cells are lysed by sonication, and the lysates cleared by centrifugation at 12000 rpm for 45-60 min on a JA20 rotor.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	=	IC50	nM	25.0	CHEMBL3587	Homo sapiens	IC50	nM	25.0
278883	16309831	CHEMBL3707981	Radioactive Kinase Assay: The ATP-KM value of the complex is 61 uM. The kinase assays are run in the presence of 100 uM ATP using 10 uM of a substrate peptide. pAUB-IN847 was used to transform the E. coli strain BL21 (DE3) containing the pUBS520 helper plasmid. Both proteins and their mutants are expressed and purified under essentially identical conditions. Protein expression is induced with 0.3 mM IPTG at an OD6oo of 0.45-0.7. Expression is then continued for about 12-16 hours at 23-25 C with agitation. Bacterial cells are harvested by centrifugation at 4000 rpm x 15 min in a Beckman JLA 8.1 rotor, and the pellets resuspended in lysis buffer (50 mM Tris HCI pH 7.6, 300 mM NaCI, 1 mM DTT, 1 mM EDTA, 5 % glycerol, Roche Complete protease inhibitor tablets). 20-30 ml lysis buffer are used per liter of E. coli culture. Cells are lysed by sonication, and the lysates cleared by centrifugation at 12000 rpm for 45-60 min on a JA20 rotor.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N2CCN(C)CC2)cc1)c1ccccc1		CHEMBL3699137	=	IC50	nM	10.0	CHEMBL3587	Homo sapiens	IC50	nM	10.0
278885	16324574	CHEMBL3707981	Radioactive Kinase Assay: The ATP-KM value of the complex is 61 uM. The kinase assays are run in the presence of 100 uM ATP using 10 uM of a substrate peptide. pAUB-IN847 was used to transform the E. coli strain BL21 (DE3) containing the pUBS520 helper plasmid. Both proteins and their mutants are expressed and purified under essentially identical conditions. Protein expression is induced with 0.3 mM IPTG at an OD6oo of 0.45-0.7. Expression is then continued for about 12-16 hours at 23-25 C with agitation. Bacterial cells are harvested by centrifugation at 4000 rpm x 15 min in a Beckman JLA 8.1 rotor, and the pellets resuspended in lysis buffer (50 mM Tris HCI pH 7.6, 300 mM NaCI, 1 mM DTT, 1 mM EDTA, 5 % glycerol, Roche Complete protease inhibitor tablets). 20-30 ml lysis buffer are used per liter of E. coli culture. Cells are lysed by sonication, and the lysates cleared by centrifugation at 12000 rpm for 45-60 min on a JA20 rotor.	B	O=C(C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCC2)cc1)c1ccccc1)NCC(F)F		CHEMBL3699139	=	IC50	nM	3.0	CHEMBL3587	Homo sapiens	IC50	nM	3.0
278887	16332488	CHEMBL3707981	Radioactive Kinase Assay: The ATP-KM value of the complex is 61 uM. The kinase assays are run in the presence of 100 uM ATP using 10 uM of a substrate peptide. pAUB-IN847 was used to transform the E. coli strain BL21 (DE3) containing the pUBS520 helper plasmid. Both proteins and their mutants are expressed and purified under essentially identical conditions. Protein expression is induced with 0.3 mM IPTG at an OD6oo of 0.45-0.7. Expression is then continued for about 12-16 hours at 23-25 C with agitation. Bacterial cells are harvested by centrifugation at 4000 rpm x 15 min in a Beckman JLA 8.1 rotor, and the pellets resuspended in lysis buffer (50 mM Tris HCI pH 7.6, 300 mM NaCI, 1 mM DTT, 1 mM EDTA, 5 % glycerol, Roche Complete protease inhibitor tablets). 20-30 ml lysis buffer are used per liter of E. coli culture. Cells are lysed by sonication, and the lysates cleared by centrifugation at 12000 rpm for 45-60 min on a JA20 rotor.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCC2)cc1)c1ccccc1		CHEMBL3699141	=	IC50	nM	5.0	CHEMBL3587	Homo sapiens	IC50	nM	5.0
	16376462	CHEMBL3734486	Inhibition of recombinant human MEK1 using fluorescein-labeled peptide as substrate by fluorescence-electrophoretic mobility shift assay	B	Cl.NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O		CHEMBL3732044	=	Inhibition	%	69.0	CHEMBL3587	Homo sapiens	INH	%	69.0
	16379697	CHEMBL3736653	Inhibition of MAP2K1 (unknown origin) at 200 nM by ELISA	B	COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735816	=	Inhibition	%	-7.7	CHEMBL3587	Homo sapiens	INH	%	-7.7
	16379698	CHEMBL3736653	Inhibition of MAP2K1 (unknown origin) at 200 nM by ELISA	B	COc1ccc2c(c1C(C)N1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735890	=	Inhibition	%	-0.4	CHEMBL3587	Homo sapiens	INH	%	-0.4
	16388308	CHEMBL3737365	Inhibition of MEK1 (unknown origin) at 1 uM by selectscreen kinase profiling assay in presence of ATP	B	COc1cc2c(cc1OC)CN(CC(=O)Nc1ccc3c(c1)/C(=C/c1cnc[nH]1)C(=O)N3)CC2		CHEMBL3091673	=	Inhibition	%	37.0	CHEMBL3587	Homo sapiens	INH	%	37.0
	16423193	CHEMBL3750088	Inhibition of MEK1 (unknown origin) using biotinylated ERK1 as substrate incubated for 2 hrs by fluorescence analysis	B	NC(=O)c1c(Nc2ccc(I)cc2F)cc(F)cc1Oc1cccc(NS(N)(=O)=O)c1		CHEMBL2376666	=	IC50	nM	14.0	CHEMBL3587	Homo sapiens	IC50	nM	14.0
	16423194	CHEMBL3750088	Inhibition of MEK1 (unknown origin) using biotinylated ERK1 as substrate incubated for 2 hrs by fluorescence analysis	B	CN(C)S(=O)(=O)Nc1cccc(Oc2cc(F)cc(Nc3ccc(I)cc3F)c2C(N)=O)c1		CHEMBL2376663	=	IC50	nM	21.0	CHEMBL3587	Homo sapiens	IC50	nM	21.0
	16423195	CHEMBL3750088	Inhibition of MEK1 (unknown origin) using biotinylated ERK1 as substrate incubated for 2 hrs by fluorescence analysis	B	CCNS(=O)(=O)Nc1cccc(Oc2cc(F)cc(Nc3ccc(I)cc3F)c2C(N)=O)c1		CHEMBL3747136	=	IC50	nM	15.0	CHEMBL3587	Homo sapiens	IC50	nM	15.0
	16423196	CHEMBL3750088	Inhibition of MEK1 (unknown origin) using biotinylated ERK1 as substrate incubated for 2 hrs by fluorescence analysis	B	NC(=O)c1c(Nc2ccc(I)cc2F)cc(F)cc1Oc1ccc(F)c(NS(N)(=O)=O)c1		CHEMBL3747368	=	IC50	nM	94.0	CHEMBL3587	Homo sapiens	IC50	nM	94.0
	16423197	CHEMBL3750088	Inhibition of MEK1 (unknown origin) using biotinylated ERK1 as substrate incubated for 2 hrs by fluorescence analysis	B	NC(=O)c1c(Nc2ccc(I)cc2F)cc(F)cc1Oc1ccc(F)c(NS(N)(=O)=O)c1F		CHEMBL3746516	=	IC50	nM	118.0	CHEMBL3587	Homo sapiens	IC50	nM	118.0
	16423198	CHEMBL3750088	Inhibition of MEK1 (unknown origin) using biotinylated ERK1 as substrate incubated for 2 hrs by fluorescence analysis	B	Cc1ccc(Oc2cc(F)cc(Nc3ccc(I)cc3F)c2C(N)=O)cc1NS(N)(=O)=O		CHEMBL3747610	=	IC50	nM	262.0	CHEMBL3587	Homo sapiens	IC50	nM	262.0
	16423199	CHEMBL3750088	Inhibition of MEK1 (unknown origin) using biotinylated ERK1 as substrate incubated for 2 hrs by fluorescence analysis	B	NC(=O)c1c(Nc2ccc(I)cc2F)cc(F)cc1Oc1ccc(Cl)c(NS(N)(=O)=O)c1		CHEMBL3745994	=	IC50	nM	345.0	CHEMBL3587	Homo sapiens	IC50	nM	345.0
	16423200	CHEMBL3750088	Inhibition of MEK1 (unknown origin) using biotinylated ERK1 as substrate incubated for 2 hrs by fluorescence analysis	B	COc1ccc(Oc2cc(F)cc(Nc3ccc(I)cc3F)c2C(N)=O)cc1NS(N)(=O)=O		CHEMBL3747637	=	IC50	nM	592.0	CHEMBL3587	Homo sapiens	IC50	nM	592.0
	16423201	CHEMBL3750088	Inhibition of MEK1 (unknown origin) using biotinylated ERK1 as substrate incubated for 2 hrs by fluorescence analysis	B	CCOc1ccc(Oc2cc(F)cc(Nc3ccc(I)cc3F)c2C(N)=O)cc1NS(N)(=O)=O		CHEMBL3746213	=	IC50	nM	1900.0	CHEMBL3587	Homo sapiens	IC50	nM	1900.0
	16423202	CHEMBL3750088	Inhibition of MEK1 (unknown origin) using biotinylated ERK1 as substrate incubated for 2 hrs by fluorescence analysis	B	NC(=O)c1c(Nc2ccc(I)cc2F)cc(F)cc1Oc1ccc2c(c1)N(S(N)(=O)=O)CCO2		CHEMBL3746203	=	IC50	nM	127.0	CHEMBL3587	Homo sapiens	IC50	nM	127.0
	16423203	CHEMBL3750088	Inhibition of MEK1 (unknown origin) using biotinylated ERK1 as substrate incubated for 2 hrs by fluorescence analysis	B	Cc1c(NS(N)(=O)=O)cccc1Oc1cc(F)cc(Nc2ccc(I)cc2F)c1C(N)=O		CHEMBL3747256	=	IC50	nM	15.0	CHEMBL3587	Homo sapiens	IC50	nM	15.0
	16423204	CHEMBL3750088	Inhibition of MEK1 (unknown origin) using biotinylated ERK1 as substrate incubated for 2 hrs by fluorescence analysis	B	NC(=O)c1c(Nc2ccc(I)cc2F)cc(F)cc1Oc1cccc(NS(N)(=O)=O)c1Cl		CHEMBL3747359	=	IC50	nM	18.0	CHEMBL3587	Homo sapiens	IC50	nM	18.0
	16423205	CHEMBL3750088	Inhibition of MEK1 (unknown origin) using biotinylated ERK1 as substrate incubated for 2 hrs by fluorescence analysis	B	NC(=O)c1c(Nc2ccc(I)cc2F)cc(F)cc1Oc1cccc(NS(N)(=O)=O)c1Br		CHEMBL3746537	=	IC50	nM	32.0	CHEMBL3587	Homo sapiens	IC50	nM	32.0
	16423206	CHEMBL3750088	Inhibition of MEK1 (unknown origin) using biotinylated ERK1 as substrate incubated for 2 hrs by fluorescence analysis	B	Cc1ccc(NS(N)(=O)=O)cc1Oc1cc(F)cc(Nc2ccc(I)cc2F)c1C(N)=O		CHEMBL3747496	=	IC50	nM	899.0	CHEMBL3587	Homo sapiens	IC50	nM	899.0
	16423207	CHEMBL3750088	Inhibition of MEK1 (unknown origin) using biotinylated ERK1 as substrate incubated for 2 hrs by fluorescence analysis	B	COc1cc(NS(N)(=O)=O)cc(Oc2cc(F)cc(Nc3ccc(I)cc3F)c2C(N)=O)c1		CHEMBL3746690	=	IC50	nM	941.0	CHEMBL3587	Homo sapiens	IC50	nM	941.0
	16423208	CHEMBL3750088	Inhibition of MEK1 (unknown origin) using biotinylated ERK1 as substrate incubated for 2 hrs by fluorescence analysis	B	NC(=O)c1c(Nc2ccc(I)cc2F)cc(F)cc1Oc1ccccc1NS(N)(=O)=O		CHEMBL3746142	=	IC50	nM	81.0	CHEMBL3587	Homo sapiens	IC50	nM	81.0
	16423209	CHEMBL3750088	Inhibition of MEK1 (unknown origin) using biotinylated ERK1 as substrate incubated for 2 hrs by fluorescence analysis	B	NC(=O)c1c(Nc2ccc(I)cc2F)cc(F)cc1Oc1cccc(F)c1NS(N)(=O)=O		CHEMBL3746158	=	IC50	nM	107.0	CHEMBL3587	Homo sapiens	IC50	nM	107.0
	16423210	CHEMBL3750088	Inhibition of MEK1 (unknown origin) using biotinylated ERK1 as substrate incubated for 2 hrs by fluorescence analysis	B	Cc1cccc(Oc2cc(F)cc(Nc3ccc(I)cc3F)c2C(N)=O)c1NS(N)(=O)=O		CHEMBL3747708	=	IC50	nM	379.0	CHEMBL3587	Homo sapiens	IC50	nM	379.0
	16423211	CHEMBL3750088	Inhibition of MEK1 (unknown origin) using biotinylated ERK1 as substrate incubated for 2 hrs by fluorescence analysis	B	NC(=O)c1c(Nc2ccc(I)cc2F)cc(F)cc1Oc1cccc(CS(N)(=O)=O)c1		CHEMBL2376667	=	IC50	nM	32.0	CHEMBL3587	Homo sapiens	IC50	nM	32.0
	16423212	CHEMBL3750088	Inhibition of MEK1 (unknown origin) using biotinylated ERK1 as substrate incubated for 2 hrs by fluorescence analysis	B	NCCS(=O)(=O)Nc1cccc(Oc2cc(F)cc(Nc3ccc(I)cc3F)c2C(N)=O)c1		CHEMBL3746569	=	IC50	nM	11.0	CHEMBL3587	Homo sapiens	IC50	nM	11.0
	16423213	CHEMBL3750088	Inhibition of MEK1 (unknown origin) using biotinylated ERK1 as substrate incubated for 2 hrs by fluorescence analysis	B	NC(=O)c1c(Nc2ccc(I)cc2F)cc(F)cc1Oc1cccc(CNS(N)(=O)=O)c1		CHEMBL3746923	=	IC50	nM	37.0	CHEMBL3587	Homo sapiens	IC50	nM	37.0
	16423214	CHEMBL3750088	Inhibition of MEK1 (unknown origin) using biotinylated ERK1 as substrate incubated for 2 hrs by fluorescence analysis	B	CC(NS(N)(=O)=O)c1cccc(Oc2cc(F)cc(Nc3ccc(I)cc3F)c2C(N)=O)c1		CHEMBL3747516	=	IC50	nM	83.0	CHEMBL3587	Homo sapiens	IC50	nM	83.0
	16423215	CHEMBL3750088	Inhibition of MEK1 (unknown origin) using biotinylated ERK1 as substrate incubated for 2 hrs by fluorescence analysis	B	CCS(=O)(=O)Nc1cccc(Oc2cc(F)c(F)c(Nc3ccc(I)cc3F)c2C(N)=O)c1		CHEMBL3747066	=	IC50	nM	12.0	CHEMBL3587	Homo sapiens	IC50	nM	12.0
	16423216	CHEMBL3750088	Inhibition of MEK1 (unknown origin) using biotinylated ERK1 as substrate incubated for 2 hrs by fluorescence analysis	B	CCS(=O)(=O)Nc1cccc(Oc2c(F)c(F)cc(Nc3ccc(I)cc3F)c2C(N)=O)c1		CHEMBL3746467	=	IC50	nM	15.0	CHEMBL3587	Homo sapiens	IC50	nM	15.0
	16423217	CHEMBL3750088	Inhibition of MEK1 (unknown origin) using biotinylated ERK1 as substrate incubated for 2 hrs by fluorescence analysis	B	NC(=O)c1c(Oc2cccc(NS(N)(=O)=O)c2)cc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL3746736	=	IC50	nM	13.0	CHEMBL3587	Homo sapiens	IC50	nM	13.0
	16423218	CHEMBL3750088	Inhibition of MEK1 (unknown origin) using biotinylated ERK1 as substrate incubated for 2 hrs by fluorescence analysis	B	CN(C)S(=O)(=O)Nc1cccc(Oc2cc(F)c(F)c(Nc3ccc(I)cc3F)c2C(N)=O)c1		CHEMBL3747294	=	IC50	nM	10.0	CHEMBL3587	Homo sapiens	IC50	nM	10.0
	16423219	CHEMBL3750088	Inhibition of MEK1 (unknown origin) using biotinylated ERK1 as substrate incubated for 2 hrs by fluorescence analysis	B	NC(=O)c1c(Oc2ccc(F)c(NS(N)(=O)=O)c2)cc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL3746559	=	IC50	nM	14.0	CHEMBL3587	Homo sapiens	IC50	nM	14.0
	16423220	CHEMBL3750088	Inhibition of MEK1 (unknown origin) using biotinylated ERK1 as substrate incubated for 2 hrs by fluorescence analysis	B	NC(=O)c1c(Oc2cccc(CNS(N)(=O)=O)c2)cc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL3746640	=	IC50	nM	21.0	CHEMBL3587	Homo sapiens	IC50	nM	21.0
	16423221	CHEMBL3750088	Inhibition of MEK1 (unknown origin) using biotinylated ERK1 as substrate incubated for 2 hrs by fluorescence analysis	B	NC(=O)c1c(Oc2cccc(CS(N)(=O)=O)c2)cc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL3746031	=	IC50	nM	22.0	CHEMBL3587	Homo sapiens	IC50	nM	22.0
	16423222	CHEMBL3750088	Inhibition of MEK1 (unknown origin) using biotinylated ERK1 as substrate incubated for 2 hrs by fluorescence analysis	B	NC(=O)c1c(Oc2ccc(F)c(NS(N)(=O)=O)c2F)cc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL3746103	=	IC50	nM	28.0	CHEMBL3587	Homo sapiens	IC50	nM	28.0
	16423223	CHEMBL3750088	Inhibition of MEK1 (unknown origin) using biotinylated ERK1 as substrate incubated for 2 hrs by fluorescence analysis	B	Cc1c(NS(N)(=O)=O)cccc1Oc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1C(N)=O		CHEMBL3747047	=	IC50	nM	14.0	CHEMBL3587	Homo sapiens	IC50	nM	14.0
	16423224	CHEMBL3750088	Inhibition of MEK1 (unknown origin) using biotinylated ERK1 as substrate incubated for 2 hrs by fluorescence analysis	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	IC50	nM	13.0	CHEMBL3587	Homo sapiens	IC50	nM	13.0
	16423225	CHEMBL3750088	Inhibition of MEK1 (unknown origin) using biotinylated ERK1 as substrate incubated for 2 hrs by fluorescence analysis	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	=	IC50	nM	31.0	CHEMBL3587	Homo sapiens	IC50	nM	31.0
	16423355	CHEMBL3751470	Inhibition of MEK1 in human HeLa-MaTu-ADR matched pair cells assessed as reduction in ERK phosphorylation	B	NC(=O)c1c(Oc2cccc(CNS(N)(=O)=O)c2)cc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL3746640	=	IC50	nM	8.7	CHEMBL3587	Homo sapiens	IC50	nM	8.7
	16423356	CHEMBL3751471	Inhibition of MEK1 in human HeLa-MaTu matched pair cells assessed as reduction in ERK phosphorylation	B	NC(=O)c1c(Oc2cccc(CNS(N)(=O)=O)c2)cc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL3746640	=	IC50	nM	1.8	CHEMBL3587	Homo sapiens	IC50	nM	1.8
	16423357	CHEMBL3751472	Resistance index, ratio of IC50 for inhibition of MEK1 in human HeLa-MaTu-ADR matched pair cells assessed as reduction in ERK phosphorylation to IC50 for inhibition of MEK1 in human HeLa-MaTu matched pair cells assessed as reduction in ERK phosphorylation	B	NC(=O)c1c(Oc2cccc(CNS(N)(=O)=O)c2)cc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL3746640	=	Ratio IC50		5.0	CHEMBL3587	Homo sapiens	Ratio IC50		5.0
	16423360	CHEMBL3751470	Inhibition of MEK1 in human HeLa-MaTu-ADR matched pair cells assessed as reduction in ERK phosphorylation	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	=	IC50	nM	3700.0	CHEMBL3587	Homo sapiens	IC50	uM	3.7
	16423361	CHEMBL3751471	Inhibition of MEK1 in human HeLa-MaTu matched pair cells assessed as reduction in ERK phosphorylation	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	=	IC50	nM	14.0	CHEMBL3587	Homo sapiens	IC50	nM	14.0
	16425330	CHEMBL3751262	Inhibition of MEK1 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	4.5	CHEMBL3587	Homo sapiens	INH	%	4.5
	16431896	CHEMBL3747989	Inhibition of human MEK1 using ERK2 as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	16446725	CHEMBL3756290	Inhibition of recombinant human MEK1 assessed as residual activity at 1 uM by radiometric assay in presence of [gamma-33P]-ATP relative to control	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341	=	Activity	%	11.5	CHEMBL3587	Homo sapiens	Activity	%	11.5
	16446734	CHEMBL3757137	Inhibition of recombinant human MEK1 by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341	=	IC50	nM	142.0	CHEMBL3587	Homo sapiens	IC50	nM	142.0
	16451507	CHEMBL3760630	Inhibition of MEK1 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	2.0	CHEMBL3587	Homo sapiens	INH	%	2.0
	16451739	CHEMBL3760630	Inhibition of MEK1 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4c(Cl)cccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758602	=	Inhibition	%	4.3	CHEMBL3587	Homo sapiens	INH	%	4.3
	16452415	CHEMBL3761298	Inhibition of MEK1 (unknown origin) at 1000 nM	B	CC1(C)OCc2c(Nc3n[nH]c4c(Cl)cccc34)nc(-c3cn[nH]c3C(F)F)nc21		CHEMBL3758739	=	Inhibition	%	-4.5	CHEMBL3587	Homo sapiens	INH	%	-4.5
	16458460	CHEMBL3761586	Inhibition of MAP2K1 (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccccc3C(N)=O)cc12)c1ccccc1		CHEMBL3759085	=	Inhibition	%	3.0	CHEMBL3587	Homo sapiens	INH	%	3.0
	16458461	CHEMBL3761586	Inhibition of MAP2K1 (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccc(C(=O)NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3758800	=	Inhibition	%	6.0	CHEMBL3587	Homo sapiens	INH	%	6.0
	16458462	CHEMBL3761586	Inhibition of MAP2K1 (unknown origin) at 500 nM	B	CN(C)CCNC(=O)c1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3s2)cc1		CHEMBL3758376	=	Inhibition	%	12.0	CHEMBL3587	Homo sapiens	INH	%	12.0
	16458463	CHEMBL3761586	Inhibition of MAP2K1 (unknown origin) at 500 nM	B	COc1cc(C(N)=O)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3759480	=	Inhibition	%	10.0	CHEMBL3587	Homo sapiens	INH	%	10.0
	16458464	CHEMBL3761586	Inhibition of MAP2K1 (unknown origin) at 500 nM	B	COc1ccc(C(=O)NCCN(C)C)cc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3758582	=	Inhibition	%	3.0	CHEMBL3587	Homo sapiens	INH	%	3.0
	16458465	CHEMBL3761586	Inhibition of MAP2K1 (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3759559	=	Inhibition	%	4.0	CHEMBL3587	Homo sapiens	INH	%	4.0
	16458466	CHEMBL3761586	Inhibition of MAP2K1 (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3758682	=	Inhibition	%	18.0	CHEMBL3587	Homo sapiens	INH	%	18.0
	16458467	CHEMBL3761586	Inhibition of MAP2K1 (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccccc3)ncnc2s1		CHEMBL3758768	=	Inhibition	%	15.0	CHEMBL3587	Homo sapiens	INH	%	15.0
	16458468	CHEMBL3761586	Inhibition of MAP2K1 (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3sc(-c4ccc(CO)cc4OC)cc23)c1		CHEMBL3758802	=	Inhibition	%	3.0	CHEMBL3587	Homo sapiens	INH	%	3.0
	16458469	CHEMBL3761586	Inhibition of MAP2K1 (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1		CHEMBL3758351	=	Inhibition	%	12.0	CHEMBL3587	Homo sapiens	INH	%	12.0
	16458470	CHEMBL3761586	Inhibition of MAP2K1 (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	7.0	CHEMBL3587	Homo sapiens	INH	%	7.0
	16466478	CHEMBL3767833	Inhibition of human MEK1 at 10 uM	B	Cc1cncn1-c1cc(C(=O)Nc2cccc(CNc3ccc4c(C(=O)N[C@@H](C)C(N)=O)[nH]nc4c3)c2)cc(C(F)(F)F)c1		CHEMBL3764798	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	INH	%	0.0
	16485745	CHEMBL3771593	Inhibition of human recombinant MEK1 assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	Cc1c(Cl)cccc1NC(=O)c1sc2nc3c(cc2c1N)C(=O)CC3		CHEMBL3771285	=	Activity	%	100.0	CHEMBL3587	Homo sapiens	Activity	%	100.0
	16495125	CHEMBL3776243	Inhibition of N-terminal His6-tagged recombinant human MEK1 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-14.0	CHEMBL3587	Homo sapiens	Activity	%	-14.0
	16496044	CHEMBL3776243	Inhibition of N-terminal His6-tagged recombinant human MEK1 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-6.0	CHEMBL3587	Homo sapiens	Activity	%	-6.0
Not Active	16496864	CHEMBL3776412	Inhibition of human MKK1 (2 to 393 residues) at 1 uM by radioactive [33P]-ATP filter binding assay	B	O=c1[nH]cnc2c(-n3cc(CCN4CCC(c5cccc(Cl)c5)CC4)cn3)nccc12		CHEMBL3774537		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
	16507197	CHEMBL3777895	Inhibition of recombinant MKK1 (unknown origin) assessed as residual activity at 1 uM relative to control	B	CC(O)CNc1nc(NCc2ccc(-c3ccccn3)cc2)c2[nH]nc(C(C)C)c2n1		CHEMBL3774632	=	Activity	%	87.0	CHEMBL3587	Homo sapiens	Activity	%	87.0
	16508231	CHEMBL3776243	Inhibition of N-terminal His6-tagged recombinant human MEK1 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	1.0	CHEMBL3587	Homo sapiens	Activity	%	1.0
Not Active	16514144	CHEMBL3782192	Inhibition of partial length human MEK1 expressed in mammalian system at 1 uM	B	Cc1cnc(N)nc1OCC(C)(C)CO		CHEMBL3780032		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
	16565475	CHEMBL3804243	Inhibition of N-terminal GST-tagged MEK1 (unknown origin) expressed in freestyle293 system preincubated for 5 mins using GST-tagged ERK1 K71A as substrate measured after 20 mins in presence of [gamma-33P]ATP by scintillation counting method	B	C[C@H](c1ccccc1)N1c2cc(-n3c(=O)[nH]c4ncccc43)ccc2C(=O)NC1(C)C		CHEMBL3798011	>	IC50	nM	1000.0	CHEMBL3587	Homo sapiens	IC50	nM	1000.0
	16580644	CHEMBL3802869	Inhibition of N-terminal GST-tagged MEK1 (unknown origin) expressed in freestyle293 system preincubated for 5 mins using K71A as substrate at 1 uM measured after 60 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CCN1c2cc(-c3c[nH]c4ncccc34)ccc2C(=O)NC1(C)C		CHEMBL3798713	=	Inhibition	%	66.0	CHEMBL3587	Homo sapiens	INH	%	66.0
	16580645	CHEMBL3802869	Inhibition of N-terminal GST-tagged MEK1 (unknown origin) expressed in freestyle293 system preincubated for 5 mins using K71A as substrate at 1 uM measured after 60 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CCN1c2cc(-n3c(=O)[nH]c4ncccc43)ccc2C(=O)NC1(C)C		CHEMBL3798933	=	Inhibition	%	-2.0	CHEMBL3587	Homo sapiens	INH	%	-2.0
	16593500	CHEMBL3812354	Inhibition of full length His-tagged human recombinant MEK1 expressed in baculovirus expression system at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	<	Inhibition	%	40.0	CHEMBL3587	Homo sapiens	INH	%	40.0
	16594870	CHEMBL3812448	Inhibition of full length human MEK1 assessed as enzyme activity at 10 uM by KINOMEScan assay	B	O=C1C2=C(C(=O)c3c(O)ccc(O)c31)[C@@H](O)[C@@H](O)[C@@H](O)C2		CHEMBL1987813	=	Activity	%	92.0	CHEMBL3587	Homo sapiens	Activity	%	92.0
	16595581	CHEMBL3813585	Inhibition of human MEK1 after 40 mins in presence of MgATP	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	1.0	CHEMBL3587	Homo sapiens	IC50	nM	1.0
	16611988	CHEMBL3815479	Inhibition of human MKK1 (2 to 393 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	-67.0	CHEMBL3587	Homo sapiens	Activity	%	-67.0
	16611989	CHEMBL3815479	Inhibition of human MKK1 (2 to 393 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814340	=	Activity	%	-21.0	CHEMBL3587	Homo sapiens	Activity	%	-21.0
	16611990	CHEMBL3815479	Inhibition of human MKK1 (2 to 393 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3814140	=	Activity	%	-77.0	CHEMBL3587	Homo sapiens	Activity	%	-77.0
	16611991	CHEMBL3815479	Inhibition of human MKK1 (2 to 393 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3815046	=	Activity	%	-82.0	CHEMBL3587	Homo sapiens	Activity	%	-82.0
Active	16613021	CHEMBL3815522	Inhibition of MEK1 phosphorylation in human rhabdomyosarcoma cells infected with EV71 BC08 GU475127 assessed as inhibition of ERK1/2 phosphorylation at 6.25 to 25 uM pre-treated for 1 hr followed by viral infection measured after 24 hrs by western blotting analysis	B	CNS(=O)(=O)Nc1cccc(Cn2c(=O)oc3cc(OC(=O)N(C)C)ccc3c2=O)c1F		CHEMBL3814978		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Active	16613062	CHEMBL3815522	Inhibition of MEK1 phosphorylation in human rhabdomyosarcoma cells infected with EV71 BC08 GU475127 assessed as inhibition of ERK1/2 phosphorylation at 6.25 to 25 uM pre-treated for 1 hr followed by viral infection measured after 24 hrs by western blotting analysis	B	CN(C)C(=O)Oc1ccc2c(=O)n(Cc3cccc(NS(=O)(=O)NCCC#N)c3F)c(=O)oc2c1		CHEMBL3814173		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Active	16613085	CHEMBL3815525	Inhibition of MEK1 phosphorylation in human rhabdomyosarcoma cells infected with EV71 BC08 GU475127 assessed as inhibition of ERK1/2 phosphorylation at 0.4 to 10 uM pre-treated for 1 hr followed by viral infection measured after 24 hrs by western blotting analysis	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Active	16613086	CHEMBL3815526	Inhibition of MEK1 phosphorylation in human rhabdomyosarcoma cells infected with EV71 BC08 GU475127 assessed as inhibition of ERK1/2 phosphorylation at 30 uM pre-treated for 1 hr followed by viral infection measured after 24 hrs by western blotting analysis	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
	16614533	CHEMBL3816804	Inhibition of human MEK1 at 1 uM using ERK2 as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	INH	%	0.0
	16618165	CHEMBL3817266	Inhibition of full length recombinant human His-tagged MEK1 expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
Active	16620469	CHEMBL3820569	Inhibition of MEK1 in human D54 cells assessed as inhibition of ERK1/2 phosphorylation at 1 to 25 uM incubated for 1 hr by Western blotting	B	O=C(NOCCOCCOCCOCCN1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL3819302		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Active	16620470	CHEMBL3820569	Inhibition of MEK1 in human D54 cells assessed as inhibition of ERK1/2 phosphorylation at 1 to 25 uM incubated for 1 hr by Western blotting	B	O=C(NOCCNCCCCS(=O)(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL3819520		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Active	16620471	CHEMBL3820569	Inhibition of MEK1 in human D54 cells assessed as inhibition of ERK1/2 phosphorylation at 1 to 25 uM incubated for 1 hr by Western blotting	B	O=C(NOCCNCCCCCC(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL3818677		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Active	16620472	CHEMBL3820569	Inhibition of MEK1 in human D54 cells assessed as inhibition of ERK1/2 phosphorylation at 1 to 25 uM incubated for 1 hr by Western blotting	B	O=C(CNCCONC(=O)c1ccc(F)c(F)c1Nc1ccc(I)cc1F)NCCCCCC(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3819622		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Active	16620473	CHEMBL3820568	Inhibition of MEK1 in human A549 cells assessed as inhibition of ERK1/2 phosphorylation at 1 to 25 uM incubated for 1 hr by Western blotting	B	O=C(NOCCOCCOCCOCCN1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL3819302		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Active	16620474	CHEMBL3820568	Inhibition of MEK1 in human A549 cells assessed as inhibition of ERK1/2 phosphorylation at 1 to 25 uM incubated for 1 hr by Western blotting	B	O=C(NOCCNCCCCS(=O)(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL3819520		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Active	16620475	CHEMBL3820568	Inhibition of MEK1 in human A549 cells assessed as inhibition of ERK1/2 phosphorylation at 1 to 25 uM incubated for 1 hr by Western blotting	B	O=C(NOCCNCCCCCC(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL3818677		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Active	16620476	CHEMBL3820568	Inhibition of MEK1 in human A549 cells assessed as inhibition of ERK1/2 phosphorylation at 1 to 25 uM incubated for 1 hr by Western blotting	B	O=C(CNCCONC(=O)c1ccc(F)c(F)c1Nc1ccc(I)cc1F)NCCCCCC(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3819622		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
	16620484	CHEMBL3820565	Inhibition of purified MEK1 (unknown origin) assessed as reduction in phosphorylation of inactive Erk2 incubated for 30 mins by Kinase-Glo luminescent kinase assay	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	IC50	nM	15.0	CHEMBL3587	Homo sapiens	IC50	nM	15.0
	16620485	CHEMBL3820565	Inhibition of purified MEK1 (unknown origin) assessed as reduction in phosphorylation of inactive Erk2 incubated for 30 mins by Kinase-Glo luminescent kinase assay	B	O=C(NOCCO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL244488	=	IC50	nM	13.0	CHEMBL3587	Homo sapiens	IC50	nM	13.0
	16620486	CHEMBL3820565	Inhibition of purified MEK1 (unknown origin) assessed as reduction in phosphorylation of inactive Erk2 incubated for 30 mins by Kinase-Glo luminescent kinase assay	B	O=C(NOCCOCCOCCOCCN1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL3819302	=	IC50	nM	0.015	CHEMBL3587	Homo sapiens	IC50	nM	0.015
	16620487	CHEMBL3820565	Inhibition of purified MEK1 (unknown origin) assessed as reduction in phosphorylation of inactive Erk2 incubated for 30 mins by Kinase-Glo luminescent kinase assay	B	O=C(NOCCNCCCCS(=O)(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL3819520	=	IC50	nM	56.7	CHEMBL3587	Homo sapiens	IC50	nM	56.7
	16620488	CHEMBL3820565	Inhibition of purified MEK1 (unknown origin) assessed as reduction in phosphorylation of inactive Erk2 incubated for 30 mins by Kinase-Glo luminescent kinase assay	B	O=C(NOCCNCCCCCC(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL3818677	=	IC50	nM	0.019	CHEMBL3587	Homo sapiens	IC50	nM	0.019
	16620489	CHEMBL3820565	Inhibition of purified MEK1 (unknown origin) assessed as reduction in phosphorylation of inactive Erk2 incubated for 30 mins by Kinase-Glo luminescent kinase assay	B	O=C(CNCCONC(=O)c1ccc(F)c(F)c1Nc1ccc(I)cc1F)NCCCCCC(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3819622	=	IC50	nM	0.5	CHEMBL3587	Homo sapiens	IC50	nM	0.5
	16620490	CHEMBL3820565	Inhibition of purified MEK1 (unknown origin) assessed as reduction in phosphorylation of inactive Erk2 incubated for 30 mins by Kinase-Glo luminescent kinase assay	B	NCCONC(=O)c1ccc(F)c(F)c1Nc1ccc(I)cc1F	Outside typical range	CHEMBL3818606	=	IC50	nM	0.00715	CHEMBL3587	Homo sapiens	IC50	nM	0.00715
	16627544	CHEMBL3820348	Inhibition of full length recombinant human N-terminal GST-tagged C-terminal His6-tagged MEK1 expressed in Escherichia coli at 1 uM by radiometric assay relative to control	B	Cc1cc(-c2cnn3c(NCC4CCOCC4)nc(Oc4ccccc4)nc23)ccc1C(=O)NC1CC1		CHEMBL3819210	=	Inhibition	%	9.0	CHEMBL3587	Homo sapiens	INH	%	9.0
	16627545	CHEMBL3820348	Inhibition of full length recombinant human N-terminal GST-tagged C-terminal His6-tagged MEK1 expressed in Escherichia coli at 1 uM by radiometric assay relative to control	B	O=C(N[C@@H](c1ccccn1)C1CC1)c1ccc2[nH]nc(-c3ccc(N4C5CCC4CC(O)C5)cc3)c2c1		CHEMBL3818239	=	Inhibition	%	41.0	CHEMBL3587	Homo sapiens	INH	%	41.0
	16642000	CHEMBL3826412	Inhibition of His-tagged full-length recombinant human MAP2K1 expressed in baculovirus system at 100 nM by Z-lyte assay	B	O=C(CNC(=O)c1cccn(Cc2ccc(F)c(F)c2)c1=O)Nc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2	Outside typical range	CHEMBL3824119	=	Inhibition	%	-13.0	CHEMBL3587	Homo sapiens	INH	%	-13.0
	16654189	CHEMBL3830946	Inhibition of human MKK1 (2 to 393 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	27.0	CHEMBL3587	Homo sapiens	Activity	%	27.0
	16737955	CHEMBL3856672	Inhibition of recombinant human MEK1 expressed in Escherichia coli assessed as remaining activity at 10 uM preincubated for 15 mins followed by myelin basic protein substrate addition for 30 mins in presence of [gamma-32P]ATP by TR-FRET assay	B	CNCCOc1ccc(-c2sc3nc(-c4cccs4)nc(NN4C(=O)C=C(C)C4=O)c3c2C)cc1.Cl		CHEMBL3966536	=	Activity	%	103.0	CHEMBL3587	Homo sapiens	Activity	%	103.0
	16739409	CHEMBL3857062	Inhibition of His tagged recombinant full length human MEK1 expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3901622	=	Inhibition	%	10.0	CHEMBL3587	Homo sapiens	INH	%	10.0
	16739410	CHEMBL3857062	Inhibition of His tagged recombinant full length human MEK1 expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN4CCCCC4)cc3)cc12)c1ccccc1		CHEMBL3891846	=	Inhibition	%	10.0	CHEMBL3587	Homo sapiens	INH	%	10.0
	16739411	CHEMBL3857062	Inhibition of His tagged recombinant full length human MEK1 expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	7.0	CHEMBL3587	Homo sapiens	INH	%	7.0
	16837444	CHEMBL3876107	Inhibition of human recombinant full length His-tagged MAP2K1 expressed in baculovirus expression system	B	CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21		CHEMBL3884319	=	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	nM	10000.0
	16840476	CHEMBL3876689	Inhibition of full length recombinant human His-tagged MEK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	IC50	nM	2.9	CHEMBL3587	Homo sapiens	IC50	nM	2.9
	16840477	CHEMBL3876689	Inhibition of full length recombinant human His-tagged MEK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3884960	=	IC50	nM	78.0	CHEMBL3587	Homo sapiens	IC50	nM	78.0
	16840478	CHEMBL3876689	Inhibition of full length recombinant human His-tagged MEK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	IC50	nM	142.0	CHEMBL3587	Homo sapiens	IC50	nM	142.0
	16840479	CHEMBL3876689	Inhibition of full length recombinant human His-tagged MEK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Nc1ccccc1Sc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3884813	=	IC50	nM	2480.0	CHEMBL3587	Homo sapiens	IC50	nM	2480.0
	16840480	CHEMBL3876689	Inhibition of full length recombinant human His-tagged MEK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Oc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3884569	=	IC50	nM	16.0	CHEMBL3587	Homo sapiens	IC50	nM	16.0
	16840481	CHEMBL3876689	Inhibition of full length recombinant human His-tagged MEK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	CCC(=O)Nc1ccccc1Oc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3884614	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	nM	10000.0
	16840482	CHEMBL3876689	Inhibition of full length recombinant human His-tagged MEK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	CN1CCN(c2ccc(Nc3ncc(Cl)c(Oc4ccccc4NC(=O)CCl)n3)cc2)CC1		CHEMBL3883823	=	IC50	nM	2500.0	CHEMBL3587	Homo sapiens	IC50	nM	2500.0
	16840483	CHEMBL3876689	Inhibition of full length recombinant human His-tagged MEK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Nc1cc(NC(C)=O)ccc1Oc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3884222	=	IC50	nM	4810.0	CHEMBL3587	Homo sapiens	IC50	nM	4810.0
	16840484	CHEMBL3876689	Inhibition of full length recombinant human His-tagged MEK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Nc1ccccc1Oc1ccnc(Nc2ccc(N3CCN(C)CC3)cc2)n1		CHEMBL3884555	=	IC50	nM	4470.0	CHEMBL3587	Homo sapiens	IC50	nM	4470.0
	16840485	CHEMBL3876689	Inhibition of full length recombinant human His-tagged MEK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C		CHEMBL3885038	=	IC50	nM	1630.0	CHEMBL3587	Homo sapiens	IC50	nM	1630.0
	16840486	CHEMBL3876689	Inhibition of full length recombinant human His-tagged MEK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1OC		CHEMBL3883761	=	IC50	nM	1300.0	CHEMBL3587	Homo sapiens	IC50	nM	1300.0
	16840487	CHEMBL3876689	Inhibition of full length recombinant human His-tagged MEK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C1CC1		CHEMBL3884914	=	IC50	nM	763.0	CHEMBL3587	Homo sapiens	IC50	nM	763.0
	16840488	CHEMBL3876689	Inhibition of full length recombinant human His-tagged MEK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2ccc(N3CCN(C)CC3)cc2)nc(N)c1Cl		CHEMBL3884215	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	nM	10000.0
	16840489	CHEMBL3876689	Inhibition of full length recombinant human His-tagged MEK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Nc1ccccc1-n1ccc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc21		CHEMBL3885053	=	IC50	nM	6810.0	CHEMBL3587	Homo sapiens	IC50	nM	6810.0
	16840490	CHEMBL3876689	Inhibition of full length recombinant human His-tagged MEK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Oc1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2)ncc1Cl		CHEMBL3884229	=	IC50	nM	8.9	CHEMBL3587	Homo sapiens	IC50	nM	8.9
	16840491	CHEMBL3876689	Inhibition of full length recombinant human His-tagged MEK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Oc1ccccc1Nc1nc(Nc2cccc(N3CCOCC3)c2)ncc1Cl		CHEMBL3884616	=	IC50	nM	11.0	CHEMBL3587	Homo sapiens	IC50	nM	11.0
	16840492	CHEMBL3876689	Inhibition of full length recombinant human His-tagged MEK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Oc1ccccc1Nc1nc(Nc2cccc(N3CCN(C(C)=O)CC3)c2)ncc1Cl		CHEMBL3885421	=	IC50	nM	9.5	CHEMBL3587	Homo sapiens	IC50	nM	9.5
	16840493	CHEMBL3876689	Inhibition of full length recombinant human His-tagged MEK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(C)c2)ncc1Cl		CHEMBL3884143	=	IC50	nM	9.8	CHEMBL3587	Homo sapiens	IC50	nM	9.8
	16840494	CHEMBL3876689	Inhibition of full length recombinant human His-tagged MEK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(C(F)F)c2)ncc1Cl		CHEMBL3884642	=	IC50	nM	26.0	CHEMBL3587	Homo sapiens	IC50	nM	26.0
	16840495	CHEMBL3876689	Inhibition of full length recombinant human His-tagged MEK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(C3CCOCC3)c2)ncc1Cl		CHEMBL3884281	=	IC50	nM	8.2	CHEMBL3587	Homo sapiens	IC50	nM	8.2
	16840496	CHEMBL3876689	Inhibition of full length recombinant human His-tagged MEK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	IC50	nM	8.5	CHEMBL3587	Homo sapiens	IC50	nM	8.5
	16840589	CHEMBL3876703	Inhibition of full length human GST-tagged MEK1 using ERK1/ERK2 peptide substrate in presence of ATP by ADP-Glo chemiluminescence assay	B	O=S1(=O)Nc2c(cc(F)c(F)c2Nc2ccc(I)cc2F)OC[C@H](O)[C@H](O)CC12CC2		CHEMBL3884776	=	IC50	nM	21.0	CHEMBL3587	Homo sapiens	IC50	nM	21.0
	16880683	CHEMBL3880853	Inhibition of MEK1 (unknown origin) using ERK2 as substrate after 40 mins by ELISA	B	CCNc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@@H](C)[C@H](C)OC2=O		CHEMBL1097999	=	IC50	nM	13.0	CHEMBL3587	Homo sapiens	IC50	nM	13.0
	16880684	CHEMBL3880853	Inhibition of MEK1 (unknown origin) using ERK2 as substrate after 40 mins by ELISA	B	CNc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@@H](O)C(=O)/C=C/[C@@H](C)[C@H](C)OC2=O		CHEMBL3957257	=	IC50	nM	4.8	CHEMBL3587	Homo sapiens	IC50	nM	4.8
	16880685	CHEMBL3880853	Inhibition of MEK1 (unknown origin) using ERK2 as substrate after 40 mins by ELISA	B	CNc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@@H](C)[C@H](C)OC2=O		CHEMBL1097700	=	IC50	nM	2.8	CHEMBL3587	Homo sapiens	IC50	nM	2.8
	16880686	CHEMBL3880853	Inhibition of MEK1 (unknown origin) using ERK2 as substrate after 40 mins by ELISA	B	C[C@@H]1OC(=O)c2c(O)cc(NC3CC3)cc2/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@H]1C		CHEMBL3936269	=	IC50	nM	657.0	CHEMBL3587	Homo sapiens	IC50	nM	657.0
	16880687	CHEMBL3880853	Inhibition of MEK1 (unknown origin) using ERK2 as substrate after 40 mins by ELISA	B	C[C@@H]1OC(=O)c2c(O)cc(CCCn3ccnc3)cc2/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@H]1C		CHEMBL3900978	=	IC50	nM	9.5	CHEMBL3587	Homo sapiens	IC50	nM	9.5
	16880688	CHEMBL3880853	Inhibition of MEK1 (unknown origin) using ERK2 as substrate after 40 mins by ELISA	B	C[C@@H]1OC(=O)c2c(O)cc(NOC[C@H](O)CO)cc2/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@H]1C		CHEMBL3898203	=	IC50	nM	187.0	CHEMBL3587	Homo sapiens	IC50	nM	187.0
	16880689	CHEMBL3880853	Inhibition of MEK1 (unknown origin) using ERK2 as substrate after 40 mins by ELISA	B	C[C@@H]1OC(=O)c2c(O)cc(NCCOP(=O)(O)O)cc2/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@H]1C		CHEMBL3925395	>	IC50	nM	330.0	CHEMBL3587	Homo sapiens	IC50	nM	330.0
	16880690	CHEMBL3880853	Inhibition of MEK1 (unknown origin) using ERK2 as substrate after 40 mins by ELISA	B	C[C@@H]1OC(=O)c2c(O)cc(NCC(=O)O)cc2/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@H]1C		CHEMBL3950457	=	IC50	nM	366.0	CHEMBL3587	Homo sapiens	IC50	nM	366.0
	16880691	CHEMBL3880853	Inhibition of MEK1 (unknown origin) using ERK2 as substrate after 40 mins by ELISA	B	C[C@@H]1OC(=O)c2c(O)cc(NCC(N)=O)cc2/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@H]1C		CHEMBL3915384	=	IC50	nM	99.0	CHEMBL3587	Homo sapiens	IC50	nM	99.0
	16880692	CHEMBL3880853	Inhibition of MEK1 (unknown origin) using ERK2 as substrate after 40 mins by ELISA	B	CNC(=O)CNc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@@H](C)[C@H](C)OC2=O		CHEMBL3912705	=	IC50	nM	657.0	CHEMBL3587	Homo sapiens	IC50	nM	657.0
	16880693	CHEMBL3880853	Inhibition of MEK1 (unknown origin) using ERK2 as substrate after 40 mins by ELISA	B	C[C@@H]1OC(=O)c2c(O)cc(NCC(=O)N(C)C)cc2/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@H]1C		CHEMBL3914342	=	IC50	nM	318.0	CHEMBL3587	Homo sapiens	IC50	nM	318.0
	16880694	CHEMBL3880853	Inhibition of MEK1 (unknown origin) using ERK2 as substrate after 40 mins by ELISA	B	COCCOCCOCCNCNc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@@H](C)[C@H](C)OC2=O		CHEMBL3963562	=	IC50	nM	756.0	CHEMBL3587	Homo sapiens	IC50	nM	756.0
	16880695	CHEMBL3880853	Inhibition of MEK1 (unknown origin) using ERK2 as substrate after 40 mins by ELISA	B	COCCNc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@@H](C)[C@H](C)OC2=O		CHEMBL3931700	=	IC50	nM	172.0	CHEMBL3587	Homo sapiens	IC50	nM	172.0
	16880696	CHEMBL3880853	Inhibition of MEK1 (unknown origin) using ERK2 as substrate after 40 mins by ELISA	B	C[C@@H]1OC(=O)c2c(O)cc(NCCO)cc2/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@H]1C		CHEMBL1097699	=	IC50	nM	91.0	CHEMBL3587	Homo sapiens	IC50	nM	91.0
	16880697	CHEMBL3880853	Inhibition of MEK1 (unknown origin) using ERK2 as substrate after 40 mins by ELISA	B	C[C@@H]1OC(=O)c2c(O)cc(N3CCNC3=O)cc2/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@H]1C		CHEMBL3967300	=	IC50	nM	484.0	CHEMBL3587	Homo sapiens	IC50	nM	484.0
	16880698	CHEMBL3880853	Inhibition of MEK1 (unknown origin) using ERK2 as substrate after 40 mins by ELISA	B	C[C@@H]1OC(=O)c2c(O)cc(N3CCOC3=O)cc2/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@H]1C		CHEMBL3922219	=	IC50	nM	187.0	CHEMBL3587	Homo sapiens	IC50	nM	187.0
	16880699	CHEMBL3880853	Inhibition of MEK1 (unknown origin) using ERK2 as substrate after 40 mins by ELISA	B	C[C@@H]1OC(=O)c2c(O)cc(NCCNCCO)cc2/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@H]1C		CHEMBL3954863	=	IC50	nM	846.0	CHEMBL3587	Homo sapiens	IC50	nM	846.0
	16880700	CHEMBL3880853	Inhibition of MEK1 (unknown origin) using ERK2 as substrate after 40 mins by ELISA	B	C[C@@H]1OC(=O)c2c(O)cc(NCCNCC(O)CO)cc2/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@H]1C		CHEMBL3970354	=	IC50	nM	658.0	CHEMBL3587	Homo sapiens	IC50	nM	658.0
	16880701	CHEMBL3880853	Inhibition of MEK1 (unknown origin) using ERK2 as substrate after 40 mins by ELISA	B	C[C@@H]1OC(=O)c2c(O)cc(NCCN3CCCC3)cc2/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@H]1C		CHEMBL3973244	=	IC50	nM	356.0	CHEMBL3587	Homo sapiens	IC50	nM	356.0
	16880702	CHEMBL3880853	Inhibition of MEK1 (unknown origin) using ERK2 as substrate after 40 mins by ELISA	B	C[C@@H]1OC(=O)c2c(O)cc(NCCN3CCOCC3)cc2/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@H]1C		CHEMBL3974111	=	IC50	nM	91.0	CHEMBL3587	Homo sapiens	IC50	nM	91.0
	16880703	CHEMBL3880853	Inhibition of MEK1 (unknown origin) using ERK2 as substrate after 40 mins by ELISA	B	C[C@@H]1OC(=O)c2c(O)cc(NCCN3CCN(C)CC3)cc2/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@H]1C		CHEMBL3933684	=	IC50	nM	471.0	CHEMBL3587	Homo sapiens	IC50	nM	471.0
	16880704	CHEMBL3880853	Inhibition of MEK1 (unknown origin) using ERK2 as substrate after 40 mins by ELISA	B	C[C@@H]1OC(=O)c2c(O)cc(NCCn3ccnc3)cc2/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@H]1C		CHEMBL3986872	=	IC50	nM	120.0	CHEMBL3587	Homo sapiens	IC50	nM	120.0
	16880705	CHEMBL3880852	Inhibition of MEK1 (unknown origin) using ERK2 as substrate after 40 mins in presence of 100 uM ATP by ELISA	B	CNc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@@H](C)[C@H](C)OC2=O		CHEMBL1097700	=	IC50	nM	70.0	CHEMBL3587	Homo sapiens	IC50	nM	70.0
	16880706	CHEMBL3880851	Inhibition of MEK1 (unknown origin) using ERK2 as substrate after 40 mins in presence of 10 uM ATP by ELISA	B	CNc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@@H](C)[C@H](C)OC2=O		CHEMBL1097700	=	IC50	nM	10.0	CHEMBL3587	Homo sapiens	IC50	nM	10.0
	16880707	CHEMBL3880853	Inhibition of MEK1 (unknown origin) using ERK2 as substrate after 40 mins by ELISA	B	C[C@@H]1OC(=O)c2c(O)cc(NCC(O)CO)cc2/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@H]1C		CHEMBL3970061	=	IC50	nM	56.0	CHEMBL3587	Homo sapiens	IC50	nM	56.0
	16880708	CHEMBL3880853	Inhibition of MEK1 (unknown origin) using ERK2 as substrate after 40 mins by ELISA	B	C[C@@H]1OC(=O)c2c(O)cc(NCC3CCNCC3)cc2/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@H]1C		CHEMBL3956374	=	IC50	nM	356.0	CHEMBL3587	Homo sapiens	IC50	nM	356.0
	16880709	CHEMBL3880853	Inhibition of MEK1 (unknown origin) using ERK2 as substrate after 40 mins by ELISA	B	C[C@@H]1OC(=O)c2c(O)cc(NOCC(=O)O)cc2/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@H]1C		CHEMBL3943250	>	IC50	nM	330.0	CHEMBL3587	Homo sapiens	IC50	nM	330.0
	16880710	CHEMBL3880853	Inhibition of MEK1 (unknown origin) using ERK2 as substrate after 40 mins by ELISA	B	CCNc1cc(O)c2c(c1)C#CC[C@H](O)[C@H](O)C(=O)/C=C\[C@@H](C)[C@H](C)OC2=O		CHEMBL3940603	=	IC50	nM	182.0	CHEMBL3587	Homo sapiens	IC50	nM	182.0
	16880711	CHEMBL3880853	Inhibition of MEK1 (unknown origin) using ERK2 as substrate after 40 mins by ELISA	B	CNc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@@H](O)C(=O)/C=C\[C@@H](C)[C@H](C)OC2=O		CHEMBL3895505	=	IC50	nM	421.0	CHEMBL3587	Homo sapiens	IC50	nM	421.0
	16880712	CHEMBL3880853	Inhibition of MEK1 (unknown origin) using ERK2 as substrate after 40 mins by ELISA	B	CCNc1cc(O)c2c(c1)/C=C/C[C@H](OC(=O)C(F)(F)F)[C@@H](O)C(=O)/C=C\[C@@H](C)[C@H](C)OC2=O		CHEMBL3893740	=	IC50	nM	79.0	CHEMBL3587	Homo sapiens	IC50	nM	79.0
	16880713	CHEMBL3880853	Inhibition of MEK1 (unknown origin) using ERK2 as substrate after 40 mins by ELISA	B	CCNc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@@H](O)C(=O)/C=C/[C@@H](C)[C@H](C)OC2=O		CHEMBL3898540	=	IC50	nM	240.0	CHEMBL3587	Homo sapiens	IC50	nM	240.0
	16880714	CHEMBL3880853	Inhibition of MEK1 (unknown origin) using ERK2 as substrate after 40 mins by ELISA	B	CCNc1cc(O)c2c(c1)/C=C/C[C@@H]1OC(=O)O[C@@H]1C(=O)/C=C\[C@@H](C)[C@H](C)OC2=O		CHEMBL3948014	=	IC50	nM	145.0	CHEMBL3587	Homo sapiens	IC50	nM	145.0
Active	16880715	CHEMBL3880854	Competitive inhibition of MEK1 (unknown origin) using ERK2 as substrate after 40 mins by ELISA	B	CNc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@@H](C)[C@H](C)OC2=O		CHEMBL1097700		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
	16880722	CHEMBL3880859	Inhibition of human MEK1 after 40 mins in presence of [gamma33P-ATP] by scintillation counting	B	CNc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@@H](C)[C@H](C)OC2=O		CHEMBL1097700	=	IC50	nM	10.0	CHEMBL3587	Homo sapiens	IC50	nM	10.0
	16880749	CHEMBL3880874	Inhibition of human MEK1 assessed as remaining activity at 0.1 uM after 40 mins in presence of [gamma33P-ATP] by scintillation counting	B	CNc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@@H](C)[C@H](C)OC2=O		CHEMBL1097700	=	Activity	%	30.0	CHEMBL3587	Homo sapiens	Activity	%	30.0
	16880750	CHEMBL3880875	Inhibition of human MEK1 assessed as remaining activity at 1 uM after 40 mins in presence of [gamma33P-ATP] by scintillation counting	B	CNc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@@H](C)[C@H](C)OC2=O		CHEMBL1097700	=	Activity	%	4.0	CHEMBL3587	Homo sapiens	Activity	%	4.0
	16895023	CHEMBL3882096	Inhibition of N-terminal 6His-tagged MEK1 (2 to 393 residues) (unknown origin) expressed in Escherichia coli assessed as decrease in incorporation of gamma-33P from gamma-33P-ATP into N-terminal His-tagged ERK2 K52R mutant after 120 mins by scintillation counting method	B	O=C(CCCONC(=O)c1ccc(F)c(F)c1Nc1ccc(I)cc1F)NO		CHEMBL3967834	=	IC50	nM	100.0	CHEMBL3587	Homo sapiens	IC50	uM	0.1
	16895024	CHEMBL3882096	Inhibition of N-terminal 6His-tagged MEK1 (2 to 393 residues) (unknown origin) expressed in Escherichia coli assessed as decrease in incorporation of gamma-33P from gamma-33P-ATP into N-terminal His-tagged ERK2 K52R mutant after 120 mins by scintillation counting method	B	O=C(CCCCCONC(=O)c1ccc(F)c(F)c1Nc1ccc(I)cc1F)NO		CHEMBL3928172	=	IC50	nM	100.0	CHEMBL3587	Homo sapiens	IC50	uM	0.1
1901	17601081	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cn1c(=O)cc(Nc2ccc(I)cc2F)c2c(=O)n(CCO)cnc21		CHEMBL1684061	=	IC50	nM	10.0	CHEMBL3587	Homo sapiens	IC50	nM	10.0
1902	17601082	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cn1c(=O)cc(Nc2ccc(I)cc2F)c2c(=O)n(C[C@H](O)CO)cnc21		CHEMBL1684064	=	IC50	nM	10.0	CHEMBL3587	Homo sapiens	IC50	nM	10.0
1903	17601083	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cc1c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc2n(C)c1=O		CHEMBL1684067	<	IC50	nM	5.0	CHEMBL3587	Homo sapiens	IC50	nM	5.0
1904	17601084	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cc1c(Nc2ccc(Br)cc2F)c2c(=O)n(C[C@H](O)CO)cnc2n(C)c1=O		CHEMBL3644804	>	IC50	nM	16.0	CHEMBL3587	Homo sapiens	IC50	nM	16.0
1905	17601085	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cc1c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@H](O)CO)cnc2n(C)c1=O		CHEMBL1684071	<	IC50	nM	5.0	CHEMBL3587	Homo sapiens	IC50	nM	5.0
1906	17601086	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(CCO)cnc21		CHEMBL1684072	=	IC50	nM	10.0	CHEMBL3587	Homo sapiens	IC50	nM	10.0
1907	17601087	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cn1c(=O)c(F)c(Nc2ccc(C#N)cc2F)c2c(=O)n(C[C@H](O)CO)cnc21		CHEMBL3644805	=	IC50	nM	10.0	CHEMBL3587	Homo sapiens	IC50	nM	10.0
1910	17601088	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cn1c(=O)c(F)c(Nc2ccc(NCS(C)(=O)=O)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL3644806	>	IC50	nM	16.0	CHEMBL3587	Homo sapiens	IC50	nM	16.0
1923	17601089	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cn1c(=O)c(F)c(Nc2ccc(Br)cc2F)c2c(=O)n(C[C@H](O)CO)cnc21		CHEMBL3644807	=	IC50	nM	10.0	CHEMBL3587	Homo sapiens	IC50	nM	10.0
213397	17602776	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cn1cnc2c(c(Nc3ccc(I)cc3F)cc(=O)n2C)c1=O		CHEMBL1684060	>	IC50	nM	16.0	CHEMBL3587	Homo sapiens	IC50	nM	16.0
213399	17602778	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	COC(=O)Cn1cnc2c(c(Nc3ccc(I)cc3F)cc(=O)n2C)c1=O		CHEMBL3644808	>	IC50	nM	16.0	CHEMBL3587	Homo sapiens	IC50	nM	16.0
213402	17602781	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cn1c(=O)cc(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1684063	<	IC50	nM	5.0	CHEMBL3587	Homo sapiens	IC50	nM	5.0
213403	17602782	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cn1c(=O)c(Cl)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@H](O)CO)cnc21		CHEMBL3644809	<	IC50	nM	5.0	CHEMBL3587	Homo sapiens	IC50	nM	5.0
213406	17602785	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cc1c(Nc2ccc(Br)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc2n(C)c1=O		CHEMBL3644810	>	IC50	nM	16.0	CHEMBL3587	Homo sapiens	IC50	nM	16.0
213407	17602786	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cc1c(Nc2ccc(Br)cc2F)c2c(=O)n(CCO)cnc2n(C)c1=O		CHEMBL3644811	>	IC50	nM	16.0	CHEMBL3587	Homo sapiens	IC50	nM	16.0
213408	17602787	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cc1c(Nc2ccc(I)cc2F)c2c(=O)[nH]cnc2n(C)c1=O		CHEMBL3644812	<	IC50	nM	5.0	CHEMBL3587	Homo sapiens	IC50	nM	5.0
213409	17602788	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cc1c(Nc2ccc(I)cc2F)c2c(=O)n(CCO)cnc2n(C)c1=O		CHEMBL1684073	<	IC50	nM	5.0	CHEMBL3587	Homo sapiens	IC50	nM	5.0
213410	17602789	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cc1c(Nc2ccccc2F)c2c(=O)n(CCO)cnc2n(C)c1=O		CHEMBL3644813	>	IC50	nM	16.0	CHEMBL3587	Homo sapiens	IC50	nM	16.0
213411	17602790	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	C#Cc1ccc(Nc2c(C)c(=O)n(C)c3ncn(C[C@@H](O)CO)c(=O)c23)c(F)c1		CHEMBL3644814	=	IC50	nM	10.0	CHEMBL3587	Homo sapiens	IC50	nM	10.0
213413	17602792	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	<	IC50	nM	5.0	CHEMBL3587	Homo sapiens	IC50	nM	5.0
213414	17602793	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@H](O)CO)cnc21		CHEMBL1684070	<	IC50	nM	5.0	CHEMBL3587	Homo sapiens	IC50	nM	5.0
213415	17602794	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cn1c(=O)c(F)c(Nc2ccc(Br)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1684068	>	IC50	nM	16.0	CHEMBL3587	Homo sapiens	IC50	nM	16.0
213417	17602796	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	C#Cc1ccc(Nc2c(F)c(=O)n(C)c3ncn(C[C@@H](O)CO)c(=O)c23)c(F)c1		CHEMBL1684069	<	IC50	nM	5.0	CHEMBL3587	Homo sapiens	IC50	nM	5.0
213419	17602798	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cn1c(=O)cc(Nc2ccc(I)cc2F)c2c(=O)n(C(CO)CO)cnc21		CHEMBL3644815	=	IC50	nM	10.0	CHEMBL3587	Homo sapiens	IC50	nM	10.0
213420	17602799	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C(CO)CO)cnc21		CHEMBL1684074	<	IC50	nM	5.0	CHEMBL3587	Homo sapiens	IC50	nM	5.0
213421	17602800	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cn1c(=O)cc(Nc2ccc(I)cc2F)c2c(=O)n(OCCO)cnc21		CHEMBL3644816	=	IC50	nM	10.0	CHEMBL3587	Homo sapiens	IC50	nM	10.0
213422	17602801	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cn1c(=O)cc(Nc2ccc(I)cc2F)c2c(=O)n(OC[C@H](O)CO)cnc21		CHEMBL3644817	=	IC50	nM	10.0	CHEMBL3587	Homo sapiens	IC50	nM	10.0
213423	17602802	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(OC[C@H](O)CO)cnc21		CHEMBL1684075	<	IC50	nM	5.0	CHEMBL3587	Homo sapiens	IC50	nM	5.0
213424	17602803	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cn1c(=O)c(Cl)c(Nc2ccc(Br)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL3644818	=	IC50	nM	10.0	CHEMBL3587	Homo sapiens	IC50	nM	10.0
213425	17602804	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cn1c(=O)c(Cl)c(Nc2ccc(I)cc2F)c2c(=O)n(CCO)cnc21		CHEMBL3644819	<	IC50	nM	5.0	CHEMBL3587	Homo sapiens	IC50	nM	5.0
213426	17602805	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cn1c(=O)cc(Nc2ccc(I)cc2F)c2c(=O)n(CCCO)cnc21		CHEMBL1684062	<	IC50	nM	5.0	CHEMBL3587	Homo sapiens	IC50	nM	5.0
213427	17602806	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cn1c(=O)c(Cl)c(Nc2ccc(I)cc2F)c2c(=O)n(CCCO)cnc21		CHEMBL3644820	<	IC50	nM	5.0	CHEMBL3587	Homo sapiens	IC50	nM	5.0
213428	17602807	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cn1c(=O)cc(Nc2ccc(Br)cc2F)c2c(=O)n(CCCO)cnc21		CHEMBL3644821	>	IC50	nM	16.0	CHEMBL3587	Homo sapiens	IC50	nM	16.0
213429	17602808	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cn1c(=O)c(Cl)c(Nc2ccc(Br)cc2F)c2c(=O)n(CCCO)cnc21		CHEMBL3644822	=	IC50	nM	10.0	CHEMBL3587	Homo sapiens	IC50	nM	10.0
213430	17602809	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cn1c(=O)cc(Nc2ccc(Br)cc2Cl)c2c(=O)n(CCCO)cnc21		CHEMBL3644823	>	IC50	nM	16.0	CHEMBL3587	Homo sapiens	IC50	nM	16.0
213431	17602810	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cn1c(=O)c(Cl)c(Nc2ccc(Br)cc2Cl)c2c(=O)n(CCCO)cnc21		CHEMBL3644824	>	IC50	nM	16.0	CHEMBL3587	Homo sapiens	IC50	nM	16.0
213432	17602811	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	CN(C)CCn1cnc2c(c(Nc3ccc(I)cc3F)cc(=O)n2C)c1=O		CHEMBL1684066	>	IC50	nM	16.0	CHEMBL3587	Homo sapiens	IC50	nM	16.0
213433	17602812	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	CC(O)Cn1cnc2c(c(Nc3ccc(I)cc3F)cc(=O)n2C)c1=O		CHEMBL3644825	>	IC50	nM	16.0	CHEMBL3587	Homo sapiens	IC50	nM	16.0
213434	17602813	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cn1c(=O)cc(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CCO)cnc21		CHEMBL1684065	>	IC50	nM	16.0	CHEMBL3587	Homo sapiens	IC50	nM	16.0
213435	17602814	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	CC(O)Cn1cnc2c(c(Nc3ccc(I)cc3F)c(Cl)c(=O)n2C)c1=O		CHEMBL3644826	=	IC50	nM	10.0	CHEMBL3587	Homo sapiens	IC50	nM	10.0
213437	17602816	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cn1c(=O)cc(Nc2ccc(I)cc2F)c2c(=O)n(Cc3ccccc3)cnc21		CHEMBL3644827	>	IC50	nM	16.0	CHEMBL3587	Homo sapiens	IC50	nM	16.0
213438	17602817	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cc1c(Nc2ccc(I)cc2F)c2c(=O)n(C(CO)CO)cnc2n(C)c1=O		CHEMBL3644828	=	IC50	nM	10.0	CHEMBL3587	Homo sapiens	IC50	nM	10.0
213439	17602818	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	C#Cc1ccc(Nc2c(C)c(=O)n(C)c3ncn(C[C@H](O)CO)c(=O)c23)c(F)c1		CHEMBL3644829	=	IC50	nM	10.0	CHEMBL3587	Homo sapiens	IC50	nM	10.0
213441	17602819	CHEMBL3705246	Enzyme Assay: The inhibitory properties of compounds relative to MEK1 or MEK2 may be determined using a black 384-well-plate format under the following reaction conditions: 50 mM HEPES pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 1 nM MEK1 or 4 nM MEK2, 25 nM ERK1, 400 μM ATP, 500 nM IPTTPITTYFFFK-5FAM-COOH (FI-Erktide), and 1% DMSO. Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices. The assay reaction may be initiated as follows: 2 μl of the mixture of 1.5 μM FI-Erktide and 75 nM ERK with 2 Î¼l of inhibitor (2 fold serial dilutions for 11 data points for each inhibitor) containing 3% DMSO were added to each well of the plate, followed by the addition of 2 μl of the mixture of 3 nM MEK1 or 12 nM MEK2 and 1200 μM ATP to initiate the reaction (final enzyme concentration was 1 nM for MEK1 or 4 nM for MEK2). The reaction mixture may then be incubated at room temperature for 22 min, and quenched and developed by addition of 20 μl of 1:200 dilution of progressive IMAP beads (Molecular Devices) in 80% buffer A, 20% bufferB and 0.003% Tween 20. Fluorescence polarization of the resulting reaction mixtures may be measured after a 1 hour incubation at room temperature.	B	Cc1c(Nc2ccc(I)cc2F)c2c(=O)n(C)cnc2n(C)c1=O		CHEMBL3644830	=	IC50	nM	10.0	CHEMBL3587	Homo sapiens	IC50	nM	10.0
215813	17604951	CHEMBL3705284	In Vitro Inhibition Assay: MEK phosphorylation inhibition activity.	B	CC(C)(C#N)c1cccc(C(=O)Nc2cccc(Oc3ccc4nc(NC(=O)C5CC5)sc4c3C#N)c2)c1Cl		CHEMBL3669309	<	IC50	nM	300.0	CHEMBL3587	Homo sapiens	IC50	nM	300.0
215814	17604952	CHEMBL3705284	In Vitro Inhibition Assay: MEK phosphorylation inhibition activity.	B	CC(=O)Nc1nc2ccc(Oc3cccc(NC(=O)Nc4ccc(C(C)(C)C)cc4)c3)c(C#N)c2s1		CHEMBL3669310	<	IC50	nM	300.0	CHEMBL3587	Homo sapiens	IC50	nM	300.0
215815	17604953	CHEMBL3705284	In Vitro Inhibition Assay: MEK phosphorylation inhibition activity.	B	N#Cc1c(Oc2ccc(F)c(NC(=O)Nc3ccc(C(F)(F)F)cc3)c2)ccc2nc(NC(=O)C3CC3)sc12		CHEMBL3125886	<	IC50	nM	300.0	CHEMBL3587	Homo sapiens	IC50	nM	300.0
215816	17604954	CHEMBL3705284	In Vitro Inhibition Assay: MEK phosphorylation inhibition activity.	B	CC(=O)Nc1nc2ccc(Oc3cccc(NC(=O)Cc4cccc(C(F)(F)F)c4)c3)c(C#N)c2s1		CHEMBL3639681	<	IC50	nM	300.0	CHEMBL3587	Homo sapiens	IC50	nM	300.0
215817	17604955	CHEMBL3705284	In Vitro Inhibition Assay: MEK phosphorylation inhibition activity.	B	N#Cc1c(Oc2ccc(F)c(NC(=O)Cc3cccc(C(F)(F)F)c3)c2)ccc2nc(NC(=O)C3CC3)sc12		CHEMBL3125890	<	IC50	nM	300.0	CHEMBL3587	Homo sapiens	IC50	nM	300.0
215818	17604956	CHEMBL3705284	In Vitro Inhibition Assay: MEK phosphorylation inhibition activity.	B	COC(=O)c1c(Oc2ccc(F)c(NC(=O)Cc3cccc(C(F)(F)F)c3)c2)ccc2nc(NC(=O)C3CC3)sc12		CHEMBL3669311	<	IC50	nM	300.0	CHEMBL3587	Homo sapiens	IC50	nM	300.0
223493	17612083	CHEMBL3705128	Inhibition Assay: Inhibition assay using MEK kinase.	B	O=C(NOCCO)c1cc(COCCO)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL464238	=	IC50	nM	21.0	CHEMBL3587	Homo sapiens	IC50	nM	21.0
223494	17612084	CHEMBL3705128	Inhibition Assay: Inhibition assay using MEK kinase.	B	C#Cc1ccc(Nc2c(C(=O)NOCCO)cc(COCCO)c(F)c2F)c(F)c1		CHEMBL3640619	=	IC50	nM	32.0	CHEMBL3587	Homo sapiens	IC50	nM	32.0
223495	17612085	CHEMBL3705128	Inhibition Assay: Inhibition assay using MEK kinase.	B	O=C(NOCCO)c1cc(COCCCO)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL3640620	=	IC50	nM	23.0	CHEMBL3587	Homo sapiens	IC50	nM	23.0
223496	17612086	CHEMBL3705128	Inhibition Assay: Inhibition assay using MEK kinase.	B	O=C(NOCCO)c1cc(COCC(O)CO)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL3640621	=	IC50	nM	15.0	CHEMBL3587	Homo sapiens	IC50	nM	15.0
223497	17612087	CHEMBL3705128	Inhibition Assay: Inhibition assay using MEK kinase.	B	CS(=O)(=O)CCOCc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)c(F)c1F		CHEMBL3640622	=	IC50	nM	31.0	CHEMBL3587	Homo sapiens	IC50	nM	31.0
223498	17612088	CHEMBL3705128	Inhibition Assay: Inhibition assay using MEK kinase.	B	O=C(NOCCO)c1cc(CNOCCO)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1684491	=	IC50	nM	19.0	CHEMBL3587	Homo sapiens	IC50	nM	19.0
223499	17612089	CHEMBL3705128	Inhibition Assay: Inhibition assay using MEK kinase.	B	CNC(=O)CCONCc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)c(F)c1F		CHEMBL3640623	=	IC50	nM	49.0	CHEMBL3587	Homo sapiens	IC50	nM	49.0
223500	17612090	CHEMBL3705128	Inhibition Assay: Inhibition assay using MEK kinase.	B	CC(=O)NCCONCc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)c(F)c1F		CHEMBL3640624	=	IC50	nM	140.0	CHEMBL3587	Homo sapiens	IC50	nM	140.0
223501	17612091	CHEMBL3705128	Inhibition Assay: Inhibition assay using MEK kinase.	B	CS(=O)(=O)CCONCc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)c(F)c1F		CHEMBL3640625	=	IC50	nM	32.0	CHEMBL3587	Homo sapiens	IC50	nM	32.0
223502	17612092	CHEMBL3705128	Inhibition Assay: Inhibition assay using MEK kinase.	B	O=C(NOCCO)c1cc(CNOCCCO)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL3640626	=	IC50	nM	19.0	CHEMBL3587	Homo sapiens	IC50	nM	19.0
223503	17612093	CHEMBL3705128	Inhibition Assay: Inhibition assay using MEK kinase.	B	CNC(=O)CONCc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)c(F)c1F		CHEMBL3640627	=	IC50	nM	28.0	CHEMBL3587	Homo sapiens	IC50	nM	28.0
223504	17612094	CHEMBL3705128	Inhibition Assay: Inhibition assay using MEK kinase.	B	CONCc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)c(F)c1F		CHEMBL3640628	=	IC50	nM	68.0	CHEMBL3587	Homo sapiens	IC50	nM	68.0
223505	17612095	CHEMBL3705128	Inhibition Assay: Inhibition assay using MEK kinase.	B	CC(C)(O)CONCc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)c(F)c1F		CHEMBL3640629	=	IC50	nM	68.0	CHEMBL3587	Homo sapiens	IC50	nM	68.0
223506	17612096	CHEMBL3705128	Inhibition Assay: Inhibition assay using MEK kinase.	B	C[S+]([O-])CCONCc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)c(F)c1F		CHEMBL3640630	=	IC50	nM	12.0	CHEMBL3587	Homo sapiens	IC50	nM	12.0
223507	17612097	CHEMBL3705128	Inhibition Assay: Inhibition assay using MEK kinase.	B	CON(C=O)Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)c(F)c1F		CHEMBL3640631	=	IC50	nM	35.0	CHEMBL3587	Homo sapiens	IC50	nM	35.0
223508	17612098	CHEMBL3705128	Inhibition Assay: Inhibition assay using MEK kinase.	B	CON(Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)c(F)c1F)C(C)=O		CHEMBL1684492	=	IC50	nM	8.6	CHEMBL3587	Homo sapiens	IC50	nM	8.6
223509	17612099	CHEMBL3705128	Inhibition Assay: Inhibition assay using MEK kinase.	B	CCC(=O)N(Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)c(F)c1F)OC		CHEMBL3640632	=	IC50	nM	29.0	CHEMBL3587	Homo sapiens	IC50	nM	29.0
223510	17612100	CHEMBL3705128	Inhibition Assay: Inhibition assay using MEK kinase.	B	CON(Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)c(F)c1F)C(=O)C(C)C		CHEMBL3640633	=	IC50	nM	35.0	CHEMBL3587	Homo sapiens	IC50	nM	35.0
223511	17612101	CHEMBL3705128	Inhibition Assay: Inhibition assay using MEK kinase.	B	CON(Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)c(F)c1F)C(=O)CO		CHEMBL3640634	=	IC50	nM	43.0	CHEMBL3587	Homo sapiens	IC50	nM	43.0
223512	17612102	CHEMBL3705128	Inhibition Assay: Inhibition assay using MEK kinase.	B	COCC(=O)N(Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)c(F)c1F)OC		CHEMBL3640635	=	IC50	nM	28.0	CHEMBL3587	Homo sapiens	IC50	nM	28.0
223513	17612103	CHEMBL3705128	Inhibition Assay: Inhibition assay using MEK kinase.	B	C#Cc1ccc(Nc2c(C(=O)NOCCO)cc(CN(OC)C(C)=O)c(F)c2F)c(F)c1		CHEMBL3640636	=	IC50	nM	48.0	CHEMBL3587	Homo sapiens	IC50	nM	48.0
223514	17612104	CHEMBL3705128	Inhibition Assay: Inhibition assay using MEK kinase.	B	C#Cc1ccc(Nc2c(C(=O)NOCCO)cc(CN(OC)C(=O)CC)c(F)c2F)c(F)c1		CHEMBL3640637	=	IC50	nM	65.0	CHEMBL3587	Homo sapiens	IC50	nM	65.0
223515	17612105	CHEMBL3705128	Inhibition Assay: Inhibition assay using MEK kinase.	B	C#Cc1ccc(Nc2c(C(=O)NOCCO)cc(CN(OC)C(=O)C(C)C)c(F)c2F)c(F)c1		CHEMBL3640638	=	IC50	nM	70.0	CHEMBL3587	Homo sapiens	IC50	nM	70.0
223516	17612106	CHEMBL3705128	Inhibition Assay: Inhibition assay using MEK kinase.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	=	IC50	nM	8.8	CHEMBL3587	Homo sapiens	IC50	nM	8.8
223517	17612107	CHEMBL3705128	Inhibition Assay: Inhibition assay using MEK kinase.	B	O=C(NOCCO)c1cc(CN2OCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1684493	=	IC50	nM	7.2	CHEMBL3587	Homo sapiens	IC50	nM	7.2
223518	17612108	CHEMBL3705128	Inhibition Assay: Inhibition assay using MEK kinase.	B	CC1(C)CON(Cc2cc(C(=O)NOCCO)c(Nc3ccc(I)cc3F)c(F)c2F)C1=O		CHEMBL3640639	=	IC50	nM	37.0	CHEMBL3587	Homo sapiens	IC50	nM	37.0
223519	17612109	CHEMBL3705128	Inhibition Assay: Inhibition assay using MEK kinase.	B	C#Cc1ccc(Nc2c(C(=O)NOCCO)cc(CN3OCCCC3=O)c(F)c2F)c(F)c1		CHEMBL3640640	=	IC50	nM	56.0	CHEMBL3587	Homo sapiens	IC50	nM	56.0
223520	17612110	CHEMBL3705128	Inhibition Assay: Inhibition assay using MEK kinase.	B	C#Cc1ccc(Nc2c(C(=O)NOCCO)cc(CN3OCCC3=O)c(F)c2F)c(F)c1		CHEMBL3640641	=	IC50	nM	40.0	CHEMBL3587	Homo sapiens	IC50	nM	40.0
223521	17612111	CHEMBL3705128	Inhibition Assay: Inhibition assay using MEK kinase.	B	O=C(NOCCO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL244488	=	IC50	nM	2.0	CHEMBL3587	Homo sapiens	IC50	nM	2.0
223522	17612112	CHEMBL3705128	Inhibition Assay: Inhibition assay using MEK kinase.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	IC50	nM	5.2	CHEMBL3587	Homo sapiens	IC50	nM	5.2
223523	17612113	CHEMBL3705128	Inhibition Assay: Inhibition assay using MEK kinase.	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	=	IC50	nM	130.0	CHEMBL3587	Homo sapiens	IC50	nM	130.0
Inactive	17910267	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910268	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Active	17910269	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	=	Kd	nM	2039.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	2039.0
Inactive	17910270	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910271	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Active	17910272	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	3668.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	3668.0
Inactive	17910273	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910274	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Active	17910275	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	=	Kd	nM	3326.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	3326.0
Inactive	17910276	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910277	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17910278	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	=	Kd	nM	7032.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	7032.0
Inactive	17910279	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910280	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Active	17910281	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	1162.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	1162.0
Inactive	17910282	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Active	17910283	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	=	Kd	nM	3314.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	3314.0
Inactive	17910284	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910285	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910286	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910287	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910288	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910289	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910290	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910291	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910292	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910293	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Active	17910294	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	=	Kd	nM	62.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	62.0
Inactive	17910295	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910296	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910297	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910298	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910299	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910300	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910301	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910302	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910303	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910304	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910305	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910306	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910307	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910308	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910309	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910310	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910311	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910312	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910313	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910314	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910315	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910316	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910317	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910318	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910319	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910320	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910321	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910322	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910323	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910324	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910325	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Active	17910326	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	=	Kd	nM	30.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30.0
Inactive	17910327	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910328	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Active	17910329	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	Kd	nM	12.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	12.0
Inactive	17910330	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910331	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910332	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910333	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Active	17910334	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	968.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	968.0
Inactive	17910335	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910336	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910337	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910338	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910339	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910340	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910341	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910342	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Active	17910343	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	=	Kd	nM	29.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	29.0
Inactive	17910344	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910345	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Active	17910346	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	=	Kd	nM	3173.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	3173.0
Inactive	17910347	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910348	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910349	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910350	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910351	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910352	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910353	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Active	17910354	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	=	Kd	nM	279.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	279.0
Inactive	17910355	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910356	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910357	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910358	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910359	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910360	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910361	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Active	17910362	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	=	Kd	nM	352.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	352.0
Inactive	17910363	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910364	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910365	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910366	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910367	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910368	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910369	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910370	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910371	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Active	17910372	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	=	Kd	nM	24.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	24.0
Inactive	17910373	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910374	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910375	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910376	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910377	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910378	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Active	17910379	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	=	Kd	nM	130.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	130.0
Inactive	17910380	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910381	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Active	17910382	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	=	Kd	nM	41.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	41.0
Inactive	17910383	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910384	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910385	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910386	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910387	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910388	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Active	17910389	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	3933.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	3933.0
Inactive	17910390	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910391	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910392	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Active	17910393	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Kd	nM	1747.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	1747.0
Inactive	17910394	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Active	17910395	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	=	Kd	nM	2755.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	2755.0
Inactive	17910396	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Active	17910397	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	=	Kd	nM	72.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	72.0
Inactive	17910398	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910399	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910400	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910401	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910402	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910403	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910404	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910405	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910406	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910407	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17910408	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	2330.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	2330.0
Inactive	17910409	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910410	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910411	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910412	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910413	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910414	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Active	17910415	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	=	Kd	nM	19.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	19.0
Active	17910416	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	2420.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	2420.0
Active	17910417	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Kd	nM	3426.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	3426.0
Inactive	17910418	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910419	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910420	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910421	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910422	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910423	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910424	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910425	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910426	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Active	17910427	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	=	Kd	nM	3007.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	3007.0
Inactive	17910428	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910429	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910430	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910431	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910432	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910433	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910434	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910435	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910436	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910437	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910438	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910439	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910440	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910441	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910442	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910443	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910444	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910445	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910446	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910447	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910448	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910449	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910450	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910451	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910452	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910453	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910454	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910455	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910456	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910457	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Active	17910458	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	=	Kd	nM	21.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	21.0
Inactive	17910459	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Active	17910460	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	=	Kd	nM	309.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	309.0
Inactive	17910461	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910462	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910463	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Active	17910464	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	=	Kd	nM	45.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	45.0
Inactive	17910465	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910466	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910467	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910468	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Active	17910469	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	2580.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	2580.0
Inactive	17910470	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910471	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910472	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910473	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910474	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910475	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910476	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910477	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17910478	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Kd	nM	429.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	429.0
Inactive	17910479	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910480	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910481	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910482	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910483	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910484	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Active	17910485	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	=	Kd	nM	18457.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	18457.0
Inactive	17910486	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910487	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910488	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910489	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910490	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910491	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910492	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910493	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910494	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910495	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910496	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910497	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910498	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910499	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910500	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910501	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910502	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910503	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910504	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910505	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910506	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910507	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910508	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	30000.0
Active	17910509	CHEMBL3991751	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	8773.0	CHEMBL3587	Homo sapiens	Kd apparent	nM	8773.0
	17964922	CHEMBL3995031	Inhibition of full length human MEK1 (M1 to V393 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by KINOMEscan assay relative to control	B	CNc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)c(C)c2)ncn1		CHEMBL4060295	=	Activity	%	100.0	CHEMBL3587	Homo sapiens	Activity	%	100.0
	17971059	CHEMBL3995862	Inhibition of human MEK1 at 10 uM using ERK2 as substrate in presence of [33P]ATP by Hotspot assay relative to control	B	COc1cc2cc(Oc3ccc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)cc3)c(C)nc2cc1OC		CHEMBL4100501	=	Inhibition	%	-0.2575	CHEMBL3587	Homo sapiens	INH	%	-0.2575
	17979258	CHEMBL3998065	Inhibition of full length recombinant human His-tagged MEK1 expressed in baculovirus expression system at 10 uM by Z'-LYTE assay relative to control	B	CC1=Nc2c(Sc3ccccc3)ncnc2Sc2ccccc21		CHEMBL4061152	=	Inhibition	%	2.0	CHEMBL3587	Homo sapiens	INH	%	2.0
	18008707	CHEMBL4003790	Inhibition of human MEK1 using inactive MAPK2 as substrate in presence of [gamma-33P]ATP at 1 uM after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CCCC[C@@H]3N)nc21		CHEMBL4088144	=	Inhibition	%	10.0	CHEMBL3587	Homo sapiens	INH	%	10.0
	18008708	CHEMBL4003790	Inhibition of human MEK1 using inactive MAPK2 as substrate in presence of [gamma-33P]ATP at 1 uM after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL4066861	=	Inhibition	%	8.0	CHEMBL3587	Homo sapiens	INH	%	8.0
	18008709	CHEMBL4003790	Inhibition of human MEK1 using inactive MAPK2 as substrate in presence of [gamma-33P]ATP at 1 uM after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cc(N)cc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL4078898	=	Inhibition	%	6.0	CHEMBL3587	Homo sapiens	INH	%	6.0
	18012405	CHEMBL4004225	Inhibition of MEK1 (unknown origin)	B	COc1cc2ncccc2cc1NC(=O)c1csc2cncnc12		CHEMBL3822972	>	IC50	nM	50000.0	CHEMBL3587	Homo sapiens	IC50	uM	50.0
	18031784	CHEMBL4007726	Inhibition of MEK1 (unknown origin) after 60 mins by TR-FRET assay	B	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	=	IC50	nM	139.0	CHEMBL3587	Homo sapiens	IC50	uM	0.139
	18031785	CHEMBL4007726	Inhibition of MEK1 (unknown origin) after 60 mins by TR-FRET assay	B	FC(F)(F)CNc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2ccoc12		CHEMBL4078893	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	18031786	CHEMBL4007726	Inhibition of MEK1 (unknown origin) after 60 mins by TR-FRET assay	B	FC(F)(F)CNc1nc(Nc2ccc3cn[nH]c3c2)nc2ccoc12		CHEMBL4066664	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	18031787	CHEMBL4007726	Inhibition of MEK1 (unknown origin) after 60 mins by TR-FRET assay	B	CC1(C)OCC(=O)Nc2cc(Nc3nc(NCC(F)(F)F)c4occc4n3)ccc21		CHEMBL4069365	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	18031788	CHEMBL4007726	Inhibition of MEK1 (unknown origin) after 60 mins by TR-FRET assay	B	Cc1n[nH]c2cc(Nc3nc(NC4CC4)c4occc4n3)ccc12		CHEMBL4062803	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
Not Determined	18066743	CHEMBL4014544	Inhibition of human MEK1	B	COc1ccc(-c2cnc3scc(NC(=O)C4CCCCC4)c3c2)cc1OC		CHEMBL3334979		IC50			CHEMBL3587	Homo sapiens	IC50		
	18066744	CHEMBL4014545	Inhibition of human MEK1 at 10 uM relative to control	B	CCOc1cc(/C=C2\Oc3ccc(OC)cc3C2=O)ccc1O		CHEMBL4105195	<	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	18066745	CHEMBL4014545	Inhibition of human MEK1 at 10 uM relative to control	B	COc1ccc2c(c1)C(=O)/C(=C/c1ccc(O)c(O)c1)O2		CHEMBL4087337	<	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	18066746	CHEMBL4014545	Inhibition of human MEK1 at 10 uM relative to control	B	O=C1/C(=C/c2ccc(O)c(O)c2)Oc2cc(O)ccc21		CHEMBL490355	<	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	18083237	CHEMBL4018025	Inhibition of wild-type human MEK1 (M1 to V393 residues) expressed in Sf9 insect cells at 1 uM using ERK2-K54R as substrate by filter binding method relative to control	B	CS(=O)(=O)N1CCN(Cc2cn3cc(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1		CHEMBL2087474	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	INH	%	0.0
Not Active	18083238	CHEMBL4018025	Inhibition of wild-type human MEK1 (M1 to V393 residues) expressed in Sf9 insect cells at 1 uM using ERK2-K54R as substrate by filter binding method relative to control	B	Nc1ncc(-c2cn3c4c(nc3c(N3CCOCC3)n2)CCN(S(=O)(=O)C2CC2)C4)cn1		CHEMBL4098032		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Not Active	18083239	CHEMBL4018025	Inhibition of wild-type human MEK1 (M1 to V393 residues) expressed in Sf9 insect cells at 1 uM using ERK2-K54R as substrate by filter binding method relative to control	B	CS(=O)(=O)N1CCc2c(nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn23)C1		CHEMBL4068727		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
	18083240	CHEMBL4018025	Inhibition of wild-type human MEK1 (M1 to V393 residues) expressed in Sf9 insect cells at 1 uM using ERK2-K54R as substrate by filter binding method relative to control	B	Nc1ncc(-c2cn3c4c(nc3c(N3CCOCC3)n2)CN(c2ccc(F)cc2)CC4)cn1		CHEMBL4088855	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	INH	%	0.0
	18099878	CHEMBL4021785	Inhibition of MEK1 (unknown origin)	B	Cc1ccc(CNc2nc(N)nc3[nH]c4cc(C)c(O)cc4c23)cc1		CHEMBL4098682	>	IC50	nM	100000.0	CHEMBL3587	Homo sapiens	IC50	uM	100.0
	18114261	CHEMBL4025233	Inhibition of wild-type human full length MEK1 (M1 to V393 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL3587	Homo sapiens	Activity	%	100.0
	18117612	CHEMBL4025923	Inhibition of recombinant human N-terminal GST-fused MEK1 expressed in Escherichia coli at 3 uM relative to control	B	COc1ccc(-c2nnc(-n3c(-c4ccccc4)nc4cc(Cl)ccc4c3=O)s2)cc1		CHEMBL4103440	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	INH	%	0.0
Not Active	18134447	CHEMBL4029530	Inhibition of MEK1 (unknown origin) at <1 uM using GST-ERK1 as substrate preincubated for 5 mins followed by substrate addition measured after 20 mins in presence of [gamma33P]ATP by scintillation counter method	B	CSc1sc(C(N)=O)c2c1-c1sncc1CC2		CHEMBL4082469		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Not Active	18134504	CHEMBL4029530	Inhibition of MEK1 (unknown origin) at <1 uM using GST-ERK1 as substrate preincubated for 5 mins followed by substrate addition measured after 20 mins in presence of [gamma33P]ATP by scintillation counter method	B	COCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1		CHEMBL4066819		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
	18153013	CHEMBL4034530	Inhibition of MAP2K1 (unknown origin) labeling at conserved Lysine 2 (DVKPSNILVI) at 10 uM relative to control	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	9.0	CHEMBL3587	Homo sapiens	INH	%	9.0
	18153083	CHEMBL4034368	Inhibition of MAP2K1 (unknown origin) labeling at conserved Lysine 2 (IMHRDVKPS) at 10 uM relative to control	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	-5.0	CHEMBL3587	Homo sapiens	INH	%	-5.0
	18153292	CHEMBL4034369	Inhibition of MAP2K1 Lysine 1 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	-2.1	CHEMBL3587	Homo sapiens	INH	%	-2.1
	18185969	CHEMBL4040603	Inhibition of N-terminal GST tagged/C-terminal His6-tagged recombinant full length human Mek1 expressed in Escherichia coli cells at 10 uM relative to control	B	N#Cc1c[nH]c2nc(N)nc(-c3ccc(S(N)(=O)=O)cc3)c12		CHEMBL4089551	>	Inhibition	%	80.0	CHEMBL3587	Homo sapiens	INH	%	80.0
	18203757	CHEMBL4044044	Inhibition of wild-type human full length MEK1 (M1 to V393 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL3587	Homo sapiens	Activity	%	100.0
	18211598	CHEMBL4045730	Inhibition of MAP2K1 conserved Lys2 (IMHRDVKPSNILVNSR) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-32.1	CHEMBL3587	Homo sapiens	INH	%	-32.1
	18211622	CHEMBL4045728	Inhibition of MAP2K1 conserved Lys2 (DVKPSNILVNSR) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-14.7	CHEMBL3587	Homo sapiens	INH	%	-14.7
	18211873	CHEMBL4045969	Inhibition of MAP2K1 conserved Lys2 (DVKPSNILVNSR) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-14.6	CHEMBL3587	Homo sapiens	INH	%	-14.6
	18211875	CHEMBL4045971	Inhibition of MAP2K1 conserved Lys2 (IMHRDVKPSNILVNSR) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	-5.6	CHEMBL3587	Homo sapiens	INH	%	-5.6
	18231701	CHEMBL4050193	Inhibition of human MEK1 using ERK2 as substrate in presence of [gamma-32P]ATP	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	45.8	CHEMBL3587	Homo sapiens	IC50	10'-8M	4.58
Not Determined	18231731	CHEMBL4050193	Inhibition of human MEK1 using ERK2 as substrate in presence of [gamma-32P]ATP	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339		IC50			CHEMBL3587	Homo sapiens	IC50		
	18232148	CHEMBL4050357	Inhibition of human MKK1 assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	86.0	CHEMBL3587	Homo sapiens	Activity	%	86.0
	18232355	CHEMBL4050453	Binding affinity to full-length human MEK1 expressed in mammalian system assessed as control score at 1 uM by KINOMEScan assay	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(OCc4ccccn4)c(Cl)c3)c3c(N)ncnc32)C1		CHEMBL4068839	=	Activity	%	0.4	CHEMBL3587	Homo sapiens	Activity	%	0.4
	18232364	CHEMBL4050462	Inhibition of full-length recombinant human His-tagged MEK1 expressed in baculovirus by Z'-LYTE assay	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(OCc4ccccn4)c(Cl)c3)c3c(N)ncnc32)C1		CHEMBL4068839	=	IC50	nM	161.0	CHEMBL3587	Homo sapiens	IC50	nM	161.0
	18236533	CHEMBL4051363	Inhibition of MEK1 (unknown origin)	B	COCCN1C(=O)c2cc(-c3nc(Nc4ccnn4C)ncc3C)cn2C[C@H]1C		CHEMBL4086507	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	18236534	CHEMBL4051363	Inhibition of MEK1 (unknown origin)	B	Cc1cccc(CN2C(=O)c3cc(-c4nc(Nc5ccnn5C)ncc4C)cn3C[C@H]2C)n1		CHEMBL4071576	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	18236535	CHEMBL4051363	Inhibition of MEK1 (unknown origin)	B	COCCN1C(=O)c2cc(-c3nc(Nc4ccnn4C)ncc3C)cn2C[C@@H]1C		CHEMBL4098608	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	18236536	CHEMBL4051363	Inhibition of MEK1 (unknown origin)	B	Cc1cccc(CN2C(=O)c3cc(-c4nc(Nc5ccnn5C)ncc4C)cn3C[C@@H]2C)n1		CHEMBL4075638	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	18236537	CHEMBL4051363	Inhibition of MEK1 (unknown origin)	B	COCCN1CCn2cc(-c3nc(Nc4ccnn4C)ncc3C)cc2C1=O		CHEMBL4090886	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	18236538	CHEMBL4051363	Inhibition of MEK1 (unknown origin)	B	Cc1cccc(CN2CCn3cc(-c4nc(Nc5ccnn5C)ncc4C)cc3C2=O)n1		CHEMBL4101072	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	18236539	CHEMBL4051363	Inhibition of MEK1 (unknown origin)	B	Cc1cccc(CN2C(=O)c3cc(-c4ccnc(Nc5ccnn5C)n4)cn3CC2C)n1		CHEMBL4083098	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	18236540	CHEMBL4051363	Inhibition of MEK1 (unknown origin)	B	Cc1cccc(CN2C(=O)c3cc(-c4ccnc(Nc5ccnn5C)n4)cn3CC2C)n1		CHEMBL4083098	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	18236541	CHEMBL4051363	Inhibition of MEK1 (unknown origin)	B	O=C1NCCn2cc(-c3ccnc(NC4CCOCC4)n3)cc21		CHEMBL4072622	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	18236542	CHEMBL4051363	Inhibition of MEK1 (unknown origin)	B	COCCN1CCc2c(cc(-c3ccnc(Nc4ccnn4C)n3)n2C)C1=O		CHEMBL4061051	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	18236543	CHEMBL4051363	Inhibition of MEK1 (unknown origin)	B	COCCN1CCc2c(cc(-c3ccnc(NC4CCOCC4)n3)n2C)C1=O		CHEMBL4082931	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	18236544	CHEMBL4051363	Inhibition of MEK1 (unknown origin)	B	Cn1c(-c2ccnc(NC3CCOCC3)n2)cc2c1CCN(Cc1ccccc1)C2=O		CHEMBL4103768	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	18236545	CHEMBL4051363	Inhibition of MEK1 (unknown origin)	B	Cn1c(-c2ccnc(NC3CCOCC3)n2)cc2c1CCNC2=O		CHEMBL4079515	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	18236546	CHEMBL4051363	Inhibition of MEK1 (unknown origin)	B	COCCN1C(=O)c2cc(-c3nc(Nc4ccnn4C)ncc3C)[nH]c2C[C@H]1C		CHEMBL4065992	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	18236547	CHEMBL4051363	Inhibition of MEK1 (unknown origin)	B	COCCN1C(=O)c2cc(-c3nc(Nc4ccnn4C)ncc3C)[nH]c2C[C@@H]1C		CHEMBL4087393	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	18236548	CHEMBL4051363	Inhibition of MEK1 (unknown origin)	B	COCCN1C(=O)c2cc(-c3ccnc(Nc4ccnn4C)n3)[nH]c2C[C@H]1C		CHEMBL4088284	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	18236561	CHEMBL4051363	Inhibition of MEK1 (unknown origin)	B	O=C(Nc1ccc2[nH]nc(-c3ccncc3)c2c1)[C@@H]1CCN(CC(=O)N2CCN(c3ccc(-c4ncccn4)cc3)CC2)C1		CHEMBL3590107	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	18236562	CHEMBL4051363	Inhibition of MEK1 (unknown origin)	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	18236563	CHEMBL4051363	Inhibition of MEK1 (unknown origin)	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	18236564	CHEMBL4051363	Inhibition of MEK1 (unknown origin)	B	CN1CCN(c2ccc(Nc3nccc(-c4cc5c([nH]4)CCNC5=O)n3)cc2)CC1		CHEMBL4105185	=	IC50	nM	1900.0	CHEMBL3587	Homo sapiens	IC50	uM	1.9
	18236565	CHEMBL4051363	Inhibition of MEK1 (unknown origin)	B	O=C1NCCc2[nH]c(-c3ccnc(NC4CCOCC4)n3)cc21		CHEMBL4080944	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	18236566	CHEMBL4051363	Inhibition of MEK1 (unknown origin)	B	CN1CCc2[nH]c(-c3ccnc(NC4CCOCC4)n3)cc2C1=O		CHEMBL4070818	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	18236567	CHEMBL4051363	Inhibition of MEK1 (unknown origin)	B	O=C1c2cc(-c3ccnc(NC4CCOCC4)n3)[nH]c2CCN1Cc1ccccc1		CHEMBL4097186	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	18236568	CHEMBL4051363	Inhibition of MEK1 (unknown origin)	B	O=C1c2cc(-c3ccnc(NC4CCOCC4)n3)[nH]c2CCN1[C@H](CO)c1ccccc1		CHEMBL4078489	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	18236569	CHEMBL4051363	Inhibition of MEK1 (unknown origin)	B	O=C1c2cc(-c3ccnc(NC4CCOCC4)n3)[nH]c2CCN1[C@H](CO)c1ccc(F)c(Cl)c1		CHEMBL4096522	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	18236570	CHEMBL4051363	Inhibition of MEK1 (unknown origin)	B	O=C1c2cc(-c3ccnc(NC4CCOCC4)n3)[nH]c2CCN1[C@H](CO)c1ccc(Cl)c(F)c1		CHEMBL4100076	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	18236571	CHEMBL4051363	Inhibition of MEK1 (unknown origin)	B	COCCN1CCc2[nH]c(-c3ccnc(NC4CCOCC4)n3)cc2C1=O		CHEMBL4074437	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	18236572	CHEMBL4051363	Inhibition of MEK1 (unknown origin)	B	Cc1cccc(CN2CCc3[nH]c(-c4ccnc(NC5CCOCC5)n4)cc3C2=O)n1		CHEMBL4068705	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	18236573	CHEMBL4051363	Inhibition of MEK1 (unknown origin)	B	COCCN1CCc2[nH]c(-c3ccnc(Nc4ccnn4C)n3)cc2C1=O		CHEMBL4074311	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	18236574	CHEMBL4051363	Inhibition of MEK1 (unknown origin)	B	COCCN1C(=O)c2cc(-c3ccnc(Nc4ccnn4C)n3)[nH]c2C[C@@H]1C		CHEMBL4060050	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
	18250437	CHEMBL4054254	Inhibition of recombinant human MEK1 using inactivated ERK2 as substrate at 100 uM after 60 mins in presence of ATP relative to control	B	CCCCCCCCCCCCCCC(=O)NC1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4081419	=	Inhibition	%	12.0	CHEMBL3587	Homo sapiens	INH	%	12.0
	18253465	CHEMBL4055016	Inhibition of wild-type human full length MAP2K1 (M1 to V393 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	80.0	CHEMBL3587	Homo sapiens	Activity	%	80.0
	18253466	CHEMBL4055016	Inhibition of wild-type human full length MAP2K1 (M1 to V393 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	94.0	CHEMBL3587	Homo sapiens	Activity	%	94.0
	18275013	CHEMBL4118383	Inhibition of MAP2K1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled IMHRDVKPSNILVNSR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	60.0	CHEMBL3587	Homo sapiens	INH	%	60.0
	18275014	CHEMBL4118383	Inhibition of MAP2K1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled IMHRDVKPSNILVNSR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	-7.9	CHEMBL3587	Homo sapiens	INH	%	-7.9
	18275015	CHEMBL4118383	Inhibition of MAP2K1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled IMHRDVKPSNILVNSR probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	89.4	CHEMBL3587	Homo sapiens	INH	%	89.4
	18275016	CHEMBL4118384	Inhibition of MAP2K1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled KLIHLEIKPAIR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	62.7	CHEMBL3587	Homo sapiens	INH	%	62.7
	18275017	CHEMBL4118384	Inhibition of MAP2K1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled KLIHLEIKPAIR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	13.9	CHEMBL3587	Homo sapiens	INH	%	13.9
	18275018	CHEMBL4118384	Inhibition of MAP2K1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled KLIHLEIKPAIR probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	85.3	CHEMBL3587	Homo sapiens	INH	%	85.3
	18275022	CHEMBL4118386	Inhibition of MAP2K1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DVKPSNILVNSR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	71.7	CHEMBL3587	Homo sapiens	INH	%	71.7
	18275023	CHEMBL4118386	Inhibition of MAP2K1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DVKPSNILVNSR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	7.9	CHEMBL3587	Homo sapiens	INH	%	7.9
	18275024	CHEMBL4118386	Inhibition of MAP2K1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DVKPSNILVNSR probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	95.0	CHEMBL3587	Homo sapiens	INH	%	95.0
	18275368	CHEMBL4118502	Inhibition of full length human MEK1 (1 to 393 residues) expressed in mammalian expression system assessed as enzyme activity at 1 uM by KINOMEScan assay relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Activity	%	0.65	CHEMBL3587	Homo sapiens	Activity	%	0.65
Active	18275841	CHEMBL4118801	Binding affinity to MAP2K1 in human NCI-H23 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL3587	Homo sapiens	Activity		
Active	18275983	CHEMBL4118943	Binding affinity to MAP2K1 in human NCI-H358 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL3587	Homo sapiens	Activity		
	18276140	CHEMBL4119070	Inhibition of full length human MEK1 (1 to 393 residues) expressed in mammalian expression system assessed as enzyme activity at 10 uM by KINOMEScan assay relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Activity	%	0.05	CHEMBL3587	Homo sapiens	Activity	%	0.05
Active	18281681	CHEMBL4119818	Inhibition of MEK1 in human A375 cell lysate assessed as reduction in ERK1/2 phosphorylation at Thr202/Tyr204 at 20 uM after 1 hr by Western blot analysis	B	O=C(NOCCOCCOCCOCCC(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL4127114		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Active	18281682	CHEMBL4119818	Inhibition of MEK1 in human A375 cell lysate assessed as reduction in ERK1/2 phosphorylation at Thr202/Tyr204 at 20 uM after 1 hr by Western blot analysis	B	O=C(NOCCOCCOCCOCCN1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL3819302		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
	18281711	CHEMBL4119809	Inhibition of recombinant human GST-tagged MEK1 expressed in baculovirus infected Sf9 insect cells using inactive ERK2 as substrate preincubated for 30 mins followed by substrate addition measured after 2 hrs by kinase-glo reagent based bioluminescence assay	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	IC50	nM	15.0	CHEMBL3587	Homo sapiens	IC50	nM	15.0
	18281712	CHEMBL4119809	Inhibition of recombinant human GST-tagged MEK1 expressed in baculovirus infected Sf9 insect cells using inactive ERK2 as substrate preincubated for 30 mins followed by substrate addition measured after 2 hrs by kinase-glo reagent based bioluminescence assay	B	O=C(NOCCOCCOCCOCCC(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL4127114	=	IC50	nM	182.0	CHEMBL3587	Homo sapiens	IC50	nM	182.0
	18281713	CHEMBL4119809	Inhibition of recombinant human GST-tagged MEK1 expressed in baculovirus infected Sf9 insect cells using inactive ERK2 as substrate preincubated for 30 mins followed by substrate addition measured after 2 hrs by kinase-glo reagent based bioluminescence assay	B	O=C(NOCCOCCOCCOCCN1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL3819302	=	IC50	nM	398.0	CHEMBL3587	Homo sapiens	IC50	nM	398.0
	18282161	CHEMBL4120116	Inhibition of recombinant full length His-tagged human MEK1 expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	14.8	CHEMBL3587	Homo sapiens	INH	%	14.8
	18282480	CHEMBL4120116	Inhibition of recombinant full length His-tagged human MEK1 expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	INH	%	0.0
	18327792	CHEMBL4135689	Inhibition of human wild type partial length MEK1 (M1 to V393 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control	B	CCc1ccc2nc(C(c3ccc(OC)c(OC)c3)n3cc(CCN4CCCCC4)nn3)sc2c1		CHEMBL4174041	=	Inhibition	%	40.0	CHEMBL3587	Homo sapiens	INH	%	40.0
Not Active	18405108	CHEMBL4150879	Inhibition of wild-type MEK1 (unknown origin) at 10 uM using inactive ERK2 as substrate pretreated for 20 mins followed by substrate addition and measured after 30 mins in presence of [gamma32P]ATP by autoradiography	B	N=C1C2=C(NCC[S+]2[O-])C(=O)c2[nH]cc(CO)c21		CHEMBL4160862		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Not Active	18405109	CHEMBL4150879	Inhibition of wild-type MEK1 (unknown origin) at 10 uM using inactive ERK2 as substrate pretreated for 20 mins followed by substrate addition and measured after 30 mins in presence of [gamma32P]ATP by autoradiography	B	N=C1C2=C(NCCS2)C(=O)c2[nH]cc(CO)c21		CHEMBL4168800		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Not Active	18405110	CHEMBL4150879	Inhibition of wild-type MEK1 (unknown origin) at 10 uM using inactive ERK2 as substrate pretreated for 20 mins followed by substrate addition and measured after 30 mins in presence of [gamma32P]ATP by autoradiography	B	CSC1=C(N)C(=O)c2[nH]cc(CO)c2C1=N		CHEMBL4164264		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
	18434125	CHEMBL4156107	Inhibition of recombinant human full length His-tagged MEK1 expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2sc(-c3ccc(O)cc3)cc12)c1ccccc1		CHEMBL4177361	=	Inhibition	%	21.0	CHEMBL3587	Homo sapiens	INH	%	21.0
	18434219	CHEMBL4156107	Inhibition of recombinant human full length His-tagged MEK1 expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	CCC(=O)Nc1ccc(-c2c[nH]c3ncnc(N[C@H](C)c4ccccc4)c23)cc1		CHEMBL4167749	=	Inhibition	%	15.0	CHEMBL3587	Homo sapiens	INH	%	15.0
	18434279	CHEMBL4156107	Inhibition of recombinant human full length His-tagged MEK1 expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	CN(C)CCn1cc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL4159505	=	Inhibition	%	6.0	CHEMBL3587	Homo sapiens	INH	%	6.0
	18434351	CHEMBL4156107	Inhibition of recombinant human full length His-tagged MEK1 expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	OCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1		CHEMBL4175024	=	Inhibition	%	10.0	CHEMBL3587	Homo sapiens	INH	%	10.0
	18440299	CHEMBL4157123	Binding affinity to wild-type human full length MEK1 (M1 to V393 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	97.0	CHEMBL3587	Homo sapiens	Activity	%	97.0
	18443253	CHEMBL4157922	Inhibition of human MKK1 assessed as enzyme residual activity at 100 nM by radiometric filter binding assay relative to control	B	NCCCC[C@@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)CCCCCNC(=O)CCC(=O)Nc1ncc(-c2ccc(C(=O)O)cc2)s1)C(=O)O		CHEMBL4177303	=	Activity	%	88.0	CHEMBL3587	Homo sapiens	Activity	%	88.0
	18449841	CHEMBL4178080	Inhibition of human MKK1 (2 to 393 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	115.0	CHEMBL3587	Homo sapiens	Activity	%	115.0
	18450274	CHEMBL4178304	Inhibition of recombinant full length N-terminal GST-tagged MEK1 (unknown origin) assessed as change in enzyme activity at 1 uM in presence of 1 uM ATP relative to control	B	CCN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)cc(F)c7C6=O)c5CO)ccnc4[nH]3)nc2)CC1		CHEMBL3967108	=	Activity	%	-14.0	CHEMBL3587	Homo sapiens	Activity	%	-14.0
	18450324	CHEMBL4178304	Inhibition of recombinant full length N-terminal GST-tagged MEK1 (unknown origin) assessed as change in enzyme activity at 1 uM in presence of 1 uM ATP relative to control	B	O=C1c2c(F)cc(C3CC3)cc2OCCN1c1cccc(-c2ccnc3[nH]c(C4=CCN(C5COC5)CC4)cc23)c1CO		CHEMBL3966346	=	Activity	%	-20.0	CHEMBL3587	Homo sapiens	Activity	%	-20.0
	18457590	CHEMBL4179653	Inhibition of wild-type human MEK1 (M1 to V393 residues) expressed in Sf9 insect cells at 1 uM using ERK2-K54R as substrate by filter binding method relative to control	B	CS(=O)(=O)N1CCN(Cc2cc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn3n2)CC1		CHEMBL4212439	<	Inhibition	%	25.0	CHEMBL3587	Homo sapiens	INH	%	25.0
	18457591	CHEMBL4179653	Inhibition of wild-type human MEK1 (M1 to V393 residues) expressed in Sf9 insect cells at 1 uM using ERK2-K54R as substrate by filter binding method relative to control	B	CS(=O)(=O)N1CCN(Cc2nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn3n2)CC1		CHEMBL4217392	<	Inhibition	%	25.0	CHEMBL3587	Homo sapiens	INH	%	25.0
	18457592	CHEMBL4179653	Inhibition of wild-type human MEK1 (M1 to V393 residues) expressed in Sf9 insect cells at 1 uM using ERK2-K54R as substrate by filter binding method relative to control	B	CS(=O)(=O)N1CCN(Cc2cn3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1		CHEMBL4208064	<	Inhibition	%	25.0	CHEMBL3587	Homo sapiens	INH	%	25.0
	18457593	CHEMBL4179653	Inhibition of wild-type human MEK1 (M1 to V393 residues) expressed in Sf9 insect cells at 1 uM using ERK2-K54R as substrate by filter binding method relative to control	B	CS(=O)(=O)N1CCN(Cc2nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)c(Cl)n3n2)CC1		CHEMBL4205584	<	Inhibition	%	25.0	CHEMBL3587	Homo sapiens	INH	%	25.0
	18462179	CHEMBL4180866	Inhibition of human full length MKK1 assessed as residual activity at 1 uM after 30 mins in presence of [gamma-33P]ATP relative to control	B	CC(C)=CCC/C(C)=C/Cn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4203120	=	Activity	%	90.0	CHEMBL3587	Homo sapiens	Activity	%	90.0
	18463766	CHEMBL4181182	Inhibition of recombinant human full length N-terminal GST-tagged and C-terminal His6-tagged MEK1 expressed in Escherichia coli at 10 uM by filter binding radioactive ATP transferase assay relative to control	B	C=C(C)n1c(=O)n(C(C)=O)c2cc(Br)cnc21		CHEMBL4212680	=	Inhibition	%	-2.0	CHEMBL3587	Homo sapiens	INH	%	-2.0
	18484255	CHEMBL4185902	Binding affinity to wild-type human full length MEK1 (M1 to V393 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	100.0	CHEMBL3587	Homo sapiens	Activity	%	100.0
	18484739	CHEMBL4185902	Binding affinity to wild-type human full length MEK1 (M1 to V393 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	52.0	CHEMBL3587	Homo sapiens	Activity	%	52.0
	18489533	CHEMBL4187274	Inhibition of wild-type human full length MEK1 (M1 to V393 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	Fc1cc(F)cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4207079	=	Activity	%	79.0	CHEMBL3587	Homo sapiens	Activity	%	79.0
	18501915	CHEMBL4189547	Inhibition of human MEK1 (M1 to V393 residues) expressed in mammalian expression system at 1 uM by KINOMEscan assay relative to control	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	>	Inhibition	%	99.0	CHEMBL3587	Homo sapiens	INH	%	99.0
	18507718	CHEMBL4191044	Inhibition of recombinant full-length human MEK1 at 1 uM using inactive MAPK2 as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	-1.0	CHEMBL3587	Homo sapiens	INH	%	-1.0
	18569322	CHEMBL4220448	Inhibition of MEK1 (unknown origin) using Ser/Thr 03 peptide substrate after 4 hrs by fluorescence assay	B	O=C(NOC[C@H](O)CO)c1cc2c(c(F)c1Nc1ccc(I)cc1F)OCC2		CHEMBL4225401	=	IC50	nM	7.0	CHEMBL3587	Homo sapiens	IC50	nM	7.0
	18569323	CHEMBL4220448	Inhibition of MEK1 (unknown origin) using Ser/Thr 03 peptide substrate after 4 hrs by fluorescence assay	B	O=C(NOC[C@@H](O)CO)c1cc2c(c(F)c1Nc1ccc(I)cc1F)OCC2		CHEMBL4226300	=	IC50	nM	6.0	CHEMBL3587	Homo sapiens	IC50	nM	6.0
	18569324	CHEMBL4220448	Inhibition of MEK1 (unknown origin) using Ser/Thr 03 peptide substrate after 4 hrs by fluorescence assay	B	O=C(NOCCO)c1cc2c(c(F)c1Nc1ccc(I)cc1F)OCC2		CHEMBL4225654	=	IC50	nM	5.7	CHEMBL3587	Homo sapiens	IC50	nM	5.7
	18569325	CHEMBL4220448	Inhibition of MEK1 (unknown origin) using Ser/Thr 03 peptide substrate after 4 hrs by fluorescence assay	B	O=C(NOCCO)c1cc2c(c(F)c1Nc1ccc(Br)cc1Cl)OCC2		CHEMBL4227816	=	IC50	nM	441.0	CHEMBL3587	Homo sapiens	IC50	nM	441.0
	18569326	CHEMBL4220448	Inhibition of MEK1 (unknown origin) using Ser/Thr 03 peptide substrate after 4 hrs by fluorescence assay	B	O=C(NC[C@H](O)CO)c1cc2c(c(F)c1Nc1ccc(I)cc1F)OCC2		CHEMBL4226967	>	IC50	nM	1000.0	CHEMBL3587	Homo sapiens	IC50	nM	1000.0
	18569327	CHEMBL4220448	Inhibition of MEK1 (unknown origin) using Ser/Thr 03 peptide substrate after 4 hrs by fluorescence assay	B	O=C(NC[C@@H](O)CO)c1cc2c(c(F)c1Nc1ccc(I)cc1F)OCC2		CHEMBL4227199	>	IC50	nM	1000.0	CHEMBL3587	Homo sapiens	IC50	nM	1000.0
	18569328	CHEMBL4220448	Inhibition of MEK1 (unknown origin) using Ser/Thr 03 peptide substrate after 4 hrs by fluorescence assay	B	O=C(NOCCO)c1cc2c(c(Cl)c1Nc1ccc(I)cc1F)OCC2		CHEMBL4225180	=	IC50	nM	21.5	CHEMBL3587	Homo sapiens	IC50	nM	21.5
	18569329	CHEMBL4220448	Inhibition of MEK1 (unknown origin) using Ser/Thr 03 peptide substrate after 4 hrs by fluorescence assay	B	O=C(NOCCO)c1cc2c(cc1Nc1ccc(I)cc1F)OCC2		CHEMBL4228687	=	IC50	nM	62.8	CHEMBL3587	Homo sapiens	IC50	nM	62.8
	18569330	CHEMBL4220448	Inhibition of MEK1 (unknown origin) using Ser/Thr 03 peptide substrate after 4 hrs by fluorescence assay	B	O=C(c1cc2c(c(F)c1Nc1ccc(I)cc1F)OCC2)N1C[C@@H](O)CO1		CHEMBL4224923	>	IC50	nM	1000.0	CHEMBL3587	Homo sapiens	IC50	nM	1000.0
	18569331	CHEMBL4220448	Inhibition of MEK1 (unknown origin) using Ser/Thr 03 peptide substrate after 4 hrs by fluorescence assay	B	O=C(NOC[C@H](O)CO)c1cc2ccoc2c(F)c1Nc1ccc(I)cc1F		CHEMBL4228425	=	IC50	nM	3.9	CHEMBL3587	Homo sapiens	IC50	nM	3.9
	18569332	CHEMBL4220448	Inhibition of MEK1 (unknown origin) using Ser/Thr 03 peptide substrate after 4 hrs by fluorescence assay	B	O=C(NOCCO)c1cc2ccoc2c(F)c1Nc1ccc(I)cc1F		CHEMBL4229260	=	IC50	nM	3.4	CHEMBL3587	Homo sapiens	IC50	nM	3.4
	18569333	CHEMBL4220448	Inhibition of MEK1 (unknown origin) using Ser/Thr 03 peptide substrate after 4 hrs by fluorescence assay	B	CC(C)(CO)ONC(=O)c1cc2ccoc2c(F)c1Nc1ccc(I)cc1F		CHEMBL4228161	=	IC50	nM	7.6	CHEMBL3587	Homo sapiens	IC50	nM	7.6
	18569334	CHEMBL4220448	Inhibition of MEK1 (unknown origin) using Ser/Thr 03 peptide substrate after 4 hrs by fluorescence assay	B	O=C(NOC(CO)CO)c1cc2ccoc2c(F)c1Nc1ccc(I)cc1F		CHEMBL4228999	=	IC50	nM	10.8	CHEMBL3587	Homo sapiens	IC50	nM	10.8
	18569335	CHEMBL4220448	Inhibition of MEK1 (unknown origin) using Ser/Thr 03 peptide substrate after 4 hrs by fluorescence assay	B	O=C(NOCCCO)c1cc2ccoc2c(F)c1Nc1ccc(I)cc1F		CHEMBL4225400	=	IC50	nM	29.8	CHEMBL3587	Homo sapiens	IC50	nM	29.8
	18569336	CHEMBL4220448	Inhibition of MEK1 (unknown origin) using Ser/Thr 03 peptide substrate after 4 hrs by fluorescence assay	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	=	IC50	nM	9.0	CHEMBL3587	Homo sapiens	IC50	nM	9.0
	18577639	CHEMBL4222224	Inhibition of recombinant human full length His-tagged MEK1 expressed in baculovirus expression system at 1 uM using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay relative to control	B	C=CC(=O)Nc1cccc(NC(=O)Nc2ccnc(Nc3ccc(N4CCC(N5CCOCC5)CC4)cc3OC)n2)c1		CHEMBL4225781	=	Inhibition	%	-1.8	CHEMBL3587	Homo sapiens	INH	%	-1.8
	18577663	CHEMBL4222224	Inhibition of recombinant human full length His-tagged MEK1 expressed in baculovirus expression system at 1 uM using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay relative to control	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	=	Inhibition	%	9.0	CHEMBL3587	Homo sapiens	INH	%	9.0
	18577687	CHEMBL4222224	Inhibition of recombinant human full length His-tagged MEK1 expressed in baculovirus expression system at 1 uM using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay relative to control	B	C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3699588	=	Inhibition	%	1.4	CHEMBL3587	Homo sapiens	INH	%	1.4
	18653527	CHEMBL4230140	Inhibition of MEK1 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	13.0	CHEMBL3587	Homo sapiens	INH	%	13.0
	18653528	CHEMBL4230140	Inhibition of MEK1 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	-8.0	CHEMBL3587	Homo sapiens	INH	%	-8.0
	18655433	CHEMBL4230802	Binding affinity to wild-type human full length MEK1 (M1 to V393 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	97.0	CHEMBL3587	Homo sapiens	Activity	%	97.0
	18663929	CHEMBL4232913	Inhibition of full length human MEK1 (M1 to V393 residues) expressed in mammalian expression system assessed as residual activity at 5 uM by KINOMEscan assay relative to control	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	=	Activity	%	91.0	CHEMBL3587	Homo sapiens	Activity	%	91.0
	18664026	CHEMBL4233010	Binding affinity to full length human MEK1 (M1 to V393 residues) expressed in mammalian expression system by KINOMEscan assay	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	>=	Kd	nM	5000.0	CHEMBL3587	Homo sapiens	Kd	uM	5.0
	18665396	CHEMBL4233353	Inhibition of MEK1 (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	nM	10000.0
	18674749	CHEMBL4235384	Inhibition of MEK1 (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	1000.0	CHEMBL3587	Homo sapiens	Ki	nM	1000.0
Not Determined	18674750	CHEMBL4235384	Inhibition of MEK1 (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242		Ki			CHEMBL3587	Homo sapiens	Ki		
	18674751	CHEMBL4235384	Inhibition of MEK1 (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525	>	Ki	nM	10000.0	CHEMBL3587	Homo sapiens	Ki	nM	10000.0
	18697658	CHEMBL4254331	Inhibition of wild-type human full length MEK1 (M1 to V393 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCNc1cc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2C(F)(F)F)ccn1		CHEMBL4281348	=	Activity	%	96.0	CHEMBL3587	Homo sapiens	Activity	%	96.0
Not Active	18723844	CHEMBL4258706	Inhibition of human MEK1 at 100 uM after 40 mins in presence of [gamma-33P-ATP] by scintillation counting analysis	B	CCOc1c(S(=O)(=O)NC2CC(C)(C)NC(C)(C)C2)ccc(Cl)c1Cl		CHEMBL1502722		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
	18725394	CHEMBL4259091	Inhibition of wild-type MEK1 (unknown origin)	B	CC(=O)n1nc(C)c(-c2ccc(Cl)c(Cl)c2)c1N		CHEMBL4276946	>	IC50	nM	100000.0	CHEMBL3587	Homo sapiens	IC50	uM	100.0
	18751040	CHEMBL4263858	Inhibition of MEK1 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	-2.0	CHEMBL3587	Homo sapiens	INH	%	-2.0
	18752006	CHEMBL4264391	Binding affinity to wild-type human full length MEK1 (M1 to V393 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	100.0	CHEMBL3587	Homo sapiens	Activity	%	100.0
	18761535	CHEMBL4266588	Inhibition of recombinant human N-terminal His6-tagged full length MEK1 expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	20.0	CHEMBL3587	Homo sapiens	INH	%	20.0
	18761806	CHEMBL4266588	Inhibition of recombinant human N-terminal His6-tagged full length MEK1 expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	3.0	CHEMBL3587	Homo sapiens	INH	%	3.0
	18761969	CHEMBL4266588	Inhibition of recombinant human N-terminal His6-tagged full length MEK1 expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	-1.0	CHEMBL3587	Homo sapiens	INH	%	-1.0
	18764386	CHEMBL4267048	Inhibition of human MKK1 at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)c(NS(C)(=O)=O)c3)c(-c3ccnc(NCC4CC4)n3)s2)CC1		CHEMBL4286841	<	Inhibition	%	70.0	CHEMBL3587	Homo sapiens	INH	%	70.0
	18764387	CHEMBL4267048	Inhibition of human MKK1 at 100 nM	B	CN1CCC(c2nc(-c3cccc(S(C)(=O)=O)c3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4286880	<	Inhibition	%	70.0	CHEMBL3587	Homo sapiens	INH	%	70.0
	18764388	CHEMBL4267048	Inhibition of human MKK1 at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)cc3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4288103	<	Inhibition	%	70.0	CHEMBL3587	Homo sapiens	INH	%	70.0
	18782848	CHEMBL4270714	Inhibition of MKK1 (unknown origin) assessed as residual enzyme activity at 1 uM relative to untreated control	B	Cc1cccc(-c2nn3c(c2-c2ccc(O)cc2)C(C)C(C)(C)C3)n1		CHEMBL4277021	>	Activity	%	80.0	CHEMBL3587	Homo sapiens	Activity	%	80.0
Not Active	18847298	CHEMBL4304922	Inhibition of wild-type human full length MEK1 (M1 to V393 residues) expressed in mammalian expression system at 1 uM by Kinomescan method	B	O=C(Nc1ccc2[nH]nc(-c3ccc4[nH]ccc4c3)c2c1)c1c(Cl)cccc1Cl		CHEMBL4517719		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
	18858055	CHEMBL4307901	Binding affinity to wild-type human full length MEK1 (M1 to V393 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	84.0	CHEMBL3587	Homo sapiens	Activity	%	84.0
	18864272	CHEMBL4309595	Inhibition of human MEK1 at 10 uM using ERK2 (K52R) as substrate after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	COc1cc(Cl)cc(-c2nn(-c3cccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)c3)cc2-c2ccncc2)c1		CHEMBL4436746	=	Inhibition	%	-7.99	CHEMBL3587	Homo sapiens	INH	%	-7.99
	18886134	CHEMBL4313428	Inhibition of human MEK1 at 10 uM using ERK2 as substrate by [gamma-33P]-ATP assay relative to control	B	COc1ccc(-c2nn(-c3cccc(NC(=O)c4cccc(C(F)(F)F)c4)c3)cc2-c2ccncc2)cc1Cl		CHEMBL4553144	=	Inhibition	%	12.19	CHEMBL3587	Homo sapiens	INH	%	12.19
	18886219	CHEMBL4313428	Inhibition of human MEK1 at 10 uM using ERK2 as substrate by [gamma-33P]-ATP assay relative to control	B	COc1ccc(-c2nn(-c3cccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)c3)cc2-c2ccncc2)cc1Cl		CHEMBL4559825	=	Inhibition	%	-4.12	CHEMBL3587	Homo sapiens	INH	%	-4.12
	18892646	CHEMBL4314603	Inhibition of recombinant full-length human MEK1 assessed as residual activity at 10 uM using unactive MAPK2 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	100.0	CHEMBL3587	Homo sapiens	Activity	%	100.0
	18910076	CHEMBL4320879	Inhibition of MEK1 (unknown origin)	B	O=C(NOCCCO)c1ccc(F)c(F)c1Nc1ccc(F)cc1F		CHEMBL4443751	=	IC50	nM	120.0	CHEMBL3587	Homo sapiens	IC50	nM	120.0
	18910077	CHEMBL4320879	Inhibition of MEK1 (unknown origin)	B	O=C(NOCCCO)c1ccc(F)c(F)c1Nc1ccc(Cl)cc1F		CHEMBL4590482	=	IC50	nM	26.0	CHEMBL3587	Homo sapiens	IC50	nM	26.0
	18910078	CHEMBL4320879	Inhibition of MEK1 (unknown origin)	B	O=C(NOCCCO)c1ccc(F)c(F)c1Nc1ccc(Br)cc1F		CHEMBL4530560	=	IC50	nM	7.7	CHEMBL3587	Homo sapiens	IC50	nM	7.7
	18910079	CHEMBL4320879	Inhibition of MEK1 (unknown origin)	B	O=C(NOCCCO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL4588064	=	IC50	nM	2.0	CHEMBL3587	Homo sapiens	IC50	nM	2.0
	18916463	CHEMBL4322128	Inhibition of MEK1 (unknown origin)	B	NCC1(O)CN(C(=O)c2ccc(F)c(F)c2Nc2ccc(I)cc2F)C1		CHEMBL2146888	=	IC50	nM	6.6	CHEMBL3587	Homo sapiens	IC50	nM	6.6
	18919442	CHEMBL4322799	Binding affinity to recombinant full-length N-terminal His-FLAG-tagged MAP2K1 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	328.0	CHEMBL3587	Homo sapiens	Kd	nM	328.0
	18919630	CHEMBL4322799	Binding affinity to recombinant full-length N-terminal His-FLAG-tagged MAP2K1 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	428.0	CHEMBL3587	Homo sapiens	Kd	nM	428.0
	18924783	CHEMBL4324293	Inhibition of recombinant full length His-tagged human MEK1 expressed in baculovirus expression system at 1 uM relative to control	B	COC[C@H]1Cn2cc(-c3nc(Nc4ccnn4C)ncc3C)nc2C(=O)N1Cc1ccc(F)c(F)c1		CHEMBL4482864	=	Inhibition	%	-2.5	CHEMBL3587	Homo sapiens	INH	%	-2.5
Not Active	18924792	CHEMBL4324303	Inhibition of recombinant full length His-tagged human MEK1 expressed in baculovirus expression system at > 10 uM	B	COC[C@H]1Cn2cc(-c3nc(Nc4ccnn4C)ncc3C)nc2C(=O)N1Cc1ccc(F)c(F)c1		CHEMBL4482864		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
	18924802	CHEMBL4324315	Inhibition of recombinant full length His-tagged human MEK1 expressed in baculovirus expression system at 1 uM by GST-tagged full length human inactive ERK2 coupled cascade assay relative to control	B	COC[C@H]1Cn2cc(-c3nc(Nc4ccnn4C)ncc3C)nc2C(=O)N1Cc1ccc(F)c(F)c1		CHEMBL4482864	=	Inhibition	%	104.0	CHEMBL3587	Homo sapiens	INH	%	104.0
	18925601	CHEMBL4324546	Inhibition of recombinant full length human His-tagged MEK1 expressed in baculovirus expression system using ERK K52R dead variant as substrate preincubated for 20 mins followed by incubation with 33P-ATP addition for 2 hrs by hotspot kinase assay	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	IC50	nM	82.0	CHEMBL3587	Homo sapiens	IC50	nM	82.0
	18925602	CHEMBL4324546	Inhibition of recombinant full length human His-tagged MEK1 expressed in baculovirus expression system using ERK K52R dead variant as substrate preincubated for 20 mins followed by incubation with 33P-ATP addition for 2 hrs by hotspot kinase assay	B	Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCCCCCCNCCCONC(=O)c2ccc(F)c(F)c2Nc2ccc(I)cc2F)C(C)(C)C)cc1		CHEMBL4470937	=	IC50	nM	1500.0	CHEMBL3587	Homo sapiens	IC50	nM	1500.0
	18925603	CHEMBL4324546	Inhibition of recombinant full length human His-tagged MEK1 expressed in baculovirus expression system using ERK K52R dead variant as substrate preincubated for 20 mins followed by incubation with 33P-ATP addition for 2 hrs by hotspot kinase assay	B	Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@H]2C[C@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCCCCCCNCCCONC(=O)c2ccc(F)c(F)c2Nc2ccc(I)cc2F)C(C)(C)C)cc1		CHEMBL4446127	=	IC50	nM	1600.0	CHEMBL3587	Homo sapiens	IC50	nM	1600.0
	18934082	CHEMBL4326614	Inhibition of human MEK1 at 10 uM using ERK2 (K52R) as substrate by [gamma-33P]-ATP assay relative to control	B	CC(=O)N1CCN(c2ccc(Nc3ncc(C(F)(F)F)c(N4Cc5cccc(N(C)S(C)(=O)=O)c5C4)n3)cc2)CC1		CHEMBL4476226	=	Inhibition	%	3.6	CHEMBL3587	Homo sapiens	INH	%	3.6
	18938065	CHEMBL4327759	Inhibition of human MEK1 assessed as residual activity at 1 uM using ERK2 as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	94.43	CHEMBL3587	Homo sapiens	Activity	%	94.43
	18938066	CHEMBL4327759	Inhibition of human MEK1 assessed as residual activity at 1 uM using ERK2 as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	92.98	CHEMBL3587	Homo sapiens	Activity	%	92.98
	18938604	CHEMBL4328123	Inhibition of human MEK1 assessed as residual activity at 100 uM using ERK2 as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL3587	Homo sapiens	Activity	%	65.0
	18938984	CHEMBL4328487	Inhibition of human MEK1 using ERK2 as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	23.9	CHEMBL3587	Homo sapiens	IC50	10'-8M	2.39
	18950239	CHEMBL4331091	Inhibition of human MEK1 assessed as residual activity at 10 uM using ERK2 as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by Hotspot assay relative to control	B	CN1CCC(Nc2ccc(C(=O)Nc3cc(-c4cc(C#N)cs4)n[nH]3)cc2)CC1		CHEMBL4473820	=	Activity	%	91.87	CHEMBL3587	Homo sapiens	Activity	%	91.87
	18953685	CHEMBL4331932	Inhibition of MKK1 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(NC3CCCCC3)c12		CHEMBL4440433	=	Inhibition	%	57.0	CHEMBL3587	Homo sapiens	INH	%	57.0
	18953751	CHEMBL4331932	Inhibition of MKK1 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(Nc3ccccc3F)c12		CHEMBL4449552	=	Inhibition	%	57.0	CHEMBL3587	Homo sapiens	INH	%	57.0
	18953846	CHEMBL4331932	Inhibition of MKK1 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(OC3CCCCC3)c12		CHEMBL4524629	=	Inhibition	%	96.0	CHEMBL3587	Homo sapiens	INH	%	96.0
	18953938	CHEMBL4331991	Inhibition of MKK1 (unknown origin) at 1 uM relative to control	B	CC(C)n1cc(-c2n[nH]c3ccnc(OC4CCOCC4)c23)cn1		CHEMBL4589022	=	Inhibition	%	57.0	CHEMBL3587	Homo sapiens	INH	%	57.0
	18954002	CHEMBL4331991	Inhibition of MKK1 (unknown origin) at 1 uM relative to control	B	c1cc(-c2n[nH]c3ccnc(OC4CCOCC4)c23)cc(N2CCOCC2)n1		CHEMBL4460272	=	Inhibition	%	7.0	CHEMBL3587	Homo sapiens	INH	%	7.0
	18954069	CHEMBL4331932	Inhibition of MKK1 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(Nc3ccc4ncsc4c3)c12		CHEMBL4588446	=	Inhibition	%	93.0	CHEMBL3587	Homo sapiens	INH	%	93.0
	18958966	CHEMBL4333488	Binding affinity to wild-type human full length MEK1 (M1 to V393 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	96.0	CHEMBL3587	Homo sapiens	Activity	%	96.0
	18964431	CHEMBL4335154	Inhibition of recombinant human MEK1 assessed as residual activity at 1 uM using inactive MAPK2 as substrate incubated for 40 mins in presence of [gamma-33ATP by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	88.0	CHEMBL3587	Homo sapiens	Activity	%	88.0
	18964432	CHEMBL4335154	Inhibition of recombinant human MEK1 assessed as residual activity at 1 uM using inactive MAPK2 as substrate incubated for 40 mins in presence of [gamma-33ATP by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	96.0	CHEMBL3587	Homo sapiens	Activity	%	96.0
	18971971	CHEMBL4336981	Inhibition of recombinant human MEK1 assessed as residual activity at 10 uM using inactive MAPK2 as substrate incubated for 40 mins in presence of [gamma-33ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	85.0	CHEMBL3587	Homo sapiens	Activity	%	85.0
	18989213	CHEMBL4340755	Inhibition of recombinant human wild-type full-length MEK1 (M1 to V393 residues) expressed in Sf9 insect cells using ERK2-K54R as substrate measured after 60 mins in presence of [gamma-33P]-ATP by scintillation counting method	B	CN(CCc1ccc(-c2ccccc2)cc1)Cc1cn(C)c2ccc(C(=O)Nc3ccc(F)cc3)cc12		CHEMBL4446681	>	IC50	nM	100000.0	CHEMBL3587	Homo sapiens	IC50	uM	100.0
	19035314	CHEMBL4350410	Inhibition of human MEK1 assessed as residual activity at 10 uM using ERK2 as substrate by [gamma-33P]-ATP assay	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccncn1)c2=O		CHEMBL4439094	=	Activity	%	100.0	CHEMBL3587	Homo sapiens	Activity	%	100.0
Not Active	19039710	CHEMBL4351932	Inhibition of recombinant full-length human MEK1 at 10 uM using unactive MAPK2 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Active	19041174	CHEMBL4352435	Inhibition of human MEK1 at 10 uM using ERK2 as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
	19043770	CHEMBL4353236	Inhibition of human MEK1 using ERK2 as substrate at 0.1 uM in presence of 33P-gamma ATP by hotspot kinase assay relative to control	B	CN1CCC(Nc2ccc(C(=O)Nc3cc(-c4ccc5c(c4)OCO5)n[nH]3)cc2)CC1		CHEMBL4456471	=	Inhibition	%	108.41	CHEMBL3587	Homo sapiens	INH	%	108.41
	19059679	CHEMBL4357980	Binding affinity to wild-type human full length MEK1 (M1 to V393 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	93.0	CHEMBL3587	Homo sapiens	Activity	%	93.0
	19067284	CHEMBL4360614	Inhibition of MEK1 (unknown origin) phosphorylation by [gamma-33P]-ATP assay	B	CCNc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@@H](C)[C@H](C)OC2=O		CHEMBL1097999	=	IC50	nM	50.0	CHEMBL3587	Homo sapiens	IC50	nmol/L	50.0
	19090244	CHEMBL4365818	Inhibition of wild-type human full length MEK1 (M1 to V393 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	70.0	CHEMBL3587	Homo sapiens	Activity	%	70.0
	19091997	CHEMBL4366471	Inhibition of human MEK1 at 100 nM using ERK2 as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	1.42	CHEMBL3587	Homo sapiens	INH	%	1.42
	19093732	CHEMBL4367060	Inhibition of recombinant full length GST-tagged human MEK1 expressed in baculovirus infected sf9 insect cells at 20 uM measured after 30 to 90 mins by HTRF based Lanthascreen Eu kinase binding assay relative to AZD6244	B	COc1cc(/C=C2\C(=O)NN(c3ccc(I)cc3)C2=O)ccc1OC(C)=O		CHEMBL4550493	=	Inhibition	%	60.1	CHEMBL3587	Homo sapiens	INH	%	60.1
	19093733	CHEMBL4367060	Inhibition of recombinant full length GST-tagged human MEK1 expressed in baculovirus infected sf9 insect cells at 20 uM measured after 30 to 90 mins by HTRF based Lanthascreen Eu kinase binding assay relative to AZD6244	B	Cc1ccc(S(=O)(=O)Nc2cc(SCC(=O)O)c(O)c3ccccc23)cc1		CHEMBL1868007	=	Inhibition	%	90.3	CHEMBL3587	Homo sapiens	INH	%	90.3
	19093734	CHEMBL4367065	Inhibition of recombinant full length GST-tagged human MEK1 expressed in baculovirus infected sf9 insect cells at 2 uM measured after 30 to 90 mins by HTRF based Lanthascreen Eu kinase binding assay relative to AZD6244	B	Cc1ccc(S(=O)(=O)Nc2cc(SCC(=O)O)c(O)c3ccccc23)cc1		CHEMBL1868007	=	Inhibition	%	32.1	CHEMBL3587	Homo sapiens	INH	%	32.1
	19093735	CHEMBL4367065	Inhibition of recombinant full length GST-tagged human MEK1 expressed in baculovirus infected sf9 insect cells at 2 uM measured after 30 to 90 mins by HTRF based Lanthascreen Eu kinase binding assay relative to AZD6244	B	COc1cc(/C=C2\C(=O)NN(c3ccc(I)cc3)C2=O)ccc1OC(C)=O		CHEMBL4550493	=	Inhibition	%	11.9	CHEMBL3587	Homo sapiens	INH	%	11.9
	19118096	CHEMBL4372263	Inhibition of MKK1 (unknown origin) at 1 uM by radioactivity-based assay relative to control	B	O=C(Nc1ccnnc1)c1cc(N2CCOCC2)ccc1OCc1ccccc1		CHEMBL4457647	=	Inhibition	%	84.0	CHEMBL3587	Homo sapiens	INH	%	84.0
	19144955	CHEMBL4377971	Inhibition of recombinant full-length human MEK1 at 1 uM using unactive MAPK2 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	22.0	CHEMBL3587	Homo sapiens	INH	%	22.0
	19146845	CHEMBL4378947	Inhibition of recombinant full-length human MEK1 at 10 uM using unactive MAPK2 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	-3.0	CHEMBL3587	Homo sapiens	INH	%	-3.0
	19147919	CHEMBL4379393	Inhibition of recombinant full length human MEK1 using inactive MAPK2 as substrate incubated for 40 mins in presence of [gamma-33ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	uM	10.0
Active	19149575	CHEMBL4379928	Inhibition of MEK1 in human A375 cells assessed as reduction in ERK1/2 phosphorylation at 10 uM incubated for 1 to 16 hrs in presence of poly(I:C) stimulation by Surefire assay	B	Cc1cc(NS(=O)(=O)c2ccccc2)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL4527608		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Active	19149599	CHEMBL4379932	Inhibition of MEK1 in human A375 cells assessed as reduction in IL6 secretion at 1 to 10 uM incubated for 12 hrs followed by poly(I:C) treatment and measured after 4 hrs by AlphaLISA assay	B	Cc1cc(NS(=O)(=O)c2ccccc2)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL4527608		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
	19149607	CHEMBL4379939	Inhibition of MEK1 (unknown origin) incubated for 60 mins in presence of ATP by Kinase Glo luminescence assay	B	Cc1cc(NS(=O)(=O)c2ccccc2)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL4527608	=	IC50	nM	398.11	CHEMBL3587	Homo sapiens	pIC50		6.4
Active	19149610	CHEMBL4379937	Inhibition of MEK1 in human A375 cells assessed as inhibition of ERK1/2 phosphorylation at 1 to 10 uM incubated for 12 hrs followed by poly(I:C) treatment and measured after 4 hrs by Surefire assay	B	Cc1cc(NS(=O)(=O)c2ccccc2)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL4527608		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
	19149611	CHEMBL4379939	Inhibition of MEK1 (unknown origin) incubated for 60 mins in presence of ATP by Kinase Glo luminescence assay	B	Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)CCc2ccc(S(=O)(=O)Nc3cc(C)c(=O)n(C)c3Nc3ccc(I)cc3F)cc2)C(C)(C)C)cc1		CHEMBL4473576	=	IC50	nM	100.0	CHEMBL3587	Homo sapiens	pIC50		7.0
	19149616	CHEMBL4379939	Inhibition of MEK1 (unknown origin) incubated for 60 mins in presence of ATP by Kinase Glo luminescence assay	B	Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCOCCOCCNC(=O)CCc2ccc(S(=O)(=O)Nc3cc(C)c(=O)n(C)c3Nc3ccc(I)cc3F)cc2)C(C)(C)C)cc1		CHEMBL4528327	=	IC50	nM	100.0	CHEMBL3587	Homo sapiens	pIC50		7.0
	19149620	CHEMBL4379939	Inhibition of MEK1 (unknown origin) incubated for 60 mins in presence of ATP by Kinase Glo luminescence assay	B	Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)COc2ccc(S(=O)(=O)Nc3cc(C)c(=O)n(C)c3Nc3ccc(I)cc3F)cc2)C(C)(C)C)cc1		CHEMBL4458609	=	IC50	nM	158.49	CHEMBL3587	Homo sapiens	pIC50		6.8
	19159507	CHEMBL4382611	Binding affinity to wild-type human full length MEK1 (M1 to V393 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	72.0	CHEMBL3587	Homo sapiens	Activity	%	72.0
	19181077	CHEMBL4387288	Inhibition of recombinant full length human His-tagged MEK1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-3 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	4.7	CHEMBL3587	Homo sapiens	INH	%	4.7
	19181303	CHEMBL4387288	Inhibition of recombinant full length human His-tagged MEK1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-3 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	20.5	CHEMBL3587	Homo sapiens	INH	%	20.5
	19191500	CHEMBL4389330	Inhibition of wild-type human full length MEK1 (M1 to V393 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	14.0	CHEMBL3587	Homo sapiens	INH	%	14.0
	19191993	CHEMBL4389807	Inhibition of wild-type human full length MEK1 (M1 to V393 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	68.0	CHEMBL3587	Homo sapiens	INH	%	68.0
	19200249	CHEMBL4391433	Binding affinity to wild-type human full length MEK1 (M1 to V393 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	7.6	CHEMBL3587	Homo sapiens	Activity	%	7.6
	19230855	CHEMBL4397166	Inhibition of N-terminal GST-fused MEK1 (unknown origin) expressed in FreeStyle 293 cells at 100 nM using GST-ERK1(K71A) as substrate preincubated for 5 mins followed by [gamma-33P]ATP addition and measured after 20 mins by topcount scintillation counting method relative to control	B	Cc1cc(-n2cc(C(=O)N3CCO[C@@H](C)C3)c3ccc(O[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1		CHEMBL4440381	=	Inhibition	%	-1.0	CHEMBL3587	Homo sapiens	INH	%	-1.0
	19242732	CHEMBL4400067	Inhibition of full length recombinant human MEK1 assessed as residual activity at 10 uM using inactive MAPK2 as substrate incubated for 40 mins in presence of [gamma-33P]ATP at Km concentration by radiometric assay relative to control	B	COc1ccc2c(CCNc3nc(NCc4ccc(=O)[nH]c4)c4nc[nH]c4n3)c[nH]c2c1		CHEMBL4555782	=	Activity	%	11.0	CHEMBL3587	Homo sapiens	Activity	%	11.0
	19266493	CHEMBL4405443	Inhibition of wild-type human full length MEK1 (M1 to V393 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	19272035	CHEMBL4406980	Inhibition of wild-type human full length MEK1 (M1 to V393 residues) expressed in mammalian expression system assessed as enzyme remaining activity at 1000 nM by Kinomescan method relative to control	B	O=C(Nc1cccc(Br)c1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4465561	=	Activity	%	100.0	CHEMBL3587	Homo sapiens	Activity	%	100.0
	19276031	CHEMBL4408034	Inhibition of recombinant human full length MEK1 at 1 uM using as unactive MAPK2 substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	7.0	CHEMBL3587	Homo sapiens	INH	%	7.0
	19303795	CHEMBL4414247	Inhibition of MEK1 (unknown origin) assessed as residual activity at 50 uM relative to control	B	O=C(O)c1ccc(Nc2nc(-c3cccc([N+](=O)[O-])c3)cs2)cc1		CHEMBL4462082	=	Activity	%	103.0	CHEMBL3587	Homo sapiens	Activity	%	103.0
	19303832	CHEMBL4414247	Inhibition of MEK1 (unknown origin) assessed as residual activity at 50 uM relative to control	B	O=C(O)c1ccc(Nc2nc(-c3cccc(Br)c3)cs2)cc1		CHEMBL4458300	=	Activity	%	95.0	CHEMBL3587	Homo sapiens	Activity	%	95.0
	19312965	CHEMBL4416520	Inhibition of recombinant human N-terminal GST-tagged C-terminal His6-tagged full length MEK1 expressed Escherichia coli expression system at 10 uM using MBP as substrate relative to control	B	N#CC[C@H]1CC[C@H](n2c(=O)[nH]c3cnc(Nc4ccc[nH]c4=O)nc32)CC1		CHEMBL4463007	<	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	19371142	CHEMBL4424894	Inhibition of human full-length N-terminal GST-tagged/C-terminal His6-tagged MEK1 expressed in Escherichia coli using MBP as substrate	A	COc1cc(C2CN(C(=O)c3cc(COC[C@@H](O)CO)ccn3)C2)ccc1OCc1ccc(C2CC2)cc1		CHEMBL4474690	>	IC50	nM	1000.0	CHEMBL3587	Homo sapiens	IC50	nM	1000.0
	19411454	CHEMBL4427711	Inhibition of MAP2K1 (unknown origin)	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126	>=	IC50	nM	5000.0	CHEMBL3587	Homo sapiens	IC50	uM	5.0
	19411510	CHEMBL4427655	Inhibition of MAP2K1 (unknown origin) at 1 uM relative to control	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126	<=	Inhibition	%	16.0	CHEMBL3587	Homo sapiens	INH	%	16.0
	19449815	CHEMBL4433500	Inhibition of MEK1 (unknown origin)	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	=	IC50	nM	0.7	CHEMBL3587	Homo sapiens	IC50	nM	0.7
	19476593	CHEMBL4479741	Inhibition of full-length recombinant human His-tagged MAP2K1 expressed in baculovirus expression system by LanthaScreen assay	B	O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1		CHEMBL4569508	=	IC50	nM	7200.0	CHEMBL3587	Homo sapiens	IC50	nM	7200.0
	19476693	CHEMBL4479741	Inhibition of full-length recombinant human His-tagged MAP2K1 expressed in baculovirus expression system by LanthaScreen assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1		CHEMBL4550702	=	IC50	nM	12000.0	CHEMBL3587	Homo sapiens	IC50	nM	12000.0
	19476793	CHEMBL4479741	Inhibition of full-length recombinant human His-tagged MAP2K1 expressed in baculovirus expression system by LanthaScreen assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1		CHEMBL4568087	=	IC50	nM	120.0	CHEMBL3587	Homo sapiens	IC50	nM	120.0
	19476893	CHEMBL4479741	Inhibition of full-length recombinant human His-tagged MAP2K1 expressed in baculovirus expression system by LanthaScreen assay	B	Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12		CHEMBL4552628	=	IC50	nM	1100.0	CHEMBL3587	Homo sapiens	IC50	nM	1100.0
Active	19478927	CHEMBL4480181	Inhibition of recombinant full length human N-terminal GST-tagged C-terminal His6-tagged MEK1 expressed in Escherichia coli using myelin basic protein as substrate in presence of activated BRAF and ERK2 by ELISA	B	Cc1ccc(-c2nn(-c3ccccc3)cc2C(=O)NOCc2ccccc2)cc1		CHEMBL4545932		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
	19478928	CHEMBL4480181	Inhibition of recombinant full length human N-terminal GST-tagged C-terminal His6-tagged MEK1 expressed in Escherichia coli using myelin basic protein as substrate in presence of activated BRAF and ERK2 by ELISA	B	Cc1ccc(-c2nn(-c3ccccc3)cc2C(=O)NOCc2ccccc2F)cc1		CHEMBL4575118	=	IC50	nM	91.0	CHEMBL3587	Homo sapiens	IC50	nM	91.0
Active	19478929	CHEMBL4480181	Inhibition of recombinant full length human N-terminal GST-tagged C-terminal His6-tagged MEK1 expressed in Escherichia coli using myelin basic protein as substrate in presence of activated BRAF and ERK2 by ELISA	B	Cc1ccc(-c2nn(-c3ccccc3)cc2C(=O)NOCc2ccccc2Cl)cc1		CHEMBL4586091		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Active	19478930	CHEMBL4480181	Inhibition of recombinant full length human N-terminal GST-tagged C-terminal His6-tagged MEK1 expressed in Escherichia coli using myelin basic protein as substrate in presence of activated BRAF and ERK2 by ELISA	B	Cc1ccc(-c2nn(-c3ccccc3)cc2C(=O)NOCc2ccc(Cl)cc2Cl)cc1		CHEMBL4528906		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Active	19478931	CHEMBL4480181	Inhibition of recombinant full length human N-terminal GST-tagged C-terminal His6-tagged MEK1 expressed in Escherichia coli using myelin basic protein as substrate in presence of activated BRAF and ERK2 by ELISA	B	COc1ccc(-c2nn(-c3ccccc3)cc2C(=O)NOCc2ccccc2)cc1		CHEMBL4556810		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Active	19478932	CHEMBL4480181	Inhibition of recombinant full length human N-terminal GST-tagged C-terminal His6-tagged MEK1 expressed in Escherichia coli using myelin basic protein as substrate in presence of activated BRAF and ERK2 by ELISA	B	COc1ccc(-c2nn(-c3ccccc3)cc2C(=O)NOCc2ccccc2F)cc1		CHEMBL4560047		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Active	19478933	CHEMBL4480181	Inhibition of recombinant full length human N-terminal GST-tagged C-terminal His6-tagged MEK1 expressed in Escherichia coli using myelin basic protein as substrate in presence of activated BRAF and ERK2 by ELISA	B	COc1ccc(-c2nn(-c3ccccc3)cc2C(=O)NOCc2ccccc2Cl)cc1		CHEMBL4580386		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Active	19478934	CHEMBL4480181	Inhibition of recombinant full length human N-terminal GST-tagged C-terminal His6-tagged MEK1 expressed in Escherichia coli using myelin basic protein as substrate in presence of activated BRAF and ERK2 by ELISA	B	COc1ccc(-c2nn(-c3ccccc3)cc2C(=O)NOCc2ccc(Cl)cc2Cl)cc1		CHEMBL4577383		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Not Active	19478935	CHEMBL4480181	Inhibition of recombinant full length human N-terminal GST-tagged C-terminal His6-tagged MEK1 expressed in Escherichia coli using myelin basic protein as substrate in presence of activated BRAF and ERK2 by ELISA	B	O=C(NOCc1ccccc1)c1cn(-c2ccccc2)nc1-c1ccc(F)cc1		CHEMBL4575979		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Not Active	19478936	CHEMBL4480181	Inhibition of recombinant full length human N-terminal GST-tagged C-terminal His6-tagged MEK1 expressed in Escherichia coli using myelin basic protein as substrate in presence of activated BRAF and ERK2 by ELISA	B	O=C(NOCc1ccccc1F)c1cn(-c2ccccc2)nc1-c1ccc(F)cc1		CHEMBL4580566		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Not Active	19478937	CHEMBL4480181	Inhibition of recombinant full length human N-terminal GST-tagged C-terminal His6-tagged MEK1 expressed in Escherichia coli using myelin basic protein as substrate in presence of activated BRAF and ERK2 by ELISA	B	O=C(NOCc1ccccc1Cl)c1cn(-c2ccccc2)nc1-c1ccc(F)cc1		CHEMBL4568694		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Not Active	19478938	CHEMBL4480181	Inhibition of recombinant full length human N-terminal GST-tagged C-terminal His6-tagged MEK1 expressed in Escherichia coli using myelin basic protein as substrate in presence of activated BRAF and ERK2 by ELISA	B	O=C(NOCc1ccc(Cl)cc1Cl)c1cn(-c2ccccc2)nc1-c1ccc(F)cc1		CHEMBL4575359		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
	19478939	CHEMBL4480181	Inhibition of recombinant full length human N-terminal GST-tagged C-terminal His6-tagged MEK1 expressed in Escherichia coli using myelin basic protein as substrate in presence of activated BRAF and ERK2 by ELISA	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	IC50	nM	89.0	CHEMBL3587	Homo sapiens	IC50	nM	89.0
	19478940	CHEMBL4480182	Inhibition of MEK1 in BRAF mutant human A549 cells assessed as reduction in ERK1/2 phosphorylation by ELISA	B	Cc1ccc(-c2nn(-c3ccccc3)cc2C(=O)NOCc2ccccc2F)cc1		CHEMBL4575118	=	IC50	nM	610.0	CHEMBL3587	Homo sapiens	IC50	uM	0.61
	20600570	CHEMBL4603522	Inhibition of recombinant full length human His-tagged MEK1 expressed in baculovirus expression system using serine/threonine-3 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL3587	Homo sapiens	IC50	uM	100.0
	20629076	CHEMBL4610390	Inhibition of wild-type human full length MEK1 (M1 to V393 residues) expressed in mammalian expression system assessed as residual activity at 500 nM by Kinomescan method relative to control	B	CCOC(=O)c1cnc2ccc(-c3ccncc3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL4646793	=	Activity	%	69.0	CHEMBL3587	Homo sapiens	Activity	%	69.0
	20629084	CHEMBL4610398	Inhibition of wild-type human full length MEK1 (M1 to V393 residues) expressed in mammalian expression system assessed as residual activity at 100 nM by Kinomescan method relative to control	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Activity	%	1.7	CHEMBL3587	Homo sapiens	Activity	%	1.7
	22391800	CHEMBL4667006	Inhibition of recombinant human His-tagged full length MEK1 expressed in baculovirus expression system using Ser/Thr 03 as substrate at 0.1 uM incubated for 60 mins by Z'-lyte assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc(Cl)ccc1OC(F)F)c1cnn2cccnc12		CHEMBL4744172	=	Inhibition	%	-8.0	CHEMBL3587	Homo sapiens	INH	%	-8.0
	22391801	CHEMBL4667006	Inhibition of recombinant human His-tagged full length MEK1 expressed in baculovirus expression system using Ser/Thr 03 as substrate at 0.1 uM incubated for 60 mins by Z'-lyte assay relative to control	B	Cn1cc(NC(=O)c2cnn3cccnc23)c(-c2cc(Cl)ccc2OC(F)F)n1		CHEMBL4777342	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	INH	%	0.0
	22391802	CHEMBL4667006	Inhibition of recombinant human His-tagged full length MEK1 expressed in baculovirus expression system using Ser/Thr 03 as substrate at 0.1 uM incubated for 60 mins by Z'-lyte assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc2ccccc2cc1OC(F)F)c1cnn2cccnc12		CHEMBL4745474	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	INH	%	0.0
	22392097	CHEMBL4667192	Inhibition of recombinant human His-tagged full length MEK1 expressed in baculovirus expression system using Ser/Thr 03 as substrate at 10 uM incubated for 60 mins by Z'-lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	-6.5	CHEMBL3587	Homo sapiens	INH	%	-6.5
	22423479	CHEMBL4674315	Inhibition of human MEK1 using ERK2 as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	96.61	CHEMBL3587	Homo sapiens	Activity	%	96.61
	22423480	CHEMBL4674315	Inhibition of human MEK1 using ERK2 as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	71.29	CHEMBL3587	Homo sapiens	Activity	%	71.29
	22448331	CHEMBL4680019	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in presence of AMP-PNP by SPR assay	B	COc1ccc(C2CC(=O)NCCS2)cc1		CHEMBL4787244	=	Kd	nM	450000.0	CHEMBL3587	Homo sapiens	Kd	uM	450.0
	22448332	CHEMBL4680019	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in presence of AMP-PNP by SPR assay	B	CCN(C)c1cc(-c2ccccc2O)nc2nccn12		CHEMBL4763766	=	Kd	nM	82000.0	CHEMBL3587	Homo sapiens	Kd	uM	82.0
	22448333	CHEMBL4680019	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in presence of AMP-PNP by SPR assay	B	O=c1[nH]ccc2nc(-c3ccccc3)cn12		CHEMBL4789122	=	Kd	nM	70000.0	CHEMBL3587	Homo sapiens	Kd	uM	70.0
	22448334	CHEMBL4680019	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in presence of AMP-PNP by SPR assay	B	O=C(c1cccnc1)c1cc2ccccc2[nH]1		CHEMBL1550931	=	Kd	nM	65000.0	CHEMBL3587	Homo sapiens	Kd	uM	65.0
	22448335	CHEMBL4680019	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in presence of AMP-PNP by SPR assay	B	CC(=O)Nc1ccc2c(C(F)(F)F)cc(=O)oc2c1		CHEMBL1951645	=	Kd	nM	138000.0	CHEMBL3587	Homo sapiens	Kd	uM	138.0
	22448336	CHEMBL4680019	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in presence of AMP-PNP by SPR assay	B	COc1ccc(-c2cccc(=O)[nH]2)cc1		CHEMBL4754482	=	Kd	nM	572000.0	CHEMBL3587	Homo sapiens	Kd	uM	572.0
	22448337	CHEMBL4680019	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in presence of AMP-PNP by SPR assay	B	O=c1[nH]ccc2nc(-c3ccc(I)cc3)cn12		CHEMBL4740336	=	Kd	nM	28000.0	CHEMBL3587	Homo sapiens	Kd	uM	28.0
	22448338	CHEMBL4680019	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in presence of AMP-PNP by SPR assay	B	O=C(CC1SCCNC1=O)Nc1ccc(Cl)c(Cl)c1		CHEMBL1464768	=	Kd	nM	65000.0	CHEMBL3587	Homo sapiens	Kd	uM	65.0
	22448339	CHEMBL4680019	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in presence of AMP-PNP by SPR assay	B	O=C(CC1SCCNC1=O)Nc1ccccc1		CHEMBL4753431	=	Kd	nM	19000.0	CHEMBL3587	Homo sapiens	Kd	uM	19.0
	22448340	CHEMBL4680019	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in presence of AMP-PNP by SPR assay	B	COc1ccccc1NC(=O)CC1SCCNC1=O		CHEMBL4779731	=	Kd	nM	160000.0	CHEMBL3587	Homo sapiens	Kd	uM	160.0
	22448341	CHEMBL4680019	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in presence of AMP-PNP by SPR assay	B	COc1cccc(NC(=O)CC2SCCNC2=O)c1		CHEMBL4751171	=	Kd	nM	488000.0	CHEMBL3587	Homo sapiens	Kd	uM	488.0
	22448342	CHEMBL4680019	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in presence of AMP-PNP by SPR assay	B	COc1ccc(NC(=O)CC2SCCNC2=O)cc1		CHEMBL4790340	=	Kd	nM	1900.0	CHEMBL3587	Homo sapiens	Kd	uM	1.9
	22448343	CHEMBL4680019	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in presence of AMP-PNP by SPR assay	B	COc1ccc(NC(=O)CC2SCCNC2=O)cc1F		CHEMBL4753541	=	Kd	nM	3400.0	CHEMBL3587	Homo sapiens	Kd	uM	3.4
	22448344	CHEMBL4680019	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in presence of AMP-PNP by SPR assay	B	CCOc1ccc(NC(=O)CC2SCCNC2=O)cc1		CHEMBL4753078	=	Kd	nM	1800.0	CHEMBL3587	Homo sapiens	Kd	uM	1.8
	22448345	CHEMBL4680019	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in presence of AMP-PNP by SPR assay	B	O=C(CC1SCCNC1=O)Nc1ccc(OC(F)F)cc1		CHEMBL4743364	=	Kd	nM	10000.0	CHEMBL3587	Homo sapiens	Kd	uM	10.0
	22448346	CHEMBL4680019	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in presence of AMP-PNP by SPR assay	B	O=C(CC1SCCNC1=O)Nc1ccc(OC(F)(F)F)cc1		CHEMBL4762833	>	Kd	nM	1000000.0	CHEMBL3587	Homo sapiens	Kd	uM	1000.0
	22448347	CHEMBL4680019	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in presence of AMP-PNP by SPR assay	B	O=C(CC1SCCNC1=O)Nc1ccc(O)cc1		CHEMBL4756172	=	Kd	nM	14000.0	CHEMBL3587	Homo sapiens	Kd	uM	14.0
	22448348	CHEMBL4680019	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in presence of AMP-PNP by SPR assay	B	O=C(CC1SCCNC1=O)Nc1ccc2c(c1)OCO2		CHEMBL4761941	=	Kd	nM	3300.0	CHEMBL3587	Homo sapiens	Kd	uM	3.3
	22448349	CHEMBL4680019	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in presence of AMP-PNP by SPR assay	B	O=C(CC1SCCNC1=O)Nc1ccc(F)cc1		CHEMBL4753827	=	Kd	nM	2600.0	CHEMBL3587	Homo sapiens	Kd	uM	2.6
	22448350	CHEMBL4680019	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in presence of AMP-PNP by SPR assay	B	O=C(CC1SCCNC1=O)Nc1ccc(Cl)cc1		CHEMBL1375223	=	Kd	nM	7400.0	CHEMBL3587	Homo sapiens	Kd	uM	7.4
	22448351	CHEMBL4680019	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in presence of AMP-PNP by SPR assay	B	COc1ccc(NC(=O)[C@H]2SCCNC2=O)cc1		CHEMBL4795273	=	Kd	nM	330.0	CHEMBL3587	Homo sapiens	Kd	uM	0.33
	22448352	CHEMBL4680019	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in presence of AMP-PNP by SPR assay	B	COc1ccc(NC(=O)[C@@H]2SCCNC2=O)cc1		CHEMBL4776489	=	Kd	nM	30000.0	CHEMBL3587	Homo sapiens	Kd	uM	30.0
	22448353	CHEMBL4680019	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in presence of AMP-PNP by SPR assay	B	COc1ccc(N(C)C(=O)C2SCCNC2=O)cc1		CHEMBL4778346	>	Kd	nM	1000000.0	CHEMBL3587	Homo sapiens	Kd	uM	1000.0
	22448354	CHEMBL4680020	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in absence of AMP-PNP by SPR assay	B	COc1ccc(C2CC(=O)NCCS2)cc1		CHEMBL4787244	=	Kd	nM	430000.0	CHEMBL3587	Homo sapiens	Kd	uM	430.0
	22448355	CHEMBL4680020	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in absence of AMP-PNP by SPR assay	B	CCN(C)c1cc(-c2ccccc2O)nc2nccn12		CHEMBL4763766	=	Kd	nM	72000.0	CHEMBL3587	Homo sapiens	Kd	uM	72.0
	22448356	CHEMBL4680020	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in absence of AMP-PNP by SPR assay	B	O=c1[nH]ccc2nc(-c3ccccc3)cn12		CHEMBL4789122	=	Kd	nM	38000.0	CHEMBL3587	Homo sapiens	Kd	uM	38.0
	22448357	CHEMBL4680020	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in absence of AMP-PNP by SPR assay	B	O=C(c1cccnc1)c1cc2ccccc2[nH]1		CHEMBL1550931	=	Kd	nM	59000.0	CHEMBL3587	Homo sapiens	Kd	uM	59.0
	22448358	CHEMBL4680020	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in absence of AMP-PNP by SPR assay	B	CC(=O)Nc1ccc2c(C(F)(F)F)cc(=O)oc2c1		CHEMBL1951645	=	Kd	nM	275000.0	CHEMBL3587	Homo sapiens	Kd	uM	275.0
	22448359	CHEMBL4680020	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in absence of AMP-PNP by SPR assay	B	COc1ccc(-c2cccc(=O)[nH]2)cc1		CHEMBL4754482	=	Kd	nM	384000.0	CHEMBL3587	Homo sapiens	Kd	uM	384.0
	22448360	CHEMBL4680020	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in absence of AMP-PNP by SPR assay	B	O=C(CC1SCCNC1=O)Nc1ccc(Cl)c(Cl)c1		CHEMBL1464768	=	Kd	nM	87000.0	CHEMBL3587	Homo sapiens	Kd	uM	87.0
	22448361	CHEMBL4680020	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in absence of AMP-PNP by SPR assay	B	O=C(CC1SCCNC1=O)Nc1ccccc1		CHEMBL4753431	=	Kd	nM	16000.0	CHEMBL3587	Homo sapiens	Kd	uM	16.0
	22448362	CHEMBL4680020	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in absence of AMP-PNP by SPR assay	B	COc1ccccc1NC(=O)CC1SCCNC1=O		CHEMBL4779731	=	Kd	nM	237000.0	CHEMBL3587	Homo sapiens	Kd	uM	237.0
	22448363	CHEMBL4680020	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in absence of AMP-PNP by SPR assay	B	COc1cccc(NC(=O)CC2SCCNC2=O)c1		CHEMBL4751171	=	Kd	nM	487000.0	CHEMBL3587	Homo sapiens	Kd	uM	487.0
	22448364	CHEMBL4680020	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in absence of AMP-PNP by SPR assay	B	COc1ccc(NC(=O)CC2SCCNC2=O)cc1		CHEMBL4790340	=	Kd	nM	2500.0	CHEMBL3587	Homo sapiens	Kd	uM	2.5
Not Determined	22448365	CHEMBL4680020	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in absence of AMP-PNP by SPR assay	B	COc1ccc(NC(=O)CC2SCCNC2=O)cc1F		CHEMBL4753541		Kd			CHEMBL3587	Homo sapiens	Kd		
	22448366	CHEMBL4680020	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in absence of AMP-PNP by SPR assay	B	CCOc1ccc(NC(=O)CC2SCCNC2=O)cc1		CHEMBL4753078	=	Kd	nM	1600.0	CHEMBL3587	Homo sapiens	Kd	uM	1.6
Not Determined	22448367	CHEMBL4680020	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in absence of AMP-PNP by SPR assay	B	O=C(CC1SCCNC1=O)Nc1ccc(OC(F)F)cc1		CHEMBL4743364		Kd			CHEMBL3587	Homo sapiens	Kd		
Not Determined	22448368	CHEMBL4680020	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in absence of AMP-PNP by SPR assay	B	O=C(CC1SCCNC1=O)Nc1ccc(OC(F)(F)F)cc1		CHEMBL4762833		Kd			CHEMBL3587	Homo sapiens	Kd		
Not Determined	22448369	CHEMBL4680020	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in absence of AMP-PNP by SPR assay	B	O=C(CC1SCCNC1=O)Nc1ccc(O)cc1		CHEMBL4756172		Kd			CHEMBL3587	Homo sapiens	Kd		
	22448370	CHEMBL4680020	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in absence of AMP-PNP by SPR assay	B	O=C(CC1SCCNC1=O)Nc1ccc2c(c1)OCO2		CHEMBL4761941	=	Kd	nM	6000.0	CHEMBL3587	Homo sapiens	Kd	uM	6.0
	22448371	CHEMBL4680020	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in absence of AMP-PNP by SPR assay	B	O=C(CC1SCCNC1=O)Nc1ccc(F)cc1		CHEMBL4753827	=	Kd	nM	2900.0	CHEMBL3587	Homo sapiens	Kd	uM	2.9
	22448372	CHEMBL4680020	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in absence of AMP-PNP by SPR assay	B	O=C(CC1SCCNC1=O)Nc1ccc(Cl)cc1		CHEMBL1375223	=	Kd	nM	14000.0	CHEMBL3587	Homo sapiens	Kd	uM	14.0
	22448373	CHEMBL4680020	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in absence of AMP-PNP by SPR assay	B	COc1ccc(NC(=O)[C@H]2SCCNC2=O)cc1		CHEMBL4795273	=	Kd	nM	660.0	CHEMBL3587	Homo sapiens	Kd	uM	0.66
	22448374	CHEMBL4680020	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in absence of AMP-PNP by SPR assay	B	COc1ccc(NC(=O)[C@@H]2SCCNC2=O)cc1		CHEMBL4776489	=	Kd	nM	36000.0	CHEMBL3587	Homo sapiens	Kd	uM	36.0
Not Determined	22448375	CHEMBL4680020	Binding affinity to full length biotinylated 6His/Avi-tagged/Tev-fused human MEK1 expressed in Escherichia coli in absence of AMP-PNP by SPR assay	B	COc1ccc(N(C)C(=O)C2SCCNC2=O)cc1		CHEMBL4778346		Kd			CHEMBL3587	Homo sapiens	Kd		
	22752654	CHEMBL4700131	Inhibition of human MKK1 by kinase-profiling analysis	B	C#Cc1nc(Nc2cccc(CC(N)=O)c2)nc2[nH]cnc12		CHEMBL4786783	=	IC50	nM	550.0	CHEMBL3587	Homo sapiens	IC50	uM	0.55
	22759642	CHEMBL4701770	Inhibition of human MEK1 at 1 uM using fluorescently labeled peptide substrate measured after 3 hrs by microfluidic mobility shift assay relative to control	B	CN(C)C(=O)c1ccc(Oc2nc(-c3cnc(N)s3)nc(N3CCOCC3)n2)cc1		CHEMBL4782133	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	INH	%	0.0
	22790986	CHEMBL4709491	Inhibition of MEK1 (unknown origin) assessed as residual activity at 0.1 uM preincubated for 20 min followed by [gamma33P]ATP addition and measured after 120 mins by Hotspot assay relative to control	B	Cc1cccn(-c2ccc(-c3ccc4c(C(=O)NCc5ccncc5)n[nH]c4c3)c(Cl)c2)c1=O		CHEMBL4758500	=	Activity	%	84.39	CHEMBL3587	Homo sapiens	Activity	%	84.39
Dose-dependent effect	22804697	CHEMBL4712208	Inhibition of MEK1 phosphorylation in human HT-29 cells incubated for 24 hrs by Western blot analysis	B	Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCCCCCCN(C)CCCONC(=O)c2ccc(F)c(F)c2Nc2ccc(I)cc2F)C(C)(C)C)cc1		CHEMBL4741845		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Dose-dependent effect	22804698	CHEMBL4712208	Inhibition of MEK1 phosphorylation in human HT-29 cells incubated for 24 hrs by Western blot analysis	B	Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCCCCCCCNCCCCONC(=O)c2ccc(F)c(F)c2Nc2ccc(I)cc2F)C(C)(C)C)cc1		CHEMBL4787502		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Dose-dependent effect	22804699	CHEMBL4712208	Inhibition of MEK1 phosphorylation in human HT-29 cells incubated for 24 hrs by Western blot analysis	B	O=C1CCC(N2C(=O)c3ccc(NCCOCCOCCOCCOCCOCCNCCCONC(=O)c4ccc(F)c(F)c4Nc4ccc(I)cc4F)cc3C2=O)C(=O)N1		CHEMBL4744750		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Active	22804716	CHEMBL4712216	Inhibition of MEK1 phosphorylation in human SK-MEL-28 cells at 0.0001 to 3 uM incubated for 24 hrs by Western blot analysis	B	Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCCCCCCN(C)CCCONC(=O)c2ccc(F)c(F)c2Nc2ccc(I)cc2F)C(C)(C)C)cc1		CHEMBL4741845		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Active	22804717	CHEMBL4712216	Inhibition of MEK1 phosphorylation in human SK-MEL-28 cells at 0.0001 to 3 uM incubated for 24 hrs by Western blot analysis	B	Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCCCCCCCNCCCCONC(=O)c2ccc(F)c(F)c2Nc2ccc(I)cc2F)C(C)(C)C)cc1		CHEMBL4787502		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Not Active	22804766	CHEMBL4712238	Inhibition of MEK1 phosphorylation in human HT-29 cells at 0.3 to 3 uM incubated for 24 hrs by Western blot analysis	B	Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@H]2C[C@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCCCCCCN(C)CCCONC(=O)c2ccc(F)c(F)c2Nc2ccc(I)cc2F)C(C)(C)C)cc1		CHEMBL4780600		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Not Active	22804767	CHEMBL4712238	Inhibition of MEK1 phosphorylation in human HT-29 cells at 0.3 to 3 uM incubated for 24 hrs by Western blot analysis	B	Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@H]2C[C@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCCCCCCCNCCCCONC(=O)c2ccc(F)c(F)c2Nc2ccc(I)cc2F)C(C)(C)C)cc1		CHEMBL4753440		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Not Active	22804768	CHEMBL4712238	Inhibition of MEK1 phosphorylation in human HT-29 cells at 0.3 to 3 uM incubated for 24 hrs by Western blot analysis	B	CN1C(=O)CCC(N2C(=O)c3ccc(NCCOCCOCCOCCOCCOCCNCCCONC(=O)c4ccc(F)c(F)c4Nc4ccc(I)cc4F)cc3C2=O)C1=O		CHEMBL4779023		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
	22804813	CHEMBL4712270	Binding affinity to MEK1 (unknown origin) incubated for 1 hr by qPCR based KINOMEscan assay	B	Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCCCCCCN(C)CCCONC(=O)c2ccc(F)c(F)c2Nc2ccc(I)cc2F)C(C)(C)C)cc1		CHEMBL4741845	=	Kd	nM	400.0	CHEMBL3587	Homo sapiens	Kd	uM	0.4
	22804814	CHEMBL4712270	Binding affinity to MEK1 (unknown origin) incubated for 1 hr by qPCR based KINOMEscan assay	B	Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCCCCCCCNCCCCONC(=O)c2ccc(F)c(F)c2Nc2ccc(I)cc2F)C(C)(C)C)cc1		CHEMBL4787502	=	Kd	nM	400.0	CHEMBL3587	Homo sapiens	Kd	uM	0.4
	22804815	CHEMBL4712270	Binding affinity to MEK1 (unknown origin) incubated for 1 hr by qPCR based KINOMEscan assay	B	O=C1CCC(N2C(=O)c3ccc(NCCOCCOCCOCCOCCOCCNCCCONC(=O)c4ccc(F)c(F)c4Nc4ccc(I)cc4F)cc3C2=O)C(=O)N1		CHEMBL4744750	=	Kd	nM	660.0	CHEMBL3587	Homo sapiens	Kd	uM	0.66
	22804816	CHEMBL4712270	Binding affinity to MEK1 (unknown origin) incubated for 1 hr by qPCR based KINOMEscan assay	B	Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@H]2C[C@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCCCCCCN(C)CCCONC(=O)c2ccc(F)c(F)c2Nc2ccc(I)cc2F)C(C)(C)C)cc1		CHEMBL4780600	=	Kd	nM	380.0	CHEMBL3587	Homo sapiens	Kd	uM	0.38
	22804817	CHEMBL4712270	Binding affinity to MEK1 (unknown origin) incubated for 1 hr by qPCR based KINOMEscan assay	B	Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@H]2C[C@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCCCCCCCNCCCCONC(=O)c2ccc(F)c(F)c2Nc2ccc(I)cc2F)C(C)(C)C)cc1		CHEMBL4753440	=	Kd	nM	820.0	CHEMBL3587	Homo sapiens	Kd	uM	0.82
	22804818	CHEMBL4712270	Binding affinity to MEK1 (unknown origin) incubated for 1 hr by qPCR based KINOMEscan assay	B	CN1C(=O)CCC(N2C(=O)c3ccc(NCCOCCOCCOCCOCCOCCNCCCONC(=O)c4ccc(F)c(F)c4Nc4ccc(I)cc4F)cc3C2=O)C1=O		CHEMBL4779023	=	Kd	nM	1200.0	CHEMBL3587	Homo sapiens	Kd	uM	1.2
	22804819	CHEMBL4712270	Binding affinity to MEK1 (unknown origin) incubated for 1 hr by qPCR based KINOMEscan assay	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	Kd	nM	44.0	CHEMBL3587	Homo sapiens	Kd	uM	0.044000000000000004
	22809801	CHEMBL4713336	Inhibition of recombinant full length human MEK1 assessed as residual activity at 1 uM using unactive MAPK2 as substrate incubated for 40 mins in presence of Km ATP by radiometric scintillation counting analysis relative to control	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@H](C)C1		CHEMBL4761365	=	Activity	%	94.0	CHEMBL3587	Homo sapiens	Activity	%	94.0
	22818114	CHEMBL4715337	Inhibition of recombinant human N-terminal GST-tagged/C-terminal His6-tagged full-length MEK1 expressed in Escherichia coli at 2 uM using MBP as substrate relative to control	B	C[C@@H](c1ccc2ncccc2c1)c1nnc2sc(-c3cnn(C)c3)nn12		CHEMBL4791034	<	Inhibition	%	50.0	CHEMBL3587	Homo sapiens	INH	%	50.0
	22820518	CHEMBL4716261	Inhibition of human MEK1 assessed as residual activity at 1 uM relative to control	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Activity	%	118.0	CHEMBL3587	Homo sapiens	Activity	%	118.0
	22820519	CHEMBL4716261	Inhibition of human MEK1 assessed as residual activity at 1 uM relative to control	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	Activity	%	119.0	CHEMBL3587	Homo sapiens	Activity	%	119.0
	22836300	CHEMBL4718872	Inhibition of recombinant full length human His-tagged MAP2K1 expressed in baculovirus expression system at 500 nM using Ser/Thr 03 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	7.0	CHEMBL3587	Homo sapiens	INH	%	7.0
	22836301	CHEMBL4718872	Inhibition of recombinant full length human His-tagged MAP2K1 expressed in baculovirus expression system at 500 nM using Ser/Thr 03 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OCC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4786776	=	Inhibition	%	5.0	CHEMBL3587	Homo sapiens	INH	%	5.0
	22836302	CHEMBL4718872	Inhibition of recombinant full length human His-tagged MAP2K1 expressed in baculovirus expression system at 500 nM using Ser/Thr 03 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CN(C)CCNCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1F		CHEMBL4748367	=	Inhibition	%	13.0	CHEMBL3587	Homo sapiens	INH	%	13.0
	22836303	CHEMBL4718872	Inhibition of recombinant full length human His-tagged MAP2K1 expressed in baculovirus expression system at 500 nM using Ser/Thr 03 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CCOc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4776396	=	Inhibition	%	10.0	CHEMBL3587	Homo sapiens	INH	%	10.0
	22836304	CHEMBL4718872	Inhibition of recombinant full length human His-tagged MAP2K1 expressed in baculovirus expression system at 500 nM using Ser/Thr 03 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	COc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4783569	=	Inhibition	%	-4.0	CHEMBL3587	Homo sapiens	INH	%	-4.0
	22836305	CHEMBL4718872	Inhibition of recombinant full length human His-tagged MAP2K1 expressed in baculovirus expression system at 500 nM using Ser/Thr 03 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4780286	=	Inhibition	%	-8.0	CHEMBL3587	Homo sapiens	INH	%	-8.0
	22843209	CHEMBL4720236	Inhibition of recombinant human MEK1 using inactivated ERK2 as substrate incubate for 60 mins by LANCE assay	B	C=CC(=O)N1CCC(Cn2cc(-c3ccc4c(c3)OCO4)c3c(N)ncnc32)CC1		CHEMBL4755698	>	IC50	nM	10000.0	CHEMBL3587	Homo sapiens	IC50	nM	10000.0
	22843679	CHEMBL4720665	Inhibition of human MEK1 using ERK2 as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	17.9	CHEMBL3587	Homo sapiens	IC50	10^-8M	1.79
	22844028	CHEMBL4721014	Inhibition of human MEK1 assessed as residual activity using ERK2 as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	96.39	CHEMBL3587	Homo sapiens	Activity	%	96.39
	22844785	CHEMBL4721460	Inhibition of wild-type human full length MEK1 (M1 to V393 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	99.99	CHEMBL3587	Homo sapiens	Activity	%	99.99
Not Active	22889530	CHEMBL4729049	Inhibition of wild-type human full length MEK1 (M1 to V393 residues) expressed in mammalian expression system at 1 uM by Kinomescan method	B	COc1cc(OCc2ccnc(Nc3cnn(C)c3)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4748740		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
	22916321	CHEMBL4735612	Inhibition of MEK-1 (unknown origin) in presence of [gamma33]-ATP at 10 uM by liquid scintillation counting analysis relative to control	B	CNC(=O)c1cc(-n2ccc3cc(NC(=O)Nc4ccc(N5CCN(C)CC5)c(C(F)(F)F)c4)ccc32)ccn1		CHEMBL4797840	=	Inhibition	%	11.5	CHEMBL3587	Homo sapiens	INH	%	11.5
	22916322	CHEMBL4735612	Inhibition of MEK-1 (unknown origin) in presence of [gamma33]-ATP at 10 uM by liquid scintillation counting analysis relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Inhibition	%	37.74	CHEMBL3587	Homo sapiens	INH	%	37.74
	22949258	CHEMBL4765770	Inhibition of human wild type MEK1 assessed as residual activity at 0.1 uM relative to control	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(OC)cc13)C(=O)N2		CHEMBL104519	=	Activity	%	104.0	CHEMBL3587	Homo sapiens	Activity	%	104.0
	22949259	CHEMBL4765770	Inhibition of human wild type MEK1 assessed as residual activity at 0.1 uM relative to control	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(O)cc13)C(=O)N2		CHEMBL4798255	=	Activity	%	107.0	CHEMBL3587	Homo sapiens	Activity	%	107.0
	22949260	CHEMBL4765770	Inhibition of human wild type MEK1 assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(=O)(=O)N(C)C)cc31)cn2C		CHEMBL322153	=	Activity	%	104.0	CHEMBL3587	Homo sapiens	Activity	%	104.0
	22949261	CHEMBL4765770	Inhibition of human wild type MEK1 assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2[nH]cc(/C=C3\C(=O)Nc4ccc(S(N)(=O)=O)cc43)c2c1		CHEMBL106226	=	Activity	%	87.0	CHEMBL3587	Homo sapiens	Activity	%	87.0
	22949262	CHEMBL4765770	Inhibition of human wild type MEK1 assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(N)(=O)=O)cc31)cn2C		CHEMBL104333	=	Activity	%	82.0	CHEMBL3587	Homo sapiens	Activity	%	82.0
	22949263	CHEMBL4765770	Inhibition of human wild type MEK1 assessed as residual activity at 0.1 uM relative to control	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Activity	%	67.0	CHEMBL3587	Homo sapiens	Activity	%	67.0
	22949264	CHEMBL4765771	Inhibition of human wild type MEK1 assessed as residual activity at 1 uM relative to control	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(OC)cc13)C(=O)N2		CHEMBL104519	=	Activity	%	93.0	CHEMBL3587	Homo sapiens	Activity	%	93.0
	22949265	CHEMBL4765771	Inhibition of human wild type MEK1 assessed as residual activity at 1 uM relative to control	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(O)cc13)C(=O)N2		CHEMBL4798255	=	Activity	%	98.0	CHEMBL3587	Homo sapiens	Activity	%	98.0
	22949266	CHEMBL4765771	Inhibition of human wild type MEK1 assessed as residual activity at 1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(=O)(=O)N(C)C)cc31)cn2C		CHEMBL322153	=	Activity	%	97.0	CHEMBL3587	Homo sapiens	Activity	%	97.0
	22949267	CHEMBL4765771	Inhibition of human wild type MEK1 assessed as residual activity at 1 uM relative to control	B	COc1ccc2[nH]cc(/C=C3\C(=O)Nc4ccc(S(N)(=O)=O)cc43)c2c1		CHEMBL106226	=	Activity	%	72.0	CHEMBL3587	Homo sapiens	Activity	%	72.0
	22949268	CHEMBL4765771	Inhibition of human wild type MEK1 assessed as residual activity at 1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(N)(=O)=O)cc31)cn2C		CHEMBL104333	=	Activity	%	71.0	CHEMBL3587	Homo sapiens	Activity	%	71.0
	22949269	CHEMBL4765771	Inhibition of human wild type MEK1 assessed as residual activity at 1 uM relative to control	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Activity	%	59.0	CHEMBL3587	Homo sapiens	Activity	%	59.0
	22952896	CHEMBL4766833	Inhibition of recombinant human MEK1 assessed as residual activity at 10 uM using inactive MAPK2 as substrate incubated for 40 mins in presence of [gamma-33ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	84.0	CHEMBL3587	Homo sapiens	Activity	%	84.0
	22955550	CHEMBL4767607	Inhibition of His-tagged full length human MEK1 expressed in baculovirus expression system at 1 uM by Selectscreen kinase assay	B	COc1ccccc1-c1csc2cnc(Nc3ccc(C(=O)NC4CCNCC4)c(F)c3)nc12		CHEMBL4785582	=	Inhibition	%	27.0	CHEMBL3587	Homo sapiens	INH	%	27.0
	22989362	CHEMBL4774942	Inhibition of MEK1 (unknown origin) at 1 uM relative to control	B	Nc1n[nH]c2cccc(C#Cc3cccc(NC(=O)c4ccc(N5CCOCC5)c(C(F)(F)F)c4)c3)c12		CHEMBL4793906	<	Inhibition	%	30.0	CHEMBL3587	Homo sapiens	INH	%	30.0
	23120566	CHEMBL4804411	Inhibition of MAP2K1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4855542	=	IC50	nM	-36700.0	CHEMBL3587	Homo sapiens	IC50	uM	-36.7
	23120567	CHEMBL4804411	Inhibition of MAP2K1 in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1	Outside typical range	CHEMBL4860979	=	IC50	nM	-5500.0	CHEMBL3587	Homo sapiens	IC50	uM	-5.5
	23120568	CHEMBL4804411	Inhibition of MAP2K1 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1	Outside typical range	CHEMBL4867931	=	IC50	nM	-42200.0	CHEMBL3587	Homo sapiens	IC50	uM	-42.2
	23120569	CHEMBL4804411	Inhibition of MAP2K1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4855730	=	IC50	nM	-79800.0	CHEMBL3587	Homo sapiens	IC50	uM	-79.8
	23120570	CHEMBL4804411	Inhibition of MAP2K1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	10700.0	CHEMBL3587	Homo sapiens	IC50	uM	10.7
	23120571	CHEMBL4804411	Inhibition of MAP2K1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4859660	=	IC50	nM	-55800.0	CHEMBL3587	Homo sapiens	IC50	uM	-55.8
	23121605	CHEMBL4804593	Inhibition of MAP2K1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	INH	%	0.0
	23121606	CHEMBL4804593	Inhibition of MAP2K1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	INH	%	0.0
	23121607	CHEMBL4804593	Inhibition of MAP2K1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	INH	%	0.0
	23121608	CHEMBL4804593	Inhibition of MAP2K1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	INH	%	0.0
	23121609	CHEMBL4804593	Inhibition of MAP2K1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	INH	%	0.0
	23121610	CHEMBL4804593	Inhibition of MAP2K1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	0.0	CHEMBL3587	Homo sapiens	INH	%	0.0
	23122665	CHEMBL4805016	Inhibition of human MEK1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	59.0	CHEMBL3587	Homo sapiens	Activity	%	59.0
	23123360	CHEMBL4805604	Inhibition of human MEK1 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	63.0	CHEMBL3587	Homo sapiens	Activity	%	63.0
	23123819	CHEMBL4806063	Inhibition of DNA-tagged human MEK1 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	81.0	CHEMBL3587	Homo sapiens	Activity	%	81.0
	23124262	CHEMBL4806335	Inhibition of MEK1 (unknown origin) at 10 uM relative to control	B	Cn1cc(-n2cnc3c(NCc4nc5cc(Cl)c(Cl)cc5[nH]4)nc(N4CCOCC4)nc32)cn1		CHEMBL4877117	=	Inhibition	%	5.0	CHEMBL3587	Homo sapiens	INH	%	5.0
	23124810	CHEMBL4806621	Inhibition of human MEK1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	93.0	CHEMBL3587	Homo sapiens	Activity	%	93.0
	23124811	CHEMBL4806621	Inhibition of human MEK1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	83.0	CHEMBL3587	Homo sapiens	Activity	%	83.0
	23158848	CHEMBL4812100	Inhibition of N-terminal GST-tagged full length MEK1 (1 to 393 residues) (unknown origin) expressed in Sf21 cells at 10 uM preincubated for 10 mins followed by peptide substrate addition relative to control	B	CC(C)(C)OC(=O)c1ccc(NC(=O)c2ccc(Cl)c(S(N)(=O)=O)c2)cc1		CHEMBL4860361	=	Inhibition	%	1.56	CHEMBL3587	Homo sapiens	INH	%	1.56
	23180265	CHEMBL4816268	Inhibition of human MEK1 at 0.1 uM using ERK2 (K52R) as substrate in presence of [gamma-33P]-ATP by radiometric assay relative to control	B	Cc1ccc(NC(=O)c2ccc(C(F)(F)F)nc2)cc1NC(=O)c1cnc2ccccn12		CHEMBL4846916	=	Inhibition	%	30.0	CHEMBL3587	Homo sapiens	INH	%	30.0
	23213422	CHEMBL4822956	Inhibition of human recombinant MAP2K1 in presence of ATP by Z-lyte kinase assay	B	OC1(c2ccccc2)CSC(=S)N1Cc1ccncc1		CHEMBL4861930	=	Inhibition	%	6.0	CHEMBL3587	Homo sapiens	INH	%	6.0
	23213423	CHEMBL4822957	Inhibition of human recombinant MAP2K1 by Lanthascreen assay	B	OC1(c2ccccc2)CSC(=S)N1Cc1ccncc1		CHEMBL4861930	=	Inhibition	%	5.0	CHEMBL3587	Homo sapiens	INH	%	5.0
	23216104	CHEMBL4823619	Inhibition of recombinant human MEK1 using inactive MAPK2 as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ccnc(NC(=O)C4CC4)c3)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4873571	>	IC50	nM	1000.0	CHEMBL3587	Homo sapiens	IC50	nM	1000.0
Not Active	23270426	CHEMBL4835220	Inhibition of MEK1/MAP2K1 (unknown origin) at 10 uM	B	C[C@H]1CN(C(=O)CC[C@@]2(C3CC3)NC(=O)NC2=O)CCN1c1cc(F)cc(F)c1		CHEMBL4650334		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Active	23294453	CHEMBL4840192	Inhibition of human MEK1 in human HEK293T cells assessed as reversal of anisomycin-induced decrease of p42/44 MAPK phosphorylation at 100 uM measured after 5 hrs by Western blot assay	B	NS(=O)(=O)c1ccc(-c2n[nH]c3cc(F)ccc23)cc1		CHEMBL4879048		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Active	23294454	CHEMBL4840192	Inhibition of human MEK1 in human HEK293T cells assessed as reversal of anisomycin-induced decrease of p42/44 MAPK phosphorylation at 100 uM measured after 5 hrs by Western blot assay	B	NC(=O)c1ccc(NS(=O)(=O)c2cccc(-c3n[nH]c4cc(F)ccc34)c2)cc1		CHEMBL4866649		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Active	23294457	CHEMBL4840194	Inhibition of human MEK1 in human HPAF-II cells assessed as decrease of p42/44 MAPK phosphorylation in presence of U0126 at 10 uM measured after 5 hrs by Westren blot assay	B	NS(=O)(=O)c1ccc(-c2n[nH]c3cc(F)ccc23)cc1		CHEMBL4879048		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Active	23294458	CHEMBL4840194	Inhibition of human MEK1 in human HPAF-II cells assessed as decrease of p42/44 MAPK phosphorylation in presence of U0126 at 10 uM measured after 5 hrs by Westren blot assay	B	NC(=O)c1ccc(NS(=O)(=O)c2cccc(-c3n[nH]c4cc(F)ccc34)c2)cc1		CHEMBL4866649		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Active	23294461	CHEMBL4840196	Inhibition of human MEK1 in human MIA PaCa-2 cells assessed as decrease of p42/44 MAPK phosphorylation in presence of U0126 at 10 uM measured after 5 hrs by Westren blot assay	B	NS(=O)(=O)c1ccc(-c2n[nH]c3cc(F)ccc23)cc1		CHEMBL4879048		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
Active	23294462	CHEMBL4840196	Inhibition of human MEK1 in human MIA PaCa-2 cells assessed as decrease of p42/44 MAPK phosphorylation in presence of U0126 at 10 uM measured after 5 hrs by Westren blot assay	B	NC(=O)c1ccc(NS(=O)(=O)c2cccc(-c3n[nH]c4cc(F)ccc34)c2)cc1		CHEMBL4866649		Inhibition	%		CHEMBL3587	Homo sapiens	INH		
	23295514	CHEMBL4840526	Inhibition of recombinant His-tagged full length human MEK expressed in baculovirus expression system at 1 uM measured by select screen assay relative to control	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4c3CN(Cc3cc(F)cc(F)c3)C4(C)C)cc2)CC1		CHEMBL4849505	=	Inhibition	%	8.0	CHEMBL3587	Homo sapiens	INH	%	8.0
Not Active	23317500	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	95.0	CHEMBL3587	Homo sapiens	% Control	%	95.0
Not Active	23317968	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	95.0	CHEMBL3587	Homo sapiens	% Control	%	95.0
Not Active	23318635	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23319118	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	89.0	CHEMBL3587	Homo sapiens	% Control	%	89.0
Not Active	23319755	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	64.8	CHEMBL3587	Homo sapiens	% Control	%	64.8
Not Active	23320230	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23320908	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23321376	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	79.0	CHEMBL3587	Homo sapiens	% Control	%	79.0
Not Active	23322006	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	66.0	CHEMBL3587	Homo sapiens	% Control	%	66.0
Not Active	23322474	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	93.0	CHEMBL3587	Homo sapiens	% Control	%	93.0
Not Active	23323163	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	86.0	CHEMBL3587	Homo sapiens	% Control	%	86.0
Not Active	23323631	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23324054	CHEMBL4880673	MEK1 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1	Outside typical range	CHEMBL4593677		Inhibition	%	-11.0	CHEMBL3587	Homo sapiens	% inhibition	%	-11.0
Not Active	23324485	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23325120	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23325588	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	81.0	CHEMBL3587	Homo sapiens	% Control	%	81.0
Not Active	23326235	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	97.0	CHEMBL3587	Homo sapiens	% Control	%	97.0
Not Active	23326703	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	88.0	CHEMBL3587	Homo sapiens	% Control	%	88.0
Not Active	23327403	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	98.0	CHEMBL3587	Homo sapiens	% Control	%	98.0
Not Active	23327871	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	91.0	CHEMBL3587	Homo sapiens	% Control	%	91.0
Not Active	23328458	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	90.0	CHEMBL3587	Homo sapiens	% Control	%	90.0
Not Active	23328926	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	91.0	CHEMBL3587	Homo sapiens	% Control	%	91.0
Not Active	23329409	CHEMBL4881116	MEK1(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	115.0	CHEMBL3587	Homo sapiens	% residual kinase activity	%	115.0
Not Active	23329872	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	95.0	CHEMBL3587	Homo sapiens	% Control	%	95.0
Not Active	23330340	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	85.0	CHEMBL3587	Homo sapiens	% Control	%	85.0
Not Active	23331096	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	91.0	CHEMBL3587	Homo sapiens	% Control	%	91.0
Not Active	23331564	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23332151	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	76.2	CHEMBL3587	Homo sapiens	% Control	%	76.2
Not Active	23332617	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23333335	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	93.3	CHEMBL3587	Homo sapiens	% Control	%	93.3
Not Active	23333974	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	86.0	CHEMBL3587	Homo sapiens	% Control	%	86.0
Not Active	23334442	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23334916	CHEMBL4881539	MEKI (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		Inhibition	%	9.0	CHEMBL3587	Homo sapiens	% inhibition	%	9.0
Not Active	23335421	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	81.0	CHEMBL3587	Homo sapiens	% Control	%	81.0
Not Active	23335889	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	90.0	CHEMBL3587	Homo sapiens	% Control	%	90.0
Not Active	23336516	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	83.0	CHEMBL3587	Homo sapiens	% Control	%	83.0
Not Active	23336984	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	92.0	CHEMBL3587	Homo sapiens	% Control	%	92.0
Not Active	23337644	CHEMBL4882015	MAP2K1 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	98.0	CHEMBL3587	Homo sapiens	% Ctrl	%	98.0
Not Active	23337645	CHEMBL4882016	MAP2K1_S_D Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	92.0	CHEMBL3587	Homo sapiens	% Ctrl	%	92.0
Not Active	23338065	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	89.0	CHEMBL3587	Homo sapiens	% Control	%	89.0
Not Active	23338533	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	82.0	CHEMBL3587	Homo sapiens	% Control	%	82.0
Not Active	23339145	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	91.0	CHEMBL3587	Homo sapiens	% Control	%	91.0
Not Active	23339613	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	68.0	CHEMBL3587	Homo sapiens	% Control	%	68.0
Not Active	23340250	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	81.0	CHEMBL3587	Homo sapiens	% Control	%	81.0
Not Active	23340718	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23341375	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	97.0	CHEMBL3587	Homo sapiens	% Control	%	97.0
Not Active	23341843	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23342459	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	89.0	CHEMBL3587	Homo sapiens	% Control	%	89.0
Not Active	23342927	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23343264	CHEMBL4882449	MAP2K1 Invitrogen selectivity data (BI)	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Ctrl	%	78.0	CHEMBL3587	Homo sapiens	% Ctrl	%	78.0
Not Active	23343557	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	90.0	CHEMBL3587	Homo sapiens	% Control	%	90.0
Not Active	23344025	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	91.0	CHEMBL3587	Homo sapiens	% Control	%	91.0
Not Active	23344663	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	86.0	CHEMBL3587	Homo sapiens	% Control	%	86.0
Not Active	23345236	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	85.0	CHEMBL3587	Homo sapiens	% Control	%	85.0
Not Active	23345704	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	92.0	CHEMBL3587	Homo sapiens	% Control	%	92.0
Not Active	23346281	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23346749	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	95.0	CHEMBL3587	Homo sapiens	% Control	%	95.0
Not Active	23347351	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	79.8	CHEMBL3587	Homo sapiens	% Control	%	79.8
Not Active	23347841	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	97.6	CHEMBL3587	Homo sapiens	% Control	%	97.6
Not Active	23348420	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23348888	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	81.0	CHEMBL3587	Homo sapiens	% Control	%	81.0
Not Active	23349475	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23350093	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23350561	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23351166	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23351634	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	98.0	CHEMBL3587	Homo sapiens	% Control	%	98.0
Not Active	23352094	CHEMBL4882785	MAP2K1 (MEK1) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	8.265	CHEMBL3587	Homo sapiens	% Inhibition	%	8.2651
Not Active	23352095	CHEMBL4882786	MAP2K1 (MEK1) S218D S222D Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	6.916	CHEMBL3587	Homo sapiens	% Inhibition	%	6.9156
Not Active	23352658	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	88.0	CHEMBL3587	Homo sapiens	% Control	%	88.0
Not Active	23353126	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	74.0	CHEMBL3587	Homo sapiens	% Control	%	74.0
Not Active	23354008	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23354476	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23355208	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23355676	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23356312	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23356780	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	94.0	CHEMBL3587	Homo sapiens	% Control	%	94.0
Not Active	23357389	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23358036	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23358504	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	93.0	CHEMBL3587	Homo sapiens	% Control	%	93.0
Not Active	23359090	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	73.5	CHEMBL3587	Homo sapiens	% Control	%	73.5
Not Active	23359688	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	75.0	CHEMBL3587	Homo sapiens	% Control	%	75.0
Not Active	23360156	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	80.0	CHEMBL3587	Homo sapiens	% Control	%	80.0
Not Active	23360741	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	95.0	CHEMBL3587	Homo sapiens	% Control	%	95.0
Not Active	23361209	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23361782	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	83.0	CHEMBL3587	Homo sapiens	% Control	%	83.0
Not Active	23362318	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23362786	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23363270	CHEMBL4883251	MAP2K1 (MEK1) Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	10.88	CHEMBL3587	Homo sapiens	% inhibition	%	10.8756
Not Active	23363271	CHEMBL4883251	MAP2K1 (MEK1) Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	12.37	CHEMBL3587	Homo sapiens	% inhibition	%	12.3712
Not Active	23364428	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	99.0	CHEMBL3587	Homo sapiens	% Control	%	99.0
Not Active	23364896	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	92.0	CHEMBL3587	Homo sapiens	% Control	%	92.0
Not Active	23365635	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23366178	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	99.0	CHEMBL3587	Homo sapiens	% Control	%	99.0
Not Active	23366768	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23367236	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	89.0	CHEMBL3587	Homo sapiens	% Control	%	89.0
Not Active	23367638	CHEMBL4883991	MEK1 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	79.0	CHEMBL3587	Homo sapiens	% Residual activity with Skepinone-L	%	79.0
Not Active	23368114	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	93.0	CHEMBL3587	Homo sapiens	% Control	%	93.0
Not Active	23368582	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	98.0	CHEMBL3587	Homo sapiens	% Control	%	98.0
Not Active	23369181	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	99.0	CHEMBL3587	Homo sapiens	% Control	%	99.0
Not Active	23369649	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	78.0	CHEMBL3587	Homo sapiens	% Control	%	78.0
Not Active	23370130	CHEMBL4884374	MEK1(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	90.0	CHEMBL3587	Homo sapiens	% residual kinase activity	%	90.0
Not Active	23370617	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23371085	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	87.0	CHEMBL3587	Homo sapiens	% Control	%	87.0
Not Active	23371894	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23372362	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
	23372780	CHEMBL4884745	MEK1 [MAP2K1(M2K1LGF1)] Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL3587	Homo sapiens	pIC50		6.0
	23373189	CHEMBL4885036	MEK1 [MAP2K1(M2K1LGF1)] Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL3587	Homo sapiens	pIC50		6.0
	23373549	CHEMBL4885326	MEK1 [MAP2K1(M2K1LGF1)] Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL3587	Homo sapiens	pIC50		6.0
Not Active	23375030	CHEMBL4886019	MEK1 Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	20.5	CHEMBL3587	Homo sapiens	% Inhibition	%	20.5
Not Active	23375305	CHEMBL4886287	mitogen-activated protein kinase kinase 1 Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	-1.0	CHEMBL3587	Homo sapiens	% inhibition	%	-1.0
Not Active	23375789	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	72.0	CHEMBL3587	Homo sapiens	% Control	%	72.0
Not Active	23376257	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	88.0	CHEMBL3587	Homo sapiens	% Control	%	88.0
Not Active	23376834	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23377302	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23378162	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	85.0	CHEMBL3587	Homo sapiens	% Control	%	85.0
Not Active	23378630	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	98.0	CHEMBL3587	Homo sapiens	% Control	%	98.0
Not Active	23379797	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	95.0	CHEMBL3587	Homo sapiens	% Control	%	95.0
Not Active	23380265	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23380959	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23381607	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	92.0	CHEMBL3587	Homo sapiens	% Control	%	92.0
Not Active	23382075	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	97.0	CHEMBL3587	Homo sapiens	% Control	%	97.0
Not Active	23382699	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23383167	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	85.0	CHEMBL3587	Homo sapiens	% Control	%	85.0
Not Active	23383847	CHEMBL4887472	MAP2K1 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	76.0	CHEMBL3587	Homo sapiens	% Ctrl	%	76.0
Not Active	23383848	CHEMBL4887472	MAP2K1 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	80.0	CHEMBL3587	Homo sapiens	% Ctrl	%	80.0
Active	23384048	CHEMBL4887646	MKK1 DUNDEE kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	19.3	CHEMBL3587	Homo sapiens	% Ctrl	%	19.3
Not Active	23384341	CHEMBL4887936	MEK1(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	21.54	CHEMBL3587	Homo sapiens	% inhibition	%	21.54
Not Active	23385082	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
Not Active	23385549	CHEMBL4879806	KinomeScan assay: inhibition of MEK1	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL3587	Homo sapiens	% Control	%	100.0
